trait	pmid	date_published	size_cases	size_controls	size_other	size_total	size_effective	nsignif
&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	23279374	2013-01-02	0	0	306	306	306	1
1,5-anhydroglucitol levels	28588231	2017-06-06	0	0	7550	7550	7550	8
17-hydroxyprogesterone (17-OHP) levels	31169883	2019-06-06	0	0	2070	2070	2070	22
3-hydroxy-1-methylpropylmercapturic acid levels in smokers	26053186	2015-06-08	0	0	2284	2284	2284	28
3-hydroxypropylmercapturic acid levels in smokers	26053186	2015-06-08	0	0	2282	2282	2282	32
3-month functional outcome in ischaemic stroke (modified Rankin score)	30582445	2019-01-01	0	0	1225	1225	1225	1
ACPA-positive rheumatoid arthritis (smoking interaction)	26272072	2015-08-13	833	1740	0	2573	2253.2763311309754	8
ADAMTS13 activity	25934476	2015-05-01	0	0	3423	3423	3423	4
ADAMTS13 levels	29296746	2017-06-19	0	0	3238	3238	3238	4
AIDS progression	19115949	2009-01-01	0	1352	361	1713	1713	1
AIDS progression	21502085	2011-05-01	755	0	0	755	755	1
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	25935875	2015-05-02	1812	0	0	1812	1812	2
Abdominal aortic aneurysm	20622881	2010-07-11	1292	30503	0	31795	4957.996666142475	2
Abdominal aortic aneurysm	22055160	2011-11-04	1866	5435	0	7301	5556.340227366114	1
Abdominal aortic aneurysm	24046328	2013-09-17	1755	5314	0	7069	5277.165086999576	1
Abdominal aortic aneurysm	27899403	2016-11-29	4972	99858	0	104830	18944.728646379855	9
Abdominal aortic calcification levels	31659325	2019-10-28	0	0	9417	9417	9417	3
Ability to confide in someone	29970889	2018-07-03	64505	238062	0	302567	203012.08406733052	2
Abstraction and mental flexibility	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	1
Accelerometer-based physical activity measurement (average acceleration)	29899525	2018-06-13	0	0	91084	91084	91084	5
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	29899525	2018-06-13	0	0	90667	90667	90667	2
Accommodative esotropia	30098192	2018-08-01	224	749	0	973	689.726618705036	1
Acenocoumarol maintenance dosage	19578179	2009-07-04	0	0	1451	1451	1451	2
Acne (severe)	24399259	2014-01-07	1031	1031	0	2062	2062.0	2
Acne (severe)	24927181	2014-06-13	1893	5132	0	7025	5531.601992882563	3
Acne (severe)	30542056	2018-12-12	5602	21120	0	26722	17710.386947084797	17
Activated partial thromboplastin time	20303064	2010-03-18	0	0	1431	1431	1431	3
Activated partial thromboplastin time	22703881	2012-06-14	0	0	9240	9240	9240	8
Activated partial thromboplastin time	29403010	2018-02-05	0	0	37767	37767	37767	12
Acute anterior uveitis (with or without ankylosing spondylitis)	25200001	2014-09-08	238	9564	1199	11001	928.8847174046114	7
Acute anterior uveitis in ankylosing spondylitis	25200001	2014-09-08	1199	1731	0	2930	2833.4047781569966	3
Acute graft versus host disease in bone marrow transplantation (donor effect)	27595289	2016-09-05	0	0	656	656	656	2
Acute graft versus host disease in bone marrow transplantation (recipient effect)	27595289	2016-09-05	0	0	579	579	579	6
Acute insulin response	28490609	2017-05-10	0	0	4765	4765	4765	4
Acute insulin response (insulin secretion adjusted)	28490609	2017-05-10	0	0	4765	4765	4765	1
Acute lymphoblastic leukemia (B-cell precursor)	23996088	2013-08-30	1658	4723	0	6381	4908.781695658988	6
Acute lymphoblastic leukemia (B-cell precursor)	29296818	2017-09-08	446	3027	0	3473	1554.9000863806507	2
Acute lymphoblastic leukemia (adolescents and young adults)	25468567	2014-12-02	308	6661	0	6969	1177.5508681302913	1
Acute lymphoblastic leukemia (childhood)	19684603	2009-08-16	317	17958	0	18275	1246.005143638851	2
Acute lymphoblastic leukemia (childhood)	19684604	2009-08-16	907	2398	0	3305	2632.3582450832073	2
Acute lymphoblastic leukemia (childhood)	22076464	2011-11-11	419	474	0	893	889.6125419932812	14
Acute lymphoblastic leukemia (childhood)	23007406	2012-09-24	0	0	1268	1268	1268	1
Acute lymphoblastic leukemia (childhood)	23512250	2013-03-19	1366	3757	0	5123	4007.0755416747998	3
Acute lymphoblastic leukemia (childhood)	25310577	2014-10-13	358	1192	0	1550	1101.254193548387	2
Acute lymphoblastic leukemia (childhood)	28817678	2017-08-17	0	0	622	622	622	1
Acute lymphoblastic leukemia (childhood)	29348612	2018-01-18	3263	15977	0	19240	10838.451351351352	8
Acute lymphoblastic leukemia in childhood (B cell precursor)	27694927	2016-10-03	1658	7224	0	8882	5394.0067552353075	2
Acute lymphoblastic leukemia in childhood (B cell precursor)	29296818	2017-09-08	134	3027	0	3161	513.2780765580512	1
Acute lymphoblastic leukemia in childhood (B cell precursor)	29632299	2018-04-09	2442	14609	0	17051	8369.05237229488	9
Acute-on-chronic liver failure in hepatitis B	28130311	2017-01-27	389	391	0	780	779.9948717948718	1
Acylcarnitine levels	26068415	2015-06-12	0	0	7478	7478	7478	15
Addiction	23533358	2013-02-28	0	0	3627	3627	3627	3
Adenocarcinoma	26732429	2016-01-04	6877	6277	0	13154	13126.631899042117	3
Adenocarcinoma in never smokers	31009812	2019-04-19	1837	5355	0	7192	5471.15406006674	1
Adiponectin levels	19165155	2009-01-22	997	989	0	1986	1985.9677744209464	1
Adiponectin levels	20011104	2009-12-05	0	0	8531	8531	8531	3
Adiponectin levels	20018283	2009-12-02	0	0	4659	4659	4659	1
Adiponectin levels	20876611	2010-09-27	0	0	1776	1776	1776	3
Adiponectin levels	20887962	2010-10-08	0	0	4001	4001	4001	1
Adiponectin levels	21700879	2011-06-23	0	0	1591	1591	1591	2
Adiponectin levels	21771975	2011-07-19	382	0	0	382	382	1
Adiponectin levels	22065538	2011-11-07	0	0	3310	3310	3310	1
Adiponectin levels	22479202	2012-03-29	0	0	35355	35355	35355	16
Adiponectin levels	24105470	2013-10-14	0	0	7827	7827	7827	5
Adiponectin levels	31178129	2019-06-06	0	0	67739	67739	67739	15
Adiposity	19557161	2009-06-26	0	0	38580	38580	38580	3
Adiposity	21706003	2011-06-26	0	0	36626	36626	36626	2
Adolescent idiopathic scoliosis	25784220	2015-03-18	447	737	0	1184	1112.9695945945946	1
Adolescent idiopathic scoliosis	26211971	2015-07-23	2109	11140	0	13249	7093.1421239338815	4
Adolescent idiopathic scoliosis	26394188	2015-09-22	960	1499	0	2459	2340.8540056933716	4
Adolescent idiopathic scoliosis	28334814	2017-02-28	1456	2104	0	3560	3442.049438202247	7
Adolescent idiopathic scoliosis	30019117	2018-07-17	196	303	0	499	476.0561122244489	837
Adolescent idiopathic scoliosis	30395268	2018-11-01	3798	29678	0	33476	13468.400525749792	7
Adolescent idiopathic scoliosis	31417091	2019-08-15	5327	73884	0	79211	19875.02079256669	37
Adolescent idiopathic scoliosis (severe)	24023777	2013-09-04	554	1474	0	2028	1610.6429980276134	1
Adult asthma	27611488	2016-09-09	1750	9245	0	10995	5885.857207821738	1
Adult asthma	30578877	2018-12-19	16274	38269	0	54543	45673.300405184906	3
Adult asthma	30787307	2019-02-20	7009	7645	0	14654	14626.396888221647	3
Adult hearing difficulty	31564434	2019-09-26	87056	163333	0	250389	227152.4331819689	2
Adult onset asthma and/or BMI	31669095	2019-10-24	33418	393186	31218	457822	123200.81150669006	8
Adult onset asthma and/or waist-to-hip ratio adjusted for BMI	31669095	2019-10-24	33418	393186	31086	457690	123200.81150669006	6
Adult onset asthma or fasting glucose levels	31669095	2019-10-24	33418	393186	58047	484651	123200.81150669006	1
Adult onset asthma or type 2 diabetes	31669095	2019-10-24	33418	552394	0	585812	126046.5998784593	6
Advanced age-related macular degeneration	26691988	2015-12-21	16144	17832	0	33976	33892.13656698846	48
Advanced glycation end-product levels	26083729	2015-06-17	0	0	2318	2318	2318	2
Adventurousness	30643258	2019-01-14	0	0	557923	557923	557923	167
Adverse response to antithyroid drugs in Graves disease	30067105	2018-08-01	24	423	0	447	90.84563758389262	1
Adverse response to carbamazepine	21149285	2010-12-10	53	881	0	934	199.97002141327624	1
Adverse response to chemotherapy (amenorrhea) in breast cancer	31371054	2019-07-29	1168	0	0	1168	1168	2
Adverse response to chemotherapy in breast cancer (alopecia)	24025145	2013-09-11	303	880	0	1183	901.5722738799661	2
Adverse response to drug	30420678	2018-11-12	0	0	16226	16226	16226	9
Adverse response to inhaled corticosteroid treatment x age interaction in asthma	32119686	2020-03-02	407	376	0	783	781.7726692209451	2
Adverse response to radiation therapy	23719583	2013-05-26	0	0	320	320	320	1
Affective disorder and suicide attempts	30116032	2018-08-16	4302	13294	0	17596	13000.861104796544	1
Age at adiposity rebound	31840077	2019-09-04	0	0	6051	6051	6051	2
Age at first birth	27089180	2016-04-18	0	0	66310	66310	66310	4
Age at first birth	27798627	2016-10-31	0	0	238064	238064	238064	15
Age at first sexual intercourse	27089180	2016-04-18	0	0	125667	125667	125667	32
Age at loss of ambulation in Duchenne muscular dystrophy	30014611	2018-07-16	253	0	0	253	253	3
Age at menopause	30595370	2018-12-27	0	0	143000	143000	143000	85
Age at suicide	31476763	2019-09-02	0	0	719	719	719	1
Age at voice drop	27182965	2016-05-16	0	0	55871	55871	55871	9
Age of smoking initiation	30643251	2019-01-14	0	0	341427	341427	341427	10
Age of smoking initiation	31089300	2019-03-25	0	0	7379	7379	7379	1
Age of smoking initiation (MTAG)	30643251	2019-01-14	0	0	931815	931815	931815	170
Age spots	29895819	2018-06-12	3815	7438	0	11253	10086.54403270239	2
Age-related cognitive decline (attention/processing speed) (slope of z-scores)	30954325	2019-03-11	0	0	1145	1145	1145	1
Age-related disease endophenotypes	27790247	2016-11-03	0	0	9618	9618	9618	27
Age-related diseases and mortality	27790247	2016-11-03	0	0	9618	9618	9618	9
Age-related diseases, mortality and associated endophenotypes	27790247	2016-11-03	0	0	9618	9618	9618	28
Age-related hearing impairment	27764096	2016-10-20	6527	45882	0	52409	22856.518078955905	3
Age-related hearing impairment (SNP x SNP interaction)	24939585	2014-06-18	0	0	1489	1489	1489	49
Age-related hearing impairment (high frequency)	31645637	2019-10-23	0	0	9675	9675	9675	6
Age-related hearing impairment (low/mid frequency)	31645637	2019-10-23	0	0	9675	9675	9675	1
Age-related macular degeneration	15761122	2005-03-10	96	50	0	146	131.50684931506848	1
Age-related macular degeneration	20385819	2010-04-12	2157	1150	0	3307	3000.362866646507	7
Age-related macular degeneration	20385826	2010-04-12	979	1709	0	2688	2489.7485119047615	9
Age-related macular degeneration	20861866	2010-09-23	684	188	0	872	589.8715596330276	4
Age-related macular degeneration	21665990	2011-06-10	2594	4134	0	6728	6375.502972651605	11
Age-related macular degeneration	21909106	2011-09-11	827	3323	0	4150	2648.7913253012052	2
Age-related macular degeneration	22694956	2012-06-13	893	2199	0	3092	2540.37128072445	5
Age-related macular degeneration	23326517	2013-01-11	3772	16033	0	19805	12214.38545821762	4
Age-related macular degeneration	23455636	2013-03-03	7650	3442	48402	59494	9495.60043274432	19
Age-related macular degeneration	23536807	2013-03-11	200	197	0	397	396.97732997481114	2
Age-related macular degeneration	23577725	2013-05-01	1207	686	0	1893	1749.608029582673	3
Age-related macular degeneration (CNV vs. GA)	22705344	2012-06-15	1775	0	819	2594	2594	1
Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	28813576	2017-08-01	16122	17810	0	33932	33848.02782034658	1
Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	28813576	2017-08-01	15413	16351	0	31764	31736.300591864998	1
Age-related macular degeneration (choroidal neovascularisation)	22705344	2012-06-15	1775	4134	0	5909	4967.236419021831	6
Age-related macular degeneration (extreme sampling)	23577725	2013-05-01	725	514	0	1239	1203.0669895076676	2
Age-related macular degeneration (geographic atrophy)	22705344	2012-06-15	819	4134	0	4953	2734.299212598425	4
Age-related macular degeneration (wet)	17053108	2006-10-19	96	130	0	226	220.88495575221242	1
Age-related nuclear cataracts	24951543	2014-06-20	0	0	7140	7140	7140	2
Aging	19367585	2009-04-14	227	0	89	316	316	1
Aging (facial)	23223146	2012-12-06	0	0	502	502	502	4
Aging traits	17903295	2007-09-19	0	0	1675	1675	1675	1
Airflow obstruction	22837378	2012-07-26	3368	29507	0	32875	12091.81152851711	2
Airflow obstruction	29394082	2018-02-02	854	9549	0	10403	3135.5747380563303	1
Airflow obstruction in ever smokers	31879980	2019-12-26	0	0	5971	5971	5971	1
Airway imaging phenotypes	26030696	2015-06-01	6286	5745	0	12031	12006.672762031418	1
Airway responsiveness in chronic obstructive pulmonary disease	25514360	2014-12-16	4108	0	0	4108	4108	1
Airway wall thickness	25517131	2015-02-27	0	0	2640	2640	2640	1
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	28090653	2017-01-16	715	0	0	715	715	3
Alanine aminotransferase levels	30718733	2019-02-04	0	0	6949	6949	6949	2
Alanine aminotransferase levels	31675503	2019-10-01	0	0	14126	14126	14126	1
Alanine aminotransferase levels in excessive alcohol consumption	30589442	2018-12-27	0	0	951	951	951	1
Alanine transaminase levels	28887542	2017-09-08	0	0	9731	9731	9731	1
Alanine transaminase levels	29403010	2018-02-05	0	0	134182	134182	134182	27
Albumin-globulin ratio	29403010	2018-02-05	0	0	98626	98626	98626	50
Albuminuria	30910378	2019-03-12	0	0	217634	217634	217634	8
Alcohol and nicotine co-dependence	22488850	2012-04-04	1267	1876	0	3143	3024.997772828508	1
Alcohol and nicotine co-dependence	23216389	2012-12-06	818	1396	0	2214	2063.103884372177	1
Alcohol consumption	21270382	2011-01-26	0	0	1721	1721	1721	4
Alcohol consumption	21471458	2011-04-06	0	0	26316	26316	26316	1
Alcohol consumption	23743675	2013-06-07	0	0	5033	5033	5033	1
Alcohol consumption	27911795	2016-11-28	0	0	70460	70460	70460	1
Alcohol consumption	28937693	2017-07-25	0	0	112117	112117	112117	20
Alcohol consumption	31358974	2019-07-29	0	0	480842	480842	480842	50
Alcohol consumption (drinkers vs non-drinkers)	28485404	2017-05-09	0	0	86627	86627	86627	6
Alcohol consumption (drinkers vs non-drinkers)	31959922	2020-01-20	0	0	165084	165084	165084	6
Alcohol consumption (drinks per week)	28485404	2017-05-09	0	0	86627	86627	86627	3
Alcohol consumption (drinks per week)	30643251	2019-01-14	0	0	941280	941280	941280	99
Alcohol consumption (drinks per week)	30643258	2019-01-14	0	0	414343	414343	414343	85
Alcohol consumption (drinks per week)	30679032	2018-12-06	0	0	357854	357854	357854	51
Alcohol consumption (drinks per week)	31959922	2020-01-20	0	0	58610	58610	58610	2
Alcohol consumption (drinks per week) (MTAG)	30643251	2019-01-14	0	0	1039210	1039210	1039210	146
Alcohol consumption (heavy vs. light/non-drinkers)	27911795	2016-11-28	0	0	74711	74711	74711	1
Alcohol consumption (heavy vs. light/non-drinkers)	31998841	2020-01-15	21967	103282	0	125249	72457.12760980127	7
Alcohol consumption (max-drinks)	24277619	2013-11-26	0	0	272	272	272	1
Alcohol consumption (max-drinks)	29460428	2018-02-20	0	0	1045	1045	1045	1
Alcohol consumption (transferrin glycosylation)	21665994	2011-06-10	0	0	5181	5181	5181	6
Alcohol consumption in current drinkers	28937693	2017-07-25	0	0	108309	108309	108309	8
Alcohol dependence	19581569	2009-07-01	476	1358	0	1834	1409.8320610687024	1
Alcohol dependence	22004471	2011-10-18	1333	2168	0	3501	3301.849757212225	1
Alcohol dependence	23455491	2013-02-27	1409	1518	0	2927	2922.940895114452	1
Alcohol dependence	23456092	2013-03-01	117	279	0	396	329.72727272727275	1
Alcohol dependence	24166409	2014-01-01	5084	3800	0	8884	8698.4241332733	19
Alcohol dependence	24277619	2013-11-26	102	212	0	314	275.4649681528663	1
Alcohol dependence	28714907	2017-07-17	1331	1934	0	3265	3153.634303215926	1
Alcohol dependence	31090166	2019-05-14	3291	3389	0	6680	6678.562275449102	1
Alcohol dependence	31591379	2019-10-07	533	2848	0	3381	1795.8994380360841	2
Alcohol dependence (age at onset)	24962325	2014-06-11	685	0	1221	1906	1906	3
Alcohol dependence (desire to cut drinking)	31090166	2019-05-14	4332	6114	0	10446	10142.005743825388	1
Alcohol dependence (drinking more than intended)	31090166	2019-05-14	5143	5297	0	10440	10437.728352490421	1
Alcohol dependence (time spent drinking)	31090166	2019-05-14	2079	8366	0	10445	6660.761704164672	1
Alcohol dependence (tolerance)	31090166	2019-05-14	4458	5982	0	10440	10217.53103448276	1
Alcohol dependence or heroin dependence or methamphetamine dependence	31462767	2019-08-28	3296	2859	0	6155	6123.973354995938	3
Alcohol dependence symptom count	27151647	2016-05-05	0	0	3838	3838	3838	3
Alcohol dependence symptom count	29460428	2018-02-20	0	0	1045	1045	1045	1
Alcohol dependence symptom count	31090166	2019-05-14	0	0	10593	10593	10593	1
Alcohol misuse (trauma interaction)	28265120	2017-03-07	0	0	16361	16361	16361	1
Alcohol use disorder	30940813	2019-04-02	55584	218807	0	274391	177296.8980469476	25
Alcohol use disorder (consumption score)	30336701	2018-10-19	0	0	121604	121604	121604	9
Alcohol use disorder (consumption score)	30940813	2019-04-02	0	0	272842	272842	272842	32
Alcohol use disorder (dependence and problematic use scores)	30336701	2018-10-19	0	0	121604	121604	121604	5
Alcohol use disorder (total score)	30336701	2018-10-19	0	0	141932	141932	141932	15
Alcohol withdrawal symptoms	30252935	2018-09-25	0	0	1297	1297	1297	1
Alcoholic chronic pancreatitis	28754779	2017-07-28	1959	6040	0	7999	5916.919614951868	72
Allergic disease (asthma, hay fever or eczema)	29083406	2017-10-30	180129	180709	0	360838	360837.067725683	136
Allergic disease (asthma, hay fever or eczema)	29679657	2018-04-18	180129	180709	0	360838	360837.067725683	4
Allergic disease (asthma, hay fever or eczema)	29785011	2018-05-21	25685	76768	0	102453	76983.04900783773	33
Allergic disease (asthma, hay fever or eczema)	31361310	2019-07-30	106772	239773	0	346545	295500.356444329	79
Allergic rhinitis	22036096	2011-11-01	3933	8965	0	12898	10934.825554349512	1
Allergic rhinitis	25085501	2014-08-02	2712	2921	0	5633	5625.245517486242	5
Allergic rhinitis	30013184	2018-07-16	59762	152358	0	212120	171699.39272110126	42
Allergic rhinitis	31361310	2019-07-30	18915	239773	0	258688	70127.81876237011	27
Allergic sensitization	23817571	2013-06-30	5789	10056	0	15845	14695.912653834015	10
Allergic sensitization	30013184	2018-07-16	8040	16441	0	24481	21598.078509864794	10
Allergy	27182965	2016-05-16	66973	113768	0	180741	168625.47543722784	25
Alloimmunization response to pregnancy (HLA class I)	29168253	2017-11-22	247	753	0	1000	743.964	1
Alloimmunization response to red blood cell transfusion in sickle cell anemia	30578281	2018-12-01	144	123	0	267	265.34831460674155	1
Alopecia areata	20596022	2010-07-01	1054	3278	0	4332	3190.2234533702676	6
Alopecia areata	25608926	2015-01-22	0	7565	0	7565	7565	10
Alzheimer disease and age of onset	26830138	2016-02-02	2478	0	2049	4527	4527	44
Alzheimer's disease	17975299	2007-11-01	664	422	0	1086	1032.073664825046	1
Alzheimer's disease	17998437	2007-11-12	753	736	0	1489	1488.8059100067162	1
Alzheimer's disease	18823527	2008-09-29	1082	1239	0	2321	2310.3800086169754	1
Alzheimer's disease	19125160	2009-01-07	491	479	0	970	969.8515463917525	1
Alzheimer's disease	19734902	2009-09-06	3941	7848	0	11789	10494.178641106115	3
Alzheimer's disease	19734903	2009-09-06	2032	5328	0	7360	5883.965217391305	3
Alzheimer's disease	20061627	2009-09-11	331	368	0	699	697.0414878397711	1
Alzheimer's disease	20460622	2010-05-12	3006	0	22604	25610	25610	1
Alzheimer's disease	21460840	2011-04-03	6688	13685	0	20373	17969.917047072107	4
Alzheimer's disease	21627779	2011-05-31	3009	3006	0	6015	6014.998503740649	5
Alzheimer's disease	22245343	2012-01-08	0	209	548	757	757	2
Alzheimer's disease	22430674	2012-03-20	2025	5328	0	7353	5869.277845777234	1
Alzheimer's disease	22832961	2012-05-15	1291	938	0	2229	2173.0964558097803	3
Alzheimer's disease	23150908	2012-11-14	3550	8888	0	12438	10147.097604116418	1
Alzheimer's disease	24755620	2014-04-22	2540	2029	0	4569	4511.849420004377	1
Alzheimer's disease	24770881	2014-04-27	0	1542	0	1542	1542	1
Alzheimer's disease	28183528	2017-02-06	15574	17689	0	33263	33128.51949613685	10
Alzheimer's disease	30636644	2019-01-12	2741	14739	0	17480	9244.759496567505	54
Alzheimer's disease	31473137	2019-08-13	16119	12525	0	28644	28193.05613741097	19
Alzheimer's disease (APOE e4 interaction)	25778476	2015-03-17	17536	36175	0	53711	47242.82176835285	2
Alzheimer's disease (APOE e4 interaction)	28183528	2017-02-06	15574	16448	1241	33263	31998.14527512335	1
Alzheimer's disease (SNP x SNP interaction)	30201328	2018-08-09	2243	6017	0	8260	6535.6566585956425	1
Alzheimer's disease (age of onset)	22005931	2011-10-18	2222	0	0	2222	2222	1
Alzheimer's disease (cognitive decline)	23535033	2013-03-24	303	0	0	303	303	14
Alzheimer's disease (late onset)	17474819	2007-04-01	664	422	0	1086	1032.073664825046	1
Alzheimer's disease (late onset)	17553421	2007-06-07	446	290	0	736	702.9347826086957	1
Alzheimer's disease (late onset)	20885792	2010-09-23	931	1104	0	2035	2020.2928746928749	3
Alzheimer's disease (late onset)	21390209	2011-02-24	1831	1764	0	3595	3593.751321279555	2
Alzheimer's disease (late onset)	21460841	2011-04-03	8309	7366	0	15675	15618.269601275919	7
Alzheimer's disease (late onset)	23565137	2013-04-02	891	844	0	1735	1733.7268011527376	2
Alzheimer's disease (late onset)	23571587	2013-04-10	1968	3928	0	5896	5244.439620081411	1
Alzheimer's disease (late onset)	24162737	2013-10-27	17008	37154	0	54162	46668.53011336361	19
Alzheimer's disease (late onset)	26339675	2015-06-18	2451	2063	0	4514	4480.649534780682	2
Alzheimer's disease (late onset)	28714976	2017-09-01	16097	18077	0	34174	34059.28120793586	9
Alzheimer's disease (late onset)	30617256	2019-01-07	24087	55058	0	79145	67025.4366542422	22
Alzheimer's disease (late onset)	30820047	2019-02-28	21982	41944	0	63926	57692.5199762225	8
Alzheimer's disease (onset at age over 80)	30979435	2019-03-12	2399	4160	0	6559	6086.196066473547	2
Alzheimer's disease (onset between ages 58 and 79)	30979435	2019-03-12	7316	7579	0	14895	14890.356226921787	28
Alzheimer's disease biomarkers	23419831	2013-02-19	0	0	555	555	555	5
Alzheimer's disease biomarkers	23562540	2013-04-04	591	687	0	1278	1270.7887323943662	6
Alzheimer's disease in APOE e4+ carriers	25778476	2015-03-17	10352	9207	0	19559	19491.97075515108	4
Alzheimer's disease in APOE e4- carriers	25778476	2015-03-17	7184	26968	0	34152	22691.27570859686	3
Alzheimer's disease in APOE e4- carriers	28183528	2017-02-06	5903	12817	0	18720	16166.399786324786	1
Alzheimer's disease in hypertension	31055733	2019-05-05	1262	9608	0	10870	4461.930450781969	1
Alzheimer's disease in hypertension-negative individuals	31055733	2019-05-05	796	4010	0	4806	2656.6458593424886	1
Alzheimer's disease or HDL levels (pleiotropy)	30805717	2019-02-25	54162	0	60812	114974	114974	20
Alzheimer's disease or family history of Alzheimer's disease	29777097	2018-05-18	25580	48466	314278	388324	66972.4376738784	219
Alzheimer's disease or family history of Alzheimer's disease	30617256	2019-01-07	24087	383378	47793	455258	90652.45737425302	104
Alzheimer's disease or fasting glucose levels (pleiotropy)	30805717	2019-02-25	54162	0	58047	112209	112209	4
Alzheimer's disease or fasting insulin levels (pleiotropy)	30805717	2019-02-25	54162	0	51750	105912	105912	3
Alzheimer's disease or small vessel stroke	26913989	2016-02-23	20659	95811	0	116470	67978.34460376063	1
Alzheimer's disease progression score	29860282	2018-05-30	0	0	944	944	944	2
Alzheimer’s disease (clinical subgroup AD+)	31473137	2019-08-13	3797	3289	0	7086	7049.581145921536	1
Alzheimer’s disease (clinical subgroup AD++)	31473137	2019-08-13	2611	3289	0	5900	5822.087457627119	1
Alzheimer’s disease (clinical subgroup AD+++)	31473137	2019-08-13	1854	3289	0	5143	4742.606260937197	1
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+)	31473137	2019-08-13	1168	3289	0	4457	3447.6571684989904	1
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)	31473137	2019-08-13	373	3289	0	3662	1340.02949208083	1
Amino acid levels	26068415	2015-06-12	0	0	7478	7478	7478	9
Amygdala volume	31636452	2019-10-21	0	0	34431	34431	34431	1
Amyloid A serum levels	21124955	2010-11-18	0	0	4211	4211	4211	4
Amyotrophic lateral sclerosis	18084291	2007-12-16	737	721	0	1458	1457.824417009602	1
Amyotrophic lateral sclerosis	19451621	2009-05-18	1821	2258	0	4079	4032.1823976464816	2
Amyotrophic lateral sclerosis	19734901	2009-09-06	2323	9013	0	11336	7387.861326746648	3
Amyotrophic lateral sclerosis	20801717	2010-10-01	4857	8987	0	13844	12611.921121063277	2
Amyotrophic lateral sclerosis	20801718	2010-08-27	405	497	0	902	892.6164079822615	2
Amyotrophic lateral sclerosis	22959728	2012-09-05	4243	5112	0	9355	9274.277284874399	1
Amyotrophic lateral sclerosis	23624525	2013-04-28	506	1859	0	2365	1590.9581395348837	2
Amyotrophic lateral sclerosis	24931836	2014-06-27	4377	13017	0	17394	13102.313211452225	2
Amyotrophic lateral sclerosis	25442119	2014-09-06	25	1179	0	1204	97.92358803986711	1
Amyotrophic lateral sclerosis	27455348	2016-07-25	12577	23475	0	36052	32757.691667591258	6
Amyotrophic lateral sclerosis	29566793	2018-03-21	20806	59804	0	80610	61743.30847289419	6
Amyotrophic lateral sclerosis	31872054	2019-11-08	666	3988	0	4654	2282.7743876235495	4
Amyotrophic lateral sclerosis (sporadic)	24256812	2013-11-20	6100	7125	0	13225	13145.557655954632	2
Amyotrophic lateral sclerosis (sporadic)	24529757	2014-01-17	250	250	0	500	500.0	17
Amyotrophic lateral sclerosis (sporadic)	28931804	2017-09-20	13811	26325	0	40136	36234.261012557305	4
Androgen levels	22936694	2012-08-30	0	0	3225	3225	3225	5
Androstenedione levels	31169883	2019-06-06	0	0	2070	2070	2070	3
Anger	24489884	2014-01-01	0	0	8747	8747	8747	1
Angiotensin-converting enzyme activity	20066004	2010-01-12	400	0	0	400	400	2
Angiotensin-converting enzyme inhibitor intolerance	28030426	2017-03-27	0	0	5161	5161	5161	4
Ankle injury	28957384	2017-09-28	1696	97646	0	99342	6668.181272774858	2
Ankle-brachial index	22199011	2011-12-23	0	0	41692	41692	41692	1
Ankle-brachial index	31388106	2019-08-06	0	0	1437	1437	1437	2
Ankylosing spondylitis	20062062	2010-01-10	2053	5140	0	7193	5868.160711803142	5
Ankylosing spondylitis	21743469	2011-07-10	3023	8779	0	11802	8994.718522284358	10
Ankylosing spondylitis	22138694	2011-12-04	1837	4231	0	6068	5123.498352010546	2
Ankylosing spondylitis	23749187	2013-07-01	10619	15145	0	25764	24968.910883403194	44
Ankylosing spondylitis	30946743	2019-04-04	1343	1661	0	3004	2970.3368841544607	9
Ankylosing spondylitis (SNP x SNP interaction)	23749187	2013-07-01	9069	13578	0	22647	21749.261624056166	1
Annualised percent change of cerebrospinal fluid AB1-42 levels	31370031	2019-08-01	0	0	321	321	321	1
Anorexia nervosa	28494655	2017-05-12	3495	10982	0	14477	10604.98445810596	1
Anorexia nervosa	31308545	2019-07-15	16992	55525	0	72517	52041.91017278707	8
Anterior chamber depth	24603532	2014-03-06	0	0	4484	4484	4484	1
Anthropometric traits	30166351	2018-08-30	0	0	4988	4988	4988	12
Anthropometric traits (multi-trait analysis)	30166351	2018-08-30	0	0	4988	4988	4988	29
Anthropometric traits in newborns	23575227	2013-04-10	0	0	4281	4281	4281	3
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	30053915	2018-07-27	0	0	914	914	914	1
Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	30649302	2019-01-14	0	0	3344	3344	3344	1
Anti-adalimumab antibody production in response to treatment in Crohn's disease	31043678	2019-05-02	9	53	0	62	30.7741935483871	1
Anti-anoctamin 2 antibody levels	31375628	2019-08-02	0	0	11936	11936	11936	5
Anti-rubella virus IgG levels	30053915	2018-07-27	0	0	935	935	935	1
Anti-saccade response	29064472	2017-10-24	591	258	0	849	718.3886925795052	1
Anti-sp100 seropositivity in primary biliary cholangitis	30854688	2019-03-10	211	711	0	922	650.8503253796096	2
Anti-thyroid drug induced agranulocytosis	27157822	2016-05-03	38	5170	1	5209	150.89093701996927	4
Antibody level in response to infection	25758998	2015-03-11	0	0	1932	1932	1932	1
Antibody status in Tripanosoma cruzi seropositivity	24324551	2013-11-20	0	0	580	580	580	1
Anticoagulant levels	22216198	2011-12-28	0	0	418	418	418	1
Antineutrophil cytoplasmic antibody-associated vasculitis	22808956	2012-07-19	914	5259	0	6173	3114.677466385874	9
Antineutrophil cytoplasmic antibody-associated vasculitis	28029757	2016-12-28	1221	0	3258	4479	4479	6
Antinuclear antibody levels	25186300	2014-09-03	0	0	3185	3185	3185	1
Antipsychotic drug-induced weight gain	22566560	2012-05-07	0	0	139	139	139	1
Antisaccade task score	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	2
Antithyroid drug-induced agranulocytosis	26599303	2016-01-12	20	775	0	795	77.9874213836478	1
Antitragus size	26105758	2015-06-24	0	0	4919	4919	4919	1
Anxiety	31906708	2020-01-07	0	0	199611	199611	199611	6
Anxiety and stress-related disorders	31116379	2019-05-22	12655	19225	0	31880	30526.019447929735	1
Anxiety and stress-related disorders (excluding adjustment disorder)	31116379	2019-05-22	8517	19225	0	27742	23608.871025881333	1
Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	31116379	2019-05-22	11560	19225	0	30785	28876.530777976284	1
Anxiety and stress-related disorders (including obsessive-compulsive disorder)	31116379	2019-05-22	13533	19225	0	32758	31768.96330667318	1
Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	31116379	2019-05-22	12096	42215	0	54311	37608.0455156414	1
Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	31116379	2019-05-22	10311	19225	0	29536	26845.744176598047	1
Anxiety disorder	26754954	2016-01-12	7016	14745	0	21761	19015.839345618308	1
Anxiety disorder (factor score)	26754954	2016-01-12	0	0	18186	18186	18186	1
Anxiety disorder (factor score)	31886626	2019-12-30	0	0	34696	34696	34696	2
Anxiety disorders	31906708	2020-01-07	34189	190141	0	224330	115913.71014130968	2
Anxiety symptoms	31748690	2019-11-20	19012	58113	0	77125	57301.49010048623	1
Anxiety/tension (special factor of neuroticism)	30867560	2019-03-13	0	0	270059	270059	270059	20
Aortic coarctation	29590334	2018-03-24	39	140661	0	140700	155.95675906183368	1
Aortic root size	19584346	2009-07-08	0	0	12612	12612	12612	4
Aortic root size	21223598	2011-01-11	0	0	1086	1086	1086	1
Aortic root size	28394258	2017-04-10	0	0	30201	30201	30201	8
Aortic stiffness	22068335	2011-11-08	0	0	24850	24850	24850	1
Aortic valve stenosis	29511194	2018-03-07	2457	0	349342	351799	351799	3
Aortic valve stenosis	32186652	2020-03-18	3469	41234	0	44703	12799.207748920653	1
Aortic-valve calcification	23388002	2013-02-17	0	0	6942	6942	6942	1
Apolipoprotein A-IV levels	27412012	2016-07-12	0	0	13813	13813	13813	2
Apolipoprotein A1 levels	29084231	2017-10-30	0	0	8372	8372	8372	12
Apolipoprotein B levels	29084231	2017-10-30	0	0	8372	8372	8372	5
Apolipoprotein Levels	23031429	2012-10-03	0	0	1720	1720	1720	3
Appendicitis	30392061	2018-11-03	18773	114907	0	133680	64546.65203470976	1
Appendicular lean mass	28724990	2017-07-19	0	0	28330	28330	28330	3
Appendicular lean mass	31761296	2019-11-21	0	0	181862	181862	181862	573
Arsenic metabolism	22383894	2012-02-23	0	0	1313	1313	1313	2
Arsenic metabolism	27352405	2016-06-28	0	0	2428	2428	2428	4
Arterial stiffness	20031579	2009-04-01	0	0	4221	4221	4221	1
Arterial stiffness	31070453	2019-04-11	0	0	131686	131686	131686	2
Arterial stiffness index	31235810	2019-06-24	0	0	127121	127121	127121	4
Arthritis (juvenile idiopathic)	18576341	2008-06-24	130	1952	0	2082	487.5312199807876	1
Arthritis (juvenile idiopathic)	27005825	2016-03-22	388	2500	0	2888	1343.4903047091411	1
Asparaginase hypersensitivity in acute lymphoblastic leukemia	25987655	2015-05-18	3126	0	0	3126	3126	1
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	27114598	2016-04-25	0	0	5185	5185	5185	3
Aspartate aminotransferase levels	21900944	2011-09-08	0	0	866	866	866	1
Aspartate aminotransferase levels	29403010	2018-02-05	0	0	134154	134154	134154	28
Aspartate aminotransferase levels	30718733	2019-02-04	0	0	6949	6949	6949	4
Aspartate aminotransferase levels	31219225	2019-06-20	0	0	3644	3644	3644	2
Aspartate aminotransferase levels in low alcohol consumption	30589442	2018-12-27	0	0	8716	8716	8716	1
Aspartate aminotransferase levels in non-alcoholic fatty liver disease	31311600	2019-07-17	0	0	1075	1075	1075	1
Aspirin hydrolysis (plasma)	23508960	2013-03-18	0	0	2054	2054	2054	1
Asthma	17611496	2007-07-26	994	1243	0	2237	2209.2838623156013	1
Asthma	19426955	2009-05-07	359	846	0	1205	1008.1792531120333	1
Asthma	20032318	2009-12-23	793	1988	0	2781	2267.5066522833513	2
Asthma	20860503	2010-09-23	10365	16110	0	26475	25228.351274787536	6
Asthma	21804548	2011-07-31	1532	3304	0	4836	4186.706368899917	13
Asthma	21804549	2011-07-31	5388	0	0	5388	5388	5
Asthma	21814517	2011-07-21	938	2376	0	3314	2690.0277610138805	2
Asthma	21907864	2011-09-10	12475	19967	0	32442	30711.833425806053	2
Asthma	22561531	2012-05-05	933	3346	0	4279	2918.268754381865	1
Asthma	23028483	2012-09-28	1716	16888	0	18604	6230.876800688024	2
Asthma	23181788	2012-12-04	1238	2617	0	3855	3361.7079118028532	1
Asthma	27182965	2016-05-16	28399	128843	0	157242	93079.77148598975	27
Asthma	27611488	2016-09-09	3091	18553	0	21644	10598.28552947699	6
Asthma	28461288	2017-05-01	2144	2893	0	5037	4925.623982529283	3
Asthma	29273806	2017-12-22	23948	118538	0	142486	79691.98444759485	40
Asthma	29785011	2018-05-21	14085	76768	0	90853	47605.572958515404	6
Asthma	30929738	2019-03-28	40544	300671	0	341215	142905.851430916	140
Asthma	31361310	2019-07-30	41926	239773	0	281699	142744.17442731425	101
Asthma	31619474	2019-10-17	46802	347481	0	394283	164986.121765331	130
Asthma	31959851	2020-01-20	69189	702199	0	771388	251932.6025865064	85
Asthma	32296059	2020-04-15	88486	447859	0	536345	295550.4496098593	312
Asthma (adult onset)	30929738	2019-03-28	26582	300671	0	327253	97691.2238787727	40
Asthma (adult onset)	31036433	2019-04-26	21564	318237	0	339801	80782.13622679157	20
Asthma (adult onset)	31669095	2019-10-24	33418	393186	0	426604	123200.81150669006	77
Asthma (age of onset)	31036433	2019-04-26	0	0	37846	37846	37846	22
Asthma (childhood onset)	22560479	2012-05-02	0	0	573	573	573	2
Asthma (childhood onset)	23829686	2013-07-05	0	0	429	429	429	3
Asthma (childhood onset)	24241537	2013-11-17	1173	2511	0	3684	3198.048859934853	4
Asthma (childhood onset)	29273806	2017-12-22	8976	18399	0	27375	24131.422684931506	5
Asthma (childhood onset)	30929738	2019-03-28	13962	300671	0	314633	53369.71648873449	98
Asthma (childhood onset)	31036433	2019-04-26	9433	318237	0	327670	36645.767033906064	60
Asthma (childhood onset)	31669095	2019-10-24	13435	393186	0	406621	51964.39839555754	219
Asthma (corticosteroid response)	24486069	2014-01-31	0	0	124	124	124	1
Asthma (moderate or severe)	30552067	2018-12-11	5135	25675	0	30810	17116.666666666668	25
Asthma (time to childhood onset) x early life tobacco smoke interaction	31379025	2019-08-04	0	0	8273	8273	8273	1
Asthma (time to onset)	27130862	2016-04-06	5462	8424	0	13886	13254.180613567622	6
Asthma and anxiety disorder	31619474	2019-10-17	52512	359081	0	411593	183249.5836615297	1
Asthma and attention deficit hyperactivity disorder	31619474	2019-10-17	65901	381675	0	447576	224791.00018767765	7
Asthma and hay fever	24388013	2013-12-30	6685	14091	0	20776	18135.990566037734	10
Asthma and major depressive disorder	31619474	2019-10-17	106653	460635	0	567288	346406.79623048607	10
Asthma onset (childhood vs adult)	30929738	2019-03-28	28835	0	0	28835	28835	32
Asthma or allergic disease (pleiotropy)	29785011	2018-05-21	39770	76768	0	116538	104792.02869450308	38
Asthma x Hispanic interaction (2df)	30456811	2018-11-19	1249	1751	0	3000	2915.998666666667	1
Asthma x air pollution interaction (2df)	30456811	2018-11-19	1249	1751	0	3000	2915.998666666667	1
Asymmetrical dimethylarginine levels	24159190	2013-10-24	0	0	5110	5110	5110	1
Asymmetrical dimethylarginine levels	25245031	2014-09-21	0	0	6734	6734	6734	1
Atazanavir levels	29315502	2018-01-09	0	0	398	398	398	1
Atopic asthma	31669095	2019-10-24	23982	393169	0	417151	90413.10180725924	198
Atopic dermatitis	19349984	2009-04-06	939	975	1367	3281	1913.3228840125391	1
Atopic dermatitis	21666691	2011-06-13	1012	1362	0	2374	2322.3993260320135	1
Atopic dermatitis	22197932	2011-12-25	5606	20565	0	26171	17620.631997248864	3
Atopic dermatitis	23042114	2012-10-07	1472	7971	0	9443	4970.162871968654	10
Atopic dermatitis	23886662	2013-07-25	1563	4054	0	5617	4512.303364785473	4
Atopic dermatitis	25574825	2015-01-08	2079	3867	0	5946	5408.3370332996965	4
Atopic dermatitis	25865352	2015-04-10	870	5293	0	6163	2988.7457407106926	3
Atopic dermatitis	26482879	2015-10-19	21399	95464	0	116863	69922.35818009122	29
Atopic march	26542096	2015-11-06	1151	10030	0	11181	4130.052768088722	7
Atopy	28927820	2017-09-16	925	735	0	1660	1638.2530120481929	1
Atrial fibrillation	19597491	2009-07-13	2385	33752	0	36137	8910.371087804744	2
Atrial fibrillation	19597492	2009-07-13	3413	0	37105	40518	40518	2
Atrial fibrillation	20173747	2010-02-21	1335	12844	0	14179	4837.221242682841	2
Atrial fibrillation	22544366	2012-04-29	6707	52426	0	59133	23785.106928449426	9
Atrial fibrillation	28416818	2017-04-17	20815	111303	758	132876	70142.50730407666	37
Atrial fibrillation	28416822	2017-04-17	8180	28612	0	36792	25445.331593824747	16
Atrial fibrillation	29237688	2017-12-01	2987	117299	0	120286	11651.301498096203	2
Atrial fibrillation	29290336	2018-01-04	6337	61607	0	67944	22983.84310608737	8
Atrial fibrillation	29892015	2018-06-11	65446	522744	0	588190	232656.1405260205	213
Atrial fibrillation	30061737	2018-07-30	60620	970216	0	1030836	228220.5662976458	142
Atrial fibrillation/atrial flutter	17603472	2007-07-01	550	4476	0	5026	1959.2518901711103	2
Attention deficit hyperactivity disorder	18839057	2008-10-07	343	304	0	647	644.6491499227203	2
Attention deficit hyperactivity disorder	23728934	2013-05-31	1040	963	0	2003	2000.0399400898652	1
Attention deficit hyperactivity disorder	29325848	2017-12-02	19099	34194	0	53293	49017.40986621132	3
Attention deficit hyperactivity disorder	30478444	2018-11-26	20183	35191	0	55374	51306.385885072414	8
Attention deficit hyperactivity disorder	30563984	2018-12-18	480	1208	0	1688	1374.0284360189573	1
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	30818988	2019-03-01	20183	35191	11757	67131	51306.385885072414	1
Attention deficit hyperactivity disorder or cannabis use	30610198	2019-01-04	32719	50410	0	83129	79364.11071948418	16
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	30818988	2019-03-01	20183	35191	11772	67146	51306.385885072414	1
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	30818988	2019-03-01	20183	35191	24024	79398	51306.385885072414	3
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	30818988	2019-03-01	20183	35191	11646	67020	51306.385885072414	2
Attention function	29907492	2018-06-12	127	136	0	263	262.6920152091255	1
Autism	19404256	2009-04-28	1204	6491	3881	11576	4062.4634178037686	1
Autism	20663923	2010-07-27	0	1880	2754	4634	4634	1
Autism	24189344	2013-11-05	136	984	1100	2220	477.9428571428571	4
Autism and educational attainment (MTAG)	30804558	2019-02-25	18381	27969	328917	375267	44366.618252427186	3
Autism and major depressive disorder (MTAG)	30804558	2019-02-25	130283	340082	0	470365	376787.4157813613	6
Autism spectrum disorder	30804558	2019-02-25	18381	27969	0	46350	44366.618252427186	4
Autism spectrum disorder or schizophrenia	28540026	2017-05-22	7387	8567	0	15954	15866.724081734987	301
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	23453885	2013-02-27	33332	27888	0	61220	60735.89127736035	17
Autism spectrum disorder-related traits	25534755	2014-09-30	0	0	2575	2575	2575	1
Autoimmune hepatitis in primary sclerosing cholangitis	28779025	2017-08-04	107	3159	0	3266	413.97795468462954	2
Autoimmune hepatitis type-1	24768677	2014-04-23	649	13436	0	14085	2476.383102591409	1
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	22922229	2012-12-01	2733	9364	0	12097	8462.201206910804	4
Autoimmune traits	30595370	2018-12-27	0	0	459000	459000	459000	75
Autoimmune traits (pleiotropy)	30572963	2018-12-20	0	22308	37160	59468	59468	38
Automobile speeding propensity	30643258	2019-01-14	0	0	404291	404291	404291	42
Axial length	24144296	2013-08-08	0	0	12531	12531	12531	5
Axial length	25823570	2015-03-31	0	0	3248	3248	3248	1
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	29296818	2017-09-08	333	3027	0	3360	1199.9892857142856	2
B cell acute lymphoblastic leukaemia (hyperdiploid negative)	29296818	2017-09-08	410	3027	0	3437	1444.364271166715	1
B cell acute lymphoblastic leukaemia (normal cytogenetics)	29296818	2017-09-08	193	3027	0	3220	725.727950310559	3
B cell non-Hodgkin lymphoma	23749188	2013-06-09	253	1438	0	1691	860.5890005913661	1
B-cell acute lymphoblastic leukaemia	31767839	2019-11-25	5321	16666	0	21987	16133.130668122072	9
B-cell acute lymphoblastic leukaemia (ETV6-RUNX1 positive)	31767839	2019-11-25	936	16666	0	17602	3544.9098966026586	1
B-cell acute lymphoblastic leukaemia (high-hyperdiploidy)	31767839	2019-11-25	1369	16666	0	18035	5060.328028832825	1
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	28112199	2017-01-23	7097	7324	0	14421	14417.426808127037	9
B-type natriuretic peptide levels	25561047	2015-01-05	0	0	2790	2790	2790	2
B-type natriuretic peptide levels	29237677	2017-12-01	0	0	4932	4932	4932	1
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	29237677	2017-12-01	0	0	4932	4932	4932	3
B6 vitamer levels (multivariate analysis)	30583557	2018-12-22	0	0	493	493	493	1
BMI (adjusted for smoking behaviour)	28443625	2017-04-26	0	0	196760	196760	196760	79
BMI (smoking interaction)	28443625	2017-04-26	0	0	196760	196760	196760	1
BMI at 1 year old	31575865	2019-10-01	0	0	6970	6970	6970	3
BMI at 1.5 years old	31575865	2019-10-01	0	0	6800	6800	6800	4
BMI at 2 years old	31575865	2019-10-01	0	0	4631	4631	4631	1
BMI at 3 months old	31575865	2019-10-01	0	0	7970	7970	7970	1
BMI at 6 months old	31575865	2019-10-01	0	0	8017	8017	8017	2
BMI at 7 years old	31575865	2019-10-01	0	0	4629	4629	4629	1
BMI at 8 months old	31575865	2019-10-01	0	0	7197	7197	7197	2
BMI at adiposity peak	31840077	2019-09-04	0	0	6219	6219	6219	1
BMI at adiposity rebound	31840077	2019-09-04	0	0	6051	6051	6051	1
BMI in non-smokers	28443625	2017-04-26	0	0	153041	153041	153041	55
BMI in smokers	28443625	2017-04-26	0	0	42543	42543	42543	14
BRCA1/2-negative high-risk breast cancer	30323354	2018-10-15	1469	5979	0	7448	4717.05209452202	5
Bacterial meningitis	28928442	2017-09-19	842	82778	0	83620	3334.0863908155943	1
Bacterial meningitis	31092817	2019-05-15	2345	345042	0	347387	9316.681280531511	1
Balding	26926045	2016-03-01	0	0	6357	6357	6357	2
Balding type 1	30595370	2018-12-27	0	0	208000	208000	208000	338
Barrett's esophagus	22961001	2012-09-09	1852	5172	0	7024	5454.751708428246	2
Barrett's esophagus	27527254	2016-08-12	6167	17159	0	23326	18146.197890765667	5
Barrett's esophagus  or Esophageal adenocarcinoma	27527254	2016-08-12	10279	17159	0	27438	25712.859683650415	14
Barrett's esophagus  or Esophageal adenocarcinoma	31527586	2019-09-16	13678	19247	0	32925	31983.048261199703	1
Basal cell carcinoma	18849993	2008-10-12	930	33117	0	34047	3618.3875231297916	2
Basal cell carcinoma	19151717	2009-01-18	1505	28890	0	30395	5721.921368646158	1
Basal cell carcinoma	21700618	2011-06-23	2045	6013	0	8058	6104.038222884091	3
Basal cell carcinoma	21946351	2011-09-25	2121	39614	0	41735	8052.8375703845695	1
Basal cell carcinoma	24403052	2014-01-08	4208	109408	0	113616	16208.592592592591	10
Basal cell carcinoma	25855136	2015-04-09	4572	266358	0	270930	17979.386203078288	13
Basal cell carcinoma	27539887	2016-08-19	0	274252	0	274252	274252	32
Basal cell carcinoma	28177523	2017-02-22	17187	287054	0	304241	64864.32923899146	1
Basal cell carcinoma	31174203	2019-06-07	31787	619351	0	651138	120940.93870730934	71
Basal metabolic rate	31453325	2019-08-14	0	0	341584	341584	341584	5
Basal metabolic rate variance	31453325	2019-08-14	0	0	341584	341584	341584	5
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	29551627	2018-03-15	407	0	0	407	407	1
Basophil percentage of granulocytes	27863252	2016-11-17	0	0	170223	170223	170223	62
Basophil percentage of white cells	27863252	2016-11-17	0	0	171996	171996	171996	65
Beard thickness	26926045	2016-03-01	0	0	2922	2922	2922	4
Behcet's disease	20622878	2010-07-11	1215	1278	0	2493	2491.407942238267	2
Behcet's disease	20622879	2010-07-11	611	737	0	1348	1336.2225519287833	2
Behcet's disease	23001997	2012-12-06	147	951	0	1098	509.2786885245902	6
Behcet's disease	23291587	2013-01-06	1215	1278	0	2493	2491.407942238267	5
Behcet's disease	24326010	2013-12-10	292	294	0	586	585.9931740614335	2
Behcet's disease	25799145	2015-03-23	330	5843	6	6179	1249.4346346994978	1
Behcet's disease	27548383	2016-08-22	278	1517	0	1795	939.7793871866295	3
Benign prostatic hyperplasia and lower urinary tract symptoms	30410027	2018-11-08	20621	280541	0	301162	76836.20059635678	20
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	30410027	2018-11-08	18138	277213	0	295351	68096.46006277276	19
Beta thalassemia/hemoglobin E disease	20183929	2009-11-19	618	0	0	618	618	3
Beta-2 microglubulin plasma levels	23417110	2013-02-16	0	0	6728	6728	6728	12
Beta-trace protein levels	23328707	2013-01-16	0	0	6720	6720	6720	1
Betaine levels in individuals undergoing cardiac evaluation	26822151	2016-01-29	0	0	1985	1985	1985	2
Bicuspid aortic valve	31387361	2019-08-07	452	1834	0	2286	1450.5126859142608	1
Biliary atresia	20460270	2010-05-11	281	481	0	762	709.50656167979	1
Biliary atresia	30102696	2018-08-13	343	1716	0	2059	1143.444390480816	1
Bilirubin levels	19414484	2009-05-04	0	0	9464	9464	9464	2
Bilirubin levels	19419973	2009-05-06	0	0	4300	4300	4300	3
Bilirubin levels	20639394	2010-07-16	0	0	8841	8841	8841	7
Bilirubin levels	21646302	2011-06-06	0	0	6307	6307	6307	3
Bilirubin levels	22085899	2011-11-16	0	0	619	619	619	1
Bilirubin levels	23371916	2013-01-31	0	0	1452	1452	1452	10
Bilirubin levels	23642732	2013-04-19	0	0	1180	1180	1180	1
Bilirubin levels	31319653	2019-07-12	0	0	33598	33598	33598	5
Bilirubin levels	31675503	2019-10-01	0	0	14126	14126	14126	2
Bilirubin levels	32084209	2020-02-21	0	0	4457	4457	4457	4
Bilirubin levels in extreme obesity	25246029	2014-09-23	1868	0	0	1868	1868	1
Bilirubin levels in tenofovir-treated HIV infection	26148204	2015-09-01	501	0	0	501	501	20
Binge eating behaviour and bipolar disorder	29391396	2018-02-02	398	1811	0	2209	1305.166138524219	1
Binge eating behaviour in bipolar disorder	29391396	2018-02-02	398	1231	0	1629	1203.039901780233	1
Biochemical measures	19260141	2009-02-01	0	0	898	898	898	1
Biomedical quantitative traits	19396169	2009-04-26	0	0	8842	8842	8842	4
Bipolar I disorder	31043756	2019-05-01	14879	31358	0	46237	40363.836927136275	14
Bipolar disorder	17486107	2007-05-08	461	563	0	1024	1013.8398437499999	1
Bipolar disorder	18711365	2008-08-17	4387	6209	0	10596	10282.704039260097	1
Bipolar disorder	20351715	2010-03-30	4387	6209	0	10596	10282.704039260097	2
Bipolar disorder	21254220	2011-02-01	1868	2938	0	4806	4567.77694548481	2
Bipolar disorder	21353194	2011-02-23	682	1300	0	1982	1789.303733602422	1
Bipolar disorder	21926972	2011-09-18	7481	9250	0	16731	16543.960313191084	2
Bipolar disorder	22182935	2011-12-20	6568	8187	0	14755	14577.354388342937	5
Bipolar disorder	22205951	2011-12-21	1000	1034	0	2034	2033.431661750246	2
Bipolar disorder	24618891	2014-03-11	9747	14278	0	24025	23170.475088449533	5
Bipolar disorder	27329760	2016-06-21	7647	27303	0	34950	23895.398111587983	6
Bipolar disorder	28072414	2017-01-10	13903	0	19279	33182	33182	8
Bipolar disorder	28115744	2017-01-24	7481	71137	2964	81582	27076.54211503727	6
Bipolar disorder	31043756	2019-05-01	20352	31358	0	51710	49367.473680139236	32
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	27890468	2016-10-18	9776	21363	0	31139	26827.411027971353	1
Bipolar disorder (body mass index interaction)	24322204	2013-12-10	388	1020	0	1408	1124.3181818181818	3
Bipolar disorder and schizophrenia	20889312	2010-10-01	1822	2412	0	4234	4151.78460085026	2
Bipolar disorder lithium response (categorical) or schizophrenia	29121268	2017-11-09	37693	1662	2014	41369	6367.248481768517	8
Bipolar disorder lithium response (continuous) or schizophrenia	29121268	2017-11-09	39575	0	2014	41589	41589	8
Bipolar disorder or attention deficit hyperactivity disorder	27890468	2016-10-18	14259	21363	0	35622	34205.26831733198	2
Bipolar disorder or body mass index	31754094	2019-11-21	20352	31358	322154	373864	49367.473680139236	13
Bipolar disorder or major depressive disorder	20351715	2010-03-30	6082	7970	0	14052	13798.331910048391	1
Bipolar disorder or type 2 diabetes	31754094	2019-11-21	47030	163890	0	210920	146173.84221505784	2
Birdshot chorioretinopathy	24957906	2014-06-22	117	693	0	810	400.3999999999999	2
Birth length	25281659	2014-10-03	0	0	28459	28459	28459	1
Birth length (MTAG)	31681408	2019-10-11	0	0	182902	182902	182902	27
Birth weight	20372150	2010-04-06	0	0	10623	10623	10623	2
Birth weight	23202124	2012-12-02	0	0	26836	26836	26836	7
Birth weight	24950379	2014-06-20	0	0	4593	4593	4593	1
Birth weight	27680694	2016-10-13	0	0	142558	142558	142558	58
Birth weight	31043758	2019-05-01	0	0	321223	321223	321223	213
Birth weight	31097437	2019-05-16	0	0	188039	188039	188039	73
Birth weight	31453325	2019-08-14	0	0	197758	197758	197758	1
Birth weight (MTAG)	31681408	2019-10-11	0	0	182902	182902	182902	40
Birth weight variance	31453325	2019-08-14	0	0	197758	197758	197758	1
Bisphosphonate-associated atypical femoral fracture	31006051	2019-04-20	50	4891	1	4942	197.97611819469742	4
Bitter alcoholic beverage consumption	31046077	2019-05-02	0	0	336448	336448	336448	31
Bitter beverage consumption	31046077	2019-05-02	0	0	85852	85852	85852	9
Bitter non-alcoholic beverage consumption	31046077	2019-05-02	0	0	85852	85852	85852	9
Bitter taste perception	23966204	2013-08-20	0	0	503	503	503	3
Bitter taste perception	30223776	2018-09-17	0	0	2928	2928	2928	5
Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	31005965	2019-04-21	0	0	368	368	368	1
Bitter taste perception (multivariate analysis)	30223776	2018-09-17	0	0	2928	2928	2928	9
Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	31005965	2019-04-21	0	0	372	372	372	1
Bitter taste response	20675712	2010-07-31	0	0	1457	1457	1457	1
Black vs. blond hair color	18483556	2008-05-16	0	0	2287	2287	2287	6
Black vs. non-black hair color	26184321	2015-07-13	0	0	7091	7091	7091	1
Black vs. red hair color	18483556	2008-05-16	0	0	2287	2287	2287	6
Bladder cancer	19648920	2009-08-02	969	957	0	1926	1925.9252336448599	1
Bladder cancer	20972438	2010-10-24	3532	5120	0	8652	8360.536292186776	8
Bladder cancer	21750109	2011-07-12	2234	41603	0	43837	8480.607888313525	1
Bladder cancer	21824976	2011-08-08	4501	6076	0	10577	10342.469887491729	1
Bladder cancer	24163127	2013-10-24	6911	11818	0	18729	17443.365475999788	10
Bladder cancer	25281661	2014-10-03	531	0	5581	6112	6112	1
Bladder cancer	27206850	2016-03-29	578	1006	0	1584	1468.3535353535353	1
Blond vs non-blond hair color	26184321	2015-07-13	0	0	7091	7091	7091	5
Blond vs. brown hair color	17952075	2007-10-21	0	0	2986	2986	2986	4
Blond vs. brown hair color	18488028	2008-05-18	0	0	5130	5130	5130	1
Blond vs. brown/black hair color	30531825	2018-12-10	0	0	323317	323317	323317	213
Blood and toenail selenium levels	25343990	2014-10-24	0	0	9639	9639	9639	12
Blood cell traits (multivariate analysis)	31080455	2019-04-26	0	0	6407	6407	6407	11
Blood glucose levels	29615537	2018-03-01	0	0	33431	33431	33431	2
Blood metabolite levels	24816252	2014-05-11	0	0	7824	7824	7824	245
Blood metabolite levels	25898920	2015-04-22	0	0	3953	3953	3953	4
Blood metabolite levels	26401656	2015-09-24	0	0	2107	2107	2107	25
Blood metabolite levels	27453504	2016-07-25	0	0	2076	2076	2076	1
Blood metabolite levels	31502714	2019-09-10	0	0	1788	1788	1788	4
Blood metabolite ratios	24816252	2014-05-11	0	0	5591	5591	5591	54
Blood osmolality (transformed sodium)	28360221	2017-03-30	0	0	61869	61869	61869	2
Blood pressure	17903302	2007-09-19	0	0	1327	1327	1327	1
Blood pressure	21572416	2011-05-15	0	0	19608	19608	19608	12
Blood pressure	21909110	2011-09-11	0	0	74064	74064	74064	32
Blood pressure	23972371	2013-08-20	0	0	29378	29378	29378	8
Blood pressure	24001895	2013-09-03	0	0	26600	26600	26600	1
Blood pressure	24903457	2014-06-05	0	0	7486	7486	7486	1
Blood pressure	24954895	2014-06-19	0	0	55796	55796	55796	4
Blood pressure (anthropometric measures interaction)	24903457	2014-06-05	0	0	7486	7486	7486	1
Blood pressure (smoking interaction)	25189868	2014-09-03	0	0	6889	6889	6889	5
Blood pressure measurement (cold pressor test)	24165912	2013-10-28	0	0	1881	1881	1881	2
Blood pressure measurement (high sodium and potassium intervention)	24165912	2013-10-28	0	0	1836	1836	1836	5
Blood pressure measurement (high sodium intervention)	24165912	2013-10-28	0	0	1840	1840	1840	1
Blood pressure measurement (low sodium intervention)	24165912	2013-10-28	0	0	1850	1850	1850	4
Blood pressure traits (multi-trait analysis)	28498854	2017-05-12	0	0	31155	31155	31155	9
Blood protein levels	23696881	2013-05-16	0	0	1209	1209	1209	15
Blood protein levels	28240269	2017-02-27	0	0	997	997	997	583
Blood protein levels	28915241	2017-09-15	0	0	961	961	961	266
Blood protein levels	29875488	2018-06-06	0	0	3301	3301	3301	2784
Blood protein levels	30072576	2018-08-02	0	0	3200	3200	3200	2793
Blood protein levels	30111768	2018-08-15	0	0	6861	6861	6861	8
Blood protein levels in cardiovascular risk	28369058	2017-04-03	0	0	3394	3394	3394	75
Blood sugar levels	29403010	2018-02-05	0	0	93146	93146	93146	20
Blood trace element (Cu levels)	23720494	2013-05-29	0	0	2603	2603	2603	2
Blood trace element (Se levels)	23720494	2013-05-29	0	0	5477	5477	5477	2
Blood trace element (Zn levels)	23720494	2013-05-29	0	0	2603	2603	2603	3
Blood urea nitrogen levels	29403010	2018-02-05	0	0	139818	139818	139818	44
Blood urea nitrogen levels	29558500	2018-03-20	0	0	7064	7064	7064	1
Blood urea nitrogen levels	31152163	2019-05-31	0	0	416178	416178	416178	111
Blue vs. brown eyes	17952075	2007-10-21	0	0	2986	2986	2986	1
Blue vs. green eyes	17952075	2007-10-21	0	0	2986	2986	2986	3
Blue vs. green eyes	18488028	2008-05-18	0	0	5130	5130	5130	1
Body fat distribution (arm fat ratio)	30664634	2019-01-21	0	0	116138	116138	116138	95
Body fat distribution (leg fat ratio)	30664634	2019-01-21	0	0	116138	116138	116138	132
Body fat distribution (trunk fat ratio)	30664634	2019-01-21	0	0	116138	116138	116138	150
Body fat mass	28224759	2017-02-22	0	0	9179	9179	9179	3
Body fat mass	28552196	2017-06-01	0	0	15201	15201	15201	4
Body fat percentage	26833246	2016-02-01	0	0	78525	78525	78525	27
Body fat percentage	28270201	2017-03-07	0	0	26343	26343	26343	6
Body fat percentage	30593698	2018-12-28	0	0	155961	155961	155961	96
Body fat percentage	31453325	2019-08-14	0	0	341632	341632	341632	3
Body fat percentage	31752434	2019-11-19	0	0	828	828	828	9
Body fat percentage variance	31453325	2019-08-14	0	0	341632	341632	341632	5
Body mass (lean)	19268274	2009-03-04	0	0	973	973	973	1
Body mass (lean)	23108985	2012-10-30	0	0	1627	1627	1627	1
Body mass in chronic obstructive pulmonary disease	21037115	2010-10-29	2950	0	0	2950	2950	1
Body mass index	17434869	2007-04-12	5485	5174	0	10659	10649.92588422929	1
Body mass index	18454148	2008-05-04	0	0	16876	16876	16876	2
Body mass index	19079260	2008-12-14	0	0	73758	73758	73758	10
Body mass index	19079261	2008-12-14	0	0	32387	32387	32387	7
Body mass index	20935630	2010-10-10	0	0	123865	123865	123865	32
Body mass index	22344219	2012-02-19	0	0	27715	27715	27715	6
Body mass index	22982992	2012-09-12	0	0	133154	133154	133154	1
Body mass index	23563607	2013-04-07	0	0	16068	16068	16068	10
Body mass index	23583978	2013-04-14	0	0	39144	39144	39144	6
Body mass index	23669352	2013-05-12	0	0	13627	13627	13627	7
Body mass index	24064335	2013-10-08	0	0	20913	20913	20913	2
Body mass index	24348519	2013-12-03	0	0	2860	2860	2860	1
Body mass index	24861553	2014-05-26	0	0	86739	86739	86739	16
Body mass index	25673413	2015-02-12	0	0	238944	238944	238944	231
Body mass index	25953783	2015-05-07	0	0	9377	9377	9377	7
Body mass index	26426971	2015-10-01	0	0	309889	309889	309889	188
Body mass index	26961502	2016-03-10	29925	89763	0	119688	89771.99969921797	19
Body mass index	27455349	2016-07-25	0	0	3072	3072	3072	1
Body mass index	28270201	2017-03-07	0	0	26763	26763	26763	5
Body mass index	28296344	2017-03-13	0	0	1570	1570	1570	1
Body mass index	28448500	2017-04-27	0	0	161368	161368	161368	191
Body mass index	28552196	2017-06-01	0	0	56793	56793	56793	19
Body mass index	28892062	2017-09-11	0	0	158284	158284	158284	251
Body mass index	29273807	2017-12-22	0	0	526508	526508	526508	89
Body mass index	29381148	2017-12-21	0	0	102514	102514	102514	17
Body mass index	30045251	2018-07-01	0	0	8832	8832	8832	5
Body mass index	30108127	2018-08-14	0	0	334487	334487	334487	208
Body mass index	30108283	2018-08-14	0	0	901	901	901	1
Body mass index	30239722	2018-09-14	0	0	806834	806834	806834	1157
Body mass index	30271922	2018-05-03	0	0	772825	772825	772825	4
Body mass index	30595370	2018-12-27	0	0	458000	458000	458000	917
Body mass index	31217584	2019-06-19	0	0	49335	49335	49335	42
Body mass index	31453325	2019-08-14	0	0	346393	346393	346393	22
Body mass index	31498392	2019-09-09	0	0	5251	5251	5251	1
Body mass index	31513605	2019-09-12	0	0	8842	8842	8842	1
Body mass index	31669095	2019-10-24	0	0	457822	457822	457822	1636
Body mass index	31675503	2019-10-01	0	0	14126	14126	14126	2
Body mass index	31978080	2020-01-24	0	0	4626	4626	4626	1
Body mass index (SNP x SNP interaction)	22344221	2012-02-19	0	0	26620	26620	26620	8
Body mass index (adult)	28430825	2017-04-21	0	0	42752	42752	42752	21
Body mass index (age <50)	26426971	2015-10-01	0	0	112279	112279	112279	10
Body mass index (age interaction)	25953783	2015-05-07	0	0	9377	9377	9377	2
Body mass index (age>50)	26426971	2015-10-01	0	0	197610	197610	197610	8
Body mass index (change over time)	25133637	2014-08-18	0	0	4983	4983	4983	1
Body mass index (change over time) in chronic obstructive pulmonary disease	28044437	2017-01-02	237	0	0	237	237	1
Body mass index (change over time) in gastrointestinal cancer	28044437	2017-01-02	204	0	0	204	204	1
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	28044437	2017-01-02	441	0	0	441	441	1
Body mass index (joint analysis main effects and physical activity interaction)	28448500	2017-04-27	0	0	161368	161368	161368	162
Body mass index (joint analysis main effects and smoking interaction)	28443625	2017-04-26	0	0	196760	196760	196760	72
Body mass index (physical activity interaction)	28448500	2017-04-27	0	0	161368	161368	161368	1
Body mass index in asthmatics	23517042	2013-04-01	0	0	6151	6151	6151	1
Body mass index in physically active individuals	28448500	2017-04-27	0	0	123097	123097	123097	105
Body mass index in physically inactive individuals	28448500	2017-04-27	0	0	38595	38595	38595	20
Body mass index variance	26278006	2015-08-17	0	0	14131	14131	14131	1
Body mass index variance	31453325	2019-08-14	0	0	346393	346393	346393	22
Body mass index x sex x age interaction (4df test)	26426971	2015-10-01	0	0	309889	309889	309889	12
Bone fracture in osteoporosis	28580392	2016-08-27	0	0	10305	10305	10305	1
Bone mineral accretion in asthma (oral corticosteroid dose interaction)	26025128	2015-05-27	0	0	489	489	489	4
Bone mineral content	31790847	2019-11-29	0	0	1030	1030	1030	1
Bone mineral density	18455228	2008-04-29	0	0	2094	2094	2094	2
Bone mineral density	19249006	2009-02-25	0	0	1000	1000	1000	1
Bone mineral density	20096396	2010-01-20	0	0	785	785	785	1
Bone mineral density	21124946	2010-11-18	0	0	1934	1934	1934	1
Bone mineral density	21533022	2011-04-21	0	0	1955	1955	1955	3
Bone mineral density	22792070	2012-07-05	0	0	2659	2659	2659	2
Bone mineral density	22792071	2012-07-05	0	0	5672	5672	5672	1
Bone mineral density	23437003	2013-02-21	0	0	5878	5878	5878	5
Bone mineral density	23572186	2013-04-09	0	0	5866	5866	5866	1
Bone mineral density	23644456	2013-05-05	4931	69034	0	73965	18409.066666666666	2
Bone mineral density	24249740	2013-11-17	0	0	11140	11140	11140	16
Bone mineral density (Ward's triangle area)	27397699	2016-07-07	0	0	5596	5596	5596	1
Bone mineral density (femoral neck)	26911590	2016-02-25	0	0	1042	1042	1042	1
Bone mineral density (hip)	18445777	2008-04-29	0	0	5861	5861	5861	4
Bone mineral density (hip)	19079262	2008-12-14	0	0	6865	6865	6865	3
Bone mineral density (hip)	19801982	2009-10-04	0	0	19195	19195	19195	9
Bone mineral density (hip)	26733130	2016-01-06	0	0	20162	20162	20162	4
Bone mineral density (hip)	27311723	2016-06-16	0	0	6912	6912	6912	4
Bone mineral density (hip)	30172743	2018-08-30	0	0	2286	2286	2286	4
Bone mineral density (hip) and age at menarche	26312577	2015-08-27	0	0	826	826	826	1
Bone mineral density (paediatric, lower limb)	24945404	2014-06-19	0	0	9416	9416	9416	7
Bone mineral density (paediatric, skull)	24945404	2014-06-19	0	0	9385	9385	9385	15
Bone mineral density (paediatric, total body less head)	24945404	2014-06-19	0	0	9416	9416	9416	10
Bone mineral density (paediatric, total body less head)	28743860	2017-07-25	0	0	10414	10414	10414	7
Bone mineral density (paediatric, upper limb)	24945404	2014-06-19	0	0	9416	9416	9416	8
Bone mineral density (spine)	18445777	2008-04-29	0	0	5861	5861	5861	6
Bone mineral density (spine)	19079262	2008-12-14	0	0	6865	6865	6865	3
Bone mineral density (spine)	19801982	2009-10-04	0	0	19195	19195	19195	15
Bone mineral density (spine)	26733130	2016-01-06	0	0	20132	20132	20132	6
Bone mineral density (spine)	26911590	2016-02-25	0	0	1042	1042	1042	1
Bone mineral density (spine)	27424934	2016-07-15	0	0	2729	2729	2729	1
Bone mineral density (total hip)	27424934	2016-07-15	0	0	2729	2729	2729	2
Bone mineral density (total hip)	29883787	2018-06-05	0	0	2110	2110	2110	3
Bone properties (heel)	24430505	2014-01-14	0	0	14260	14260	14260	17
Bone ultrasound measurement (broadband ultrasound attenuation)	28472463	2017-05-04	0	0	16627	16627	16627	13
Bone ultrasound measurement (velocity of sound)	28472463	2017-05-04	0	0	16627	16627	16627	9
Brain connectivity	23471985	2013-03-05	0	0	331	331	331	12
Brain imaging	20100581	2010-01-22	529	204	0	733	588.9004092769441	1
Brain imaging measurements	30305740	2018-10-10	0	0	8428	8428	8428	6
Brain region volumes	31676860	2019-11-01	0	0	19629	19629	19629	1080
Brain structure	22504417	2012-04-15	2020	5775	0	7795	5986.144964720975	2
Brain volume in infants (grey matter)	28763065	2017-08-01	0	0	428	428	428	1
Brain volume in infants (white matter)	28763065	2017-08-01	0	0	428	428	428	1
Brainstem volume	31636452	2019-10-21	0	0	28809	28809	28809	16
Branched-chain amino acid levels (Isoleucine)	27898682	2016-11-29	0	0	16596	16596	16596	5
Branched-chain amino acid levels (Leucine)	27898682	2016-11-29	0	0	16596	16596	16596	1
Branched-chain amino acid levels (Valine)	27898682	2016-11-29	0	0	16596	16596	16596	1
Breakfast cereal skipping frequency	31190057	2019-06-13	0	0	193860	193860	193860	6
Breakfast skipping	31190057	2019-06-13	1359	10604	0	11963	4818.468945916576	6
Breast Cancer in BRCA1 mutation carriers	23544013	2013-03-27	1426	1301	0	2727	2721.2702603593693	2
Breast Cancer in BRCA1 mutation carriers	29058716	2017-10-23	7784	7782	0	15566	15565.999743029679	4
Breast cancer	17529967	2007-05-27	390	364	0	754	753.1034482758621	5
Breast cancer	17529973	2007-05-27	1145	1142	0	2287	2286.9960647135986	1
Breast cancer	17529974	2007-05-27	1599	11546	0	13145	5617.970026626093	2
Breast cancer	18326623	2008-03-11	249	299	0	548	543.4379562043796	1
Breast cancer	19219042	2009-02-15	1505	1522	0	3027	3026.904525933267	1
Breast cancer	19330027	2009-05-01	390	364	0	754	753.1034482758621	2
Breast cancer	19330030	2009-03-29	1145	1142	0	2287	2286.9960647135986	4
Breast cancer	20453838	2010-05-09	3659	4897	0	8556	8376.86909770921	8
Breast cancer	20585626	2010-06-24	2073	2084	0	4157	4156.970892470531	1
Breast cancer	20852631	2010-09-19	1193	1190	0	2383	2382.9962232480066	1
Breast cancer	20872241	2010-09-26	2702	5726	0	8428	7342.976744186048	1
Breast cancer	21263130	2011-01-24	2839	3507	0	6346	6275.684210526316	7
Breast cancer	21908515	2011-09-09	2062	2066	0	4128	4127.996124031008	1
Breast cancer	22037553	2011-10-30	3749	3670	0	7419	7418.1587815069415	1
Breast cancer	22383897	2012-02-23	2918	2324	0	5242	5174.690576115986	1
Breast cancer	22452962	2012-03-27	2273	2052	0	4325	4313.707283236994	1
Breast cancer	22976474	2012-09-13	4670	31608	0	36278	16275.358068250729	3
Breast cancer	23535729	2013-04-01	10052	12575	0	22627	22345.675520395987	62
Breast cancer	23535733	2013-04-01	4193	35194	0	39387	14986.512504125727	10
Breast cancer	24143190	2013-10-15	2642	2099	0	4741	4678.808690149758	3
Breast cancer	25038754	2014-07-20	5113	4337	0	9450	9386.277671957672	3
Breast cancer	25327703	2014-10-20	1497	3213	0	4710	4084.807643312102	2
Breast cancer	25751625	2015-04-01	15748	18084	0	33832	33670.70607708678	120
Breast cancer	27117709	2016-04-27	4939	14352	0	19291	14697.947851329634	20
Breast cancer	27354352	2016-06-27	7619	6286	0	13905	13777.212225818052	6
Breast cancer	29058716	2017-10-23	21919	65908	0	87827	65794.6850968381	10
Breast cancer	29059683	2017-10-23	76192	63082	0	139274	138039.9426741531	379
Breast cancer	31757997	2019-11-22	6669	21930	0	28599	20455.42431553551	15
Breast cancer (early onset)	24493630	2014-02-03	3523	2702	0	6225	6116.720321285141	18
Breast cancer (estrogen-receptor negative)	27117709	2016-04-27	4939	14352	0	19291	14697.947851329634	15
Breast cancer (estrogen-receptor negative)	28171663	2016-09-04	1391	4774	0	6165	4308.602757502027	2
Breast cancer (estrogen-receptor negative)	29058716	2017-10-23	14135	58126	0	72261	45480.190420835585	31
Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	24325915	2013-12-09	1529	3399	0	4928	4218.401785714285	2
Breast cancer (estrogen-receptor positive)	28171663	2016-09-04	1894	4774	0	6668	5424.088782243552	1
Breast cancer (male)	23001122	2012-09-23	823	2795	0	3618	2543.156440022112	2
Breast cancer (survival)	25890600	2015-04-18	37954	0	0	37954	37954	2
Breast cancer in BRCA2 mutation carriers	21060860	2010-10-28	899	804	0	1703	1697.7005284791546	1
Breast cancer in BRCA2 mutation carriers	23544012	2013-03-27	0	0	8211	8211	8211	3
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	29059430	2017-11-01	131	493	0	624	413.9935897435898	1
Breast milk fatty acid composition (infant genotype effect)	29514873	2018-03-07	0	0	1142	1142	1142	1
Breast milk fatty acid composition (maternal genotype effect)	29514873	2018-03-07	0	0	1142	1142	1142	10
Breast size	22747683	2012-06-30	0	0	16175	16175	16175	7
Breast size	27182965	2016-05-16	0	0	33790	33790	33790	12
Breast size	29855537	2018-05-31	0	0	5609	5609	5609	6
Broad depression or bipolar disorder	30626913	2019-01-09	16721	18769	51258	86748	35371.81730064807	2
Broad depression or major depressive disorder (recurrent)	30626913	2019-01-09	14543	14856	51258	80657	29395.667607741765	1
Broad depression or major depressive disorder (self-reported)	30626913	2019-01-09	84847	241266	51258	377371	251087.1544771291	3
Broad depression or schizophrenia	30626913	2019-01-09	46229	122594	51258	220081	134280.23494429077	16
Bronchial hyperresponsiveness in asthma	27439200	2016-07-20	920	980	0	1900	1898.1052631578948	1
Bronchial neuroendocrine tumor	27492634	2016-08-01	128	4542	0	4670	497.96659528907924	1
Bronchodilator response in asthma	25562107	2015-03-01	0	0	724	724	724	1
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	24280104	2013-11-23	172	409	0	581	484.32358003442334	4
Brown vs. black hair color	30531825	2018-12-10	0	0	283920	283920	283920	56
Brown vs. non-brown hair color	26184321	2015-07-13	0	0	7091	7091	7091	7
Brugada syndrome	23872634	2013-07-21	312	1115	0	1427	975.1366503153469	3
Burning and freckling	18488028	2008-05-18	0	0	5130	5130	5130	1
Butyrylcholinesterase levels	21862451	2011-08-23	0	0	6879	6879	6879	3
C-X-C motif chemokine 10 levels	25147954	2014-08-22	0	0	653	653	653	1
C-peptide levels in type I diabetes	29404672	2018-02-05	0	0	3479	3479	3479	1
C-reactive protein	18439548	2008-04-24	0	0	6345	6345	6345	7
C-reactive protein	18439552	2008-04-24	0	0	909	909	909	1
C-reactive protein	19567438	2009-07-01	0	0	17967	17967	17967	5
C-reactive protein	21196492	2010-12-31	0	0	10112	10112	10112	3
C-reactive protein	21647738	2011-06-07	0	0	1709	1709	1709	2
C-reactive protein	22492993	2012-04-05	0	0	837	837	837	1
C-reactive protein	22939635	2012-08-28	0	0	11828	11828	11828	10
C-reactive protein	23844046	2013-07-02	0	0	6692	6692	6692	4
C-reactive protein (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	2
C-reactive protein and white blood cell count	22788528	2012-07-13	0	0	8722	8722	8722	9
C-reactive protein levels	21300955	2011-02-07	0	0	66185	66185	66185	18
C-reactive protein levels	24763700	2014-04-24	0	0	7626	7626	7626	3
C-reactive protein levels	28548082	2017-05-26	0	0	3213	3213	3213	1
C-reactive protein levels	29403010	2018-02-05	0	0	75391	75391	75391	7
C-reactive protein levels	30388399	2018-11-01	0	0	206158	206158	206158	133
C-reactive protein levels	31217584	2019-06-19	0	0	28520	28520	28520	39
C-reactive protein levels	31900758	2020-01-03	0	0	418642	418642	418642	526
C-reactive protein levels in ischemic stroke	26718567	2015-12-30	2100	0	0	2100	2100	1
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	27286809	2016-06-10	0	0	164900	164900	164900	20
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	27286809	2016-06-10	0	0	160454	160454	160454	21
C-reactive protein levels or total cholesterol levels (pleiotropy)	27286809	2016-06-10	0	0	165184	165184	165184	20
C-reactive protein levels or triglyceride levels (pleiotropy)	27286809	2016-06-10	0	0	161598	161598	161598	21
C4b binding protein levels	20212171	2010-03-08	0	0	352	352	352	1
CCL19 levels	25147954	2014-08-22	0	0	653	653	653	1
CCL24 levels	25147954	2014-08-22	0	0	653	653	653	1
CD40 ligand levels	25147954	2014-08-22	0	0	653	653	653	1
CD4:CD8 lymphocyte ratio	20045101	2009-12-31	0	0	3627	3627	3627	1
CD8-positive T-lymphocyte count	20045101	2009-12-31	0	0	3627	3627	3627	1
CTACK levels	27989323	2016-12-13	0	0	3631	3631	3631	3
CXCL5 levels	25147954	2014-08-22	0	0	653	653	653	2
Cadmium levels	26025379	2015-05-29	0	0	949	949	949	1
Caffeine consumption	21490707	2011-04-07	0	0	47431	47431	47431	2
Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	27702941	2016-10-03	0	0	9054	9054	9054	8
Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	27702941	2016-10-03	0	0	5261	5261	5261	1
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	27702941	2016-10-03	0	0	5353	5353	5353	1
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	27702941	2016-10-03	0	0	5323	5323	5323	29
Calcaneal bone ultrasound measurement (speed of sound)	26686025	2015-12-12	0	0	1895	1895	1895	1
Calcaneus stiffness index	30779856	2019-02-19	0	0	7742	7742	7742	3
Calcific aortic valve stenosis	29511167	2018-03-07	1009	1017	0	2026	2025.9684106614015	1
Calcific aortic valve stenosis	32141789	2019-10-15	5115	354072	0	359187	20168.63951089544	4
Calcium levels	20661308	2010-07-22	0	0	12865	12865	12865	1
Calcium levels	20705733	2010-08-12	0	0	20611	20611	20611	1
Calcium levels	24068962	2013-09-19	0	0	39400	39400	39400	8
Calcium levels	25972035	2015-05-14	0	0	4558	4558	4558	1
Calcium levels	29403010	2018-02-05	0	0	71701	71701	71701	17
Cancer	27197191	2016-04-20	61851	61820	0	123671	123670.99222938278	4
Cancer (pleiotropy)	27197191	2016-04-20	61851	61820	0	123671	123670.99222938278	14
Cannabis dependence symptom count	27028160	2016-03-30	0	0	14754	14754	14754	4
Cannabis use	30150663	2018-08-27	0	0	184765	184765	184765	8
Cannabis use (age at onset)	30003630	2018-07-13	0	0	24953	24953	24953	1
Cannabis use disorder	31209380	2019-06-17	2387	48985	0	51372	9104.3521762828	1
Capecitabine sensitivity	22864933	2012-01-03	0	0	503	503	503	1
Carbamazepine-induced maculopapular exanthema	29288229	2017-12-29	180	1066	0	1246	615.9871589085072	1
Carbamazepine-induced reaction with eosinophilia and systemic symptoms	31066027	2019-05-07	25	10701	0	10726	99.76692149916092	1
Carbamazepine-induced serious cutaneous adverse reaction	31066027	2019-05-07	43	10701	0	10744	171.31161578555472	2
Cardia gastric cancer	26129866	2015-06-30	1189	2708	0	3897	3304.913523222992	1
Cardiac Troponin-T levels	23247143	2012-12-16	0	0	11544	11544	11544	2
Cardiac Troponin-T levels	31014085	2019-04-24	0	0	10395	10395	10395	4
Cardiac hypertrophy	21348951	2011-02-01	0	0	851	851	851	1
Cardiac muscle measurement	21212386	2011-01-06	0	0	1258	1258	1258	1
Cardiac structure and function	19584346	2009-07-08	0	0	12612	12612	12612	1
Cardiac troponin-I levels	31014085	2019-04-24	0	0	14579	14579	14579	5
Cardiometabolic and hematological traits	27668658	2016-11-01	0	0	35981	35981	35981	17
Cardiovascular disease	30595370	2018-12-27	0	0	459000	459000	459000	285
Cardiovascular disease risk factors	21943158	2011-09-24	0	0	11683	11683	11683	19
Cardiovascular heart disease in diabetics	23982368	2013-08-28	669	1641	0	2310	1901.0025974025973	1
Cardiovascular risk factors	20838585	2010-09-09	0	0	525	525	525	2
Carotenoid and tocopherol levels	19185284	2009-01-29	0	0	1191	1191	1191	2
Carotenoid levels	23696881	2013-05-16	0	0	1200	1200	1200	3
Carotenoid levels (alpha-carotene)	28002826	2016-12-22	0	0	433	433	433	3
Carotid atherosclerosis in HIV infection	20009918	2010-01-01	0	0	177	177	177	1
Carotid intima media thickness	21909108	2011-09-11	0	0	31211	31211	31211	5
Carotid intima media thickness	26343869	2015-09-05	0	0	810	810	810	3
Carotid intima media thickness	30510157	2018-12-03	0	0	71128	71128	71128	11
Carotid intima media thickness (maximum)	31801372	2019-12-05	0	0	22179	22179	22179	3
Carotid intima media thickness (mean)	31801372	2019-12-05	0	0	22179	22179	22179	12
Carotid intima media thickness (mean-maximum)	31801372	2019-12-05	0	0	22179	22179	22179	8
Carotid intima media thickness in rheumatoid arthritis	30251476	2018-09-24	0	0	1355	1355	1355	1
Carotid plaque	30510157	2018-12-03	21540	26894	0	48434	47842.15716232399	5
Carotid plaque burden	28282560	2017-02-24	0	0	7189	7189	7189	2
Carpal tunnel syndrome	30833571	2019-03-04	12312	389344	0	401656	47738.39631923836	16
Cataracts (operation)	31816047	2019-12-09	21679	387283	0	408962	82119.20087440887	20
Caudate nucleus volume	31636452	2019-10-21	0	0	37741	37741	37741	16
Celiac disease	17558408	2007-06-10	778	1422	0	2200	2011.4836363636364	2
Celiac disease	18311140	2008-03-02	767	1422	0	2189	1993.0086797624483	5
Celiac disease	20190752	2010-02-28	4533	10750	0	15283	12753.975004907415	27
Celiac disease	22057235	2011-11-06	12041	12228	0	24269	24267.559108327496	35
Celiac disease	23936387	2013-08-02	0	0	206	206	206	1
Celiac disease	24999842	2014-07-07	1550	3084	0	4634	4126.197669400087	4
Celiac disease	25920553	2015-04-29	425	453	0	878	877.1070615034168	23
Celiac disease	30572963	2018-12-20	11489	22308	0	33797	30333.652336006155	29
Celiac disease	31591516	2019-10-07	12948	14826	0	27774	27647.014906027216	4
Celiac disease and Rheumatoid arthritis	26546613	2016-01-01	26200	20754	0	46954	46322.34101461004	24
Celiac disease or Rheumatoid arthritis	21383967	2011-02-24	10072	27981	0	38053	29624.432449478358	12
Cellular adhesion molecule (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	1
Central corneal thickness	20485516	2010-05-13	301	301	5378	5980	602.0	2
Central corneal thickness	20719862	2010-08-18	0	0	1445	1445	1445	5
Central corneal thickness	22814818	2012-07-20	0	0	3931	3931	3931	2
Central corneal thickness	23493294	2013-03-14	0	0	1644	1644	1644	1
Central corneal thickness	28171582	2016-11-15	0	0	3584	3584	3584	5
Central corneal thickness	29760442	2018-05-14	0	0	25910	25910	25910	57
Central corneal thickness	29847655	2018-05-01	0	0	210	210	210	2
Central corneal thickness	30894546	2019-03-20	0	0	6125	6125	6125	6
Central corneal thickness	31798171	2019-11-27	0	0	16204	16204	16204	31
Central retinal arteriolar equivalent	26567291	2015-11-13	0	0	24275	24275	24275	1
Central retinal vein equivalent	26567291	2015-11-13	0	0	24275	24275	24275	4
Central serous retinopathy	31872073	2019-12-12	610	2850	0	3460	2009.8265895953755	4
Ceramide levels	31551469	2019-09-24	0	0	2045	2045	2045	7
Cerebral amyloid angiopathy	25188341	2014-09-04	1673	1134	0	2807	2703.501246882793	1
Cerebral amyloid deposition (PET imaging)	26252872	2015-08-07	0	0	883	883	883	1
Cerebral amyloid deposition (PET imaging)	30361487	2018-10-25	0	0	983	983	983	27
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	26252872	2015-08-07	0	0	370	370	370	1
Cerebral amyloid deposition positivity (PET imaging)	26252872	2015-08-07	0	0	646	646	646	1
Cerebral blood flow	28627999	2017-06-19	0	0	4472	4472	4472	1
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	25027320	2014-07-15	0	0	363	363	363	2
Cerebrospinal AB1-42 levels in mild cognitive impairment	29274321	2017-12-20	581	0	0	581	581	1
Cerebrospinal AB1-42 levels in normal cognition	29274321	2017-12-20	0	0	305	305	305	3
Cerebrospinal P-tau181p levels	28247064	2017-02-28	0	0	3146	3146	3146	5
Cerebrospinal T-tau levels	20932310	2010-10-08	281	109	0	390	314.14358974358976	1
Cerebrospinal T-tau levels	28247064	2017-02-28	0	0	3146	3146	3146	2
Cerebrospinal fluid AB1-42 levels	20932310	2010-10-08	281	109	0	390	314.14358974358976	1
Cerebrospinal fluid AB1-42 levels	26252872	2015-08-07	561	215	0	776	621.7268041237113	2
Cerebrospinal fluid AB1-42 levels	28247064	2017-02-28	0	0	3146	3146	3146	4
Cerebrospinal fluid AB1-42 levels	28641921	2017-05-15	113	0	730	843	843	4
Cerebrospinal fluid AB1-42 levels	29274321	2017-12-20	771	0	305	1076	1076	2
Cerebrospinal fluid AB1-42 levels	30319691	2018-09-24	531	0	281	812	812	5
Cerebrospinal fluid beta-site APP cleaving enzyme levels	29751835	2018-05-11	249	91	0	340	266.5764705882353	1
Cerebrospinal fluid biomarker levels	28031287	2016-11-26	0	0	133	133	133	65
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	25340798	2014-10-23	0	0	574	574	574	5
Cerebrospinal fluid neurofilament light levels	31930058	2019-11-01	0	0	263	263	263	1
Cerebrospinal fluid p-Tau181p:AB1-42 ratio	30319691	2018-09-24	531	0	281	812	812	4
Cerebrospinal fluid p-tau levels	29274321	2017-12-20	771	0	305	1076	1076	1
Cerebrospinal fluid p-tau levels in mild cognitive impairment	29274321	2017-12-20	581	0	0	581	581	2
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	30583557	2018-12-22	0	0	493	493	493	1
Cerebrospinal fluid sTREM-2 levels	31204042	2019-05-21	0	0	449	449	449	1
Cerebrospinal fluid sTREM-2 levels	31413141	2019-08-01	0	0	813	813	813	2
Cerebrospinal fluid sTREM-2 levels	31708768	2019-10-25	194	0	807	1001	1001	35
Cerebrospinal fluid t-tau levels	28641921	2017-05-15	113	0	730	843	843	3
Cerebrospinal fluid t-tau levels	29274321	2017-12-20	771	0	305	1076	1076	1
Cerebrospinal fluid t-tau levels in mild cognitive impairment	29274321	2017-12-20	581	0	0	581	581	1
Cerebrospinal fluid t-tau levels in normal cognition	29274321	2017-12-20	0	0	305	305	305	2
Cerebrospinal fluid t-tau:AB1-42 ratio	28641921	2017-05-15	113	0	730	843	843	21
Cerebrospinal fluid t-tau:AB1-42 ratio	30153862	2018-08-28	0	0	3146	3146	3146	8
Cerebrospinal fluid t-tau:AB1-42 ratio	30319691	2018-09-24	531	0	281	812	812	5
Cerebrospinal fluid α-synuclein levels	29959729	2018-06-29	49	0	160	209	209	2
Cervical artery dissection	25420145	2014-11-24	1393	14416	0	15809	5081.02675691062	2
Cervical cancer	23482656	2013-03-12	1034	3948	0	4982	3277.584905660377	3
Cervical cancer	23817570	2013-06-30	1364	3028	0	4392	3761.559198542805	4
Cervical cancer	27285765	2016-06-07	1637	4442	0	6079	4784.704063168284	1
Cervical cancer	28806749	2017-08-14	2866	6481	0	9347	7948.880282443564	7
Cervical cancer	30412241	2018-11-09	2609	4712	0	7321	6716.9009698128675	3
Cervical cancer	31488892	2019-09-05	538	39556	0	40094	2123.123459869307	14
Cervical cancer (multi-trait analysis)	31488892	2019-09-05	538	39556	0	40094	2123.123459869307	3
Change in glucose in response to thiazide diuretic treatment in hypertension	29523524	2018-03-09	0	0	310	310	310	3
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	25813999	2015-04-01	0	0	64	64	64	1
Change in neurofilament light levels	31295725	2019-07-11	0	0	545	545	545	1
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	31299468	2019-06-29	0	0	1345	1345	1345	1
Change in serum metabolite levels	31636271	2019-10-21	0	0	3351	3351	3351	6
Change in serum metabolite levels (CMS)	31636271	2019-10-21	0	0	3351	3351	3351	6
Cheek morphology (partial least square model)	30174134	2018-08-16	0	0	694	694	694	1
Chemerin levels	30866520	2019-03-07	0	0	2197	2197	2197	1
Chickenpox	28928442	2017-09-19	107769	15982	0	123751	55671.92695008525	4
Childhood absence epilepsy	30531953	2018-12-10	778	24218	0	24996	3015.1390622499603	2
Childhood and early adolescence aggressive behavior	26087016	2015-06-18	0	0	18988	18988	18988	1
Childhood body mass index	26604143	2015-11-24	0	0	34744	34744	34744	28
Childhood body mass index	31752434	2019-11-19	0	0	828	828	828	2
Childhood dental caries in permanent teeth	29931343	2018-06-20	5875	7478	0	13353	13160.563169325244	1
Childhood dental caries in primary teeth	29931343	2018-06-20	14452	21588	0	36040	34627.05615982242	1
Childhood ear infection	27182965	2016-05-16	46936	74874	0	121810	115402.21866841803	15
Childhood ear infection	28928442	2017-09-19	46936	74874	0	121810	115402.21866841803	25
Childhood maltreatment	32066696	2020-01-27	0	0	124711	124711	124711	3
Childhood obesity	31504550	2019-07-05	13005	15599	0	28604	28368.758914837086	10
Childhood onset systemic lupus erythematosus	29967481	2018-07-02	781	0	0	781	781	2
Childhood onset ulcerative colitis	29562276	2018-03-01	466	2099	0	2565	1525.3551656920079	1
Childhood steroid-sensitive nephrotic syndrome	29903748	2018-06-14	385	3267	0	3652	1377.6506024096384	5
Childhood steroid-sensitive nephrotic syndrome	30012571	2018-07-16	224	412	0	636	580.4276729559749	1
Childhood steroid-sensitive nephrotic syndrome	31263063	2019-07-01	422	5642	0	6064	1570.5303430079155	8
Chin dimples	27182965	2016-05-16	58032	13457	0	71489	43695.48456405881	46
Chloride levels	29403010	2018-02-05	0	0	126402	126402	126402	19
Cholelithiasis-related traits in sickle cell anemia	22558097	2012-04-27	905	0	0	905	905	1
Cholesterol	20066028	2010-01-08	0	0	656	656	656	1
Cholesterol	31902109	2020-01-04	0	0	6840	6840	6840	13
Cholesterol efflux capacity	29674289	2018-04-12	0	0	607	607	607	2
Cholesterol efflux capacity	30369316	2018-08-01	3487	1806	0	5293	4759.13243907047	3
Cholesterol efflux capacity (ABCA-1 dependent assay)	30369316	2018-08-01	3487	1806	0	5293	4759.13243907047	2
Cholesterol efflux capacity (BHK stimulated assay)	30369316	2018-08-01	3487	1806	0	5293	4759.13243907047	1
Cholesterol efflux capacity (cAMP stimulated assay)	30369316	2018-08-01	3487	1806	0	5293	4759.13243907047	2
Cholesterol ester levels in large LDL	29084231	2017-10-30	0	0	8372	8372	8372	6
Cholesterol ester levels in medium HDL	29084231	2017-10-30	0	0	8372	8372	8372	5
Cholesterol ester levels in medium LDL	29084231	2017-10-30	0	0	8372	8372	8372	9
Cholesterol ester levels in medium VLDL	29084231	2017-10-30	0	0	8372	8372	8372	2
Cholesterol ester levels in very large HDL	29084231	2017-10-30	0	0	8372	8372	8372	3
Cholesterol, total	19060911	2008-12-07	0	0	22562	22562	22562	12
Cholesterol, total	20686565	2010-08-05	0	0	100184	100184	100184	52
Cholesterol, total	24097068	2013-10-06	0	0	94595	94595	94595	72
Cholesterol, total	24886709	2014-06-02	0	0	3701	3701	3701	2
Cholesterol, total	25961943	2015-05-11	0	0	62166	62166	62166	47
Cholesterol, total	26582766	2015-11-18	0	0	8344	8344	8344	11
Cholesterol, total	26780889	2016-01-19	0	0	4383	4383	4383	6
Cholesterol, total	27036123	2016-04-01	0	0	60024	60024	60024	29
Cholesterol, total	28270201	2017-03-07	0	0	26122	26122	26122	17
Cholesteryl ester levels	31551469	2019-09-24	0	0	2045	2045	2045	9
Cholesteryl ester transfer protein levels	29728394	2018-05-01	0	0	4248	4248	4248	3
Chronic back pain	30261039	2018-09-27	29531	128494	0	158025	96049.51910140799	3
Chronic bronchitis and chronic obstructive pulmonary disease	25241909	2014-09-21	1844	5269	0	7113	5463.818923098552	5
Chronic central serous retinopathy	30073298	2018-08-02	521	3577	0	4098	1819.0502684236212	1
Chronic central serous retinopathy	30480742	2018-11-01	137	1174	0	1311	490.7337909992372	1
Chronic hepatitis B infection	23760081	2013-06-10	400	1000	0	1400	1142.857142857143	6
Chronic hepatitis B infection	24940741	2014-06-18	321	304	0	625	624.5376	5
Chronic hepatitis B infection	25802187	2015-04-28	2514	1130	0	3644	3118.3534577387486	9
Chronic hepatitis C infection	20060832	2010-01-07	0	0	1362	1362	1362	1
Chronic hepatitis C infection	20173735	2010-02-21	1286	0	0	1286	1286	2
Chronic hepatitis C infection	21725309	2011-07-03	977	0	0	977	977	1
Chronic hepatitis C infection	23420232	2013-02-19	2401	0	0	2401	2401	2
Chronic hepatitis C infection	24376798	2013-12-20	481	2963	0	3444	1655.288037166086	1
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	26974007	2016-03-14	52262	34213	0	86475	82707.82566059555	227
Chronic kidney disease	20383146	2010-04-11	0	0	67093	67093	67093	24
Chronic kidney disease	22479191	2012-03-29	0	0	74354	74354	74354	2
Chronic kidney disease	24351856	2013-12-18	301	276	0	577	575.9168110918545	1
Chronic kidney disease	26831199	2016-01-21	12385	104780	0	117165	44303.34314855119	5
Chronic kidney disease	29124443	2017-11-09	606	1040	0	1646	1531.5674362089915	16
Chronic kidney disease	31015462	2019-04-23	2044	65575	0	67619	7928.854316094589	3
Chronic kidney disease	31152163	2019-05-31	64164	561055	0	625219	230316.30849350386	24
Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes	31537649	2019-09-19	2235	14993	0	17228	7780.207801253773	1
Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes	31537649	2019-09-19	4266	14838	0	19104	13253.540201005024	2
Chronic kidney disease and serum creatinine levels	20686651	2010-07-29	1689	37076	0	38765	6461.639520185736	1
Chronic lymphocytic leukemia	18758461	2008-08-31	505	1438	0	1943	1494.9871332990222	6
Chronic lymphocytic leukemia	21131588	2010-12-03	407	296	0	703	685.4736842105264	2
Chronic lymphocytic leukemia	22700719	2012-06-13	1121	3745	0	4866	3451.0028771064526	5
Chronic lymphocytic leukemia	23770605	2013-06-16	2179	6221	0	8400	6455.028095238095	20
Chronic lymphocytic leukemia	24292274	2013-12-01	1739	5199	0	6938	5212.488325165754	12
Chronic lymphocytic leukemia	26956414	2016-03-09	3100	7667	0	10767	8829.83189374942	19
Chronic lymphocytic leukemia	28165464	2017-02-06	0	0	17691	17691	17691	35
Chronic lymphocytic leukemia or multiple sclerosis	31407831	2019-08-13	12264	24529	0	36793	32704.44443236485	7
Chronic lymphocytic leukemia or rheumatoid arthritis	31407831	2019-08-13	6413	11232	0	17645	16328.889997166334	1
Chronic lymphocytic leukemia or systemic lupus erythematosus	31407831	2019-08-13	9711	23144	0	32855	27362.822584081572	4
Chronic mountain sickness	31417607	2019-07-30	166	146	0	312	310.71794871794873	1
Chronic myeloid leukemia	21540461	2011-05-03	201	497	0	698	572.4756446991404	1
Chronic obstructive pulmonary disease	19300482	2009-03-20	823	810	0	1633	1632.896509491733	1
Chronic obstructive pulmonary disease	20173748	2010-02-21	2940	1380	0	4320	3756.6666666666665	2
Chronic obstructive pulmonary disease	22080838	2011-11-11	3499	1922	0	5421	4962.241652831581	2
Chronic obstructive pulmonary disease	25101718	2015-03-01	3775	4461	0	8236	8178.861097620204	1
Chronic obstructive pulmonary disease	25241909	2014-09-21	3777	3520	0	7297	7287.948471974783	3
Chronic obstructive pulmonary disease	28166215	2017-02-06	12550	45820	548	58918	39406.61298612301	23
Chronic obstructive pulmonary disease	29394082	2018-02-02	363	5253	0	5616	1358.1474358974358	2
Chronic obstructive pulmonary disease	30804561	2019-02-25	35735	222076	0	257811	123127.18790121446	102
Chronic obstructive pulmonary disease	31036433	2019-04-26	9876	318237	0	328113	38314.953836026	1
Chronic obstructive pulmonary disease (moderate to severe)	24621683	2014-02-07	6633	5704	0	12337	12267.0445002837	4
Chronic obstructive pulmonary disease (severe)	24621683	2014-02-07	3497	5704	0	9201	8671.61743288773	5
Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	30940143	2019-04-02	73351	169872	0	243223	204919.4537029804	3
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	30940143	2019-04-02	157343	360129	0	517472	438004.58573217486	22
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	30940143	2019-04-02	12550	46368	458969	517887	39507.00295325707	21
Chronic obstructive pulmonary disease-related biomarkers	23144326	2012-11-09	0	0	1951	1951	1951	17
Chronic periodontitis (localised)	30284742	2018-10-04	207	160	0	367	360.98092643051774	1
Chronic periodontitis (mean interproximal clinical attachment level)	27601451	2016-09-06	0	0	10935	10935	10935	1
Chronic rhinosinusitis	30643255	2019-01-14	5608	760086	0	765694	22267.706357892315	2
Chronic venous disease	28374850	2017-04-04	0	4942	0	4942	4942	2
Chronotype	26835600	2016-02-02	0	0	122125	122125	122125	2
Chronotype	26955885	2016-03-09	0	0	100420	100420	100420	9
Chronotype	27494321	2016-08-05	0	0	127898	127898	127898	13
Chronotype	28604731	2017-06-12	0	0	101185	101185	101185	9
Chronotype	30696823	2019-01-29	0	0	449734	449734	449734	425
Chylomicron and largest VLDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	2
Cigarettes smoked per day (MTAG)	30643251	2019-01-14	0	0	403928	403928	403928	84
Cingulate cortical amyloid beta load	26421299	2015-09-03	412	190	0	602	520.1328903654485	3
Circulating cell-free DNA	22511988	2012-04-12	0	0	1841	1841	1841	1
Circulating chemerin levels	25521368	2014-12-18	0	0	2791	2791	2791	4
Circulating chromogranin peptide levels	28011710	2016-12-22	0	0	1807	1807	1807	2
Circulating fibroblast growth factor 23 levels	30217807	2018-09-14	0	0	16624	16624	16624	5
Circulating leptin levels x sex interaction in high cardiovascular risk	31766143	2019-11-13	0	0	966	966	966	1
Circulating myeloperoxidase levels (plasma)	23620142	2013-04-24	0	0	9260	9260	9260	2
Circulating myeloperoxidase levels (serum)	23620142	2013-04-24	0	0	9305	9305	9305	3
Circulating odd-numbered chain saturated fatty acid levels (C17:0)	29738550	2018-05-08	0	0	6016	6016	6016	1
Circulating odd-numbered chain saturated fatty acid levels (C19:0)	29738550	2018-05-08	0	0	1910	1910	1910	10
Circulating vasoactive peptide levels	23381795	2013-02-04	0	0	3444	3444	3444	6
Cirrhosis	31815349	2019-12-09	1088	407873	0	408961	4340.421937544167	1
Cirrhosis (alcohol related)	26482880	2015-10-19	712	1426	0	2138	1899.55472404116	3
Cisplatin-induced ototoxicity	28039263	2016-12-30	0	0	511	511	511	1
Classic bladder exstrophy	25763902	2015-03-12	208	1703	0	1911	741.4421768707482	1
Cleft lip	20436469	2010-05-02	0	0	1863	1863	1863	2
Cleft lip with or without cleft palate	28054174	2017-01-04	814	1539	2811	5164	2129.6149596260093	23
Cleft palate	27018472	2016-04-07	78	1737	1	1816	298.59173553719006	4
Cleft palate	30452639	2018-11-19	205	2159	0	2364	748.8917089678511	2
Clinical laboratory measurements	27897004	2016-01-01	0	0	17347	17347	17347	8
Clinically amyopathic dermatomyositis	29331962	2018-01-13	33	6270	0	6303	131.30890052356023	1
Clopidogrel active metabolite levels	28207573	2017-04-01	0	0	513	513	513	7
Clostridium difficile infection in multiple myeloma	29594489	2018-03-28	57	589	0	646	207.8823529411765	3
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	26876947	2016-02-11	50	2905	0	2955	196.61590524534685	1
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	27400856	2016-07-12	66	5583	0	5649	260.9155602761551	1
Clozapine-induced cytotoxicity	25656473	2015-02-05	0	0	90	90	90	2
Coagulation factor levels	23267103	2012-12-24	0	0	3462	3462	3462	6
Cocaine dependence	23958962	2013-08-20	4291	1406	0	5697	4236.016148850272	1
Cocaine use disorder	31490055	2019-09-06	0	0	3640	3640	3640	1
Cocaine use disorder x change in residence interaction	31490055	2019-09-06	0	0	3640	3640	3640	2
Cocaine use disorder x household tobacco use interaction	31490055	2019-09-06	0	0	3640	3640	3640	1
Cocaine use disorder x non-traditional parental care interaction	31490055	2019-09-06	0	0	3640	3640	3640	1
Coenzyme Q10 levels	27149984	2016-05-05	0	0	1300	1300	1300	2
Coffee consumption	21357676	2011-02-28	0	0	6611	6611	6611	2
Coffee consumption	21876539	2011-08-30	0	0	18176	18176	18176	3
Coffee consumption	25288136	2014-10-07	0	0	48528	48528	48528	3
Coffee consumption	27561104	2016-08-25	0	0	1213	1213	1213	5
Coffee consumption	29367735	2018-01-24	0	0	6312	6312	6312	2
Coffee consumption	31046077	2019-05-02	0	0	335909	335909	335909	37
Coffee consumption	31345160	2019-07-26	0	0	6264	6264	6264	2
Coffee consumption	31959922	2020-01-20	0	0	152634	152634	152634	14
Coffee consumption (cups per day)	25288136	2014-10-07	0	0	91462	91462	91462	5
Coffee consumption (cups per day)	31217584	2019-06-19	0	0	35902	35902	35902	10
Cognitive ability	29186694	2017-11-28	0	0	107207	107207	107207	38
Cognitive ability (MTAG)	29186694	2017-11-28	0	0	436124	436124	436124	82
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	31374203	2019-08-01	77096	43456	436124	556676	111164.76793416949	235
Cognitive decline	22054870	2011-11-03	0	0	749	749	749	1
Cognitive decline	23207651	2012-12-04	0	0	3280	3280	3280	1
Cognitive decline (age-related)	24468470	2013-12-26	0	0	6655	6655	6655	2
Cognitive decline (age-related)	28078323	2016-12-21	0	0	3964	3964	3964	1
Cognitive decline rate in late mild cognitive impairment	26252872	2015-08-07	519	0	0	519	519	35
Cognitive empathy	28584286	2017-06-06	0	0	89553	89553	89553	2
Cognitive function	22126837	2011-11-28	347	353	0	700	699.9485714285714	2
Cognitive function	25644384	2015-02-03	0	0	53949	53949	53949	3
Cognitive function	28093568	2017-01-17	0	0	35298	35298	35298	2
Cognitive impairment	31201950	2019-03-06	355	6190	0	6545	1342.9793735676087	2
Cognitive impairment test score	30319691	2018-09-24	531	0	281	812	812	3
Cognitive performance	30038396	2018-07-23	0	0	257841	257841	257841	217
Cognitive performance (MTAG)	30038396	2018-07-23	0	0	402382	402382	402382	592
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	25672763	2015-02-08	117	691	0	808	400.23267326732673	1
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	28100913	2017-01-19	117	688	0	805	399.9801242236025	1
Cold sores	28928442	2017-09-19	25108	63332	0	88440	71919.4869289914	4
Collagenous colitis	26525574	2015-11-02	247	3969	0	4216	930.1166982922201	1
Colon cancer	28295283	2017-03-13	1451	0	4703	6154	6154	1
Colonoscopy-negative controls vs population controls	29228715	2017-10-09	0	4294	0	4294	4294	3
Colorectal cancer	17618283	2007-07-08	1257	1336	0	2593	2590.593135364443	1
Colorectal cancer	17618284	2007-07-08	930	960	0	1890	1889.5238095238094	1
Colorectal cancer	17934461	2007-10-14	930	960	0	1890	1889.5238095238094	1
Colorectal cancer	18372901	2008-03-30	981	1002	0	1983	1982.7776096822993	3
Colorectal cancer	18372905	2008-03-30	922	927	0	1849	1848.9864791779341	3
Colorectal cancer	19011631	2008-11-16	1902	1929	0	3831	3830.8097102584184	4
Colorectal cancer	20972440	2010-10-24	3334	4628	0	7962	7751.696558653604	5
Colorectal cancer	21242260	2011-01-17	1583	1898	0	3481	3452.495259982764	2
Colorectal cancer	21761138	2011-07-15	2906	3416	0	6322	6280.857956342929	1
Colorectal cancer	22634755	2012-05-27	8323	9457	0	17780	17707.67401574803	3
Colorectal cancer	23263487	2012-12-23	2098	5749	0	7847	6148.286988658086	5
Colorectal cancer	23266556	2012-12-21	12696	15113	0	27809	27598.92811679672	3
Colorectal cancer	24448986	2014-01-21	1773	2642	0	4415	4243.955605889015	1
Colorectal cancer	24737748	2014-04-15	5626	7817	0	13443	13085.90106375065	7
Colorectal cancer	24836286	2014-05-18	2098	6172	0	8270	6263.050060459493	14
Colorectal cancer	25023989	2014-07-14	2462	1497	0	3959	3723.782773427633	1
Colorectal cancer	25105248	2014-08-08	4520	8500	0	13020	11803.379416282643	1
Colorectal cancer	25990418	2015-05-20	7577	9979	0	17556	17227.359990886303	11
Colorectal cancer	26151821	2015-07-07	18299	19656	0	37955	37906.48336187591	16
Colorectal cancer	26965516	2016-03-08	4508	16588	0	21096	14178.745544178992	24
Colorectal cancer	27145994	2016-05-05	0	2329	0	2329	2329	2
Colorectal cancer	28295283	2017-03-13	1894	0	4703	6597	6597	1
Colorectal cancer	28960316	2017-09-28	1701	14082	0	15783	6070.704428815814	4
Colorectal cancer	29228715	2017-10-09	1614	4294	0	5908	4692.292484766418	1
Colorectal cancer	29471430	2018-02-17	6692	27178	0	33870	21479.20590493062	16
Colorectal cancer	29917119	2018-06-16	36948	30864	0	67812	67266.15183153424	22
Colorectal cancer	30104761	2018-08-13	4562	382756	0	387318	18033.067112811692	3
Colorectal cancer	30529582	2018-12-06	22775	47731	0	70506	61672.68175758091	30
Colorectal cancer	31089142	2019-05-14	31197	61770	0	92967	82912.80518893801	78
Colorectal cancer	31826910	2019-12-11	23572	48700	0	72272	63535.33318574274	26
Colorectal cancer (SNP x SNP interaction)	23300701	2012-12-26	8380	10558	0	18938	18687.515049107613	1
Colorectal cancer (alcohol consumption interaction)	27723779	2016-10-10	0	0	16823	16823	16823	1
Colorectal cancer (aspirin and/or NSAID use interaction)	25781442	2015-03-17	8634	8553	0	17187	17186.618257985687	2
Colorectal cancer (diet interaction)	24743840	2014-04-17	9287	9117	0	18404	18402.429689198	1
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	26766742	2016-01-14	554	729	0	1283	1259.1301636788778	1
Colorectal cancer or advanced adenoma	30510241	2018-12-03	58131	67347	0	125478	124801.11117486728	95
Colorectal or endometrial cancer	26621817	2015-12-01	7937	13396	0	21333	19936.0712511133	2
Common traits (Other)	20585627	2010-06-24	0	0	9126	9126	9126	5
Complement C3 and C4 levels	23028341	2012-09-13	0	0	1999	1999	1999	10
Composite immunoglobulin trait (IgA x IgG x IgM)	28628107	2017-06-19	0	0	14183	14183	14183	2
Composite immunoglobulin trait (IgA x IgG/IgM)	28628107	2017-06-19	0	0	14183	14183	14183	5
Composite immunoglobulin trait (IgA/IgG)	28628107	2017-06-19	0	0	14183	14183	14183	6
Composite immunoglobulin trait (IgA/IgM)	28628107	2017-06-19	0	0	14183	14183	14183	7
Composite immunoglobulin trait (IgG/IgM)	28628107	2017-06-19	0	0	14183	14183	14183	2
Conduct disorder (symptom count)	20585324	2010-06-27	0	0	3963	3963	3963	3
Congenital heart disease	23708191	2013-05-26	1819	5159	0	6978	5379.318429349383	1
Congenital heart malformation	23708190	2013-05-26	945	1246	0	2191	2149.6485623003196	2
Congenital left-sided heart lesions	25138779	2014-08-18	0	0	377	377	377	1
Congenital left-sided heart lesions	26965164	2016-03-09	592	2676	0	3268	1939.0354957160341	1
Contrast sensitivity	24152035	2013-10-23	0	0	985	985	985	1
Core binding factor acute myeloid leukemia	27903959	2017-01-31	175	218	0	393	388.29516539440203	1213
Corneal astigmatism	22144915	2011-12-01	2249	2005	0	4254	4240.004701457452	1
Corneal astigmatism	29422769	2018-02-05	13642	17728	0	31370	30837.791010519606	1
Corneal astigmatism	30306274	2018-10-10	0	0	86335	86335	86335	7
Corneal curvature	21665993	2011-06-10	0	0	4289	4289	4289	2
Corneal curvature	23401653	2013-01-03	0	0	2023	2023	2023	1
Corneal curvature	24963161	2014-06-24	0	0	7440	7440	7440	4
Corneal curvature	25823570	2015-03-31	0	0	3248	3248	3248	1
Corneal endothelial cell density	30894546	2019-03-20	0	0	6125	6125	6125	31
Corneal endothelial cell shape (percentage of hexagonally shaped cells)	30894546	2019-03-20	0	0	6125	6125	6125	7
Corneal endothelial cell size variation coefficient	30894546	2019-03-20	0	0	6125	6125	6125	13
Corneal hysteresis	30894546	2019-03-20	0	0	6125	6125	6125	2
Corneal hysteresis	31246245	2019-06-27	0	0	6645	6645	6645	5
Corneal resistance factor	30894546	2019-03-20	0	0	6125	6125	6125	7
Corneal resistance factor	31246245	2019-06-27	0	0	6645	6645	6645	8
Corneal structure	21979947	2011-10-06	222	3324	0	3546	832.4060913705583	1
Corneal structure	23291589	2013-01-06	0	0	20020	20020	20020	26
Coronary arterial lesions in patients with Kawasaki disease	23677057	2013-05-16	17	123	0	140	59.74285714285714	1
Coronary artery aneurysm in Kawasaki disease	27171184	2016-05-12	11	146	0	157	40.917197452229296	2
Coronary artery calcification	22144573	2011-12-05	0	0	9961	9961	9961	2
Coronary artery calcification	23561647	2013-03-13	0	0	2620	2620	2620	1
Coronary artery disease	21239051	2011-01-14	1808	915	0	2723	2430.1432243848694	3
Coronary artery disease	24262325	2013-11-21	33398	75726	0	109124	92705.4341116528	9
Coronary artery disease	26343387	2015-09-07	61289	126310	0	187599	165063.00332091324	42
Coronary artery disease	26708285	2016-02-01	2165	2266	0	4431	4428.697810877906	7
Coronary artery disease	28714974	2017-07-17	4831	115455	0	120286	18547.897677202665	20
Coronary artery disease	29212778	2017-12-06	88192	162544	0	250736	228688.0296088316	445
Coronary artery disease	29263402	2017-12-20	2169	7376	0	9545	6704.471031953903	1
Coronary artery disease	29472232	2018-02-22	280	350	0	630	622.2222222222223	4
Coronary artery disease	30104761	2018-08-13	31355	377103	0	408458	115792.21917553335	40
Coronary artery disease	30402224	2018-09-17	1482	5774	0	7256	4717.2370452039695	10
Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	28714975	2017-07-17	18467	45264	0	63731	52463.65429696693	55
Coronary artery disease and LDL cholesterol levels (multivariate analysis)	30525989	2018-12-01	122733	424528	188577	735838	380831.7787965888	2
Coronary artery disease and total cholesterol levels (multivariate analysis)	30525989	2018-12-01	122733	424528	188577	735838	380831.7787965888	1
Coronary artery disease and triglyceride levels (multivariate analysis)	30525989	2018-12-01	122733	424528	188577	735838	380831.7787965888	3
Coronary artery disease in diabetes	30003307	2018-07-12	3968	11698	0	15666	11851.822800970254	2
Coronary artery disease in type 1 diabetes	29695241	2018-04-25	0	0	3557	3557	3557	1
Coronary artery disease or ischemic stroke	24262325	2013-11-21	34622	88766	0	123388	99629.02233604563	14
Coronary artery disease or large artery stroke	24262325	2013-11-21	24400	75921	0	100321	73861.79962320949	17
Coronary heart disease	17554300	2007-06-07	1926	2938	0	4864	4653.444078947368	1
Coronary heart disease	17634449	2007-07-18	1926	2938	0	4864	4653.444078947368	3
Coronary heart disease	19198611	2009-02-08	1926	2938	0	4864	4653.444078947368	2
Coronary heart disease	19198612	2009-02-08	1222	1298	0	2520	2517.707936507936	1
Coronary heart disease	21088011	2010-11-18	1157	1748	0	2905	2784.765576592082	1
Coronary heart disease	21378988	2011-03-06	15420	15062	0	30482	30477.795420248014	8
Coronary heart disease	21378990	2011-03-06	22233	64762	0	86995	66203.96786022185	24
Coronary heart disease	21606135	2011-05-23	2078	2953	0	5031	4878.818525144106	3
Coronary heart disease	21846871	2011-08-01	15420	15062	0	30482	30477.795420248014	1
Coronary heart disease	21971053	2011-10-05	806	1337	0	2143	2011.426971535231	2
Coronary heart disease	22319020	2012-02-07	7123	6826	0	13949	13942.676320883216	1
Coronary heart disease	22745674	2012-06-20	0	0	1949	1949	1949	2
Coronary heart disease	22751097	2012-07-01	1515	5019	0	6534	4654.903581267217	7
Coronary heart disease	23364394	2013-01-31	2123	3591	0	5714	5336.85194259713	3
Coronary heart disease (SNP X SNP interaction)	21626137	2011-05-28	0	0	0	0	0	4
Corrected insulin response	24699409	2014-04-03	0	0	5372	5372	5372	5
Corrected insulin response adjusted for insulin sensitivity index	24699409	2014-04-03	0	0	4978	4978	4978	2
Cortex volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	1
Cortical amyloid beta load	29860282	2018-05-30	0	0	936	936	936	1
Cortical brain region measurements (area, volume and thickness)	30941828	2019-04-03	0	0	901	901	901	1
Cortical thickness	21810643	2011-08-01	573	481	0	1054	1045.9696394686907	1
Cortical thickness	22792071	2012-07-05	0	0	5878	5878	5878	2
Corticobasal degeneration	26077951	2015-06-16	152	3111	0	3263	579.6775973030954	3
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	29551627	2018-03-15	0	0	407	407	407	1
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	29551627	2018-03-15	0	0	407	407	407	1
Cortisol levels (plasma)	31169883	2019-06-06	0	0	7667	7667	7667	3
Cotinine and 3'-hydroxycotinine levels in current smokers	32157176	2020-03-10	0	0	5185	5185	5185	3
Cotinine glucuronidation	25293881	2014-10-07	0	0	2239	2239	2239	14
Cotinine levels in current smokers	32157176	2020-03-10	0	0	5185	5185	5185	3
Cotinine levels in smokers with chronic obstructive pulmonary disease	29631575	2018-04-10	0	0	4024	4024	4024	1
Cough in response to angiotensin-converting enzyme inhibitor drugs	26169577	2015-07-14	1595	5485	0	7080	4942.697740112993	1
Cough in response to angiotensin-converting enzyme inhibitor drugs	28084903	2017-01-13	123	1345	1	1469	450.77656675749313	2
Cranial base width	27560520	2016-08-25	0	0	2447	2447	2447	2
Craniofacial microsomia	26853712	2016-02-08	939	2012	0	2951	2560.851236868858	8
Creatine kinase levels	26838040	2016-02-03	0	0	63159	63159	63159	11
Creatine kinase levels	29403010	2018-02-05	0	0	106080	106080	106080	45
Creatine kinase levels in off-statin users	26838040	2016-02-03	0	0	6877	6877	6877	3
Creatine kinase levels in statin users	25214527	2014-09-11	0	0	3412	3412	3412	2
Creatine kinase levels in statin users	26838040	2016-02-03	0	0	5207	5207	5207	3
Creatinine levels	20383145	2010-04-11	0	0	23812	23812	23812	5
Creatinine levels	28270201	2017-03-07	0	0	23210	23210	23210	4
Creatinine levels	29124443	2017-11-09	0	0	5636	5636	5636	21
Creatinine levels	29403010	2018-02-05	0	0	142097	142097	142097	67
Creatinine levels	31015462	2019-04-23	0	0	69591	69591	69591	25
Creutzfeldt-Jakob disease	19081515	2008-12-11	117	3083	0	3200	450.88874999999996	1
Creutzfeldt-Jakob disease (sporadic)	25918841	2015-04-28	434	1939	0	2373	1418.5014749262536	2
Creutzfeldt-Jakob disease (variant)	22137330	2011-11-30	93	1504	0	1597	350.33688165309957	3
Crohn's disease	17435756	2007-04-15	946	977	0	1923	1922.5002600104003	4
Crohn's disease	17447842	2007-03-05	547	928	0	1475	1376.5857627118646	2
Crohn's disease	17554261	2007-06-06	1748	2938	0	4686	4383.801963294921	6
Crohn's disease	17554300	2007-06-07	1748	2938	0	4686	4383.801963294921	5
Crohn's disease	17684544	2007-08-08	393	399	0	792	791.9545454545455	1
Crohn's disease	17804789	2007-09-05	0	0	382	382	382	2
Crohn's disease	18587394	2008-06-29	3230	4829	0	8059	7741.739669934234	30
Crohn's disease	20570966	2010-06-22	896	3204	0	4100	2800.7648780487807	2
Crohn's disease	21102463	2010-11-21	6333	15056	0	21389	17831.529851792977	69
Crohn's disease	22293688	2012-02-01	0	0	16179	16179	16179	1
Crohn's disease	22412388	2012-03-08	737	2257	0	2994	2222.3233132932532	14
Crohn's disease	22936669	2012-08-30	1277	1488	0	2765	2748.898372513562	4
Crohn's disease	23128233	2012-11-01	12924	21442	0	34366	32254.717802479197	30
Crohn's disease	23266558	2012-12-21	0	372	0	372	372	6
Crohn's disease	23850713	2013-07-14	532	733	0	1265	1233.0624505928854	8
Crohn's disease	25489960	2015-01-01	722	461	0	1183	1125.4167371090448	2
Crohn's disease	26192919	2015-07-20	5956	14927	0	20883	17029.203083848108	141
Crohn's disease	26891255	2016-02-18	275	2369	0	2644	985.590015128593	5
Crohn's disease	28008999	2016-12-23	590	582	0	1172	1171.9453924914676	7
Crohn's disease	28067908	2017-01-09	12194	28072	0	40266	34004.8644513982	72
Crohn's disease	30500874	2018-11-29	713	2083	0	2796	2124.719599427754	5
Crohn's disease and celiac disease	21298027	2011-01-27	3998	6251	0	10249	9753.731290857646	2
Crohn's disease and psoriasis	22482804	2012-04-06	4671	10460	0	15131	12916.174740598772	2
Crohn's disease-related phenotypes	25557950	2014-12-31	1090	0	0	1090	1090	1
Cryptosporidiosis	32019797	2020-02-04	183	873	0	1056	605.1477272727273	1
Current cigarettes per day in chronic obstructive pulmonary disease	29767774	2018-05-15	3633	6305	0	9938	9219.587442141275	2
Curve progression in adolescent idiopathic scoliosis	29016859	2017-10-15	1105	832	0	1937	1898.5234899328857	1
Cutaneous lupus erythematosus	25827949	2015-05-04	151	1288	0	1439	540.6198749131341	7
Cutaneous malignant melanoma	26237428	2015-08-03	12874	23203	0	36077	33119.76295146492	7
Cutaneous nevi	19578365	2009-07-05	0	0	1524	1524	1524	2
Cutaneous psoriasis	26626624	2015-11-28	1363	4934	0	6297	4271.902175639193	5
Cutaneous squamous cell carcinoma	27424798	2016-07-18	6579	280558	0	287137	25713.037079860835	11
Cystatin C	17903292	2007-09-19	0	0	981	981	981	1
Cystic fibrosis severity	21602797	2011-05-22	2494	0	0	2494	2494	1
Cystic fibrosis-related diabetes	23670970	2013-05-13	644	2415	0	3059	2033.684210526316	1
Cytokine and corticosteroid-stimulated IL-6 production	25896417	2015-04-17	0	0	60	60	60	1
Cytokine levels	31679650	2019-10-30	0	0	9263	9263	9263	6
Cytokine network levels (multivariate analysis)	31679650	2019-10-30	0	0	9263	9263	9263	12
Cytokine-stimulated IL-6 production	25896417	2015-04-17	0	0	60	60	60	1
D-dimer levels	21502573	2011-04-21	0	0	21052	21052	21052	3
DDT metabolite (p,p'-DDE levels)	27839851	2016-11-11	0	0	1016	1016	1016	2
DHEAS levels	31169883	2019-06-06	0	0	7659	7659	7659	47
DIastolic blood pressure x physical activity interaction (2df)	31167214	2019-06-05	0	0	6704	6704	6704	1
DNA methylation (parent-of-origin)	23725790	2013-06-03	0	0	1024	1024	1024	6
DNA methylation (variation)	23725790	2013-06-03	0	0	256	256	256	3
DNA methylation variation (age effect)	30348214	2018-10-22	0	0	954	954	954	436
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	30201983	2018-09-10	0	0	443	443	443	1
Daytime nap	28604731	2017-06-12	0	113054	0	113054	113054	4
Daytime nap	30804565	2019-02-25	0	0	386577	386577	386577	7
Daytime sleep phenotypes	27126917	2016-04-29	0	0	874	874	874	3
Daytime sleepiness	28604731	2017-06-12	0	112717	0	112717	112717	6
Daytime sleepiness	30804565	2019-02-25	0	0	386548	386548	386548	1
Decline in glucose metabolism in posterior cingulate cortex	29130521	2017-11-11	414	192	0	606	524.6732673267327	3
Decreased low contrast letter acuity in multiple sclerosis	31289819	2019-09-01	0	0	582	582	582	1
Deep ovarian and/or rectovaginal disease with dense adhesions	28333195	2017-04-01	1364	0	7060	8424	8424	2
Degraded stimulus continuous performance test score	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	1
Dehydroepiandrosterone sulphate levels	21533175	2011-04-14	0	0	14846	14846	14846	8
Dehydroepiandrosterone sulphate levels	28887542	2017-09-08	0	0	9722	9722	9722	2
Delayed reward discounting	29230059	2017-12-11	0	0	23127	23127	23127	1
Delayed reward discounting	30265060	2018-09-27	0	0	986	986	986	1
Delirium	29631748	2018-03-10	421	5614	0	6035	1566.5246064623032	1
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	29246731	2017-11-02	0	0	141	141	141	6
Delta-6 desaturase activity	26584805	2015-11-19	717	644	0	1361	1357.084496693608	2
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	29246731	2017-11-02	0	0	141	141	141	1
Dementia and core Alzheimer's disease neuropathologic changes	25188341	2014-09-04	3887	1027	0	4914	3249.4497354497353	4
Dementia with Lewy bodies	29263008	2018-01-01	1216	3791	0	5007	3682.7289794288	4
Dementia with Lewy bodies	31065058	2019-05-07	720	6490	0	7210	2592.399445214979	2
Dengue shock syndrome	22001756	2011-10-16	2008	2018	0	4026	4025.9751614505712	2
Dental caries	23064961	2012-10-11	0	0	920	920	920	2
Dentate gyrus granule cell layer volume	30279459	2018-10-02	0	0	21297	21297	21297	5
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	1
Dentate gyrus molecular layer volume	30279459	2018-10-02	0	0	21297	21297	21297	5
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	1
Dentate gyrus volume x schizophrenia interaction	31155012	2019-06-03	128	144	3	275	271.05882352941177	1
Dentures	31235808	2019-06-24	77714	383317	0	461031	258456.34968581286	36
Depressed affect	29942085	2018-06-25	0	0	357957	357957	357957	157
Depression	27089181	2016-04-18	16471	58835	105739	181045	51473.78880832869	5
Depression	29700475	2018-04-26	135458	344901	0	480359	389039.0283766933	44
Depression	29942085	2018-06-25	0	0	688809	688809	688809	82
Depression	30718901	2019-02-04	246363	561190	0	807553	684816.7338614308	97
Depression (broad)	29662059	2018-04-16	113769	208811	0	322580	294577.700527001	45
Depressive and manic episodes in bipolar disorder	26297903	2015-08-20	723	0	0	723	723	1
Depressive episodes in bipolar disorder	26297903	2015-08-20	723	0	0	723	723	1
Depressive symptom (anhedonia) (binary trait)	31530331	2019-09-18	27288	121464	0	148752	89128.472410455	2
Depressive symptom (anhedonia) (ordinal trait)	31530331	2019-09-18	0	0	148752	148752	148752	2
Depressive symptom (appetite changes) (binary trait)	31530331	2019-09-18	26757	121995	0	148752	87776.17013552759	1
Depressive symptom (depressed mood) (binary trait)	31530331	2019-09-18	32263	116489	0	148752	101061.75666881789	1
Depressive symptom (depressed mood) (ordinal trait)	31530331	2019-09-18	0	0	148752	148752	148752	1
Depressive symptom (fatigue) (ordinal trait)	31530331	2019-09-18	0	0	148752	148752	148752	5
Depressive symptom (low self-esteem) (ordinal trait)	31530331	2019-09-18	0	0	148752	148752	148752	1
Depressive symptom (sleep problems) (binary trait)	31530331	2019-09-18	72302	76450	0	148752	148636.33161234806	3
Depressive symptom measurement or major depressive disorder	28049566	2016-12-08	9240	9519	51150	69909	18754.85047177355	1
Depressive symptoms	29292387	2018-01-01	0	0	354862	354862	354862	32
Depressive symptoms	30643256	2019-01-14	0	0	1067913	1067913	1067913	239
Depressive symptoms (MTAG)	29292387	2018-01-01	0	0	354862	354862	354862	64
Depressive symptoms (SSRI exposure interaction)	25649181	2015-01-20	0	0	6443	6443	6443	1
Depressive symptoms (binary sum-score)	31530331	2019-09-18	0	0	148752	148752	148752	4
Depressive symptoms (stressful life events interaction)	27529621	2016-08-16	0	0	320	320	320	1
Depressive symptoms (sum-score)	31530331	2019-09-18	0	0	148752	148752	148752	2
Depressive symptoms x dependent stressful life events interaction (1df test)	30718454	2019-02-04	0	0	4919	4919	4919	2
Depressive symptoms x dependent stressful life events interaction (2df test)	30718454	2019-02-04	0	0	4919	4919	4919	2
Dermatomyositis	27153935	2016-05-06	0	1566	127	1693	1693	2
Dermatomyositis or juvenile dermatomyositis	26362759	2015-09-11	879	15651	0	16530	3329.033030852995	1
Developmental dysplasia of the hip	30273415	2018-05-31	770	3364	0	4134	2506.318335752298	1
Diabetes (gestational)	22233651	2012-01-10	468	1242	0	1710	1359.6631578947367	2
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	27670767	2016-09-27	0	0	552	552	552	1
Diabetic kidney disease	26305897	2015-08-25	3223	2974	0	6197	6186.994997579473	2
Diabetic nephropathy in type 1 diabetes	31537649	2019-09-19	4948	12076	0	17024	14039.484962406015	2
Diabetic peripheral neuropathy in type 2 diabetes	31127053	2019-05-24	4384	784	0	5168	2660.260061919505	1
Diabetic retinopathy	21310492	2011-02-08	176	677	0	853	558.7432590855802	4
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	28753643	2017-07-28	481	0	0	481	481	3
Diarrhoea-associated Entamoeba histolytica infection	30228239	2018-09-18	170	574	0	744	524.6236559139785	1
Diastolic blood pressure	19430479	2009-05-10	0	0	29136	29136	29136	6
Diastolic blood pressure	19430483	2009-05-10	0	0	34433	34433	34433	5
Diastolic blood pressure	21909115	2011-09-11	0	0	69395	69395	69395	17
Diastolic blood pressure	25249183	2014-09-23	0	0	11816	11816	11816	9
Diastolic blood pressure	26390057	2015-09-21	0	0	99994	99994	99994	12
Diastolic blood pressure	27618447	2016-10-01	0	0	192763	192763	192763	25
Diastolic blood pressure	27618448	2016-10-01	0	0	146562	146562	146562	12
Diastolic blood pressure	27618452	2016-09-12	0	0	201529	201529	201529	53
Diastolic blood pressure	27736895	2016-10-13	0	0	38450	38450	38450	3
Diastolic blood pressure	27841878	2016-11-14	0	0	321262	321262	321262	251
Diastolic blood pressure	28135244	2017-01-30	0	0	140886	140886	140886	55
Diastolic blood pressure	28234671	2017-07-01	0	0	15914	15914	15914	1
Diastolic blood pressure	28270201	2017-03-07	0	0	26409	26409	26409	4
Diastolic blood pressure	28498854	2017-05-12	0	0	31155	31155	31155	5
Diastolic blood pressure	28548082	2017-05-26	0	0	3213	3213	3213	1
Diastolic blood pressure	28739976	2017-07-24	0	0	150134	150134	150134	42
Diastolic blood pressure	29403010	2018-02-05	0	0	136615	136615	136615	18
Diastolic blood pressure	29615537	2018-03-01	0	0	33431	33431	33431	2
Diastolic blood pressure	30224653	2018-09-17	0	0	757601	757601	757601	194
Diastolic blood pressure	30487518	2018-11-28	0	0	130777	130777	130777	85
Diastolic blood pressure	30578418	2018-12-21	0	0	459777	459777	459777	84
Diastolic blood pressure	31217584	2019-06-19	0	0	35433	35433	35433	5
Diastolic blood pressure (alcohol consumption interaction)	24376456	2013-12-12	0	0	6882	6882	6882	1
Diastolic blood pressure (cigarette smoking interaction)	29455858	2018-02-15	0	0	129913	129913	129913	45
Diastolic blood pressure (long-term average)	28348047	2017-04-01	0	0	18422	18422	18422	3
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension	31754133	2019-11-21	0	0	687	687	687	4
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	29912962	2018-06-18	0	0	72871	72871	72871	41
Diastolic blood pressure x alcohol consumption interaction (2df test)	29912962	2018-06-18	0	0	133351	133351	133351	114
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	31167214	2019-06-05	0	0	6705	6705	6705	1
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	31167214	2019-06-05	0	0	6705	6705	6705	1
Diastolic blood pressure x physical activity interaction (1df)	31167214	2019-06-05	0	0	6704	6704	6704	1
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	29455858	2018-02-15	0	0	129901	129901	129901	5
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	29455858	2018-02-15	0	0	129901	129901	129901	83
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	29455858	2018-02-15	0	0	128608	128608	128608	1
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	29455858	2018-02-15	0	0	128608	128608	128608	76
Diastolic blood pressure x sodium interaction (1df test)	27271309	2016-08-01	0	0	1876	1876	1876	1
Diastolic blood pressure x sodium interaction (2df test)	27271309	2016-08-01	0	0	1876	1876	1876	2
Dietary macronutrient intake	23372041	2013-01-30	0	0	33533	33533	33533	1
Dietary macronutrient intake	23636237	2013-05-01	0	0	37537	37537	37537	2
Dietary macronutrient intake	29988085	2018-07-09	0	0	91114	91114	91114	5
Differential aging (frontal cortex)	28330615	2017-03-18	0	0	716	716	716	1
Differential aging in older adults (frontal cortex)	28330615	2017-03-18	0	0	413	413	413	1
Differentiated thyroid cancer	28703219	2017-07-13	470	8279	0	8749	1779.0056006400732	3
Diffuse cutaneous systemic sclerosis	29293537	2018-01-02	775	3726	0	4501	2566.229726727394	2
Diffuse large B cell lymphoma	25261932	2014-09-28	3857	7666	0	11523	10263.911134253234	5
Diffuse large B-cell lymphoma or multiple sclerosis	31407831	2019-08-13	13389	24813	0	38202	34785.74493482016	4
Diffuse large B-cell lymphoma or rheumatoid arthritis	31407831	2019-08-13	7538	11516	0	19054	18223.492809908683	1
Diffuse large B-cell lymphoma or systemic lupus erythematosus	31407831	2019-08-13	10836	23428	0	34264	29636.447349988328	1
Diffusing capacity of carbon monoxide	30694715	2019-01-29	0	0	6935	6935	6935	4
Diffusing capacity of the lung for carbon monoxide traits	30049742	2018-07-26	0	0	8372	8372	8372	1
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	24121790	2013-10-13	3928	3207	0	7135	7062.142116327961	3
Digit length ratio	23263445	2012-12-22	0	0	979	979	979	1
Digit length ratio	29659830	2018-04-12	0	0	12586	12586	12586	11
Digit length ratio (left hand)	29659830	2018-04-12	0	0	15661	15661	15661	19
Digit length ratio (right hand)	29659830	2018-04-12	0	0	12636	12636	12636	10
Diisocyanate-induced asthma	25918132	2015-04-26	74	824	0	898	271.60801781737194	8
Dimensional psychopathology (Arousal)	29496196	2018-02-20	0	0	4687	4687	4687	1
Dimensional psychopathology (Cognitive)	29496196	2018-02-20	0	0	4687	4687	4687	1
Dimensional psychopathology (Social)	29496196	2018-02-20	0	0	4687	4687	4687	2
Disc degeneration (lumbar)	22993228	2012-09-19	0	0	4683	4683	4683	3
Disc degeneration (lumbar)	24216480	2013-10-08	366	3331	0	3697	1319.0651879902623	1
Disease progression in age-related macular degeneration	29346644	2018-01-15	0	0	7738	7738	7738	4
Disease progression in age-related macular degeneration (adjusted for baseline)	29346644	2018-01-15	0	0	7738	7738	7738	2
Disease progression to choroidal neovascularization form in age-related macular degeneration	29346644	2018-01-15	0	0	7141	7141	7141	4
Disease progression to geographic atrophy form in age-related macular degeneration	29346644	2018-01-15	0	0	7248	7248	7248	2
Disorders of lipid metabolism	30166351	2018-08-30	0	0	4988	4988	4988	1
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	30120083	2018-08-14	2700	68300	0	71000	10389.295774647888	2
Diverticular disease	28585551	2017-06-06	5426	0	245951	251377	251377	3
Diverticular disease	30177863	2018-09-03	27444	382284	0	409728	102423.09137769448	41
Diverticular disease	30661054	2019-01-19	31964	419135	0	451099	118796.37188289045	3
Diverticulitis	28585551	2017-06-06	2764	0	245951	248715	248715	3
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	27143689	2016-05-03	0	0	623	623	623	1
Double-edged eyelids	29895819	2018-06-12	2069	3545	0	5614	5225.938724617029	1
Drinking behavior	21372407	2011-03-01	733	729	0	1462	1461.9890560875513	2
Drinking behavior	23364009	2013-01-30	1420	3590	0	5010	4070.0998003992013	1
Drug abuse	26202629	2016-07-23	2017	6845	0	8862	6231.715188445046	1
Drug experimentation measurement	30718321	2019-02-04	0	0	22572	22572	22572	1
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	21221126	2011-01-11	72	4251	0	4323	283.20333102012495	1
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	21801394	2011-07-29	424	1881	0	2305	1384.0242950108461	3
Drug-induced cholestatic/mixed liver injury	28043905	2016-12-30	323	0	10588	10911	10911	2
Drug-induced hepatocellular liver injury	28043905	2016-12-30	474	10588	0	11062	1814.757548363768	1
Drug-induced liver injury	22968431	2012-09-09	783	3001	0	3784	2483.914376321353	1
Drug-induced liver injury	28043905	2016-12-30	0	11450	0	11450	11450	2
Drug-induced liver injury (amoxicillin-clavulanate)	21570397	2011-04-12	201	532	0	733	583.530695770805	2
Drug-induced liver injury (diclofenac)	28043905	2016-12-30	67	10588	0	10655	266.3147817925856	1
Drug-induced liver injury (flucloxacillin)	19483685	2009-05-31	58	282	0	340	192.42352941176472	2
Drug-induced liver injury (flucloxacillin)	30661239	2019-01-19	197	6835	0	7032	765.9243458475542	7
Drug-induced liver injury (statins)	28043905	2016-12-30	59	10588	0	10647	234.69221376913683	1
Drug-induced liver injury (terbinafine)	28043905	2016-12-30	14	0	10588	10602	10602	1
Drug-induced liver injury in interferon-beta-treated multiple sclerosis	30013178	2018-07-16	38	113	0	151	113.74834437086093	1
Duodenal ulcer	22387998	2012-03-04	1043	21694	0	22737	3980.6204864318074	2
Dupuytren's disease	21732829	2011-07-06	856	2836	0	3692	2630.136511375948	9
Dupuytren's disease	28886342	2017-09-07	3871	4686	0	8557	8479.376416968564	25
Dysmenorrheic pain	27454463	2016-11-01	0	0	11891	11891	11891	1
Dysmenorrheic pain severity	29855537	2018-05-31	0	0	5734	5734	5734	2
Dysphagia	26116289	2015-06-24	71	484	0	555	247.66846846846843	1
E-selectin levels	20147318	2010-02-22	503	504	0	1007	1006.9990069513408	1
E-selectin levels	25147954	2014-08-22	0	0	653	653	653	1
EGFR mutation-positive lung adenocarcinoma	27501781	2016-08-09	663	4367	0	5030	2302.4421471172964	6
Ear morphology	26105758	2015-06-24	0	0	4919	4919	4919	7
Ear protrusion	26105758	2015-06-24	0	0	4919	4919	4919	1
Early age at menarche	29773799	2018-05-17	0	0	30266	30266	30266	1
Early cardiac repolarization	22342860	2012-02-15	0	0	1870	1870	1870	1
Early cardiac repolarization	31600170	2019-10-10	3305	36151	0	39456	12112.637368207625	1
Early diabetic kidney disease in type 2 diabetes	29703844	2018-04-27	1989	2238	0	4227	4212.33215046132	1
Early onset atrial fibrillation	28460022	2017-04-27	672	3700	0	4372	2274.83989021043	4
Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	31434886	2019-08-21	2160	1820	0	3980	3950.954773869347	1
Early response to risperidone in schizophrenia	26856250	2016-02-09	86	0	0	86	86	1
Early-onset Parkinson's disease	28256260	2017-02-02	403	1650	0	2053	1295.5674622503652	13
Ease of getting up in the morning	28604731	2017-06-12	0	0	112866	112866	112866	5
Ease of getting up in the morning	30804565	2019-02-25	0	0	385949	385949	385949	70
Eczema	30595370	2018-12-27	0	0	459000	459000	459000	182
Eczema	31361310	2019-07-30	7884	239773	0	247657	30532.071889750747	16
Educational attainment	23722424	2013-05-30	0	0	101069	101069	101069	3
Educational attainment	25201988	2014-09-08	0	0	106736	106736	106736	5
Educational attainment	27046643	2016-04-05	0	0	111114	111114	111114	15
Educational attainment (MTAG)	30038396	2018-07-23	0	0	1311438	1311438	1311438	1343
Educational attainment (college completion)	23722424	2013-05-30	0	0	126559	126559	126559	1
Educational attainment (college completion)	27225129	2016-05-26	0	0	280007	280007	280007	34
Educational attainment (years of education)	23722424	2013-05-30	0	0	126559	126559	126559	3
Educational attainment (years of education)	27225129	2016-05-26	0	0	405072	405072	405072	162
Educational attainment (years of education)	30038396	2018-07-23	0	0	1131881	1131881	1131881	1640
Educational attainment (years of education)	30595370	2018-12-27	0	0	455000	455000	455000	291
Ejection fraction	29403010	2018-02-05	0	0	19516	19516	19516	3
Ejection fraction in Tripanosoma cruzi seropositivity	24324551	2013-11-20	0	0	580	580	580	1
Electrocardiographic conduction measures	23463857	2013-03-05	0	0	5272	5272	5272	5
Electrocardiographic traits	20062061	2010-01-10	0	0	6543	6543	6543	2
Electrocardiographic traits	20062063	2010-01-10	0	0	12670	12670	12670	13
Electrocardiographic traits	25055868	2014-07-23	0	0	2994	2994	2994	2
Electroencephalogram traits	29947131	2018-06-26	0	0	8425	8425	8425	2
Electroencephalographic traits in alcoholism	22554406	2012-05-03	0	0	1677	1677	1677	1
Elevated serum carcinoembryonic antigen levels	24941225	2014-06-18	0	0	1999	1999	1999	13
Elevated serum prostate-specific antigen levels in healthy men	28471803	2017-05-03	0	0	2841	2841	2841	2
Emotional dysregulation	27643478	2016-09-09	0	0	2600	2600	2600	1
Empathy quotient	29527006	2018-03-12	0	0	46861	46861	46861	1
Emphysema distribution in smoking	27669027	2016-09-26	0	0	11532	11532	11532	9
Emphysema imaging phenotypes	26030696	2015-06-01	6286	5745	0	12031	12006.672762031418	7
End-stage coagulation	23381943	2013-01-01	0	0	2100	2100	2100	23
End-stage kidney disease	31178898	2019-05-24	1105	31694	0	32799	4271.089972255251	1
End-stage renal disease	29885931	2018-06-06	2650	1656	0	4306	4076.5443567115653	1
End-stage renal disease (non-diabetic)	20532800	2010-06-08	464	478	0	942	941.7919320594481	1
End-stage renal disease in Type 1 diabetics	24029427	2013-09-12	645	1590	0	2235	1835.4362416107383	1
End-stage renal disease in Type 1 diabetics	31537649	2019-09-19	2187	12101	0	14288	7408.9829227323635	1
Endometrial cancer	21499250	2011-04-17	1265	5190	0	6455	4068.3810999225407	1
Endometrial cancer	27008869	2016-03-23	4907	11945	0	16852	13912.678613814383	4
Endometrial cancer	27135401	2016-05-02	2212	9544	0	11756	7183.167063627084	7
Endometrial cancer	30093612	2018-08-09	12906	108979	0	121885	46157.70518111334	18
Endometrial cancer (endometrioid histology)	30093612	2018-08-09	8758	46126	0	54884	29441.841556737847	11
Endometrial endometrioid carcinoma	27135401	2016-05-02	2082	9544	0	11626	6836.610356098401	6
Endometrioid ovarian cancer	28346442	2017-03-27	2810	40941	0	43751	10518.087358003244	1
Endometriosis	20601957	2010-07-04	1423	1318	0	2741	2736.977745348413	1
Endometriosis	21151130	2010-12-12	3194	7060	0	10254	8796.426760288668	1
Endometriosis	23104006	2012-10-28	4604	9393	0	13997	12358.468814746017	6
Endometriosis	23472165	2013-03-05	1514	12660	0	14174	5409.126569775645	2
Endometriosis	27506219	2016-08-09	50	50	0	100	100.0	1
Endometriosis	28537267	2017-05-24	17045	191858	0	208903	62616.99659650651	22
Endometriosis	28881265	2017-09-01	171	2934	0	3105	646.3304347826088	5
Endometriosis or endometrial cancer (pleiotropy)	29608257	2018-04-02	5251	9196	0	14447	13369.750398006507	2
Endothelial growth factor levels	25552591	2014-12-31	0	0	3574	3574	3574	3
Energy expenditure	30071075	2018-08-02	0	0	18770	18770	18770	8
Energy intake	30071075	2018-08-02	0	0	18770	18770	18770	4
Enteric fever	25383971	2014-11-10	432	2011	0	2443	1422.4347114203847	1
Entorhinal cortical volume (Alzheimer's disease interaction)	21116278	2010-11-30	660	279	0	939	784.4089456869009	1
Eosinophil counts	19198610	2009-02-08	0	0	9392	9392	9392	5
Eosinophil counts	27863252	2016-11-17	0	0	172275	172275	172275	209
Eosinophil counts	29403010	2018-02-05	0	0	62076	62076	62076	20
Eosinophil counts	30595370	2018-12-27	0	0	440000	440000	440000	703
Eosinophil counts	31080455	2019-04-26	0	0	1555	1555	1555	2
Eosinophil counts	31272903	2019-07-01	0	0	4650	4650	4650	6
Eosinophil percentage of granulocytes	27863252	2016-11-17	0	0	170536	170536	170536	184
Eosinophil percentage of white cells	27863252	2016-11-17	0	0	172378	172378	172378	198
Eosinophilic esophagitis	25017104	2014-07-13	657	9296	0	9953	2454.525067818748	4
Eosinophilic esophagitis	25407941	2014-11-19	603	3637	0	4240	2068.9726415094337	4
Eosinophilic esophagitis	29904099	2018-06-08	1210	3734	0	4944	3655.453074433657	1
Eosinophilic esophagitis (pediatric)	20208534	2010-03-07	181	1974	0	2155	663.1907192575405	2
Eosinophilic granulomatosis with polyangiitis	31719529	2019-11-12	534	6688	0	7222	1978.0625865411241	4
Eosinophilic granulomatosis with polyangiitis (ANCA negative)	31719529	2019-11-12	352	6688	0	7040	1337.6	2
Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	31719529	2019-11-12	159	6688	0	6847	621.2309040455674	2
Eotaxin levels	27989323	2016-12-13	0	0	8153	8153	8153	11
Epigenetic age acceleration in alcohol use disorder	31466081	2019-08-29	0	0	310	310	310	1
Epilepsy	22116939	2011-11-24	504	2947	0	3451	1721.5740365111562	1
Epilepsy	25087078	2014-07-30	8696	26157	0	34853	26105.215849424727	4
Epilepsy	30531953	2018-12-10	15212	29677	0	44889	40227.80850542449	3
Epilepsy and lamotrigine-induced maculopapular eruptions	26220383	2015-06-02	34	1080	0	1114	131.8491921005386	9
Epirubicin-induced leukopenia	21799462	2011-07-27	67	203	0	270	201.4962962962963	1
Episodic memory	25385369	2014-11-11	0	0	6705	6705	6705	1
Epithelial ovarian cancer	25134534	2014-08-19	1044	1172	0	2216	2208.6064981949457	2
Epithelial ovarian cancer	25581431	2015-01-12	4368	0	9123	13491	13491	18
Epithelial ovarian cancer	28346442	2017-03-27	0	85426	0	85426	85426	17
Epithelial ovarian cancer	30898391	2019-03-19	3238	4083	0	7321	7223.468925010244	3
Epstein Barr virus nuclear antigen 1 IgG levels	26819262	2016-01-27	0	0	6547	6547	6547	8
Epstein Barr virus nuclear antigen 1 IgG levels	29868224	2017-11-27	0	0	3635	3635	3635	2
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	26819262	2016-01-27	5545	12153	5555	23253	15230.734546276415	3
Epstein Barr virus nuclear antigen 1 IgG seropositivity	29868224	2017-11-27	1201	361	0	1562	1110.271446862996	1
Epstein-Barr virus copy number in lymphoblastoid cell lines	28654678	2017-06-27	0	0	1753	1753	1753	1
Epstein-Barr virus immune response (EBNA-1)	23326239	2013-01-10	0	0	1367	1367	1367	2
Epstein-Barr virus immune response (multivariate analysis)	29868224	2017-11-27	0	0	1473	1473	1473	1
Erectile dysfunction	30297428	2018-10-08	14215	22434	0	36649	34805.785696744795	1
Erectile dysfunction	30583798	2018-12-21	6175	217630	0	223805	24018.50271441657	1
Erectile dysfunction and prostate cancer treatment	20932654	2010-10-05	27	52	0	79	71.0886075949367	1
Erosive tooth wear (severe vs non-severe)	29898447	2018-06-13	136	1808	0	1944	505.94238683127577	18
Erythema nodosum in inflammatory bowel disease	24487271	2014-03-01	103	5653	0	5756	404.62751911049344	1
Erythrocyte cadmium concentration in never smokers	27005419	2016-03-22	0	0	1728	1728	1728	2
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	30201983	2018-09-10	0	0	454	454	454	1
Erythrocyte sedimentation rate	21700265	2011-06-22	0	0	1979	1979	1979	5
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	30201983	2018-09-10	0	0	452	452	452	1
Esophageal adenocarcinoma	27527254	2016-08-12	4112	17159	0	21271	13268.35748201777	5
Esophageal cancer	19698717	2009-08-18	182	927	0	1109	608.526600541028	2
Esophageal cancer	21642993	2011-06-05	2031	2044	0	4075	4074.958527607362	9
Esophageal cancer  (alcohol interaction)	22960999	2012-09-09	2031	2044	0	4075	4074.958527607362	2
Esophageal cancer (squamous cell)	22960999	2012-09-09	2031	2044	0	4075	4074.958527607362	7
Esophageal cancer and gastric cancer	20729852	2010-08-22	3523	2100	0	5623	5262.884581184421	3
Esophageal squamous cell cancer (length of survival)	23644492	2013-05-05	1331	0	0	1331	1331	1
Esophageal squamous cell carcinoma	25129146	2014-08-17	5337	5787	0	11124	11105.796116504855	5
Esotropia	30098192	2018-08-01	1050	3740	0	4790	3279.331941544885	1
Essential tremor	19182806	2009-02-01	452	14378	0	14830	1752.8944032366824	1
Essential tremor	27797806	2016-10-20	1778	5376	0	7154	5344.438356164384	4
Esterified cholesterol levels	29084231	2017-10-30	0	0	8372	8372	8372	7
Estimated glomerular filtration rate	29124443	2017-11-09	0	0	5636	5636	5636	19
Estimated glomerular filtration rate	29779033	2018-05-18	0	0	11283	11283	11283	2
Estimated glomerular filtration rate	30604766	2019-01-03	0	0	312296	312296	312296	116
Estimated glomerular filtration rate	31015462	2019-04-23	0	0	350514	350514	350514	147
Estimated glomerular filtration rate	31152163	2019-05-31	0	0	765348	765348	765348	557
Estimated glomerular filtration rate	31217584	2019-06-19	0	0	27900	27900	27900	4
Estimated glomerular filtration rate	31451708	2019-08-26	0	0	280722	280722	280722	148
Estimated glomerular filtration rate in diabetes	31451708	2019-08-26	0	0	91729	91729	91729	33
Estimated glomerular filtration rate in non-diabetics	31451708	2019-08-26	0	0	188993	188993	188993	98
Estradiol levels	29325096	2018-01-09	0	0	11097	11097	11097	1
Estradiol levels	31169883	2019-06-06	0	0	6798	6798	6798	7
Estradiol plasma levels (breast cancer)	23518928	2013-03-21	772	0	0	772	772	1
Estrogen receptor status in HER2 negative breast cancer	27764800	2016-10-14	5452	0	0	5452	5452	1
Estrogen receptor status in breast cancer	27764800	2016-10-14	8727	0	0	8727	8727	1
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	28429243	2017-04-20	774	0	0	774	774	1
Estrone levels	29325096	2018-01-09	0	0	7570	7570	7570	4
Eudaimonic well-being	30279531	2018-10-02	0	0	108154	108154	108154	2
Ewing sarcoma	22327514	2012-02-12	427	4352	0	4779	1555.3915044988491	3
Ewing sarcoma	30093639	2018-08-09	733	1346	0	2079	1898.25493025493	3
Excessive daytime sleepiness	27992416	2016-12-19	0	0	111648	111648	111648	3
Excessive hairiness	29895819	2018-06-12	3830	7414	0	11244	10101.607968694416	4
Excessive sweating	29895819	2018-06-12	1245	3293	0	4538	3613.7373292199204	2
Executive function in ADHD	29769613	2018-05-16	547	0	0	547	547	1
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	28416812	2017-04-18	0	0	780	780	780	1
Exfoliation glaucoma or exfoliation syndrome	24938310	2014-06-18	201	697	0	898	624.0400890868598	2
Exfoliation syndrome	25706626	2015-02-23	1484	1188	0	2672	2639.2095808383233	3
Exhaled carbon monoxide levels	25072098	2014-09-01	0	0	1768	1768	1768	1
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	29631575	2018-04-10	0	0	2706	2706	2706	1
Experiencing mood swings	29500382	2018-03-02	0	0	373733	373733	373733	69
Expressive vocabulary in infants	25226531	2014-09-16	0	0	13150	13150	13150	1
Extranodal natural killer T-cell lymphoma (nasal type)	31879220	2019-12-23	700	7752	0	8452	2568.1022243256034	2
Extraversion	27918536	2016-12-05	0	0	122886	122886	122886	4
Extremely high intelligence	29520040	2018-03-08	1247	86493	0	87740	4917.108320036472	25
Extremely high intelligence	29731509	2017-07-04	1238	8172	0	9410	4300.504144527098	1
Extrinsic epigenetic age acceleration	29374233	2018-01-26	0	0	8393	8393	8393	3
Extrinsic epigenetic age acceleration	31738745	2019-11-18	0	0	13493	13493	13493	1
Exudative age-related macular degeneration	25629512	2015-01-28	2119	5691	0	7810	6176.30166453265	7
Eye color	20585627	2010-06-24	0	0	9126	9126	9126	8
Eye color	23118974	2012-10-31	0	0	175	175	175	1
Eye color	23548203	2013-04-01	0	0	3871	3871	3871	3
Eye color	30664655	2019-01-21	0	0	6236	6236	6236	8
Eye color (brightness)	30664655	2019-01-21	0	0	6236	6236	6236	10
Eye color (hue)	30664655	2019-01-21	0	0	6236	6236	6236	2
Eye color (saturation)	30664655	2019-01-21	0	0	6236	6236	6236	5
Eye color traits	20463881	2010-05-16	0	0	5951	5951	5951	3
Eye color traits	30166351	2018-08-30	0	0	4988	4988	4988	13
Eye length	30174134	2018-08-16	0	0	694	694	694	1
Eye morphology	27560520	2016-08-25	0	0	2447	2447	2447	2
Eye morphology	29921221	2018-06-19	0	0	5643	5643	5643	1
Eye movement (horizontal position gain)	30120336	2018-08-17	0	0	166	166	166	2
Eye movement in schizophrenia (horizontal position gain)	30120336	2018-08-17	60	0	0	60	60	3
Eyebrow thickness	26926045	2016-03-01	0	0	2922	2922	2922	1
Eyebrow thickness	30248107	2018-09-24	0	0	5983	5983	5983	4
F-cell distribution	17767159	2007-09-02	0	0	179	179	179	3
F-cell distribution in sickle cell anaemia	21326311	2011-02-17	0	0	440	440	440	1
FEV1	30804560	2019-02-25	0	0	321047	321047	321047	179
Face memory	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	1
Facial attractiveness (female raters)	30946739	2019-04-04	0	0	3928	3928	3928	1
Facial attractiveness (male raters)	30946739	2019-04-04	0	0	2062	2062	2062	1
Facial depth	27560520	2016-08-25	0	0	2447	2447	2447	1
Facial morphology	22341974	2012-02-16	0	0	2185	2185	2185	1
Facial morphology	29921221	2018-06-19	0	0	5643	5643	5643	1
Facial morphology	31763980	2019-11-25	0	0	10115	10115	10115	41
Facial morphology (factor 11, projection of the nose)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 14, intercanthal width)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 17, height of vermillion upper lip)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 21, depth of nasal alae)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 22)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 3, length of philtrum)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 7, width of cartilaginous portion of nose)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology (factor 9, facial height related to vertical position of nasion)	28441456	2017-04-25	0	0	2187	2187	2187	1
Facial morphology traits (63 three-dimensional facial segments)	29459680	2018-02-19	0	0	2329	2329	2329	10
Facial pigmentation	25705849	2015-02-23	0	0	2844	2844	2844	3
Facial wrinkles	29555444	2018-03-16	0	0	3513	3513	3513	1
Factor VII	17903294	2007-09-19	0	0	886	886	886	1
Factor VII activity	30642921	2019-01-14	0	0	23434	23434	23434	21
Factor VII activity or levels	30642921	2019-01-14	0	0	27495	27495	27495	6
Factor VII levels	20231535	2010-03-15	0	0	15422	15422	15422	2
Factor VIII levels	20231535	2010-03-15	0	0	15279	15279	15279	2
Factor VIII levels	30586737	2018-11-20	0	0	32610	32610	32610	61
Factor XI	28053049	2017-02-01	0	0	16169	16169	16169	2
Fagerstrӧm test for nicotine dependence	31294817	2019-07-11	0	0	19431	19431	19431	1
Familial lung cancer	29924316	2018-06-19	1993	33960	0	35953	7530.084276694574	1
Familial squamous cell lung carcinoma	29924316	2018-06-19	367	31563	0	31930	1451.126965236455	3
Family history of Alzheimer's disease	29777097	2018-05-18	0	0	314278	314278	314278	48
Family history of Alzheimer's disease	30617256	2019-01-07	47793	328320	0	376113	166879.61075527832	16
Fast beta electroencephalogram	28040410	2016-12-28	0	0	1681	1681	1681	1
Fast beta electroencephalogram	28070124	2017-01-10	0	0	2382	2382	2382	1
Fasting blood glucose	20081858	2010-01-17	0	0	46186	46186	46186	16
Fasting blood glucose	22581228	2012-05-13	0	0	58074	58074	58074	23
Fasting blood glucose	25631608	2015-01-29	0	0	60564	60564	60564	16
Fasting blood glucose	29212154	2017-09-16	0	0	10300	10300	10300	1
Fasting blood glucose	29621232	2018-04-05	0	0	5786	5786	5786	4
Fasting blood glucose	31217584	2019-06-19	0	0	23911	23911	23911	20
Fasting blood glucose (BMI interaction)	22581228	2012-05-13	0	0	58074	58074	58074	23
Fasting blood glucose adjusted for BMI	25625282	2015-01-27	0	0	33231	33231	33231	6
Fasting blood glucose adjusted for BMI	28548082	2017-05-26	0	0	3213	3213	3213	1
Fasting blood insulin	20081858	2010-01-17	0	0	38238	38238	38238	2
Fasting blood insulin	22581228	2012-05-13	0	0	51750	51750	51750	3
Fasting blood insulin	25631608	2015-01-29	0	0	48118	48118	48118	6
Fasting blood insulin	31217584	2019-06-19	0	0	21551	21551	21551	1
Fasting blood insulin (BMI interaction)	22581228	2012-05-13	0	0	51750	51750	51750	10
Fasting blood insulin adjusted for BMI	25625282	2015-01-27	0	0	30825	30825	30825	2
Fasting blood proinsulin levels	23263489	2012-12-23	0	0	8229	8229	8229	8
Fasting glucose in pregnancy (gestational week 14-16)	30324795	2018-09-18	0	0	517	517	517	1
Fasting insulin (dietary factor interaction)	24204828	2013-10-28	0	0	820	820	820	2
Fasting plasma glucose	17903298	2007-09-19	0	0	1027	1027	1027	1
Fasting plasma glucose	18451265	2008-06-19	0	0	654	654	654	1
Fasting plasma glucose	19060907	2008-12-01	0	0	35812	35812	35812	3
Fasting plasma glucose	19060909	2008-12-07	0	0	2151	2151	2151	1
Fasting plasma glucose	19651812	2009-08-03	698	6776	0	7474	2531.2539470163233	1
Fasting plasma glucose	20152958	2010-02-11	0	0	9457	9457	9457	1
Fasting plasma glucose	22508271	2012-04-16	0	0	5550	5550	5550	1
Fasting plasma glucose	25187374	2014-09-03	0	0	24740	24740	24740	14
Fasting plasma glucose	28270201	2017-03-07	0	0	29900	29900	29900	16
Fasting plasma glucose	31170924	2019-06-06	0	0	4659	4659	4659	1
Fasting plasma glucose	31932636	2020-01-13	0	0	1353	1353	1353	3
Fasting plasma glucose (childhood)	25223902	2014-09-16	0	0	484	484	484	1
Fat body mass	24064335	2013-10-08	0	0	9172	9172	9172	2
Fat-free mass	30593698	2018-12-28	0	0	155961	155961	155961	280
Fatty acid desaturase activity (adipose tissue)	30453627	2018-11-17	0	0	783	783	783	2
Fatty acid desaturase activity (serum)	30453627	2018-11-17	0	0	1453	1453	1453	6
Fear of minor pain	28701861	2017-06-15	0	0	1583	1583	1583	3
Febrile seizures	25344690	2014-10-26	1999	4118	0	6117	5382.9537354912545	7
Febrile seizures (MMR vaccine-related)	25344690	2014-10-26	929	4118	0	5047	3031.996829799881	4
Febrile seizures (MMR vaccine-unrelated)	25344690	2014-10-26	1070	4118	0	5188	3397.270624518119	2
Feeling fed-up	29500382	2018-03-02	0	0	374971	374971	374971	60
Feeling guilty	29500382	2018-03-02	0	0	373380	373380	373380	29
Feeling hurt	29500382	2018-03-02	0	0	372047	372047	372047	46
Feeling lonely	29500382	2018-03-02	0	0	376352	376352	376352	10
Feeling miserable	29500382	2018-03-02	0	0	376097	376097	376097	64
Feeling nervous	29500382	2018-03-02	0	0	373121	373121	373121	67
Feeling tense	29500382	2018-03-02	0	0	371318	371318	371318	33
Feeling worry	29500382	2018-03-02	0	0	372869	372869	372869	71
Femoral neck bone geometry and menarche (age at onset)	23593202	2013-04-04	0	0	1728	1728	1728	1
Femoral neck bone mineral density	22504420	2012-04-15	0	0	32961	32961	32961	28
Femoral neck bone mineral density	26367794	2015-10-01	0	0	32735	32735	32735	2
Femoral neck bone mineral density	29499414	2018-02-27	0	0	40491	40491	40491	29
Femoral neck length	30888730	2019-03-19	0	0	18719	18719	18719	1
Femoral neck section modulus	30888730	2019-03-19	0	0	18719	18719	18719	1
Femoral neck size	31053729	2019-05-03	0	0	28954	28954	28954	2
Ferritin levels	25162662	2014-08-27	0	0	1999	1999	1999	1
Fetal hemoglobin levels	18245381	2008-02-05	0	0	4305	4305	4305	2
Fetal hemoglobin levels	20018918	2009-12-16	848	0	0	848	848	2
Fetal hemoglobin levels in sickle cell anemia	25372704	2014-11-05	1213	0	0	1213	1213	2
Fibrinogen	20031576	2009-04-01	0	0	22096	22096	22096	4
Fibrinogen	20031577	2009-04-01	0	0	17686	17686	17686	5
Fibrinogen	21757653	2011-07-14	0	0	3042	3042	3042	5
Fibrinogen	23969696	2013-08-22	0	0	91323	91323	91323	24
Fibrinogen levels	26561523	2015-11-10	0	0	120246	120246	120246	41
Fibrinogen levels	28107422	2017-01-20	0	0	91953	91953	91953	65
Fibrinogen levels	29403010	2018-02-05	0	0	18348	18348	18348	1
Fish intake frequency	31320941	2019-07-05	0	0	12603	12603	12603	1
Fish intake frequency	31959922	2020-01-20	0	0	153048	153048	153048	1
Focal epilepsy	30531953	2018-12-10	9671	29677	0	39348	29176.198739453084	1
Focal epilepsy (with hippocampal sclerosis)	30531953	2018-12-10	709	24218	0	24927	2755.335499659004	2
Folate pathway vitamin levels	19303062	2009-03-18	0	0	2934	2934	2934	2
Folate pathway vitamin levels	19744961	2009-09-10	0	0	4763	4763	4763	8
Folding of antihelix	26105758	2015-06-24	0	0	4919	4919	4919	2
Follicle stimulating hormone levels	24049095	2013-09-18	0	0	1999	1999	1999	2
Follicular lymphoma	19620980	2009-07-20	189	592	0	781	573.0499359795134	1
Follicular lymphoma	20639881	2010-07-18	681	750	0	1431	1427.6729559748428	2
Follicular lymphoma	21533074	2011-04-21	379	791	0	1170	1024.9196581196582	1
Follicular lymphoma	25279986	2014-10-02	2728	7758	0	10486	8073.173374022506	6
Follicular lymphoma or rheumatoid arthritis	31407831	2019-08-13	6607	11959	0	18566	17023.184961758052	1
Food addiction	27106561	2016-04-23	0	0	9314	9314	9314	1
Food allergy	29030101	2017-10-10	7268	29084	0	36352	23259.519366197186	4
Food allergy	29051540	2017-10-20	497	2387	0	2884	1645.407766990291	2
Food allergy (maternal genetic effects)	29489655	2018-03-01	0	0	588	588	588	1
Foot ulcer in diabetes and neuropathy	28672053	2017-07-03	702	2698	0	3400	2228.230588235294	1
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	25979521	2015-06-05	0	0	12400	12400	12400	1
Forearm bone mineral density	26367794	2015-10-01	0	0	8143	8143	8143	2
Fractional excretion of metabolites in chronic kidney disease	29545352	2018-03-15	1143	0	0	1143	1143	4
Fractional exhaled nitric oxide (childhood)	24315451	2013-12-05	0	0	8858	8858	8858	6
Fractional shortening	29403010	2018-02-05	0	0	19580	19580	19580	4
Fractures	30158200	2018-08-29	37857	227116	0	264973	129793.30591418747	16
Fractures	30598549	2018-12-31	53184	373611	0	426795	186226.43118124627	14
Fractures (vertebral)	29170203	2017-11-23	1553	4340	0	5893	4574.932971321908	1
Fragile X syndrome	30531935	2018-12-07	89	266	0	355	266.7492957746479	1
Freckles	17952075	2007-10-21	0	0	2986	2986	2986	3
Freckles	18488028	2008-05-18	0	0	5130	5130	5130	1
Freckles	29895819	2018-06-12	7148	4034	0	11182	10314.803076372742	7
Freckling	20585627	2010-06-24	0	0	9126	9126	9126	4
Free cholesterol levels	29084231	2017-10-30	0	0	8372	8372	8372	7
Free cholesterol levels in IDL	29084231	2017-10-30	0	0	8372	8372	8372	9
Free cholesterol levels in large HDL	29084231	2017-10-30	0	0	8372	8372	8372	5
Free cholesterol levels in large LDL	29084231	2017-10-30	0	0	8372	8372	8372	12
Free cholesterol levels in medium HDL	29084231	2017-10-30	0	0	8372	8372	8372	6
Free cholesterol levels in medium VLDL	29084231	2017-10-30	0	0	8372	8372	8372	22
Free cholesterol levels in small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	1
Free cholesterol levels in very large HDL	29084231	2017-10-30	0	0	8372	8372	8372	2
Free thyroxine concentration	25743335	2015-03-06	0	0	13651	13651	13651	4
Free thyroxine concentration	30367059	2018-10-26	0	0	49269	49269	49269	16
Frontal fibrosing alopecia	30850646	2019-03-08	1016	4145	0	5161	3263.956597558613	10
Frontotemporal dementia	24943344	2014-07-01	2154	4308	0	6462	5744.0	1
Frontotemporal dementia	29724592	2018-04-30	382	1146	0	1528	1146.0	2
Frontotemporal dementia with GRN mutation	29724592	2018-04-30	382	1146	0	1528	1146.0	1
Fructosamine levels	29844224	2018-05-29	0	0	9751	9751	9751	2
Fuchs's corneal dystrophy	20825314	2010-09-09	130	260	0	390	346.66666666666663	1
Fuchs's corneal dystrophy	28358029	2017-03-30	1404	2564	0	3968	3628.8870967741937	4
Fulminant type 1 diabetes	30552108	2018-12-14	257	419	0	676	637.1775147928994	3
GIP levels in response to oral glucose tolerance test (120 minutes)	29093273	2017-11-02	0	0	3344	3344	3344	5
GIP levels in response to oral glucose tolerance test (fasting)	29093273	2017-11-02	0	0	3344	3344	3344	2
GLP-1 levels in response to oral glucose tolerance test (120 minutes)	29093273	2017-11-02	0	0	3344	3344	3344	1
Gait rhythm	26219847	2015-07-28	0	0	2946	2946	2946	1
Gallbladder cancer	28274756	2017-03-03	1042	1709	0	2751	2589.28098873137	2
Gallstone disease	17632509	2007-07-15	280	360	0	640	630.0	1
Gallstone disease	27094239	2016-04-16	8720	55152	0	63872	30118.07615230461	2
Gallstone disease	30504769	2018-11-30	27174	736838	0	764012	104829.95456615866	28
Gallstone disease	30692554	2019-01-28	529	566	0	1095	1093.7497716894977	1
Gamma glutamyl transferase levels	22010049	2011-11-01	0	0	12526	12526	12526	4
Gamma glutamyl transferase levels	29403010	2018-02-05	0	0	118309	118309	118309	49
Gamma glutamyl transferase levels	31675503	2019-10-01	0	0	9004	9004	9004	1
Gamma glutamyl transferase levels	32084209	2020-02-21	0	0	4457	4457	4457	1
Gamma glutamyl transferase levels in low alcohol consumption	30589442	2018-12-27	0	0	8716	8716	8716	5
Gamma glutamyl transpeptidase	21909109	2011-09-11	0	0	12545	12545	12545	7
Gastric adenocarcinoma (histologically verified)	26098866	2015-06-22	2043	202533	0	204576	8090.390251055842	1
Gastric atrophy	30753327	2019-02-08	479	760	0	1239	1175.270379338176	1
Gastric cancer	22037551	2011-10-30	1006	2273	0	3279	2789.433363830436	2
Gastric cancer	26098866	2015-06-22	2500	0	205652	208152	208152	3
Gastric cancer	26129866	2015-06-30	2350	2708	0	5058	5032.661130881771	1
Gastric cancer	30281874	2018-10-03	6171	27178	0	33349	20116.397853009083	6
Gastric cancer	31383772	2019-08-05	3771	5426	0	9197	8899.182776992497	5
Gastric parietal cell autoantibody levels in type 1 diabetes	21829393	2011-08-04	4328	0	0	4328	4328	1
Gastroesophageal reflux disease	31527586	2019-09-16	80265	305011	0	385276	254173.19443723458	25
Gastrointestinal infection	32152699	2020-03-09	7197	37062	0	44259	24106.75469396055	1
Gene methylation in lung tissue	25713168	2015-02-23	0	0	1163	1163	1163	2
General cognitive ability	29844566	2018-05-29	0	0	300486	300486	300486	452
General factor of neuroticism	30867560	2019-03-13	0	0	270059	270059	270059	308
General glucose level in pregnancy (gestational week 30-32)	30324795	2018-09-18	0	0	506	506	506	1
General risk tolerance (MTAG)	30643258	2019-01-14	0	0	975353	975353	975353	312
Generalized epilepsy	22949513	2012-09-04	1527	2461	0	3988	3769.254764292879	4
Generalized epilepsy	30531953	2018-12-10	3769	26802	0	30571	13217.32857937261	11
Geographic atrophy lesion growth rate in age-related macular degeneration	31120506	2019-05-23	0	0	935	935	935	2
Gestational age at birth (child effect)	31477735	2019-09-02	0	0	84689	84689	84689	1
Gestational age at birth (maternal effect)	28598419	2017-06-09	0	0	1733	1733	1733	1
Gestational age at birth (maternal effect)	28877031	2017-09-07	0	0	43568	43568	43568	6
Giant cell arteritis	25817017	2015-03-26	1651	15306	0	16957	5961.008668986259	1
Giant cell arteritis	28041642	2016-12-29	2134	9125	0	11259	6918.109956479261	4
Glaucoma	20363506	2010-04-02	305	355	0	660	656.2121212121211	1
Glaucoma	21532571	2011-05-01	590	3956	0	4546	2053.708754949406	2
Glaucoma	22792221	2012-07-05	286	557	0	843	755.8813760379597	1
Glaucoma	25027321	2014-07-15	2209	8752	0	10961	7055.257002098349	7
Glaucoma	30054594	2018-07-27	11018	126068	0	137086	40529.80534846739	34
Glaucoma	30104761	2018-08-13	4462	397761	0	402223	17650.005912143264	11
Glaucoma	31959993	2020-01-20	7947	119318	0	127265	29803.014057282056	20
Glaucoma (exfoliation)	17690259	2007-08-09	75	14474	0	14549	298.4535019588975	1
Glaucoma (high intraocular pressure)	25173107	2014-08-31	966	1005	0	1971	1970.2283105022832	1
Glaucoma (high intraocular pressure)	26752265	2016-01-11	1868	31497	0	33365	7053.66653679005	6
Glaucoma (low intraocular pressure)	26752265	2016-01-11	725	11145	0	11870	2722.872788542544	2
Glaucoma (multi-trait analysis)	31959993	2020-01-20	7947	119318	224431	351696	29803.014057282056	20
Glaucoma (primary angle closure)	22922875	2012-08-26	1854	9608	0	11462	6216.448089338684	3
Glaucoma (primary angle closure)	27064256	2016-04-04	6525	19929	0	26454	19662.315717849855	16
Glaucoma (primary open-angle)	20835238	2010-09-12	1263	34887	0	36150	4875.494439834026	1
Glaucoma (primary open-angle)	22419738	2012-03-22	1394	6599	0	7993	4603.531089703491	1
Glaucoma (primary open-angle)	22428042	2012-03-12	833	686	0	1519	1504.774193548387	1
Glaucoma (primary open-angle)	22570617	2012-04-26	3146	3487	0	6633	6615.469320066335	4
Glaucoma (primary open-angle)	25173105	2014-08-31	1155	1922	0	3077	2885.8108547286315	6
Glaucoma (primary open-angle)	25861811	2015-04-10	3504	9746	0	13250	10309.429132075473	2
Glaucoma (primary open-angle)	26752265	2016-01-11	3853	33480	0	37333	13821.384833793161	5
Glaucoma (primary open-angle)	27623284	2016-09-13	961	4129	0	5090	3118.246758349705	1
Glaucoma (primary open-angle)	29449654	2018-02-15	3071	6750	0	9821	8442.826596069646	1
Glaucoma (primary open-angle)	29452408	2018-02-14	3980	18815	0	22795	13140.372888791399	3
Glaucoma (primary open-angle)	29891935	2018-06-11	4986	58426	0	63412	18375.830189869426	63
Glaucoma (primary open-angle)	31688885	2019-11-01	2284	2081	0	4365	4355.559221076746	1
Glioblastoma	26424050	2015-10-01	1783	7435	0	9218	5752.486439574745	7
Glioblastoma	28346443	2017-03-27	6191	0	18190	24381	24381	11
Glioblastoma	29743610	2018-05-09	4517	10686	0	15203	12699.772939551405	11
Glioblastoma (age-stratified)	30152087	2018-08-27	0	0	15094	15094	15094	19
Glioma	19578367	2009-07-05	1878	3670	0	5548	4969.185291997116	7
Glioma	21531791	2011-04-29	4147	7435	0	11582	10648.573648765327	5
Glioma	21827660	2011-08-09	781	3992	0	4773	2612.8238005447306	1
Glioma	22886559	2012-08-11	1856	4955	0	6811	5400.95727499633	3
Glioma	26424050	2015-10-01	4147	7435	0	11582	10648.573648765327	8
Glioma	28346443	2017-03-27	12469	0	18190	30659	30659	10
Glioma	29743610	2018-05-09	8037	10686	0	18723	18348.209581797786	13
Glioma	30714141	2019-02-04	992	1008	0	2000	1999.872	4
Glioma (high-grade)	19578366	2009-07-05	692	3992	0	4684	2359.064047822374	3
Glioma (high-grade)	24908248	2014-06-08	1013	6595	0	7608	3512.478969505784	3
Global electrical heterogeneity phenotypes	29622589	2018-04-05	0	0	13826	13826	13826	15
Glomerular filtration rate	23535967	2013-03-28	0	0	9049	9049	9049	6
Glomerular filtration rate	24351856	2013-12-18	301	276	0	577	575.9168110918545	1
Glomerular filtration rate	27588450	2016-09-01	0	0	71638	71638	71638	26
Glomerular filtration rate	29403010	2018-02-05	0	0	143658	143658	143658	71
Glomerular filtration rate (creatinine)	26831199	2016-01-21	0	0	133413	133413	133413	47
Glomerular filtration rate (creatinine)	28452372	2017-04-28	0	0	110517	110517	110517	49
Glomerular filtration rate (cystatin C)	28452372	2017-04-28	0	0	24063	24063	24063	3
Glomerular filtration rate in diabetes	29703844	2018-04-27	0	0	13158	13158	13158	3
Glomerular filtration rate in diabetics (creatinine)	26831199	2016-01-21	0	0	11522	11522	11522	1
Glomerular filtration rate in non diabetics (creatinine)	26831199	2016-01-21	0	0	118448	118448	118448	35
Glomerular filtration rate in type 2 diabetes	29703844	2018-04-27	0	0	9197	9197	9197	3
Glomerulosclerosis	20668430	2010-07-28	117	3290	0	3407	451.9283827414147	1
Glucocorticoid-induced osteonecrosis	26265699	2015-08-11	400	2555	0	2955	1383.4179357021997	1
Glucose homeostasis traits	25524916	2014-12-18	0	0	4176	4176	4176	2
Glucosuria	30476138	2019-04-01	10857	0	135512	146369	146369	8
Glucosuria (mild)	30476138	2019-04-01	4748	0	135512	140260	140260	2
Glucosuria (moderate to severe)	30476138	2019-04-01	6109	0	135512	141621	141621	7
Glycated hemoglobin levels	19096518	2008-12-19	0	0	14618	14618	14618	4
Glycated hemoglobin levels	20858683	2010-09-21	0	0	46368	46368	46368	11
Glycated hemoglobin levels	22290723	2012-01-30	0	0	4275	4275	4275	1
Glycated hemoglobin levels	24244560	2013-11-07	0	0	6682	6682	6682	1
Glycated hemoglobin levels	24405752	2013-12-04	0	0	4088	4088	4088	1
Glycated hemoglobin levels	24647736	2014-03-19	0	0	19017	19017	19017	9
Glycated hemoglobin levels	28887542	2017-09-08	0	0	9436	9436	9436	2
Glycated hemoglobin levels	28898252	2017-09-12	0	0	88355	88355	88355	52
Glycated hemoglobin levels	29170429	2017-11-23	0	0	7704	7704	7704	5
Glycated hemoglobin levels	31213470	2019-06-18	0	0	9636	9636	9636	10
Glycated hemoglobin levels in type 1 diabetes	30674623	2019-01-23	0	0	4622	4622	4622	1
Glycemic traits	23575436	2013-04-11	0	0	7696	7696	7696	11
Glycemic traits (multi-trait analysis)	29743933	2018-03-18	0	0	5947	5947	5947	5
Glycemic traits (pleiotropy)	31021400	2019-04-25	0	0	46186	46186	46186	16
Glycemic traits (pregnancy)	23903356	2013-07-31	0	0	4437	4437	4437	10
Glycerophospholipid levels	26068415	2015-06-12	0	0	7478	7478	7478	38
Glycine levels	30837465	2019-03-05	0	0	80003	80003	80003	50
Glycine levels	31070104	2019-05-09	0	0	19112	19112	19112	26
Gondoic acid (20:1n-9) levels	28298293	2017-03-15	0	0	15541	15541	15541	3
Gout	21983786	2011-10-09	968	40000	0	40968	3780.511618824448	2
Gout	23263486	2012-12-23	2115	67259	0	69374	8202.080606567302	2
Gout	25646370	2015-02-02	945	1213	0	2158	2124.717330861909	5
Gout	25967671	2015-05-13	1255	1848	0	3103	2989.674508540122	4
Gout	27899376	2016-11-29	945	1213	0	2158	2124.717330861909	9
Gout	29453348	2018-02-16	747	2071	0	2818	2195.936124911285	1
Gout	30899057	2019-03-21	373	6721	0	7094	1413.5511700028192	2
Gout	31578528	2019-10-02	0	0	763813	763813	763813	5
Gout in chronic kidney disease	30181573	2018-09-04	1217	3724	0	4941	3668.9803683464884	1
Gout vs. Hyperuricemia	31289104	2019-07-08	945	1003	0	1948	1946.2731006160166	5
Granulocyte count	27863252	2016-11-17	0	0	169822	169822	169822	155
Granulocyte percentage of myeloid white cells	27863252	2016-11-17	0	0	169545	169545	169545	220
Graves' disease	21841780	2011-08-14	1468	1490	0	2958	2957.836375929682	9
Graves' disease	21900946	2011-09-08	1119	2718	0	3837	3170.6458170445662	7
Graves' disease	22922229	2012-12-01	2285	9364	0	11649	7347.150828397286	4
Graves' disease	23612905	2013-04-29	1442	1468	0	2910	2909.767697594502	6
Green tea consumption	31959922	2020-01-20	0	0	152653	152653	152653	1
Growth differentiation factor-15 levels	22997280	2012-09-20	0	0	3889	3889	3889	2
Growth differentiation factor-15 levels	29628937	2018-03-23	0	0	4633	4633	4633	1
Growth differentiation factor-15 levels (conditioned on rs888663)	29628937	2018-03-23	0	0	4633	4633	4633	2
Growth-regulated protein alpha levels	27989323	2016-12-13	0	0	3505	3505	3505	6
Gut microbiome composition (summer and winter)	26528553	2015-11-03	0	0	127	127	127	1
Gut microbiome composition (winter)	26528553	2015-11-03	0	0	93	93	93	1
Gut microbiota (bacterial taxa)	27694959	2016-10-03	0	0	984	984	984	16
Gut microbiota (bacterial taxa)	27723756	2016-10-10	0	0	1812	1812	1812	51
Gut microbiota (bacterial taxa)	31519223	2019-09-13	0	0	858	858	858	23
Gut microbiota (beta diversity)	27723756	2016-10-10	0	0	1812	1812	1812	15
Gut microbiota (beta diversity)	31519223	2019-09-13	0	0	858	858	858	12
Gut microbiota (functional units)	27694959	2016-10-03	0	0	984	984	984	35
Gut microbiota relative abundance (bacterial taxa)	31519223	2019-09-13	0	0	858	858	858	58
Gynecologic disease	31488892	2019-09-05	7975	39556	0	47531	26547.651006711407	10
Gynecologic disease (multivariate analysis)	31488892	2019-09-05	7975	39556	0	47531	26547.651006711407	15
HATA volume	30279459	2018-10-02	0	0	21297	21297	21297	1
HDL Cholesterol - Triglycerides (HDLC-TG)	21386085	2011-03-08	0	0	22161	22161	22161	8
HDL cholesterol	18193043	2008-01-13	0	0	8656	8656	8656	9
HDL cholesterol	18193044	2008-01-13	0	0	2758	2758	2758	5
HDL cholesterol	19060906	2008-12-07	0	0	19840	19840	19840	14
HDL cholesterol	19060910	2008-12-07	0	0	4763	4763	4763	4
HDL cholesterol	19060911	2008-12-07	0	0	21412	21412	21412	8
HDL cholesterol	19359809	2009-04-10	0	0	900	900	900	1
HDL cholesterol	20031538	2008-10-01	0	0	4274	4274	4274	3
HDL cholesterol	20031564	2009-02-01	0	0	18245	18245	18245	1
HDL cholesterol	20686565	2010-08-05	0	0	99900	99900	99900	47
HDL cholesterol	20864672	2010-09-23	0	0	17723	17723	17723	8
HDL cholesterol	21347282	2011-02-10	0	0	7813	7813	7813	5
HDL cholesterol	21909109	2011-09-11	0	0	12545	12545	12545	8
HDL cholesterol	23505323	2013-03-15	1122	1118	0	2240	2239.9928571428572	4
HDL cholesterol	23726366	2013-05-29	0	0	11423	11423	11423	8
HDL cholesterol	24097068	2013-10-06	0	0	94595	94595	94595	71
HDL cholesterol	24507774	2014-02-01	0	0	56538	56538	56538	9
HDL cholesterol	24886709	2014-06-02	0	0	3701	3701	3701	2
HDL cholesterol	25961943	2015-05-11	0	0	62166	62166	62166	41
HDL cholesterol	26160806	2015-08-01	0	0	3681	3681	3681	2
HDL cholesterol	26582766	2015-11-18	0	0	8344	8344	8344	6
HDL cholesterol	26780889	2016-01-19	0	0	4383	4383	4383	7
HDL cholesterol	27036123	2016-04-01	0	0	59409	59409	59409	22
HDL cholesterol	28270201	2017-03-07	0	0	26086	26086	26086	26
HDL cholesterol	28371326	2017-03-30	862	880	0	1742	1741.814006888634	1
HDL cholesterol	29212154	2017-09-16	0	0	10300	10300	10300	1
HDL cholesterol	29404214	2018-01-29	0	0	2782	2782	2782	1
HDL cholesterol	30275531	2018-10-01	0	0	297626	297626	297626	158
HDL cholesterol	31170924	2019-06-06	0	0	4659	4659	4659	1
HDL cholesterol and triglyceride levels	30275891	2018-09-17	0	0	821	821	821	1
HDL cholesterol and triglyceride levels (pleiotropy)	30263053	2018-09-17	0	0	821	821	821	1
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	28736931	2017-07-24	0	0	1264	1264	1264	1
HDL cholesterol change in response to niacin in statin-treated individuals	30371334	2018-10-01	1034	1020	0	2054	2053.904576436222	1
HDL cholesterol levels	17463246	2007-04-26	0	2625	0	2625	2625	1
HDL cholesterol levels	26690388	2015-12-22	0	0	12685	12685	12685	6
HDL cholesterol levels	26763881	2016-01-14	0	0	2994	2994	2994	1
HDL cholesterol levels	28334899	2017-02-21	0	0	222097	222097	222097	98
HDL cholesterol levels	30698716	2019-01-29	0	0	127326	127326	127326	94
HDL cholesterol levels	30926973	2019-03-29	0	0	133824	133824	133824	56
HDL cholesterol levels	31675503	2019-10-01	0	0	14126	14126	14126	4
HDL cholesterol levels	31694877	2019-11-06	0	0	2231	2231	2231	9
HDL cholesterol levels	32109663	2020-02-14	0	0	7738	7738	7738	2
HDL cholesterol levels in current drinkers	30698716	2019-01-29	0	0	71394	71394	71394	134
HDL cholesterol levels in never smokers	30926973	2019-03-29	0	0	65885	65885	65885	1
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	30698716	2019-01-29	0	0	127326	127326	127326	204
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	30698716	2019-01-29	0	0	71394	71394	71394	192
HDL cholesterol levels x long total sleep time interaction (2df test)	31719535	2019-11-12	0	50140	12317	62457	62457	82
HDL cholesterol levels x loop diuretics use interaction	31806883	2019-12-06	0	0	38834	38834	38834	1
HDL cholesterol levels x short total sleep time interaction (2df test)	31719535	2019-11-12	0	49411	13046	62457	62457	90
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	30926973	2019-03-29	0	0	133819	133819	133819	1
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	30926973	2019-03-29	0	0	133819	133819	133819	4
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	30926973	2019-03-29	0	0	133822	133822	133822	4
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction	31806883	2019-12-06	0	0	46734	46734	46734	1
HDL cholesterol x physical activity interaction (1df test)	30670697	2019-01-22	0	0	120979	120979	120979	3
HDL cholesterol x physical activity interaction (2df test)	30670697	2019-01-22	0	0	120979	120979	120979	39
HIV-1 control	20041166	2009-12-24	2362	0	0	2362	2362	7
HIV-1 control	21051598	2010-11-04	974	2648	0	3622	2848.3180563224737	8
HIV-1 susceptibility	23935489	2013-07-25	6334	7247	0	13581	13519.622413666151	1
HIV-1 susceptibility	25786224	2015-03-18	327	2181	628	3136	1137.4593301435407	1
HPV seropositivity	21896673	2011-09-10	2776	2035	0	4811	4696.869673664519	1
Hair color	20585627	2010-06-24	0	0	9126	9126	9126	8
Hair color	22556244	2012-05-04	0	0	85	85	85	1
Hair color	23548203	2013-04-01	0	0	7070	7070	7070	6
Hair color	26926045	2016-03-01	0	0	6357	6357	6357	5
Hair color	29662168	2018-04-16	0	0	290891	290891	290891	24
Hair color	30595370	2018-12-27	0	0	452000	452000	452000	434
Hair color	30664655	2019-01-21	0	0	6236	6236	6236	4
Hair greying	26926045	2016-03-01	0	0	6357	6357	6357	1
Hair morphology	19896111	2009-11-04	0	0	23877	23877	23877	2
Hair morphology traits	30166351	2018-08-30	0	0	4988	4988	4988	33
Hair shape	29220522	2017-12-06	0	0	16763	16763	16763	11
Hallucinations in long-term cannabis use	31740666	2019-11-18	311	3974	0	4285	1153.7120186697782	2
Hallux valgus	32131869	2020-03-04	609	1666	0	2275	1783.9015384615384	2
Hand grip strength	27325353	2016-06-21	0	0	27581	27581	27581	1
Hand grip strength	29313844	2017-07-12	0	0	142035	142035	142035	17
Hand grip strength	29691431	2018-04-24	0	0	334825	334825	334825	166
Handedness	30166351	2018-08-30	0	0	4988	4988	4988	1
Handedness (Left-handed vs. non-left-handed)	30980028	2019-04-12	31856	299181	0	331037	115161.8693499518	3
Handedness (Left-handed vs. non-left-handed)	31504236	2019-09-05	0	0	401188	401188	401188	3
Handedness (Right-handed vs. non-right-handed)	30980028	2019-04-12	293857	37180	0	331037	132016.70218132716	3
Handedness (left-handed vs. right-handed)	31504236	2019-09-05	0	0	394889	394889	394889	3
Handedness (non-right-handed vs right-handed)	31504236	2019-09-05	0	0	401198	401198	401198	2
Handedness in dyslexia	21051773	2010-11-09	0	0	192	192	192	1
Haptoglobin levels	22403646	2012-03-05	0	0	631	631	631	1
Hashimoto thyroiditis	22922229	2012-12-01	462	9364	0	9826	1761.1105231019744	1
Hashimoto thyroiditis versus Graves' disease	25429627	2014-11-27	523	0	0	523	523	1
Hay fever and/or eczema	31361310	2019-07-30	84034	239773	0	323807	248902.3928698268	154
HbA2 levels	23043469	2012-10-09	0	0	2322	2322	2322	2
Head circumference (infant)	22504419	2012-04-15	0	0	10768	10768	10768	2
Headache	29397368	2018-01-31	74461	149321	0	223782	198739.68381728645	28
Healthspan	30729179	2019-01-30	0	0	300447	300447	300447	2
Hearing function	25060954	2014-07-24	0	0	4939	4939	4939	1
Heart failure	20445134	2010-05-05	0	0	23821	23821	23821	1
Heart failure	31919418	2020-01-09	47309	930014	0	977323	180075.7060910262	12
Heart rate	23583979	2013-04-14	0	0	92355	92355	92355	24
Heart rate	30166351	2018-08-30	0	0	4988	4988	4988	1
Heart rate in heart failure with reduced ejection fraction	31113495	2019-05-21	0	0	1043	1043	1043	2
Heart rate increase in response to exercise	29497042	2018-03-01	0	0	58818	58818	58818	11
Heart rate response to beta blockers	29478026	2018-02-24	0	0	699	699	699	2
Heart rate response to beta blockers (atenolol add-on therapy)	29478026	2018-02-24	0	0	325	325	325	12
Heart rate response to exercise	29769521	2018-05-16	0	0	67257	67257	67257	27
Heart rate response to recovery post exercise	29769521	2018-05-16	0	0	67257	67257	67257	24
Heart rate response to recovery post exercise (10 sec)	29497042	2018-03-01	0	0	58818	58818	58818	15
Heart rate response to recovery post exercise (20 sec)	29497042	2018-03-01	0	0	58818	58818	58818	16
Heart rate response to recovery post exercise (30 sec)	29497042	2018-03-01	0	0	58818	58818	58818	14
Heart rate response to recovery post exercise (40 sec)	29497042	2018-03-01	0	0	58818	58818	58818	14
Heart rate response to recovery post exercise (50 sec)	29497042	2018-03-01	0	0	58818	58818	58818	18
Heart rate variability traits (RMSSD)	28610988	2017-06-10	0	0	13767	13767	13767	1
Heart rate variability traits (RMSSD)	28613276	2017-06-14	0	0	26523	26523	26523	20
Heart rate variability traits (SDNN)	28610988	2017-06-10	0	0	13184	13184	13184	1
Heart rate variability traits (SDNN)	28613276	2017-06-14	0	0	27850	27850	27850	20
Heart rate variability traits (pvRSA/HF)	28613276	2017-06-14	0	0	24088	24088	24088	10
Heavy menstrual bleeding	31649266	2019-10-24	9813	210946	0	220759	37507.201935141944	3
Hedonic well-being	30279531	2018-10-02	0	0	221575	221575	221575	6
Heel bone mineral density	28869591	2017-09-04	0	0	142487	142487	142487	602
Heel bone mineral density	30048462	2018-07-26	0	0	394929	394929	394929	1584
Heel bone mineral density	30595370	2018-12-27	0	0	446000	446000	446000	1137
Heel bone mineral density	30598549	2018-12-31	0	0	426824	426824	426824	1103
Heel bone mineral density	31453325	2019-08-14	0	0	197261	197261	197261	6
Heel bone mineral density (MTAG)	30690781	2019-02-28	0	0	142487	142487	142487	12
Heel bone mineral density variance	31453325	2019-08-14	0	0	197261	197261	197261	6
Height	17767157	2007-09-02	0	0	4921	4921	4921	1
Height	18193045	2008-01-13	1084	1287	4298	6669	2353.6195698017714	1
Height	18391950	2008-04-06	0	0	15821	15821	15821	9
Height	18391951	2008-04-06	0	0	30968	30968	30968	23
Height	18391952	2008-04-06	0	0	13665	13665	13665	17
Height	18952825	2008-10-24	0	0	3925	3925	3925	1
Height	19343178	2009-04-03	0	0	12611	12611	12611	14
Height	19396169	2009-04-26	0	0	8842	8842	8842	4
Height	19570815	2009-07-01	0	0	10074	10074	10074	1
Height	19729412	2009-09-03	0	0	929	929	929	1
Height	19893584	2009-11-06	0	0	8842	8842	8842	1
Height	20189936	2010-02-26	0	0	19633	19633	19633	8
Height	20397748	2010-04-01	0	0	11536	11536	11536	1
Height	20881960	2010-09-29	0	0	133653	133653	133653	196
Height	21998595	2011-10-06	0	0	20427	20427	20427	13
Height	22021425	2011-10-21	0	0	8149	8149	8149	8
Height	23456168	2013-03-03	0	0	6534	6534	6534	5
Height	23563607	2013-04-07	0	0	16196	16196	16196	86
Height	25282103	2014-10-05	0	0	253288	253288	253288	173
Height	25429064	2014-11-26	0	0	36227	36227	36227	98
Height	28270201	2017-03-07	0	0	26828	26828	26828	32
Height	28552196	2017-06-01	0	0	57129	57129	57129	146
Height	29782485	2018-05-21	0	0	253288	253288	253288	18
Height	30595370	2018-12-27	0	0	458000	458000	458000	2413
Height	31217584	2019-06-19	0	0	49796	49796	49796	119
Height	31562340	2019-09-27	0	0	159095	159095	159095	575
Height	31564439	2019-09-26	0	0	345563	345563	345563	23
Height	31675503	2019-10-01	0	0	14126	14126	14126	1
Height adjusted BMI	25044758	2014-07-21	0	0	5809	5809	5809	2
Helicobacter pylori serologic status	23652523	2013-05-08	2623	7862	0	10485	7867.248831664282	2
Helix rolling	26105758	2015-06-24	0	0	4919	4919	4919	3
Help-seeking from a GP	32231276	2020-03-30	113262	219360	0	332622	298779.4231289572	24
Help-seeking from a GP (without major depressive disorder symptoms)	32231276	2020-03-30	8632	49493	0	58125	29400.33211182796	1
Help-seeking from a psychiatrist	32231276	2020-03-30	36286	297126	0	333412	129347.64238839634	5
Helping behaviour (self reported)	29324852	2018-01-11	0	0	10713	10713	10713	1
Hematocrit	19862010	2009-10-11	0	0	24167	24167	24167	8
Hematocrit	24777453	2014-04-28	0	0	24814	24814	24814	1
Hematocrit	27863252	2016-11-17	0	0	173039	173039	173039	133
Hematocrit	28017375	2016-12-22	0	0	71638	71638	71638	12
Hematocrit	28453575	2017-04-28	0	0	12502	12502	12502	3
Hematocrit	29403010	2018-02-05	0	0	108757	108757	108757	23
Hematocrit	29615537	2018-03-01	0	0	33431	33431	33431	1
Hematocrit	31869403	2019-12-23	0	0	43181	43181	43181	4
Hematological and biochemical traits	20139978	2010-02-07	0	0	14402	14402	14402	25
Hematological and biochemical traits	31902109	2020-01-04	0	0	6843	6843	6843	5
Hematological parameters	19820697	2009-10-11	0	0	4627	4627	4627	10
Hematology traits	23263863	2012-12-20	0	0	14177	14177	14177	9
Hematology traits	23303382	2013-01-10	0	0	4637	4637	4637	2
Hematology traits	30576415	2019-08-01	0	0	1225	1225	1225	4
Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	29915124	2018-06-18	166	0	0	166	166	1
Hematuria	30476138	2019-04-01	68051	0	68903	136954	136954	3
Hematuria (mild)	30476138	2019-04-01	18839	0	68903	87742	87742	1
Hematuria (moderate to severe)	30476138	2019-04-01	49212	0	68903	118115	118115	3
Hemoglobin	19820698	2009-10-11	0	0	16001	16001	16001	2
Hemoglobin	19862010	2009-10-11	0	0	24167	24167	24167	7
Hemoglobin	28453575	2017-04-28	0	0	12502	12502	12502	3
Hemoglobin	28548082	2017-05-26	0	0	3213	3213	3213	1
Hemoglobin	29403010	2018-02-05	0	0	108769	108769	108769	20
Hemoglobin A1c levels	29403010	2018-02-05	0	0	42790	42790	42790	27
Hemoglobin A1c levels	31217584	2019-06-19	0	0	11178	11178	11178	17
Hemoglobin A1c levels	31675503	2019-10-01	0	0	7526	7526	7526	2
Hemoglobin A2 levels in sickle cell anemia	25042611	2014-07-19	618	0	0	618	618	1
Hemoglobin concentration	27863252	2016-11-17	0	0	172925	172925	172925	140
Hemoglobin levels	24777453	2014-04-28	0	0	24814	24814	24814	1
Hemoglobin levels	26366553	2015-09-14	0	0	6602	6602	6602	7
Hemoglobin levels	28017375	2016-12-22	0	0	71638	71638	71638	13
Hemoglobin levels	31869403	2019-12-23	0	0	43187	43187	43187	9
Hemostatic factors and hematological phenotypes	22443383	2012-01-16	0	0	951	951	951	2
Heparin-induced thrombocytopenia	29934777	2018-06-22	96	96	0	192	192.0	1
Hepatitis	25705159	2014-12-31	1500	1500	0	3000	3000.0	8
Hepatitis B	19349983	2009-04-06	179	934	0	1113	600.848158131177	1
Hepatitis B	21750111	2011-07-12	458	2056	0	2514	1498.2466189339698	4
Hepatitis B	22004137	2011-10-01	1944	0	854	2798	2798	1
Hepatitis B	24162738	2013-10-27	951	937	0	1888	1887.8961864406776	3
Hepatitis B	28928442	2017-09-19	1425	218180	0	219605	5663.013137223652	1
Hepatitis B (viral clearance)	22737229	2012-06-21	0	184	366	550	550	4
Hepatitis B vaccine response	21764829	2011-07-15	0	0	1683	1683	1683	3
Hepatitis B vaccine response	24282030	2013-11-28	108	77	0	185	179.8054054054054	1
Hepatitis B virus-related hepatocellular carcinoma	29246937	2018-02-15	348	359	189	896	706.8288543140029	1
Hepatitis C (spontaneous viral clearance)	30593799	2018-12-26	1319	3104	0	4423	3702.6235586705857	6
Hepatitis C induced liver cirrhosis	23321320	2013-01-12	682	1045	0	1727	1650.7006369426751	5
Hepatitis C induced liver fibrosis	22841784	2012-07-26	0	0	1161	1161	1161	2
Hepatocellular carcinoma	20676096	2010-08-01	348	359	0	707	706.8288543140029	1
Hepatocellular carcinoma	21499248	2011-04-17	721	2890	0	3611	2308.1584048739965	2
Hepatocellular carcinoma	22807686	2012-07-12	1538	0	1465	3003	3003	2
Hepatocellular carcinoma in hepatitis B infection	23242368	2012-12-16	1161	1353	0	2514	2499.336515513127	2
Hepatocellular carcinoma in hepatitis B infection	29784950	2018-05-21	473	0	516	989	989	4
Hepatocellular carcinoma in hepatitis C infection	28921602	2017-09-16	502	749	0	1251	1202.2318145483614	1
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	28163062	2017-02-02	123	333	0	456	359.2894736842105	1
Hepatocyte growth factor levels	27989323	2016-12-13	0	0	8292	8292	8292	3
Hepcidin levels	21785125	2011-07-25	0	0	1657	1657	1657	6
Hepcidin levels	27846281	2016-11-15	0	0	6201	6201	6201	1
Hepcidin/ferritin ratio	27846281	2016-11-15	0	0	6201	6201	6201	9
Hepcidin/transferrin saturation ratio	27846281	2016-11-15	0	0	6201	6201	6201	1
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	25457201	2014-10-18	474	0	0	474	474	2
High IL-1beta levels in gingival crevicular fluid	30206230	2018-09-11	0	0	4910	4910	4910	71
High altitude adaptation	28373541	2017-04-03	0	0	10295	10295	10295	9
High density lipoprotein cholesterol levels	28548082	2017-05-26	0	0	3213	3213	3213	4
High density lipoprotein cholesterol levels	29083408	2017-10-30	0	0	297824	297824	297824	39
High density lipoprotein cholesterol levels	29403010	2018-02-05	0	0	70657	70657	70657	52
High density lipoprotein cholesterol levels	29507422	2018-03-05	0	0	94674	94674	94674	673
High density lipoprotein cholesterol levels	29615537	2018-03-01	0	0	33431	33431	33431	7
High density lipoprotein cholesterol levels	30108155	2018-08-14	0	0	1353	1353	1353	1
High density lipoprotein cholesterol levels	30263045	2018-09-17	0	0	817	817	817	1
High density lipoprotein cholesterol levels	30718733	2019-02-04	0	0	6949	6949	6949	16
High density lipoprotein cholesterol levels	30911093	2019-03-25	0	0	1036	1036	1036	8
High density lipoprotein cholesterol levels	31217584	2019-06-19	0	0	33063	33063	33063	110
High density lipoprotein cholesterol levels	31393916	2019-08-08	0	0	11103	11103	11103	7
High density lipoprotein cholesterol levels	31551469	2019-09-24	0	0	2045	2045	2045	1
High density lipoprotein cholesterol levels	31647587	2019-10-24	0	0	1779	1779	1779	1
High fasting blood glucose	31910446	2020-01-07	0	7423	0	7423	7423	1
High fetal hemoglobin in sickle cell disease	27022141	2016-03-27	376	360	0	736	735.6521739130435	1
High light scatter reticulocyte count	27863252	2016-11-17	0	0	170761	170761	170761	219
High light scatter reticulocyte percentage of red cells	27863252	2016-11-17	0	0	170763	170763	170763	209
High myopia	31816047	2019-12-09	2737	47635	0	50372	10353.132295719844	17
High serum lipase activity	25028398	2014-07-15	981	2985	0	3966	2953.3888048411495	1
High-grade serous ovarian cancer	28346442	2017-03-27	0	53978	0	53978	53978	16
Highest math class taken	30038396	2018-07-23	0	0	430445	430445	430445	335
Highest math class taken (MTAG)	30038396	2018-07-23	0	0	811539	811539	811539	1108
Hip bone size	31053729	2019-05-03	0	0	28900	28900	28900	7
Hip circumference	25673412	2015-02-12	0	0	143480	143480	143480	100
Hip circumference	28552196	2017-06-01	0	0	37078	37078	37078	7
Hip circumference	31453325	2019-08-14	0	0	346781	346781	346781	16
Hip circumference	31675503	2019-10-01	0	0	14126	14126	14126	1
Hip circumference (psychosocial stress interaction)	25271088	2014-10-01	0	0	5805	5805	5805	1
Hip circumference adjusted for BMI	25673412	2015-02-12	0	0	143480	143480	143480	162
Hip circumference adjusted for BMI	28552196	2017-06-01	0	0	36917	36917	36917	7
Hip circumference variance	31453325	2019-08-14	0	0	346781	346781	346781	16
Hip minimal joint space width	27701424	2016-10-04	0	0	13013	13013	13013	5
Hip shape (DXA scan)	30320955	2018-10-15	0	0	15934	15934	15934	12
Hippocampal atrophy	22745009	2012-05-15	1149	188	336	1673	646.2587883320867	4
Hippocampal atrophy rate	31760383	2019-11-23	0	0	602	602	602	2
Hippocampal fissure volume	30279459	2018-10-02	0	0	21297	21297	21297	1
Hippocampal sclerosis	25188341	2014-09-04	310	2576	0	2886	1106.805266805267	1
Hippocampal sclerosis of aging	24770881	2014-04-27	241	1998	0	2239	860.2376060741402	1
Hippocampal subfield CA1 volume	30279459	2018-10-02	0	0	21297	21297	21297	3
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	2
Hippocampal subfield CA3 volume	30279459	2018-10-02	0	0	21297	21297	21297	3
Hippocampal subfield CA4 volume	30279459	2018-10-02	0	0	21297	21297	21297	5
Hippocampal tail volume	30279459	2018-10-02	0	0	21297	21297	21297	7
Hippocampal tail volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	7
Hippocampal volume	22504421	2012-04-15	0	0	9232	9232	9232	3
Hippocampal volume	28098162	2017-01-18	0	0	26814	26814	26814	2
Hippocampal volume	29274321	2017-12-20	771	0	305	1076	1076	1
Hippocampal volume	29860282	2018-05-30	0	0	926	926	926	1
Hippocampal volume	30818988	2019-03-01	0	0	24704	24704	24704	5
Hippocampal volume in Alzheimer's disease dementia	29274321	2017-12-20	190	0	0	190	190	1
Hippocampal volume in normal cognition	29274321	2017-12-20	0	0	305	305	305	1
Hirschsprung disease	19196962	2009-02-05	181	346	0	527	475.33965844402275	2
Hirschsprung disease	25310821	2014-10-13	123	432	0	555	382.96216216216214	1
Hirschsprung disease	27702942	2016-10-03	507	1191	0	1698	1422.4664310954063	6
Hirschsprung disease	29379196	2018-01-29	170	4717	0	4887	656.3454061796604	6
Hirschsprung disease	30031151	2018-07-18	68	386	0	454	231.25991189427316	1
Hodgkin's lymphoma	21037568	2010-10-31	589	5199	0	5788	2116.2480995162405	3
Hodgkin's lymphoma	22286212	2012-01-27	1200	6417	0	7617	4043.7967703820395	3
Hodgkin's lymphoma	24149102	2013-10-22	1465	6417	0	7882	4770.822126363867	5
Hodgkin's lymphoma	24920014	2014-06-12	1816	7877	0	9693	5903.077272258331	3
Hodgkin's lymphoma	29196614	2017-12-01	3077	13680	0	16757	10047.946529808438	4
Hodgkin's lymphoma	30194254	2018-09-07	5325	22425	0	27750	17212.702702702703	5
Homeostasis model assessment of beta-cell function	20081858	2010-01-17	0	0	36466	36466	36466	7
Homeostasis model assessment of beta-cell function (dietary factor interaction)	24204828	2013-10-28	0	0	820	820	820	2
Homeostasis model assessment of insulin resistance	20081858	2010-01-17	0	0	37037	37037	37037	2
Homeostasis model assessment of insulin resistance	30327367	2018-10-16	0	0	11794	11794	11794	2
Homeostasis model assessment of insulin resistance (dietary factor interaction)	24204828	2013-10-28	0	0	820	820	820	2
Homeostasis model assessment of insulin resistance in less-fat diet	30327367	2018-10-16	0	0	1087	1087	1087	2
Homeostasis model assessment of insulin resistance in more-fat diet	30327367	2018-10-16	0	0	10707	10707	10707	2
Homoarginine levels	24047826	2013-09-18	0	0	5143	5143	5143	1
Homocysteine levels	20031578	2009-04-01	0	0	13974	13974	13974	2
Homocysteine levels	20154341	2010-02-13	0	0	1786	1786	1786	1
Homocysteine levels	23696881	2013-05-16	0	0	1208	1208	1208	1
Homocysteine levels	23824729	2013-07-03	0	0	44147	44147	44147	18
Hormone measurements	23696881	2013-05-16	0	0	1200	1200	1200	3
Hormone measurements	24049095	2013-09-18	0	0	1999	1999	1999	4
Household income	27818178	2016-11-03	0	0	96900	96900	96900	2
Household income	31844048	2019-12-16	0	0	286301	286301	286301	68
Household income (MTAG)	31844048	2019-12-16	0	0	505541	505541	505541	343
Huntington's disease (age at onset)	29750799	2018-05-11	0	0	4435	4435	4435	2
Huntington's disease progression	28642124	2017-06-20	0	0	1989	1989	1989	1
Hydrolysed wheat protein allergy	31301374	2019-07-10	452	2700	0	3152	1548.7309644670052	2
Hyperemesis gravidarum	29563502	2018-03-21	1306	0	15756	17062	17062	2
Hyperglycemia	30327367	2018-10-16	0	0	11794	11794	11794	1
Hyperglycemia in higher physical activity	30327367	2018-10-16	0	0	4976	4976	4976	2
Hyperglycemia in more-fat diet	30327367	2018-10-16	0	0	10707	10707	10707	1
Hyperinsulinemia in less-fat diet	30327367	2018-10-16	0	0	1087	1087	1087	1
Hyperinsulinemia in lower physical activity	30327367	2018-10-16	0	0	6818	6818	6818	2
Hyperinsulinemia in obesity	30327367	2018-10-16	0	0	3431	3431	3431	1
Hyperinsulinemia x BMI interaction	30327367	2018-10-16	0	0	11794	11794	11794	1
Hyperopia	25233373	2014-09-18	7068	6844	0	13912	13908.393329499713	2
Hypersomnia (HLA-DQB1*06:02 negative)	30266950	2018-09-28	119	1582	0	1701	442.69958847736626	1
Hypertension	19430479	2009-05-10	0	0	29136	29136	29136	1
Hypertension	21082022	2010-10-28	1621	1699	0	3320	3318.1674698795177	1
Hypertension	21347282	2011-02-10	4069	3848	0	7917	7910.830870279146	1
Hypertension	21909115	2011-09-11	0	0	69395	69395	69395	6
Hypertension	25249183	2014-09-23	5065	4404	0	9469	9422.85774633013	6
Hypertension	27480026	2016-08-02	271	247	0	518	516.8880308880308	1
Hypertension	27618447	2016-10-01	92652	90621	0	183273	183250.49280581428	4
Hypertension	27618448	2016-10-01	0	0	146562	146562	146562	4
Hypertension	28498854	2017-05-12	0	0	18440	18440	18440	2
Hypertension	30487518	2018-11-28	22566	28226	0	50792	50161.278626555366	68
Hypertension	31217584	2019-06-19	27123	22018	0	49141	48610.66840316639	2
Hypertension	31879980	2019-12-26	0	0	185568	185568	185568	52
Hypertension (SNP x SNP interaction)	21626137	2011-05-28	0	0	0	0	0	7
Hypertension (young onset)	19421330	2009-05-07	175	175	0	350	350.0	1
Hypertension risk in short sleep duration	22322875	2012-02-09	0	0	4965	4965	4965	1
Hyperthyroidism	30367059	2018-10-26	1840	49983	0	51823	7098.679736796403	9
Hypertriglyceridemia	20657596	2010-07-25	463	1197	0	1660	1335.4481927710842	2
Hypertriglyceridemia	23505323	2013-03-15	1122	1118	0	2240	2239.9928571428572	4
Hypertriglyceridemia	27599772	2016-09-07	927	3159	0	4086	2866.7577092511015	6
Hypertriglyceridemia	31910446	2020-01-07	0	7423	0	7423	7423	4
Hyperuricemia	28776340	2017-09-01	234	3413	0	3647	875.9440636139291	1
Hyperuricemia	29124443	2017-11-09	847	4640	0	5487	2865.0118461818847	23
Hypospadias	21113153	2010-11-28	436	494	0	930	926.3827956989247	1
Hypospadias	25108383	2014-08-10	1006	5486	0	6492	3400.441158348737	18
Hypospadias (moderate to severe)	31856834	2019-12-19	197	933	0	1130	650.6230088495576	1
Hypothyroidism	21981779	2011-10-07	1317	5053	0	6370	4178.838932496075	1
Hypothyroidism	22493691	2012-04-06	3736	35546	0	39282	13522.718395193726	5
Hypothyroidism	27182965	2016-05-16	17558	117083	0	134641	61073.32280657452	21
Hypothyroidism	30367059	2018-10-26	3340	49983	0	53323	12523.167863773606	8
Hypothyroidism	30595370	2018-12-27	0	0	459000	459000	459000	140
IDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	9
IFN-related cytopenia	21703177	2011-05-20	1287	0	0	1287	1287	1
Ideal cardiovascular health (clinical and behavioural)	27179730	2016-01-23	0	0	11708	11708	11708	1
Ideal cardiovascular health (clinical)	27179730	2016-01-23	0	0	11708	11708	11708	1
Idiopathic dilated cardiomyopathy	21459883	2011-04-01	1179	1108	0	2287	2284.795802361172	2
Idiopathic dilated cardiomyopathy	29495422	2018-02-26	662	1138	0	1800	1674.1244444444444	2
Idiopathic inflammatory myopathy	26362759	2015-09-11	2556	15651	0	18207	8788.69797330697	2
Idiopathic membranous nephropathy	21323541	2011-02-22	556	2338	0	2894	1796.7214927436073	21
Idiopathic osteonecrosis of the femoral head	29118346	2017-11-08	1547	59103	0	60650	6030.162638087387	2
Idiopathic pulmonary fibrosis	18835860	2008-10-01	159	934	0	1093	543.4803293687099	1
Idiopathic pulmonary fibrosis	24429156	2013-04-17	542	542	0	1084	1084.0	4
Idiopathic pulmonary fibrosis	29066090	2017-10-20	602	3366	0	3968	2042.673387096774	4
Idiopathic pulmonary fibrosis	31710517	2019-11-11	2668	8591	0	11259	8143.099031885602	15
IgA levels	28628107	2017-06-19	0	0	16883	16883	16883	10
IgA levels	30053915	2018-07-27	0	0	1000	1000	1000	1
IgA nephropathy	22197929	2011-12-25	1434	4270	0	5704	4293.955119214586	7
IgA nephropathy	25305756	2014-10-12	2747	3952	0	6699	6482.24749962681	25
IgA nephropathy	26028593	2015-06-01	1434	10661	0	12095	5055.93187267466	13
IgE grass sensitization	22036096	2011-11-01	2315	10032	0	12347	7523.796873734511	3
IgE levels	18846228	2008-08-22	0	0	1530	1530	1530	2
IgE levels	22075330	2011-11-08	0	0	6819	6819	6819	8
IgE levels	24324648	2013-12-04	0	0	1180	1180	1180	1
IgG N-glycosylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	8
IgG N-glycosylation phenotypes (multivariate analysis)	32128391	2020-02-19	0	0	8090	8090	8090	11
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	4
IgG digalactosylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	5
IgG disialylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	2
IgG fucosylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	7
IgG galactosylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	8
IgG glycosylation	23382691	2013-01-31	0	0	2247	2247	2247	120
IgG glycosylation patterns	29535710	2018-02-26	0	0	1823	1823	1823	293
IgG levels	22673310	2012-07-07	0	0	1999	1999	1999	1
IgG levels	23225573	2012-09-08	229	0	0	229	229	1
IgG levels	28628107	2017-06-19	0	0	15536	15536	15536	6
IgG monogalactosylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	4
IgG monosialylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	3
IgG sialylation phenotypes (multivariate analysis)	28878392	2017-09-06	0	0	1960	1960	1960	6
IgM levels	23118916	2012-10-31	0	0	1999	1999	1999	1
IgM levels	28628107	2017-06-19	0	0	14442	14442	14442	13
Illicit drug use	23942779	2013-08-14	0	0	7188	7188	7188	1
Immature fraction of reticulocytes	27863252	2016-11-17	0	0	170548	170548	170548	152
Immune reponse to smallpox (secreted IFN-alpha)	22610502	2012-05-19	0	0	711	711	711	17
Immune reponse to smallpox (secreted IL-10)	22610502	2012-05-19	0	0	711	711	711	3
Immune reponse to smallpox (secreted IL-12p40)	22610502	2012-05-19	0	0	711	711	711	4
Immune reponse to smallpox (secreted IL-1beta)	22610502	2012-05-19	0	0	711	711	711	7
Immune reponse to smallpox (secreted IL-2)	22610502	2012-05-19	0	0	711	711	711	8
Immune reponse to smallpox (secreted TNF-alpha)	22610502	2012-05-19	0	0	711	711	711	1
Immune response to measles vaccine (measles-specific neutralising antibody titre)	28289848	2017-04-01	0	0	2872	2872	2872	6
Immune response to measles-mumps-rubella vaccine	24811271	2014-05-09	0	0	883	883	883	2
Immune response to smallpox vaccine (IL-6)	22542470	2012-04-25	0	0	1014	1014	1014	7
Immune response to smallpox vaccine (IL-6)	22610502	2012-05-19	0	0	711	711	711	3
Immunoglobulin A	20694011	2010-08-08	430	1090	0	1520	1233.421052631579	3
Immunoglobulin A vasculitis	28698626	2017-07-11	285	1006	0	1291	888.3346243222308	1
Immunoglobulin G index levels in multiple sclerosis	25616667	2015-01-22	0	0	938	938	938	3
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	29547969	2018-03-14	0	0	3002	3002	3002	1
Immunoglobulin light chain (AL) amyloidosis	28025584	2016-12-27	1229	7526	0	8755	4225.907024557396	3
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	28679651	2017-07-04	426	0	0	426	426	1
Immunoglobulin light chain (AL) amyloidosis (heart involvement)	28679651	2017-07-04	835	0	0	835	835	1
Immunoglobulin light chain (AL) amyloidosis (liver involvement)	28679651	2017-07-04	194	0	0	194	194	1
Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	28679651	2017-07-04	345	0	0	345	345	2
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	28679651	2017-07-04	404	0	0	404	404	1
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	28679651	2017-07-04	535	0	0	535	535	1
Immunoglobulin measurement (zinc sulfate turbidity test)	29403010	2018-02-05	0	0	12303	12303	12303	4
Impulsivity (motor)	30718321	2019-02-04	0	0	21806	21806	21806	1
Incident atrial fibrillation	28416818	2017-04-17	7323	0	102776	110099	110099	5
Incident myocardial infarction	26950853	2016-03-07	1570	21618	0	23188	5854.797308952907	1
Incremental insulin	24699409	2014-04-03	0	0	4858	4858	4858	2
Infant head circumference (MTAG)	31681408	2019-10-11	0	0	182902	182902	182902	11
Infant length	25281659	2014-10-03	0	0	28238	28238	28238	11
Infant, child and juvenile death (proportion of children died <15 years)	30188897	2018-09-06	0	0	532	532	532	1
Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	30188897	2018-09-06	0	0	532	532	532	1
Infantile hypertrophic pyloric stenosis	22306654	2012-02-05	1001	2401	0	3402	2825.8683127572017	3
Infantile hypertrophic pyloric stenosis	23989729	2013-08-21	1001	2371	0	3372	2815.3867141162514	4
Infantile hypertrophic pyloric stenosis	30281099	2018-10-02	1395	4438	0	5833	4245.506600377164	11
Inflammatory biomarkers	22228203	2012-01-05	0	0	1092	1092	1092	1
Inflammatory biomarkers	22291609	2012-01-26	0	0	4694	4694	4694	7
Inflammatory biomarkers	24182552	2013-10-29	0	0	4443	4443	4443	3
Inflammatory biomarkers in Kawasaki disease	25266886	2014-09-30	178	0	0	178	178	1
Inflammatory bowel disease	17068223	2006-10-26	547	548	0	1095	1094.9990867579909	1
Inflammatory bowel disease	18758464	2008-08-31	1011	4250	0	5261	3266.869416460749	6
Inflammatory bowel disease	23128233	2012-11-01	12924	21442	0	34366	32254.717802479197	110
Inflammatory bowel disease	26192919	2015-07-20	12882	21770	0	34652	32372.289045365345	165
Inflammatory bowel disease	27569725	2016-08-25	1505	4041	0	5546	4386.372160115398	6
Inflammatory bowel disease	28008999	2016-12-23	1118	582	0	1700	1531.0023529411767	11
Inflammatory bowel disease	28067908	2017-01-09	25042	34915	0	59957	58331.23271678036	94
Inflammatory bowel disease (early onset)	19915574	2009-11-15	2413	6158	0	8571	6934.665266596663	4
Inflammatory skin disease	25574825	2015-01-08	6291	11899	0	18190	16461.04650907092	51
Influenza A (H1N1) infection	26379185	2015-09-17	156	549	0	705	485.9234042553192	14
Information processing speed	25869804	2015-04-14	0	0	33337	33337	33337	1
Inguinal hernia	26686553	2015-12-21	5295	67510	0	72805	19639.609916901314	4
Initial pursuit acceleration	29064472	2017-10-24	591	258	0	849	718.3886925795052	5
Initial pursuit acceleration in psychotic disorders	29064472	2017-10-24	426	0	165	591	591	9
Insomnia	27992416	2016-12-19	32155	16009	10964	59128	42751.38236026908	5
Insomnia	29520036	2018-03-08	3237	14414	0	17651	10573.478669763752	3
Insomnia	30804565	2019-02-25	0	0	1331010	1331010	1331010	364
Insomnia complaints	28604731	2017-06-12	32384	80622	0	113006	92415.01683096473	4
Insomnia complaints (continuous)	28604731	2017-06-12	32384	80622	0	113006	92415.01683096473	1
Insomnia complaints (dichotomous)	28604731	2017-06-12	32384	27128	0	59512	59047.7988977013	1
Insomnia symptoms (never/rarely vs. sometimes/usually)	30804566	2019-02-25	345022	108357	0	453379	329839.26343302184	29
Insomnia symptoms (never/rarely vs. usually)	30804566	2019-02-25	129270	108357	0	237627	235786.4954739992	45
Insulin disposition index	23263489	2012-12-23	0	0	8229	8229	8229	1
Insulin disposition index	24699409	2014-04-03	0	0	5158	5158	5158	1
Insulin disposition index	28490609	2017-05-10	0	0	4719	4719	4719	1
Insulin levels	24699409	2014-04-03	0	0	4924	4924	4924	1
Insulin levels adjusted for BMI	24699409	2014-04-03	0	0	4820	4820	4820	3
Insulin levels in response to oral glucose tolerance test (30 minutes)	29093273	2017-11-02	0	0	3344	3344	3344	1
Insulin-like growth factors	21216879	2011-01-07	0	0	10280	10280	10280	5
Insulin-related traits	22791750	2012-07-12	0	0	927	927	927	3
Insulin-related traits (multivariate analysis)	32002517	2020-01-24	0	0	62205	62205	62205	23
Insulinogenic index	23263489	2012-12-23	0	0	8229	8229	8229	4
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	21829393	2011-08-04	2498	0	0	2498	2498	1
Intake of total sugars	31005972	2019-04-21	0	0	174424	174424	174424	1
Intelligence	22449649	2012-02-28	0	0	656	656	656	3
Intelligence	28530673	2017-05-22	0	0	78308	78308	78308	31
Intelligence	29942086	2018-06-25	0	0	269867	269867	269867	524
Intelligence (MTAG)	29326435	2018-01-11	0	0	248482	248482	248482	645
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	1
Interferon alpha levels in systemic lupus erythematosus	25338677	2014-10-23	410	0	0	410	410	1
Interferon gamma levels	27989323	2016-12-13	0	0	7701	7701	7701	1
Interferon gamma-induced protein 10 levels	27989323	2016-12-13	0	0	3685	3685	3685	4
Interferon gamma-induced protein 10 levels	31217265	2019-06-19	0	0	13577	13577	13577	1
Interleukin-1-beta levels	31217265	2019-06-19	0	0	13577	13577	13577	2
Interleukin-10 levels	22205395	2011-12-29	0	0	704	704	704	7
Interleukin-10 levels	27989323	2016-12-13	0	0	7681	7681	7681	3
Interleukin-12p70 levels	27989323	2016-12-13	0	0	8270	8270	8270	5
Interleukin-13 levels	27989323	2016-12-13	0	0	3557	3557	3557	1
Interleukin-16 levels	27989323	2016-12-13	0	0	3483	3483	3483	3
Interleukin-17 levels	27989323	2016-12-13	0	0	7760	7760	7760	1
Interleukin-18 levels	20150558	2010-02-11	0	0	1523	1523	1523	2
Interleukin-18 levels	27989323	2016-12-13	0	0	3636	3636	3636	12
Interleukin-18 levels	31584380	2019-10-04	0	0	4433	4433	4433	3
Interleukin-2 receptor antagonist levels	27989323	2016-12-13	0	0	3677	3677	3677	2
Interleukin-5 levels	27989323	2016-12-13	0	0	3364	3364	3364	1
Interleukin-6 (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	2
Interleukin-6 levels	22205395	2011-12-29	0	0	697	697	697	1
Interleukin-6 receptor subunit alpha levels	25147954	2014-08-22	0	0	653	653	653	1
Interleukin-7 levels	27989323	2016-12-13	0	0	3409	3409	3409	2
Interstitial lung abnormalities	31339356	2019-07-24	1699	10274	0	11973	5831.629833792701	6
Interstitial lung disease	23583980	2013-04-14	1161	4683	0	5844	3721.3983572895277	11
Intertrochanteric region size	31053729	2019-05-03	0	0	28936	28936	28936	6
Intra-individual response time variability (selective attention)	30287865	2018-10-04	0	0	857	857	857	2
Intracerebral hemorrhage	24656865	2014-03-18	1545	1481	0	3026	3024.6463978849965	1
Intracranial aneurysm	18997786	2008-11-09	1580	6276	0	7856	5048.920570264766	4
Intracranial aneurysm	20364137	2010-04-04	2780	12515	0	15295	9098.842759071591	5
Intracranial aneurysm	22286173	2012-01-27	1383	5484	0	6867	4417.86631716907	1
Intracranial aneurysm	22961961	2012-09-06	1483	1683	0	3166	3153.365761212887	1
Intracranial aneurysm	25256182	2014-09-25	2617	2548	0	5165	5164.0782187802515	2
Intracranial aneurysm	29531279	2018-03-12	173	1772	0	1945	630.4493573264781	1
Intracranial aneurysm	30823506	2019-02-25	250	296	0	546	542.1245421245421	29
Intracranial volume	22504418	2012-04-15	0	0	8175	8175	8175	2
Intracranial volume	30818988	2019-03-01	0	0	24024	24024	24024	6
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	27418160	2016-07-14	3094	9507	0	12601	9337.245615427348	4
Intraocular pressure	22570627	2012-05-03	0	0	11972	11972	11972	2
Intraocular pressure	23836780	2013-07-07	0	0	2175	2175	2175	1
Intraocular pressure	25173106	2014-08-31	0	0	35296	35296	35296	8
Intraocular pressure	25637523	2015-01-30	0	0	8015	8015	8015	4
Intraocular pressure	28073927	2017-01-10	0	0	29578	29578	29578	15
Intraocular pressure	29235454	2017-12-13	0	0	69756	69756	69756	51
Intraocular pressure	29617998	2018-03-28	0	0	115486	115486	115486	320
Intraocular pressure	29785010	2018-05-21	0	0	139555	139555	139555	130
Intraocular pressure	30054594	2018-07-27	0	0	133492	133492	133492	106
Intraocular pressure	30591961	2018-12-24	0	0	5571	5571	5571	20
Intraocular pressure	31798171	2019-11-27	0	0	31269	31269	31269	10
Intraocular pressure	31959993	2020-01-20	0	0	133492	133492	133492	71
Intraocular pressure and central corneal thickness (multi-trait analysis)	31798171	2019-11-27	0	0	31269	31269	31269	4
Intrinsic epigenetic age acceleration	29374233	2018-01-26	0	0	8393	8393	8393	6
Intrinsic epigenetic age acceleration	31738745	2019-11-18	0	0	13493	13493	13493	10
Invasive epithelial ovarian cancer	28346442	2017-03-27	22406	40941	0	63347	57923.7561999779	13
Iris characteristics	21835309	2011-08-12	0	0	2121	2121	2121	3
Iris color	18252221	2008-01-24	0	0	1406	1406	1406	1
Iris color (L* coordinate)	30895295	2019-03-21	0	0	329	329	329	2
Iris color (a* coordinate)	29109912	2017-11-02	0	0	377	377	377	1
Iris color (a* coordinate)	30895295	2019-03-21	0	0	329	329	329	1
Iris color (b* coordinate)	29109912	2017-11-02	0	0	377	377	377	1
Iris color (b* coordinate)	30895295	2019-03-21	0	0	329	329	329	1
Iris heterochromicity	30895295	2019-03-21	0	0	329	329	329	1
Iron levels	19880490	2009-10-30	0	0	1919	1919	1919	1
Iron status biomarkers	19084217	2008-12-17	0	0	561	561	561	6
Iron status biomarkers	19820699	2009-10-11	0	0	4818	4818	4818	2
Iron status biomarkers	21149283	2010-12-10	0	0	6616	6616	6616	5
Iron status biomarkers	21208937	2011-01-04	0	0	5633	5633	5633	4
Iron status biomarkers	21483845	2011-03-31	336	343	0	679	678.9278350515465	3
Iron status biomarkers	25224454	2014-09-15	0	0	2347	2347	2347	2
Iron status biomarkers (ferritin levels)	25352340	2014-10-29	0	0	23986	23986	23986	5
Iron status biomarkers (ferritin levels)	28334935	2017-05-15	0	0	12375	12375	12375	2
Iron status biomarkers (iron levels)	25352340	2014-10-29	0	0	23986	23986	23986	5
Iron status biomarkers (iron levels)	28334935	2017-05-15	0	0	12580	12580	12580	7
Iron status biomarkers (total iron binding capacity)	28334935	2017-05-15	0	0	12586	12586	12586	16
Iron status biomarkers (transferrin levels)	25352340	2014-10-29	0	0	23986	23986	23986	9
Iron status biomarkers (transferrin saturation)	25352340	2014-10-29	0	0	23986	23986	23986	5
Iron status biomarkers (transferrin saturation)	28334935	2017-05-15	0	0	12589	12589	12589	12
Irritable bowel syndrome	29626450	2018-04-04	9576	336499	0	346075	37244.116726143184	2
Irritable mood	29500382	2018-03-02	0	0	366726	366726	366726	67
Ischemic stroke	24262325	2013-11-21	12389	62004	0	74393	41303.21702310701	1
Ischemic stroke	26089329	2015-06-18	1365	13154	0	14519	4946.6795233831535	1
Ischemic stroke	26708676	2015-12-18	16851	32473	0	49324	44376.16762630768	3
Ischemic stroke	26732560	2016-01-05	3626	21968	0	25594	12449.16277252481	1
Ischemic stroke	27997041	2016-12-20	10210	12285	0	22495	22303.5963547455	2
Ischemic stroke	29531354	2018-03-12	34217	406111	0	440328	126232.26401228174	26
Ischemic stroke (cardioembolic)	26708676	2015-12-18	3726	32473	0	36199	13369.916075029696	2
Ischemic stroke (cardioembolic)	27068588	2016-04-07	602	80613	0	81215	2390.1508834574893	1
Ischemic stroke (cardioembolic)	29531354	2018-03-12	9006	457184	0	466190	35328.07742765825	7
Ischemic stroke (large artery atherosclerosis)	26708676	2015-12-18	2715	32473	0	35188	10022.075139252018	2
Ischemic stroke (large artery atherosclerosis)	26732560	2016-01-05	681	21969	0	22650	2642.099602649007	3
Ischemic stroke (large artery atherosclerosis)	29531354	2018-03-12	6688	457184	0	463872	26366.295805739515	8
Ischemic stroke (small artery occlusion)	26708676	2015-12-18	3185	32473	0	35658	11602.053396152336	1
Ischemic stroke (small-vessel)	29531354	2018-03-12	11710	243735	0	255445	44692.78083344751	1
Ischemic stroke (undetermined subtype)	26708676	2015-12-18	9510	32473	0	41983	29423.169378081606	1
Isovolumetric relaxation time	28394258	2017-04-10	0	0	21852	21852	21852	1
Isthmus-cingulate cortex volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	1
Itch intensity from mosquito bite	28199695	2017-04-01	0	0	84724	84724	84724	57
Itch intensity from mosquito bite adjusted by bite size	28199695	2017-04-01	0	0	84724	84724	84724	78
JT interval (sulfonylurea treatment interaction)	27958378	2016-12-13	0	0	71857	71857	71857	5
Job-related exhaustion in shift workers	28364478	2016-10-10	0	0	176	176	176	1
Joint damage in rheumatoid arthritis	31596875	2019-10-09	0	0	2775	2775	2775	1
Joint damage progression in ACPA-negative rheumatoid arthritis	26077402	2015-06-15	262	0	0	262	262	1
Joint mobility (Beighton score)	27182965	2016-05-16	0	0	64143	64143	64143	14
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	23603761	2013-04-21	2816	13056	0	15872	9265.548387096775	21
Juvenile myoclonic epilepsy	30531953	2018-12-10	1177	4218	0	5395	3680.879332715477	1
KANNO antigen negativity	31020675	2019-04-24	4	415	0	419	15.8472553699284	1
Kashin-Beck disease	25303641	2014-09-25	90	1627	0	1717	341.1298776936517	1
Kawasaki disease	22081228	2011-11-13	405	6252	0	6657	1521.4420910319964	2
Kawasaki disease	22446961	2012-03-25	622	1107	0	1729	1592.9531521110468	2
Kawasaki disease	22446962	2012-03-25	428	3379	0	3807	1519.529288153402	5
Keloid	20711176	2010-08-15	178	906	0	1084	595.0848708487084	3
Keratinocyte cancer (MTAG)	31174203	2019-06-07	18538	340302	0	358840	70321.24039683424	78
Keratoconus	31855235	2019-12-19	522	655	0	1177	1161.9711129991504	1
Ketonuria	30476138	2019-04-01	41130	0	95568	136698	136698	1
Ketonuria (moderate to severe)	30476138	2019-04-01	21803	0	95568	117371	117371	1
Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes	31537649	2019-09-19	7247	12053	0	19300	18103.231295336787	1
Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes	31537649	2019-09-19	2187	2725	0	4912	4853.074104234528	1
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	31537649	2019-09-19	2187	17219	0	19406	7762.1257343089765	1
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes	31537649	2019-09-19	2987	11766	0	14753	9528.92076187894	1
Kidney function decline traits	25493955	2014-12-10	0	0	45530	45530	45530	2
Kidney stones	19561606	2009-06-28	1507	34033	0	35540	5772.395160382667	1
Kidney stones	26272126	2015-08-14	5149	0	279870	285019	285019	4
Kidney stones	31729369	2019-11-15	6536	388508	0	395044	25711.447717216313	31
Knee osteoarthritis	20305777	2010-03-18	899	3396	0	4295	2843.3098952270084	1
Knee osteoarthritis	28916551	2017-09-15	742	475	0	1217	1158.4223500410847	1
Knee osteoarthritis	30374069	2018-10-29	23877	562153	0	586030	91616.65567291777	6
Knee osteoarthritis	30664745	2019-01-21	24955	378169	0	403124	93640.73977237774	12
Knee pain	31482140	2019-08-28	22204	149312	0	171516	77318.11954569836	4
L-arginine levels	25245031	2014-09-21	0	0	6739	6739	6739	1
L-arginine levels	27656708	2016-09-22	0	0	2295	2295	2295	2
LDL (oxidized)	23247145	2012-12-17	0	0	2080	2080	2080	1
LDL cholesterol	18179892	2008-01-10	0	0	1955	1955	1955	1
LDL cholesterol	18193043	2008-01-13	0	0	8589	8589	8589	7
LDL cholesterol	18193044	2008-01-13	0	0	2758	2758	2758	7
LDL cholesterol	18262040	2008-02-09	0	0	11685	11685	11685	3
LDL cholesterol	18802019	2008-09-18	0	0	2346	2346	2346	1
LDL cholesterol	19060906	2008-12-07	0	0	19840	19840	19840	11
LDL cholesterol	19060910	2008-12-07	0	0	4763	4763	4763	3
LDL cholesterol	19060911	2008-12-07	0	0	17797	17797	17797	9
LDL cholesterol	20686565	2010-08-05	0	0	95454	95454	95454	37
LDL cholesterol	20864672	2010-09-23	0	0	17723	17723	17723	8
LDL cholesterol	21059979	2010-11-08	0	0	841	841	841	2
LDL cholesterol	21347282	2011-02-10	0	0	7565	7565	7565	3
LDL cholesterol	23067351	2012-08-23	0	0	1249	1249	1249	1
LDL cholesterol	23726366	2013-05-29	0	0	11286	11286	11286	5
LDL cholesterol	24097068	2013-10-06	0	0	94595	94595	94595	56
LDL cholesterol	24507774	2014-02-01	0	0	56538	56538	56538	5
LDL cholesterol	25961943	2015-05-11	0	0	62166	62166	62166	41
LDL cholesterol	26160806	2015-08-01	0	0	3681	3681	3681	2
LDL cholesterol	26582766	2015-11-18	0	0	8344	8344	8344	5
LDL cholesterol	26780889	2016-01-19	0	0	4383	4383	4383	4
LDL cholesterol	27036123	2016-04-01	0	0	48780	48780	48780	23
LDL cholesterol	30275531	2018-10-01	0	0	297626	297626	297626	125
LDL cholesterol levels	17463246	2007-04-26	0	2603	0	2603	2603	1
LDL cholesterol levels	26690388	2015-12-22	0	0	12685	12685	12685	5
LDL cholesterol levels	28334899	2017-02-21	0	0	205367	205367	205367	71
LDL cholesterol levels	28371326	2017-03-30	862	880	0	1742	1741.814006888634	2
LDL cholesterol levels	30698716	2019-01-29	0	0	127326	127326	127326	60
LDL cholesterol levels	30926973	2019-03-29	0	0	125692	125692	125692	45
LDL cholesterol levels	31675503	2019-10-01	0	0	14126	14126	14126	5
LDL cholesterol levels in current drinkers	30698716	2019-01-29	0	0	71394	71394	71394	85
LDL cholesterol levels in current smokers	30926973	2019-03-29	0	0	21902	21902	21902	1
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	30698716	2019-01-29	0	0	127326	127326	127326	141
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	30698716	2019-01-29	0	0	71394	71394	71394	131
LDL cholesterol levels x long total sleep time interaction (2df test)	31719535	2019-11-12	0	49548	12000	61548	61548	59
LDL cholesterol levels x loop diuretics use interaction	31806883	2019-12-06	0	0	38834	38834	38834	1
LDL cholesterol levels x short total sleep time interaction (2df test)	31719535	2019-11-12	0	48790	12758	61548	61548	70
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	30926973	2019-03-29	0	0	125641	125641	125641	1
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	30926973	2019-03-29	0	0	125641	125641	125641	4
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	30926973	2019-03-29	0	0	125637	125637	125637	1
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	30926973	2019-03-29	0	0	125637	125637	125637	2
LDL cholesterol to HDL cholesterol ratio	28046027	2017-01-03	0	0	5292	5292	5292	2
LDL cholesterol x physical activity interaction (2df test)	30670697	2019-01-22	0	0	109688	109688	109688	39
Lactate dehydrogenase levels	26838040	2016-02-03	0	0	98585	98585	98585	15
Lactate dehydrogenase levels	29403010	2018-02-05	0	0	126319	126319	126319	14
Lactate dehydrogenase levels in off-statin users	26838040	2016-02-03	0	0	6877	6877	6877	3
Lactate dehydrogenase levels in statin users	26838040	2016-02-03	0	0	6266	6266	6266	1
Language performance in older adults (adjusted for episodic memory)	28577822	2017-05-31	0	0	1560	1560	1560	1
Lapatinib-induced hepatotoxicity	25987243	2015-05-19	1258	0	0	1258	1258	3
Large HDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	14
Large LDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	7
Large artery stroke	24262325	2013-11-21	2167	49159	0	51326	8302.034290612944	1
Large artery stroke	27997041	2016-12-20	1877	12285	0	14162	6512.906369156899	1
Large artery stroke	28265093	2017-03-06	2662	9862	0	12524	8384.747365059085	1
Laryngeal squamous cell carcinoma	25194280	2014-09-07	993	1995	0	2988	2651.987951807229	3
Late-onset Alzheimer's disease	27770636	2016-10-20	1825	3784	0	5609	4924.799429488323	2
Late-onset Alzheimer's disease	29360470	2018-01-19	966	977	0	1943	1942.9377251672672	1
Late-onset myasthenia gravis	26562150	2015-10-10	532	2128	0	2660	1702.4	6
Latent autoimmune diabetes	30254083	2018-09-25	2634	5947	0	8581	7301.898613215242	1
Latent autoimmune diabetes vs. type 1 diabetes	30254083	2018-09-25	3423	0	0	3423	3423	1
Latent autoimmune diabetes vs. type 2 diabetes	30254083	2018-09-25	13177	0	0	13177	13177	4
Lateral ventricle temporal horn volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	5
Lateral ventricle volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	1
Lateral ventricular volume in normal aging	30258056	2018-09-26	0	0	23533	23533	23533	7
Laterality in neovascular age-related macular degeneration	28775256	2017-08-03	1124	0	0	1124	1124	2
Lead levels in blood	25820613	2015-03-27	0	0	5433	5433	5433	2
Lean body mass	28552196	2017-06-01	0	0	15200	15200	15200	3
Lean body mass	28724990	2017-07-19	0	0	38292	38292	38292	4
Lean mass index	32193455	2020-03-19	0	0	2207	2207	2207	1
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	25140149	2014-08-04	496	194	0	690	557.8202898550725	3
Left planum temporale grey matter volume	31887566	2019-11-29	0	0	18037	18037	18037	1
Left ventricle diastolic internal dimension	28394258	2017-04-10	0	0	30201	30201	30201	2
Left ventricular ejection fraction	31554410	2019-09-25	0	0	16923	16923	16923	1
Left ventricular internal dimension in diastole	29403010	2018-02-05	0	0	19676	19676	19676	3
Left ventricular internal dimension in systole	29403010	2018-02-05	0	0	19586	19586	19586	4
Left ventricular obstructive tract defect (inherited effect)	28468790	2017-06-01	0	0	509	509	509	1
Leishmaniasis (visceral)	23291585	2013-01-06	1346	1089	1613	4048	2407.875154004107	1
Leisure-time exercise behaviour	30102679	2018-08-10	1789	12191	0	13980	6240.25722460658	1
Length of menstrual cycle	26732621	2016-01-04	0	0	9534	9534	9534	2
Length of menstrual cycle	30202859	2018-09-07	0	0	44871	44871	44871	5
Lentiform nucleus volume	22903471	2012-08-18	508	198	1003	1709	569.8810198300283	1
Leprosy	20018961	2009-12-16	706	1225	0	1931	1791.5069911962712	6
Leprosy	22019778	2011-10-23	706	5581	0	6287	2506.878320343566	3
Leprosy	25642632	2015-02-02	1548	2150	4362	8060	3600.0	18
Leprosy	27976721	2016-12-15	2743	3573	0	6316	6206.927802406586	9
Leukocyte count in ischemic stroke	31587654	2019-10-07	0	0	2064	2064	2064	1
Leukocyte telomere length	31171785	2019-06-06	0	0	16759	16759	16759	22
Leukocyte telomere length	32109421	2020-02-20	0	0	78592	78592	78592	21
Lewy body disease	25188341	2014-09-04	0	0	3526	3526	3526	3
Life satisfaction	27089181	2016-04-18	0	0	166205	166205	166205	2
Life satisfaction	30643256	2019-01-14	0	0	80852	80852	80852	148
Lifespan	25918517	2015-04-13	0	0	679	679	679	6
Lifetime anxiety disorder	31748690	2019-11-20	25453	58113	0	83566	70801.53119689827	5
Lifetime smoking index	31689377	2019-11-06	0	0	462690	462690	462690	126
Light vs. dark hair color	26184321	2015-07-13	0	0	7091	7091	7091	7
Limited cutaneous systemic scleroderma	24387989	2014-01-02	1127	3466	0	4593	3401.856738515132	2
Limited cutaneous systemic scleroderma	29293537	2018-01-02	1169	3726	0	4895	3559.3005107252297	6
Lipid levels in hepatitis C treatment	22497812	2012-02-22	1319	0	0	1319	1319	1
Lipid metabolism phenotypes	19936222	2009-11-20	0	0	17296	17296	17296	73
Lipid metabolism phenotypes	22286219	2012-01-29	0	0	8330	8330	8330	18
Lipid or lipoprotein levels	23696881	2013-05-16	0	0	1206	1206	1206	6
Lipid traits	22028671	2011-10-20	0	0	32225	32225	32225	1
Lipid traits	24023260	2013-09-10	0	0	1782	1782	1782	6
Lipid traits	24023261	2013-09-10	0	0	839	839	839	3
Lipid traits	24386095	2013-12-30	0	0	3451	3451	3451	11
Lipid traits	30576415	2019-08-01	0	0	1225	1225	1225	8
Lipid traits (pleiotropy) (HIPO component 1)	30289880	2018-10-05	0	0	188577	188577	188577	20
Lipid traits (pleiotropy) (HIPO component 2)	30289880	2018-10-05	0	0	188577	188577	188577	4
Lipoprotein (a) - cholesterol levels	25575512	2015-01-09	0	0	1376	1376	1376	15
Lipoprotein (a) levels	26377243	2015-09-17	0	0	2895	2895	2895	18
Lipoprotein (a) levels	28512139	2017-05-16	0	0	13781	13781	13781	41
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	31186284	2019-06-11	0	0	1402	1402	1402	3
Lipoprotein (a) levels in response to niacin in statin-treated individuals	30371334	2018-10-01	1034	1020	0	2054	2053.904576436222	1
Lipoprotein phospholipase A2 activity in cardiovascular disease	28753643	2017-07-28	0	0	22156	22156	22156	14
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	28512139	2017-05-16	0	0	13781	13781	13781	27
Lipoprotein-associated phospholipase A2 activity and mass	20442857	2010-04-29	0	0	6668	6668	6668	5
Lipoprotein-associated phospholipase A2 activity and mass	22003152	2011-10-14	0	0	13664	13664	13664	7
Lipoprotein-associated phospholipase A2 activity and mass	23118302	2012-11-01	0	0	6851	6851	6851	7
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	28753643	2017-07-28	0	0	10874	10874	10874	3
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	23118302	2012-11-01	2673	2656	0	5329	5328.945768436855	2
Liver disease biomarker	30576415	2019-08-01	0	0	1225	1225	1225	1
Liver enzyme levels	18940312	2008-10-10	0	0	7751	7751	7751	10
Liver enzyme levels (alanine transaminase)	22001757	2011-10-16	0	0	61089	61089	61089	4
Liver enzyme levels (alkaline phosphatase)	22001757	2011-10-16	0	0	61089	61089	61089	14
Liver enzyme levels (gamma-glutamyl transferase)	22001757	2011-10-16	0	0	61089	61089	61089	26
Liver fibrosis in non-alcoholic fatty acid liver disease	31311600	2019-07-17	0	0	235	235	235	2
Liver fibrosis severity in HIV/hepatitis C co-infection	27339598	2016-07-29	289	0	0	289	289	2
Liver injury in anti-tuberculosis drug treatment	31109976	2019-05-20	79	239	0	318	237.49685534591197	1
Liver transplant-free survival in primary sclerosing cholangitis (time to event)	28779025	2017-08-04	3318	0	0	3318	3318	1
Lobar intracerebral hemorrhage	31430377	2019-08-20	755	1711	0	2466	2095.3852392538524	1
Lobe attachment	26105758	2015-06-24	0	0	4919	4919	4919	2
Lobe attachment (rater scored)	29198719	2017-11-30	0	0	9710	9710	9710	10
Lobe attachment (rater-scored or self-reported)	29198719	2017-11-30	0	0	74660	74660	74660	77
Lobe size	26105758	2015-06-24	0	0	4919	4919	4919	4
Local histogram emphysema pattern	25006744	2014-07-09	3510	0	6104	9614	9614	19
Logical memory (delayed recall)	29274321	2017-12-20	771	0	305	1076	1076	1
Logical memory (delayed recall) in mild cognitive impairment	29274321	2017-12-20	581	0	0	581	581	2
Logical memory (delayed recall) in normal cognition	29274321	2017-12-20	0	0	305	305	305	2
Logical memory (immediate recall)	29274321	2017-12-20	771	0	305	1076	1076	1
Logical memory (immediate recall) in mild cognitive impairment	29274321	2017-12-20	581	0	0	581	581	1
Loneliness	29970889	2018-07-03	80134	364890	0	445024	262818.1424822032	12
Loneliness	31518406	2019-09-13	0	0	511280	511280	511280	19
Loneliness (MTAG)	29970889	2018-07-03	0	0	487647	487647	487647	16
Longevity	21418511	2011-03-21	403	1670	0	2073	1298.620356970574	1
Longevity	21740922	2011-06-29	0	0	1821	1821	1821	1
Longevity	26912274	2016-02-25	2178	2299	0	4477	4473.72972972973	2
Longevity	31484785	2019-09-04	0	0	482000	482000	482000	7
Longevity (85 years and older)	24688116	2014-03-31	7729	16121	0	23850	20897.141970649893	1
Longevity (90 years and older)	24688116	2014-03-31	5406	15112	0	20518	15926.59557461741	2
Longevity (90 years and older)	25199915	2014-09-08	6036	3757	0	9793	9262.63739405698	1
Longevity (age >90th survival percentile)	31413261	2019-08-14	11262	25483	0	36745	31241.207892230235	5
Longevity (age >99th survival percentile)	31413261	2019-08-14	5662	27782	0	33444	18813.740461667265	5
Longitudinal alcohol consumption	26081443	2015-06-17	0	0	2126	2126	2126	1
Longitudinal brain connectivity change (Louvain modularity)	31996736	2020-01-29	0	0	57	57	57	1
Longitudinal brain connectivity change (characteristic path length)	31996736	2020-01-29	0	0	57	57	57	1
Longitudinal brain connectivity change (global efficiency)	31996736	2020-01-29	0	0	57	57	57	3
Longitudinal brain connectivity change (transitivity)	31996736	2020-01-29	0	0	57	57	57	2
Longitudinal change in brain amyloid plaque burden	26268530	2015-08-11	335	0	160	495	495	1
Longitudinal cocaine use	31591132	2019-10-07	0	0	2231	2231	2231	1
Low HDL-cholesterol levels	31006500	2019-04-04	2873	5966	0	8839	7756.677452200475	2
Low HDL-cholesterol levels	31910446	2020-01-07	0	7423	0	7423	7423	5
Low bone mineral density (hip)	26235824	2015-08-29	2678	0	206701	209379	209379	1
Low density lipoprotein cholesterol levels	28548082	2017-05-26	0	0	3213	3213	3213	2
Low density lipoprotein cholesterol levels	29083408	2017-10-30	0	0	297824	297824	297824	24
Low density lipoprotein cholesterol levels	29403010	2018-02-05	0	0	72866	72866	72866	29
Low density lipoprotein cholesterol levels	29507422	2018-03-05	0	0	283251	283251	283251	538
Low density lipoprotein cholesterol levels	29593015	2018-09-01	0	0	1102	1102	1102	1
Low density lipoprotein cholesterol levels	30718733	2019-02-04	0	0	6949	6949	6949	7
Low density lipoprotein cholesterol levels	30911093	2019-03-25	0	0	1036	1036	1036	1
Low density lipoprotein cholesterol levels	31217584	2019-06-19	0	0	32221	32221	32221	87
Low density lipoprotein cholesterol levels	31393916	2019-08-08	0	0	11103	11103	11103	6
Low density lipoprotein cholesterol levels	31551469	2019-09-24	0	0	2045	2045	2045	1
Low high density lipoprotein cholesterol levels	26879886	2016-02-16	1747	2335	0	4082	3997.300342969133	7
Low tan response	29739929	2018-05-08	46768	74528	0	121296	114942.80121356022	79
Low urine pH	30476138	2019-04-01	35897	0	112302	148199	148199	3
Low vWF levels	26486471	2015-10-21	0	0	34921	34921	34921	5
Low white blood cell count	29596498	2018-03-29	0	0	1997	1997	1997	1
Low-grade serous and serous borderline ovarian cancer	28346442	2017-03-27	2966	40941	0	43907	11062.56460245519	7
Lp (a) levels	19124843	2009-01-07	0	0	357	357	357	1
Lp (a) levels	21900290	2011-09-06	0	0	1450	1450	1450	4
Lumbar spine bone mineral density	22504420	2012-04-15	0	0	32961	32961	32961	32
Lumbar spine bone mineral density	26367794	2015-10-01	0	0	28498	28498	28498	4
Lumbar spine bone mineral density	29499414	2018-02-27	0	0	40491	40491	40491	32
Lumbar spine bone mineral density (integral)	27476799	2016-09-06	0	0	11080	11080	11080	3
Lumbar spine bone mineral density (trabecular)	27476799	2016-09-06	0	0	12287	12287	12287	6
Lumiracoxib-related liver injury	20639878	2010-07-18	34	0	177	211	211	1
Lung adenocarcinoma	19836008	2009-10-15	5739	5848	0	11587	11585.974626736861	5
Lung adenocarcinoma	20700438	2010-08-05	584	585	0	1169	1168.9991445680068	1
Lung adenocarcinoma	20871597	2010-09-26	1004	1900	0	2904	2627.5482093663913	2
Lung adenocarcinoma	22797724	2012-07-15	1695	5333	0	7028	5144.812179852021	4
Lung adenocarcinoma	27393504	2016-05-13	739	3601	0	4340	2452.66267281106	1
Lung adenocarcinoma	28604730	2017-06-12	11273	55483	0	66756	37477.37186170532	21
Lung adenocarcinoma	31326317	2019-07-17	15581	27355	0	42936	39707.309018073414	14
Lung cancer	18385676	2008-04-03	1154	1137	0	2291	2290.8738542121346	1
Lung cancer	18385738	2008-04-03	1926	2522	0	4448	4368.140287769785	1
Lung cancer	18780872	2008-09-17	194	219	0	413	411.48668280871675	1
Lung cancer	18978787	2008-11-02	5095	5200	0	10295	10293.929091792132	3
Lung cancer	18978790	2008-11-02	2971	3746	0	6717	6627.5813607265145	1
Lung cancer	19654303	2009-08-04	1952	1438	0	3390	3312.066076696165	3
Lung cancer	21725308	2011-07-03	2331	3077	0	5408	5305.093934911242	4
Lung cancer	23143601	2012-11-11	5510	4544	0	10054	9961.185597772032	5
Lung cancer	24880342	2014-06-01	11348	15861	0	27209	26460.45470248815	5
Lung cancer	26732429	2016-01-04	6877	6277	0	13154	13126.631899042117	3
Lung cancer	27393504	2016-05-13	1737	3602	0	5339	4687.525004682525	2
Lung cancer	28604730	2017-06-12	29266	56450	0	85716	77094.8574361846	56
Lung cancer	30104567	2018-08-13	4918	5555	0	10473	10434.255705146566	1
Lung cancer (SNP x SNP interaction)	24325914	2013-12-09	2331	3077	0	5408	5305.093934911242	1
Lung cancer in ever smokers	28604730	2017-06-12	23223	16964	0	40187	39212.180257297136	33
Lung cancer in ever smokers	30104567	2018-08-13	4628	4041	0	8669	8629.252739647018	1
Lung cancer in never smokers	31009812	2019-04-19	2676	5355	0	8031	7137.332835263353	1
Lung disease severity in cystic fibrosis	26417704	2015-09-29	6365	0	0	6365	6365	16
Lung function	31902109	2020-01-04	0	0	4291	4291	4291	2
Lung function (FEV1)	26635082	2015-12-04	0	0	38199	38199	38199	11
Lung function (FEV1)	28166213	2017-02-06	0	0	48943	48943	48943	23
Lung function (FEV1)	30061609	2018-07-30	0	0	90715	90715	90715	28
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	28167095	2017-02-04	440	0	0	440	440	1
Lung function (FEV1/FVC)	26635082	2015-12-04	0	0	38199	38199	38199	8
Lung function (FEV1/FVC)	28166213	2017-02-06	0	0	48943	48943	48943	45
Lung function (FEV1/FVC)	30061609	2018-07-30	0	0	90715	90715	90715	29
Lung function (FEV1/FVC)	30595370	2018-12-27	0	0	370000	370000	370000	688
Lung function (FEV1/FVC)	30804560	2019-02-25	0	0	321047	321047	321047	155
Lung function (FEV1/FVC)	31453325	2019-08-14	0	0	316614	316614	316614	2
Lung function (FEV1/FVC) variance	31453325	2019-08-14	0	0	316614	316614	316614	3
Lung function (FVC)	26635082	2015-12-04	0	0	38199	38199	38199	5
Lung function (FVC)	28166213	2017-02-06	0	0	48943	48943	48943	14
Lung function (FVC)	30061609	2018-07-30	0	0	90715	90715	90715	40
Lung function (FVC)	30595370	2018-12-27	0	0	372000	372000	372000	544
Lung function (FVC)	30804560	2019-02-25	0	0	321047	321047	321047	134
Lung function (forced expiratory volume in 1 second)	29095316	2017-11-01	0	0	8842	8842	8842	1
Lung function (forced vital capacity)	24929828	2014-06-15	0	0	52253	52253	52253	6
Lung function (forced vital capacity)	29095316	2017-11-01	0	0	8842	8842	8842	1
Lung function (low FEV1 vs high FEV1)	26423011	2015-09-27	0	0	29301	29301	29301	17
Lung function (maximal voluntary ventilation)	29095316	2017-11-01	0	0	8842	8842	8842	3
Lung function in heavy smokers (high FEV1 vs average FEV1)	26423011	2015-09-27	0	0	14709	14709	14709	1
Lung function in heavy smokers (low FEV1 vs high FEV1)	26423011	2015-09-27	0	0	14654	14654	14654	3
Lung function in never smokers (low FEV1 vs average FEV1)	26423011	2015-09-27	0	0	19572	19572	19572	1
Lung function in never smokers (low FEV1 vs high FEV1)	26423011	2015-09-27	0	0	14647	14647	14647	9
Luteinizing hormone levels in polycystic ovary syndrome	26284813	2015-08-18	645	0	0	645	645	1
Lymphangioleiomyomatosis (sporadic)	31000673	2019-04-18	426	852	0	1278	1136.0	1
Lymphocyte counts	27863252	2016-11-17	0	0	171643	171643	171643	188
Lymphocyte counts	29403010	2018-02-05	0	0	62076	62076	62076	14
Lymphocyte percentage of white cells	27863252	2016-11-17	0	0	171748	171748	171748	147
Lymphoma	23349640	2013-01-17	944	4044	0	4988	3061.3761026463512	6
Lysophosphatidylcholine levels	31551469	2019-09-24	0	0	2045	2045	2045	16
Lysophosphatidylethanolamine levels	31551469	2019-09-24	0	0	2045	2045	2045	6
MGMT methylation in smokers	26183928	2015-07-16	0	0	1163	1163	1163	1
MHC class I polypeptide-related sequence A levels	25147954	2014-08-22	0	0	653	653	653	1
Macroalbuminuria in type 1 diabetes	31537649	2019-09-19	2751	12124	0	14875	8968.907294117647	1
Macrophage Migration Inhibitory Factor levels	27989323	2016-12-13	0	0	3494	3494	3494	2
Macrophage colony stimulating factor levels	27989323	2016-12-13	0	0	840	840	840	1
Macrophage inflammatory protein 1b levels	27989323	2016-12-13	0	0	8243	8243	8243	66
Macular telangiectasia type 2	28250457	2017-02-27	476	1733	0	2209	1493.72204617474	3
Macular thickness	30535121	2018-12-07	0	0	59814	59814	59814	139
Magnesium levels	20700443	2010-08-05	0	0	15366	15366	15366	6
Magnesium levels	26058915	2015-05-29	0	0	2737	2737	2737	1
Major coronary event in darapladib-treated cardiovascular disease (time to event)	28753643	2017-07-28	0	0	1318	1318	1318	2
Major coronary event in placebo-treated cardiovascular disease (time to event)	28753643	2017-07-28	0	0	1440	1440	1440	2
Major depression and alcohol dependence	29071344	2017-10-25	0	0	4659	4659	4659	1
Major depressive disorder	23377640	2013-02-01	2256	0	0	2256	2256	3
Major depressive disorder	27479909	2016-08-01	84847	241266	0	326113	251087.1544771291	17
Major depressive disorder	27519822	2016-05-24	8920	9519	0	18439	18419.5411898693	1
Major depressive disorder	27777418	2016-10-25	203	196	0	399	398.87719298245617	4
Major depressive disorder	28540843	2017-05-25	1942	4565	0	6507	5449.657292146919	1
Major depressive disorder	29317602	2018-01-10	10849	32206	0	43055	32461.074811287894	1
Major depressive disorder	29728651	2018-04-27	90150	246603	0	336753	264066.0715717455	7
Major depressive disorder	31969693	2020-01-23	29475	63482	0	92957	80516.02138623234	1
Major depressive disorder (lifetime)	32231276	2020-03-30	16301	50870	0	67171	49380.34985335934	1
Major depressive disorder (probable)	29662059	2018-04-16	30603	143916	0	174519	100946.28889691093	2
Major depressive disorder (stressful life events interaction)	26845276	2016-01-01	308	780	0	1088	883.2352941176471	1
Major depressive disorder (unexposed to adversity)	29495898	2018-03-02	3139	3832	0	6971	6902.107588581266	3
Major depressive disorder in trauma-unexposed individuals	31969693	2020-01-23	9487	39677	0	49164	30625.311121959156	1
Major mood disorders	20081856	2010-01-17	6686	9068	0	15754	15393.842325758538	1
Malaria	19465909	2009-05-24	958	1382	0	2340	2263.17264957265	1
Malaria	22895189	2012-08-15	0	828	1325	2153	2153	3
Malaria	23717212	2013-05-23	5425	6891	0	12316	12141.498863267296	2
Male-pattern baldness	18849991	2008-10-12	578	547	0	1125	1124.1457777777778	2
Male-pattern baldness	18849994	2008-10-12	296	347	0	643	638.954898911353	1
Male-pattern baldness	22032556	2011-10-27	581	617	0	1198	1196.9181969949916	2
Male-pattern baldness	22693459	2012-05-31	3891	8915	0	12806	10835.003904419804	8
Male-pattern baldness	27182965	2016-05-16	9009	8491	0	17500	17484.6672	44
Male-pattern baldness	28196072	2017-02-14	0	0	52874	52874	52874	330
Male-pattern baldness	28272467	2017-03-08	10846	11672	0	22518	22487.700861532994	63
Male-pattern baldness	29146897	2017-11-17	25662	17928	0	43590	42217.78719889883	58
Male-pattern baldness	30573740	2018-12-20	0	0	205327	205327	205327	622
Mammographic density (dense area)	25342443	2014-10-24	0	0	7600	7600	7600	8
Mammographic density (non-dense area)	25342443	2014-10-24	0	0	7600	7600	7600	1
Manganese levels	26025379	2015-05-29	0	0	949	949	949	2
Marginal zone lymphoma	25569183	2015-01-08	825	6221	0	7046	2913.610559182515	2
Marginal zone lymphoma or multiple sclerosis	31407831	2019-08-13	10513	23367	0	33880	29003.21971664699	5
Marginal zone lymphoma or rheumatoid arthritis	31407831	2019-08-13	4662	10070	0	14732	12746.766223187618	2
Marginal zone lymphoma or systemic lupus erythematosus	31407831	2019-08-13	7960	21982	0	29942	23375.421815509984	3
Maternal history of Alzheimer's disease	29777097	2018-05-18	27696	260980	0	288676	100155.22010835678	1
Mathematical ability	28155865	2017-02-03	0	0	998	998	998	1
Mathematical ability in children with dyslexia	23423138	2013-02-19	200	0	0	200	200	1
Matrix metalloproteinase levels	20031604	2009-08-01	0	0	778	778	778	3
Matrix metalloproteinase-8 levels	29212897	2017-12-01	0	0	6049	6049	6049	2
Maximum cranial length	29698431	2018-04-26	0	0	4419	4419	4419	1
Maximum cranial width	29698431	2018-04-26	0	0	4419	4419	4419	1
Maximum habitual alcohol consumption	31151762	2019-04-08	0	0	143965	143965	143965	11
Mean arterial pressure	26390057	2015-09-21	0	0	99994	99994	99994	8
Mean arterial pressure	27618448	2016-10-01	0	0	146562	146562	146562	35
Mean arterial pressure	28871152	2017-09-04	0	0	12278	12278	12278	1
Mean arterial pressure	29403010	2018-02-05	0	0	136482	136482	136482	32
Mean arterial pressure	30487518	2018-11-28	0	0	130777	130777	130777	113
Mean arterial pressure (long-term average)	28348047	2017-04-01	0	0	18422	18422	18422	4
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	29912962	2018-06-18	0	0	73031	73031	73031	41
Mean arterial pressure x alcohol consumption interaction (2df test)	29912962	2018-06-18	0	0	133361	133361	133361	83
Mean arterial pressure x sodium interaction (2df test)	27271309	2016-08-01	0	0	1876	1876	1876	1
Mean corpuscular hemoglobin	19853236	2009-10-22	0	0	6015	6015	6015	3
Mean corpuscular hemoglobin	19862010	2009-10-11	0	0	24167	24167	24167	9
Mean corpuscular hemoglobin	20139978	2010-02-07	0	0	14362	14362	14362	15
Mean corpuscular hemoglobin	23263863	2012-12-20	0	0	14177	14177	14177	8
Mean corpuscular hemoglobin	27863252	2016-11-17	0	0	172332	172332	172332	275
Mean corpuscular hemoglobin	28017375	2016-12-22	0	0	39703	39703	39703	31
Mean corpuscular hemoglobin	28453575	2017-04-28	0	0	12502	12502	12502	12
Mean corpuscular hemoglobin	28548082	2017-05-26	0	0	3213	3213	3213	2
Mean corpuscular hemoglobin	29403010	2018-02-05	0	0	108054	108054	108054	95
Mean corpuscular hemoglobin	30595370	2018-12-27	0	0	443000	443000	443000	774
Mean corpuscular hemoglobin	31080455	2019-04-26	0	0	1625	1625	1625	1
Mean corpuscular hemoglobin	31675503	2019-10-01	0	0	7526	7526	7526	1
Mean corpuscular hemoglobin concentration	20139978	2010-02-07	0	0	14377	14377	14377	7
Mean corpuscular hemoglobin concentration	23263863	2012-12-20	0	0	14177	14177	14177	3
Mean corpuscular hemoglobin concentration	27863252	2016-11-17	0	0	172851	172851	172851	84
Mean corpuscular hemoglobin concentration	28017375	2016-12-22	0	0	39703	39703	39703	18
Mean corpuscular hemoglobin concentration	28453575	2017-04-28	0	0	12502	12502	12502	6
Mean corpuscular hemoglobin concentration	28548082	2017-05-26	0	0	3213	3213	3213	1
Mean corpuscular hemoglobin concentration	29403010	2018-02-05	0	0	108728	108728	108728	44
Mean corpuscular hemoglobin concentration	31080455	2019-04-26	0	0	1625	1625	1625	1
Mean corpuscular hemoglobin concentration	31217584	2019-06-19	0	0	19803	19803	19803	15
Mean corpuscular hemoglobin concentration	31675503	2019-10-01	0	0	7526	7526	7526	1
Mean corpuscular volume	19853236	2009-10-22	0	0	6015	6015	6015	2
Mean corpuscular volume	19862010	2009-10-11	0	0	24167	24167	24167	17
Mean corpuscular volume	20139978	2010-02-07	0	0	14364	14364	14364	16
Mean corpuscular volume	23263863	2012-12-20	0	0	14177	14177	14177	8
Mean corpuscular volume	27863252	2016-11-17	0	0	172433	172433	172433	306
Mean corpuscular volume	28017375	2016-12-22	0	0	51170	51170	51170	42
Mean corpuscular volume	28453575	2017-04-28	0	0	12502	12502	12502	11
Mean corpuscular volume	28548082	2017-05-26	0	0	3213	3213	3213	1
Mean corpuscular volume	29403010	2018-02-05	0	0	108256	108256	108256	109
Mean corpuscular volume	31080455	2019-04-26	0	0	1625	1625	1625	1
Mean corpuscular volume	31194788	2019-06-13	0	0	4675	4675	4675	3
Mean corpuscular volume	31675503	2019-10-01	0	0	7526	7526	7526	1
Mean diameter of HDL particles	29084231	2017-10-30	0	0	8372	8372	8372	17
Mean diameter of LDL particles	29084231	2017-10-30	0	0	8372	8372	8372	12
Mean diameter of VLDL particles	29084231	2017-10-30	0	0	8372	8372	8372	1
Mean platelet volume	19110211	2008-12-24	0	0	1606	1606	1606	3
Mean platelet volume	19221038	2009-02-12	0	0	1221	1221	1221	1
Mean platelet volume	19820697	2009-10-11	0	0	4627	4627	4627	12
Mean platelet volume	22139419	2011-11-30	0	0	18600	18600	18600	29
Mean platelet volume	22423221	2012-03-08	0	0	16388	16388	16388	3
Mean platelet volume	24026423	2013-09-12	0	0	6291	6291	6291	8
Mean platelet volume	27863252	2016-11-17	0	0	164454	164454	164454	294
Mean platelet volume	31080455	2019-04-26	0	0	1624	1624	1624	2
Mean platelet volume	31194788	2019-06-13	0	0	4675	4675	4675	5
Mean platelet volume	31675503	2019-10-01	0	0	6407	6407	6407	1
Meconium ileus in cystic fibrosis	30807572	2019-02-26	1115	5655	0	6770	3725.4505169867057	3
Medication use (HMG CoA reductase inhibitors)	31015401	2019-04-23	73475	216910	0	290385	219535.61306541317	97
Medication use (adrenergics, inhalants)	31015401	2019-04-23	28880	147565	0	176445	96612.0252769985	56
Medication use (agents acting on the renin-angiotensin system)	31015401	2019-04-23	62752	174778	0	237530	184695.30679914117	184
Medication use (anilides)	31015401	2019-04-23	83218	96592	0	179810	178815.26179856516	7
Medication use (anti-inflammatory and antirheumatic products, non-steroids)	31015401	2019-04-23	74150	90370	0	164520	162920.87284220764	6
Medication use (antidepressants)	31015401	2019-04-23	33757	270405	0	304162	120042.10368159073	1
Medication use (antiglaucoma preparations and miotics)	31015401	2019-04-23	5215	95653	0	100868	19781.512273466313	14
Medication use (antihistamines for systemic use)	31015401	2019-04-23	13984	137652	0	151636	50777.53483341687	8
Medication use (antihypertensives)	31015401	2019-04-23	6431	145949	0	152380	24638.351988449926	4
Medication use (antimigraine preparations)	31015401	2019-04-23	5521	114323	0	119844	21066.629384866996	13
Medication use (antithrombotic agents)	31015401	2019-04-23	67653	85986	0	153639	151451.41163376486	13
Medication use (beta blocking agents)	31015401	2019-04-23	31700	192324	0	224024	108857.45812948613	59
Medication use (calcium channel blockers)	31015401	2019-04-23	31904	172474	0	204378	107694.77137460979	104
Medication use (diuretics)	31015401	2019-04-23	34453	194633	0	229086	117085.99825393084	102
Medication use (drugs affecting bone structure and mineralization)	31015401	2019-04-23	7870	207798	0	215668	30331.254706307842	11
Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	31015401	2019-04-23	53137	79230	0	132367	127223.38679580258	5
Medication use (drugs used in diabetes)	31015401	2019-04-23	15272	290641	0	305913	58038.32268651545	57
Medication use (glucocorticoids)	31015401	2019-04-23	17352	188348	0	205700	63553.02860476422	19
Medication use (immunosuppressants)	31015401	2019-04-23	3954	268648	0	272602	15586.594258295978	2
Medication use (opioids)	31015401	2019-04-23	22982	55826	0	78808	65119.94376205462	3
Medication use (salicylic acid and derivatives)	31015401	2019-04-23	61583	50427	0	112010	110898.88192125704	10
Medication use (thyroid preparations)	31015401	2019-04-23	24832	280750	0	305582	91256.47453056791	132
Medication use (vasodilators used in cardiac diseases)	31015401	2019-04-23	5546	237113	0	242659	21676.98206948846	3
Medium HDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	11
Medium LDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	8
Medium VLDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	24
Melanoma	18488026	2008-05-18	864	864	0	1728	1728.0	1
Melanoma	19578364	2009-07-05	1539	3917	0	5456	4419.5476539589445	4
Melanoma	21706340	2011-06-26	0	2150	190	2340	2340	1
Melanoma	21983785	2011-10-09	2168	4387	0	6555	5803.823646071702	1
Melanoma	21983787	2011-10-09	2804	7618	0	10422	8198.377278833237	7
Melanoma	23455637	2013-03-03	1353	3566	0	4919	3923.397438503761	1
Melanoma	24980573	2014-06-30	494	5628	0	6122	1816.5514537732768	1
Melanoma	28212542	2017-02-09	4842	286565	0	291407	19046.182555669562	28
Membranous nephropathy	27333618	2016-02-04	323	345	0	668	667.2754491017964	2
Membranous nephropathy	32231244	2020-03-30	3762	7799	0	11561	10151.314938154139	10
Menarche (age at onset)	19448620	2009-05-17	0	0	17510	17510	17510	2
Menarche (age at onset)	19448622	2009-05-15	0	0	15297	15297	15297	1
Menarche (age at onset)	19448623	2009-05-17	0	0	4714	4714	4714	1
Menarche (age at onset)	21102462	2010-11-21	0	0	87802	87802	87802	33
Menarche (age at onset)	23599027	2013-04-17	0	0	18089	18089	18089	1
Menarche (age at onset)	25231870	2014-07-23	0	0	182413	182413	182413	121
Menarche (age at onset)	27182965	2016-05-16	0	0	76831	76831	76831	39
Menarche (age at onset)	29773799	2018-05-17	0	0	67029	67029	67029	20
Menarche (age at onset)	30595370	2018-12-27	0	0	242000	242000	242000	316
Menarche and menopause (age at onset)	19448621	2009-05-17	0	0	17438	17438	17438	6
Meningioma	21804547	2011-07-31	859	704	0	1563	1547.6289187460013	1
Meningioma	29762745	2018-05-12	1606	9823	0	11429	5521.30125120308	1
Meningococcal disease	20694013	2010-08-08	475	4703	0	5178	1725.7049053688681	1
Menopause (age at onset)	19448619	2009-05-15	0	0	2979	2979	2979	3
Menopause (age at onset)	22267201	2012-01-22	0	0	38968	38968	38968	17
Menopause (age at onset)	23307926	2013-01-09	3493	13598	0	17091	11116.45052951846	4
Menopause (age at onset)	26414677	2015-11-01	0	0	69626	69626	69626	52
Menopause (age at onset)	29773799	2018-05-17	0	0	43861	43861	43861	29
Menstruation quality of life impact (dysmenorrhea)	29855537	2018-05-31	3573	2161	0	5734	5386.294384373909	2
Menstruation quality of life impact (fever)	29855537	2018-05-31	112	5622	0	5734	439.2493896058598	1
Mental composite score	30120420	2018-08-17	0	0	964	964	964	2
Mental health study participation (completed survey)	31263887	2019-07-01	122647	248781	0	371428	328593.8949890692	40
Mental health study participation (provided email address)	31263887	2019-07-01	224321	147096	0	371417	355360.38270730746	16
Mercury levels	26025379	2015-05-29	0	0	949	949	949	2
Mesial temporal lobe epilepsy with hippocampal sclerosis	24014518	2013-09-06	1018	7552	0	8570	3588.3015169194864	2
Metabolic syndrome	20694148	2010-08-04	0	0	2554	2554	2554	2
Metabolic syndrome	21386085	2011-03-08	0	0	22161	22161	22161	5
Metabolic syndrome	22399527	2012-03-07	2637	7927	0	10564	7914.993941688755	22
Metabolic syndrome	28371326	2017-03-30	862	880	0	1742	1741.814006888634	2
Metabolic syndrome	30382898	2018-11-01	1328	5870	0	7198	4331.958877465962	24
Metabolic syndrome	31589552	2019-10-07	0	0	291107	291107	291107	93
Metabolic syndrome	31910446	2020-01-07	1362	6061	0	7423	4448.380439175536	1
Metabolic syndrome (bivariate traits)	21386085	2011-03-08	0	0	22161	22161	22161	13
Metabolic syndrome (multivariate analysis)	29632305	2018-04-09	1946	6427	0	8373	5974.89167562403	8
Metabolic traits	19060910	2008-12-07	0	0	4763	4763	4763	6
Metabolic traits	21886157	2011-08-31	0	0	2820	2820	2820	37
Metabolite levels	19043545	2008-11-28	0	0	284	284	284	3
Metabolite levels	20037589	2009-12-27	0	0	1029	1029	1029	5
Metabolite levels	21909109	2011-09-11	0	0	12545	12545	12545	18
Metabolite levels	21931564	2011-09-08	0	0	142	142	142	2
Metabolite levels	22286219	2012-01-29	0	0	8330	8330	8330	13
Metabolite levels	22916037	2012-08-16	0	0	6608	6608	6608	34
Metabolite levels	23281178	2013-03-01	214	188	0	402	400.318407960199	9
Metabolite levels	23378610	2013-02-01	0	0	1004	1004	1004	5
Metabolite levels	23823483	2013-07-02	0	0	2076	2076	2076	101
Metabolite levels	31628463	2019-10-19	0	0	1954	1954	1954	132
Metabolite levels  (X-11787)	23934736	2013-08-11	0	0	1260	1260	1260	2
Metabolite levels (5-HIAA/ MHPG Ratio)	23319000	2013-01-15	0	0	398	398	398	1
Metabolite levels (Pyroglutamine)	23934736	2013-08-11	0	0	1260	1260	1260	2
Metabolite levels (lipid measures)	27005778	2016-03-23	0	0	24925	24925	24925	6
Metabolite levels (lipoprotein measures)	27005778	2016-03-23	0	0	24925	24925	24925	35
Metabolite levels (small molecules and protein measures)	27005778	2016-03-23	0	0	24925	24925	24925	33
Metabolite risk score for predicting weight gain	31560688	2019-09-27	0	0	1937	1937	1937	2
Metastasis at diagnosis in osteosarcoma	26084801	2015-06-17	0	0	541	541	541	2
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	30738427	2019-02-09	379	0	0	379	379	25
Methadone dose in opioid dependence	28115739	2017-01-24	1410	0	0	1410	1410	1
Methotrexate clearance (acute lymphoblastic leukemia)	23233662	2012-12-11	1221	0	58	1279	1279	1
Methotrexate phramacokinetics (acute lymphoblastic leukemia)	19901119	2009-11-09	640	0	0	640	640	1
Microalbuminuria	26631737	2015-12-02	54116	0	0	54116	54116	1
Microalbuminuria	31511532	2019-09-11	0	0	348954	348954	348954	17
Microalbuminuria in type 1 diabetes	31537649	2019-09-19	2447	12113	0	14560	8142.997527472527	5
Microscopic colitis	31125052	2019-05-24	423	445232	0	445655	1690.3940133062572	1
Midgestational circulating levels of PBDEs	28235828	2017-04-03	0	0	790	790	790	2
Midgestational circulating levels of PBDEs (fetal genetic effect)	28235828	2017-04-03	0	0	764	764	764	1
Midgestational circulating levels of PCBs (fetal genetic effect)	28235828	2017-04-03	0	0	764	764	764	2
Midgestational circulating levels of organochlorine pesticides	28235828	2017-04-03	0	0	790	790	790	1
Midgestational cytokine/chemokine levels (fetal genetic effect)	30134952	2018-08-22	0	0	764	764	764	1
Midgestational cytokine/chemokine levels (maternal genetic effect)	30134952	2018-08-22	0	0	790	790	790	3
Midregional pro atrial natriuretic peptide levels	29237677	2017-12-01	0	0	4932	4932	4932	2
Migraine	20802479	2010-08-29	2731	10747	0	13478	8710.508087253302	1
Migraine	21666692	2011-06-12	5122	18108	0	23230	15970.585622040466	3
Migraine	22683712	2012-06-10	2326	4580	0	6906	6170.33304373009	6
Migraine	23793025	2013-06-23	23285	95425	0	118710	74870.5627158622	8
Migraine	27182965	2016-05-16	53109	230876	0	283985	172707.62165607337	23
Migraine	27322543	2016-06-20	59674	316078	0	375752	200788.16423598546	44
Migraine - clinic-based	23793025	2013-06-23	5175	13972	0	19147	15105.259309552412	4
Migraine without aura	23793025	2013-06-23	7107	69427	0	76534	25788.15632268012	6
Migraine without aura	27322543	2016-06-20	8348	139622	0	147970	31508.1288369264	7
Migraine without aura	28952330	2017-01-01	1005	1053	0	2058	2056.8804664723034	1
Mild influenza (H1N1) infection	26379185	2015-09-17	107	549	0	656	358.18902439024396	35
Mild to moderate chronic kidney disease	31178898	2019-05-24	4150	41041	0	45191	15075.58142107942	2
Milk consumption	31959922	2020-01-20	0	0	152965	152965	152965	1
Minimum ankle–brachial index	31285632	2019-07-08	0	0	17664	17664	17664	1
Mitochondrial DNA copy number	30704525	2019-01-31	0	0	3647	3647	3647	3
Mitochondrial DNA copy number (white blood cells)	30704525	2019-01-31	0	0	3405	3405	3405	1
Mitral valve prolapse	26301497	2015-08-24	1442	2439	0	3881	3624.878124194795	6
Mixed cellularity Hodgkin lymphoma	29196614	2017-12-01	828	14315	0	15143	3130.9040480750186	3
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	25030430	2014-07-17	356	447	0	803	792.6874221668743	2
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	28753643	2017-07-28	212	0	0	212	212	7
Moderate to vigorous physical activity levels	29899525	2018-06-13	0	0	377234	377234	377234	13
Modic changes	30808802	2019-02-26	994	835	0	1829	1815.1776927282667	1
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	27416945	2016-07-14	0	0	16753	16753	16753	8
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	27416945	2016-07-14	0	0	16753	16753	16753	3
Monobrow	27182965	2016-05-16	0	0	69284	69284	69284	50
Monobrow thickness	26926045	2016-03-01	0	0	2922	2922	2922	1
Monoclonal gammopathy of undetermined significance	30134812	2018-06-11	243	1285	0	1528	817.4214659685864	15
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	1
Monocyte chemoattractant protein-1 levels	23017229	2012-09-24	0	0	815	815	815	4
Monocyte chemoattractant protein-1 levels	27989323	2016-12-13	0	0	8293	8293	8293	13
Monocyte chemoattractant protein-1 levels	31217265	2019-06-19	0	0	13577	13577	13577	1
Monocyte count	23314186	2013-03-03	0	0	11014	11014	11014	3
Monocyte count	25096241	2014-08-05	0	0	33729	33729	33729	9
Monocyte count	27863252	2016-11-17	0	0	170721	170721	170721	248
Monocyte count	28193307	2017-02-14	0	0	5892	5892	5892	1
Monocyte count	29403010	2018-02-05	0	0	62076	62076	62076	34
Monocyte count	31675503	2019-10-01	0	0	7526	7526	7526	1
Monocyte percentage of white cells	27863252	2016-11-17	0	0	170494	170494	170494	236
Monocyte-lymphocyte ratio	28193307	2017-02-14	0	0	5892	5892	5892	1
Monokine induced by gamma interferon levels	27989323	2016-12-13	0	0	3685	3685	3685	2
Mononucleosis	28928442	2017-09-19	17457	68446	0	85903	55637.72264065283	1
Mood instability	29187730	2017-11-30	53525	60443	0	113968	113548.06875614208	5
Mood instability	31168069	2019-06-05	157039	206666	0	363705	356933.47052143904	46
Morbidity-free survival	17903295	2007-09-19	0	0	558	558	558	2
Morning person	30595370	2018-12-27	0	0	410000	410000	410000	157
Morning person	30696823	2019-01-29	252287	150908	0	403195	377704.3524448468	213
Morning vs. evening chronotype	26835600	2016-02-02	0	0	89283	89283	89283	23
Morning vs. evening chronotype	26955885	2016-03-09	0	0	35672	35672	35672	6
Morning vs. evening chronotype	27494321	2016-08-05	0	0	114765	114765	114765	8
Morningness	30804565	2019-02-25	0	0	434835	434835	434835	274
Mortality	27029810	2016-03-31	0	0	272081	272081	272081	2
Mortality in heart failure	27149122	2016-05-05	1798	1030	0	2828	2619.4342291371995	1
Mosaic loss of chromosome Y	27064253	2016-04-11	895	11474	0	12369	3320.9572317891507	1
Mosaic loss of chromosome Y (Y chromosome dosage)	28346444	2017-03-27	0	0	67034	67034	67034	19
Mosaic loss of chromosome Y (Y chromosome dosage)	31624269	2019-10-17	0	0	95380	95380	95380	80
Mosquito bite size	28199695	2017-04-01	0	0	84724	84724	84724	37
Motion sickness	25628336	2015-01-26	0	0	80494	80494	80494	35
Mouth morphology (principal component model)	30174134	2018-08-16	0	0	694	694	694	1
Mouth ulcers	30837455	2019-03-05	47079	414027	0	461106	169088.90478978804	92
Moyamoya disease	21048783	2010-11-04	72	45	0	117	110.76923076923077	1
Moyamoya disease	29273593	2017-12-22	755	2031	0	2786	2201.586503948313	24
Mucinous ovarian carcinoma	26075790	2015-06-15	1644	21693	0	23337	6112.746625530273	4
Mucinous ovarian carcinoma	28346442	2017-03-27	2566	40941	0	43507	9658.639391362309	6
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	23103227	2012-10-25	5368	4006	0	9374	9176.107531470023	4
Multiple myeloma	22120009	2011-11-27	1675	5903	0	7578	5219.0683557666935	2
Multiple myeloma	23955597	2013-08-18	2335	7306	0	9641	7077.900632714449	4
Multiple myeloma	26007630	2015-05-26	2194	222555	0	224749	8690.328677769423	4
Multiple myeloma	27363682	2016-07-01	7319	234385	0	241704	28389.49814649323	16
Multiple myeloma	30213928	2018-09-13	8197	241468	0	249665	31711.504552099817	6
Multiple myeloma (IgH translocation)	23502783	2013-03-17	1660	7306	0	8966	5410.64465759536	2
Multiple myeloma (hyperdiploidy)	23502783	2013-03-17	1660	7306	0	8966	5410.64465759536	4
Multiple myeloma (survival)	26198393	2015-07-22	545	0	0	545	545	1
Multiple myeloma and monoclonal gammopathy	26007630	2015-05-26	2445	294390	0	296835	9699.443124968417	5
Multiple sclerosis	17660530	2007-07-29	0	2431	931	3362	3362	2
Multiple sclerosis	18941528	2008-10-22	242	242	0	484	484.0	1
Multiple sclerosis	18997785	2008-11-09	0	45	0	45	45	1
Multiple sclerosis	19525953	2009-06-14	2624	7220	0	9844	7698.203982121089	6
Multiple sclerosis	19525955	2009-06-14	1618	3413	0	5031	4390.565692705228	2
Multiple sclerosis	20159113	2010-02-12	68	136	0	204	181.33333333333334	2
Multiple sclerosis	20453840	2010-05-09	882	872	0	1754	1753.9429874572406	2
Multiple sclerosis	20598377	2010-06-30	590	825	0	1415	1375.9717314487632	1
Multiple sclerosis	21244703	2011-01-18	2124	6720	0	8844	6455.576662143826	1
Multiple sclerosis	21833088	2011-08-11	9772	16849	0	26621	24739.630817775444	56
Multiple sclerosis	22190364	2011-12-01	5545	12153	0	17698	15230.734546276415	8
Multiple sclerosis	22457343	2012-03-28	197	234	0	431	427.8236658932715	1
Multiple sclerosis	22570697	2012-05-03	2127	4558	0	6685	5800.966940912491	1
Multiple sclerosis	23412934	2013-02-13	0	0	284	284	284	1
Multiple sclerosis	24076602	2013-11-01	14498	24091	0	38589	36204.23623312343	97
Multiple sclerosis	27386562	2016-06-17	4888	10395	0	15283	13298.635084734671	13
Multiple sclerosis	28445677	2017-04-27	2273	2148	0	4421	4417.465731734901	1
Multiple sclerosis	31604244	2019-09-01	14802	26703	0	41505	38092.548464040476	199
Multiple sclerosis (OCB status)	23472185	2013-03-05	1528	428	0	1956	1337.3905930470348	7
Multiple sclerosis and C-reactive protein levels (pleiotropy)	26920376	2016-02-26	0	0	93333	93333	93333	1
Multiple sclerosis and HDL levels (pleiotropy)	26920376	2016-02-26	0	0	215725	215725	215725	1
Multiple sclerosis and systolic blood pressure (pleiotropy)	26920376	2016-02-26	0	0	230204	230204	230204	2
Multiple sclerosis and triglyceride levels (pleiotropy)	26920376	2016-02-26	0	0	215725	215725	215725	1
Multiple sclerosis and type 2 diabetes (pleiotropy)	26920376	2016-02-26	0	0	49192	49192	49192	1
Multisite chronic pain	31194737	2019-06-13	0	0	387649	387649	387649	39
Mumps	28928442	2017-09-19	31227	54153	0	85380	79223.9742796908	9
Musician's dystonia	24375517	2013-12-26	127	984	0	1111	449.92979297929793	1
Myasthenia gravis	23055271	2012-07-16	400	5505	0	5905	1491.6172734970364	3
Myasthenia gravis	25643325	2015-04-01	972	1977	0	2949	2606.502543234995	2
Myeloid white cell count	27863252	2016-11-17	0	0	169219	169219	169219	164
Myeloproliferative neoplasms	19287384	2009-03-15	324	2999	0	3323	1169.63707493229	1
Myeloproliferative neoplasms	25849990	2015-04-07	524	2674	0	3198	1752.5653533458412	2
Myocardial infarction	17478679	2007-05-03	1607	6728	0	8335	5188.672345530894	1
Myocardial infarction	21107343	2010-11-25	194	1539	0	1733	689.130986728217	1
Myocardial infarction	24916648	2014-06-11	1666	3198	0	4864	4381.4703947368425	3
Myocardial infarction	26343387	2015-09-07	40149	126310	0	166459	121861.1235199058	23
Myocardial infarction	26708285	2016-02-01	2563	1868	0	4431	4321.989618596253	6
Myocardial infarction	31888606	2019-12-30	2967	3075	0	6042	6040.069513406157	4
Myocardial infarction (early onset)	19198609	2009-02-08	2967	3075	0	6042	6040.069513406157	9
Myocardial infarction in coronary artery disease	21239051	2011-01-14	4572	2739	0	7311	6851.433729995897	1
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	28753643	2017-07-28	0	0	740	740	740	2
Myopia	25233373	2014-09-18	3923	11696	0	15619	11750.664703246046	1
Myopia	27182965	2016-05-16	106086	85757	0	191843	189688.79973728515	50
Myopia (age of diagnosis)	29808027	2018-05-28	0	0	104293	104293	104293	112
Myopia (pathological)	21505071	2011-04-19	102	335	0	437	312.76887871853546	1
Myopia (pathological)	21640322	2011-06-02	419	669	0	1088	1030.5551470588234	1
Myopia (pathological)	22685421	2012-06-07	0	0	4944	4944	4944	1
Myopia (pathological)	23049088	2012-10-09	187	1064	0	1251	636.1886490807354	32
Myopia (pathological)	23406873	2013-02-28	665	960	0	1625	1571.446153846154	4
Myopia (severe)	23933737	2013-08-09	1603	3427	0	5030	4368.573359840954	2
Myopic maculopathy	29725004	2018-05-03	0	0	4476	4476	4476	1
Myositis	26291516	2015-08-20	1710	4724	0	6434	5022.095119676717	23
Myringotomy	28928442	2017-09-19	4138	85089	0	89227	15784.382843758056	1
N-glycan levels	21203500	2010-12-23	0	0	2559	2559	2559	8
N-glycan levels	21908519	2011-12-15	0	0	3367	3367	3367	41
N-glycan levels	31163085	2019-06-15	0	0	2763	2763	2763	7
N-terminal pro B-type natriuretic peptide levels	29237677	2017-12-01	0	0	4932	4932	4932	2
NHDL cholesterol to HDL cholesterol ratio	28046027	2017-01-03	0	0	5292	5292	5292	1
NT-proBNP levels in acute coronary syndrome	26908625	2016-01-21	0	0	3740	3740	3740	3
Narcolepsy	19412176	2009-05-03	807	1074	0	1881	1843.1004784688994	1
Narcolepsy	20711174	2010-08-15	562	702	0	1264	1248.493670886076	1
Narcolepsy	23459209	2013-01-01	1886	10421	0	12307	6387.911270008937	3
Narcolepsy	24204295	2013-10-31	1189	1997	0	3186	2981.083490269931	5
Narcolepsy (age of onset)	24204295	2013-10-31	1000	0	0	1000	1000	3
Narcolepsy (onset before 2009 H1N1 influenza pandemic)	24204295	2013-10-31	0	0	5284	5284	5284	2
Narcolepsy with cataplexy	25986216	2015-05-15	409	1562	0	1971	1296.515474378488	2
Narrowest width of the femoral neck	30888730	2019-03-19	0	0	18719	18719	18719	2
Nasal polyps	30643255	2019-01-14	4366	714681	0	719047	17357.95988857474	13
Nasopharyngeal carcinoma	19664746	2009-08-05	277	285	0	562	561.8861209964413	3
Nasopharyngeal carcinoma	20512145	2010-05-30	1583	1894	0	3477	3449.182628702905	6
Nasopharyngeal carcinoma	23209447	2012-11-29	1405	2650	0	4055	3672.749691738594	6
Nasopharyngeal carcinoma	26545403	2016-01-01	2152	3740	0	5892	5464.005431093007	4
Nasopharyngeal carcinoma	27436580	2016-07-19	1583	2979	0	4562	4134.815431828146	5
Nasopharyngeal carcinoma (SNP x SNP interaction)	24376627	2013-12-23	277	285	0	562	561.8861209964413	36
Natriuretic peptide levels	21273288	2011-01-27	0	0	1325	1325	1325	1
Natto consumption	31959922	2020-01-20	0	0	152678	152678	152678	1
Negative urgency	30718321	2019-02-04	0	0	22795	22795	22795	1
Neonatal cytokine/chemokine levels (fetal genetic effect)	30134952	2018-08-22	0	0	764	764	764	22
Neonatal cytokine/chemokine levels (maternal genetic effect)	30134952	2018-08-22	0	0	790	790	790	3
Neonatal lupus	20662065	2010-07-26	116	3351	0	3467	448.4753389097202	1
Neovascular age-related macular degeneration	28703135	2017-07-13	377	1074	0	1451	1116.1902136457616	3
Nephrolithiasis	22396660	2012-03-01	904	7471	0	8375	3225.687880597015	3
Nephropathy	20595679	2010-07-01	431	4980	0	5411	1586.6789872481982	1
Nephropathy	21399633	2011-03-13	1194	902	0	2096	2055.320610687023	5
Neuranatomic and neurocognitive phenotypes	21483430	2011-04-12	0	0	857	857	857	1
Neuritic plaque	25188341	2014-09-04	0	0	4232	4232	4232	5
Neuritic plaque	31497858	2019-09-01	0	0	5976	5976	5976	2
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	29458411	2018-02-20	3135	463	0	3598	1613.6798221234017	1
Neuritic plaques or neurofibrillary tangles (pleiotropy)	29458411	2018-02-20	3135	463	0	3598	1613.6798221234017	2
Neuroblastoma	18463370	2008-05-09	1032	2043	0	3075	2742.602926829268	1
Neuroblastoma	21124317	2010-12-01	1627	3254	0	4881	4338.666666666667	3
Neuroblastoma	22941191	2012-09-02	2101	4202	0	6303	5602.666666666667	6
Neuroblastoma (11q deletion)	28924153	2017-09-18	113	5109	0	5222	442.219073152049	1
Neuroblastoma (MYCN amplification)	28924153	2017-09-18	260	5109	0	5369	989.636803874092	2
Neuroblastoma (high-risk)	19412175	2009-05-03	397	2043	0	2440	1329.6245901639345	1
Neurociticism	29500382	2018-03-02	0	0	380506	380506	380506	181
Neurofibrillary tangles	25188341	2014-09-04	0	0	4707	4707	4707	2
Neurofibrillary tangles	31497858	2019-09-01	0	0	2701	2701	2701	3
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	29458411	2018-02-20	3135	463	0	3598	1613.6798221234017	2
Neurological blood protein biomarker levels	31320639	2019-07-18	0	0	750	750	750	69
Neuromyelitis optica	29769526	2018-05-16	129	784	0	913	443.093099671413	7
Neuromyelitis optica (AQP4-IgG-positive)	29769526	2018-05-16	66	784	0	850	243.5011764705882	7
Neuropathic pain in head and neck cancer	29884837	2018-06-08	130	913	0	1043	455.1869606903164	4
Neuroticism	25993607	2015-05-20	0	0	63661	63661	63661	1
Neuroticism	27067015	2016-04-12	0	0	106716	106716	106716	10
Neuroticism	27089181	2016-04-18	0	0	170911	170911	170911	11
Neuroticism	27918536	2016-12-05	0	0	122867	122867	122867	2
Neuroticism	29255261	2017-12-18	0	0	329821	329821	329821	142
Neuroticism	29292387	2018-01-01	0	0	168105	168105	168105	2
Neuroticism	29942085	2018-06-25	0	0	449484	449484	449484	371
Neuroticism	30595370	2018-12-27	0	0	372000	372000	372000	128
Neuroticism	30643256	2019-01-14	0	0	523783	523783	523783	263
Neuroticism	32231276	2020-03-30	0	0	274107	274107	274107	59
Neuroticism (MTAG)	29292387	2018-01-01	0	0	168105	168105	168105	37
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	29521573	2018-03-01	0	0	941	941	941	1
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	29521573	2018-03-01	0	0	941	941	941	1
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	29521573	2018-03-01	0	0	941	941	941	1
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	29521573	2018-03-01	0	0	941	941	941	1
Neutrophil count	20172861	2010-02-18	0	0	5771	5771	5771	2
Neutrophil count	21507922	2011-05-01	0	0	115	115	115	1
Neutrophil count	25096241	2014-08-05	0	0	33743	33743	33743	6
Neutrophil count	27863252	2016-11-17	0	0	170702	170702	170702	152
Neutrophil count	29066854	2017-11-01	0	0	5901	5901	5901	1
Neutrophil count	29403010	2018-02-05	0	0	62076	62076	62076	22
Neutrophil count	31080455	2019-04-26	0	0	1415	1415	1415	1
Neutrophil count	31675503	2019-10-01	0	0	7526	7526	7526	2
Neutrophil count in HIV-infection	25884002	2015-01-09	0	0	2547	2547	2547	1
Neutrophil level response to clozapine in treatment-resistant schizophrenia	30647433	2019-01-15	0	0	552	552	552	2
Neutrophil percentage of granulocytes	27863252	2016-11-17	0	0	170672	170672	170672	171
Neutrophil percentage of white cells	27863252	2016-11-17	0	0	171542	171542	171542	135
Nevirapine-induced rash	21810746	2011-08-01	149	0	0	149	149	1
Nevus count	30429480	2018-11-14	0	0	52506	52506	52506	6
Nevus count or cutaneous melanoma	30429480	2018-11-14	12874	23203	52506	88583	33119.76295146492	27
Nicotine dependence	18385739	2008-04-03	0	0	10995	10995	10995	1
Nicotine dependence	22524403	2012-04-24	0	0	3365	3365	3365	1
Nicotine dependence	26440539	2015-10-06	17074	0	0	17074	17074	2
Nicotine dependence	28440896	2017-04-25	8215	7998	0	16213	16210.095602294456	1
Nicotine dependence	28972577	2017-10-03	0	0	38602	38602	38602	1
Nicotine dependence and major depression (severity of comorbidity)	30287806	2018-10-04	0	0	3724	3724	3724	1
Nicotine glucouronidation	25293881	2014-10-07	0	0	2239	2239	2239	2
Nicotine metabolite ratio	26921259	2016-02-27	0	0	315	315	315	1
Nicotine metabolite ratio in current smokers	26407342	2015-09-25	0	0	1518	1518	1518	3
Nicotine metabolite ratio in current smokers	27488534	2016-08-03	0	0	2239	2239	2239	14
Nicotine metabolite ratio in current smokers	28921760	2017-09-16	0	0	954	954	954	3
Nicotine metabolite ratio in current smokers	32157176	2020-03-10	0	0	5185	5185	5185	2
Nicotine withdrawal	29532581	2018-03-13	0	0	2442	2442	2442	1
Nicotine withdrawal symptom count	29532581	2018-03-13	0	0	2442	2442	2442	1
Night sleep phenotypes	27126917	2016-04-29	0	0	941	941	941	3
Nodular sclerosis Hodgkin lymphoma	22086417	2011-11-15	393	3315	0	3708	1405.388349514563	1
Nodular sclerosis Hodgkin lymphoma	29196614	2017-12-01	1278	14325	0	15603	4693.289751970775	8
Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	30066433	2018-07-31	130	367	0	497	383.9839034205231	1
Non-accommodative esotropia	30098192	2018-08-01	826	2991	0	3817	2589.013361278491	1
Non-albumin protein levels	22558069	2012-04-27	0	0	9103	9103	9103	5
Non-albumin protein levels	29403010	2018-02-05	0	0	98538	98538	98538	58
Non-alcoholic fatty liver disease activity score	31311600	2019-07-17	0	0	235	235	235	2
Non-alcoholic fatty liver disease histology (other)	20708005	2010-08-10	236	0	0	236	236	1
Non-cardia gastric cancer	26129866	2015-06-30	1027	2708	0	3735	2978.437483266399	2
Non-cardia gastric cancer	26701879	2015-12-23	2031	4970	0	7001	5767.216111984002	5
Non-chemotherapy drug induced agranulocytosis	27157822	2016-05-03	234	5170	0	5404	895.4700222057735	3
Non-glioblastoma glioma	26424050	2015-10-01	2364	7435	0	9799	7174.748443718747	8
Non-glioblastoma glioma	28346443	2017-03-27	5819	0	18190	24009	24009	19
Non-glioblastoma glioma	29743610	2018-05-09	3036	10686	0	13722	9457.133362483602	7
Non-lobar intracerebral hemorrhage (MTAG)	31430377	2019-08-20	1005	1711	0	2716	2532.4815905743744	3
Non-melanoma skin cancer	23548203	2013-04-01	0	0	6747	6747	6747	3
Non-melanoma skin cancer	29739929	2018-05-08	5912	181740	0	187652	22902.96676827318	38
Non-muscle-invasive bladder cancer tumour size	31277774	2018-09-15	633	0	0	633	633	1
Non-obstructive azoospermia	22197933	2011-12-25	981	1657	0	2638	2464.771796815769	4
Non-response to bupropion and depression	27622933	2016-09-13	1861	192070	0	193931	7372.5659126184055	1
Non-small cell lung cancer	20876614	2010-09-28	621	1541	0	2162	1770.5106382978724	1
Non-small cell lung cancer	31326317	2019-07-17	27120	27355	0	54475	54473.986232216615	24
Nonalcoholic fatty liver disease	21423719	2011-03-10	0	0	7176	7176	7176	1
Nonalcoholic fatty liver disease	22719876	2012-06-14	529	932	0	1461	1349.8370978781657	1
Nonalcoholic fatty liver disease	29271184	2017-12-26	1593	2816	0	4409	4069.7555001134037	2
Nonalcoholic fatty liver disease	29385134	2018-01-31	902	7672	0	8574	3228.4320037322136	5
Nonalcoholic fatty liver disease	31311600	2019-07-17	1106	8571	0	9677	3918.373876201302	1
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	29385134	2018-01-31	58	7672	0	7730	230.25924967658474	1
Nonatopic asthma	31669095	2019-10-24	28862	422048	0	450910	108058.36531458604	101
Nonatopic asthma and/or BMI	31669095	2019-10-24	28862	422048	6912	457822	108058.36531458604	10
Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	31669095	2019-10-24	28862	422048	6780	457690	108058.36531458604	8
Nonatopic asthma or fasting glucose levels	31669095	2019-10-24	28862	422048	58047	508957	108058.36531458604	1
Nonatopic asthma or type 2 diabetes	31669095	2019-10-24	28862	581256	0	610118	109986.6627242599	5
Nonsyndromic cleft lip	31609978	2019-10-14	945	5048	0	5993	3183.954613716002	9
Nonsyndromic cleft lip with cleft palate	28232668	2017-02-24	2033	4051	0	6084	5414.650230111769	34
Nonsyndromic cleft lip with or without cleft palate	25775280	2015-03-16	858	1248	0	2106	2033.7777777777776	5
Nonsyndromic cleft lip with or without cleft palate	28087736	2017-01-13	399	1318	1461	3178	1225.1182294700059	4
Nonsyndromic cleft lip with or without cleft palate	30067744	2018-08-01	399	1318	816	2533	1225.1182294700059	1
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	30277614	2018-09-11	2142	1700	0	3842	3791.150442477876	1
Nonsyndromic cleft palate	31609978	2019-10-14	930	5048	0	5978	3141.278019404483	11
Nontyphoidal Salmonella bacteraemia	29523850	2018-03-09	180	2677	0	2857	674.6377318865943	1
Nonunion in individuals with fractures	30680360	2018-05-29	131	1629	0	1760	484.99772727272733	1
Normal facial asymmetry (angle of surface orientation score)	30631343	2018-12-18	0	0	3186	3186	3186	21
Nose length	30174134	2018-08-16	0	0	694	694	694	1
Nose morphology	27560520	2016-08-25	0	0	2447	2447	2447	2
Nose morphology	29921221	2018-06-19	0	0	5643	5643	5643	22
Nose morphology (partial least square model)	30174134	2018-08-16	0	0	694	694	694	1
Nose size	27182965	2016-05-16	0	0	67023	67023	67023	16
Nucleus accumbens volume	31636452	2019-10-21	0	0	32562	32562	32562	6
Number of alcoholic drinks required to feel an effect (long-term average)	31270906	2019-07-03	0	0	7515	7515	7515	1
Number of children ever born	27798627	2016-10-31	0	0	329139	329139	329139	3
Number of decayed, missing and filled tooth surfaces	31235808	2019-06-24	0	0	26792	26792	26792	2
Number of decayed, missing and filled tooth surfaces or use of dentures	31235808	2019-06-24	77714	383317	26792	487823	258456.34968581286	47
Number of live births	30188897	2018-09-06	0	0	981	981	981	1
Number of pregnancies	30188897	2018-09-06	0	0	981	981	981	1
Number of sexual partners	30643258	2019-01-14	0	0	370711	370711	370711	118
Number of stillbirths in continuous marriage	30188897	2018-09-06	0	0	593	593	593	1
Number of twin births	30760885	2019-02-13	8962	409591	0	418553	35080.427491858856	1
Obese vs. thin	30677029	2019-01-24	0	0	2927	2927	2927	10
Obesity	19151714	2009-01-18	1380	1416	0	2796	2795.536480686695	8
Obesity	21552555	2011-04-28	520	540	0	1060	1059.6226415094338	3
Obesity	21708048	2011-06-28	0	0	327	327	327	2
Obesity	22484627	2012-04-08	5530	8318	0	13848	13286.695551704217	2
Obesity	23563607	2013-04-07	0	65840	138658	204498	204498	66
Obesity (early onset extreme)	20421936	2010-04-22	1138	1120	0	2258	2257.8565101860054	3
Obesity (early onset extreme)	23563609	2013-04-07	1509	5380	0	6889	4713.845260560313	9
Obesity (extreme)	19553259	2009-06-24	775	3197	0	3972	2495.1409869083586	1
Obesity (extreme)	21935397	2011-09-15	2633	2740	0	5373	5370.8691606179045	1
Obesity (extreme)	30677029	2019-01-24	0	0	7916	7916	7916	10
Obesity (extreme)	31852448	2019-12-18	575	1707	0	2282	1720.464504820333	1
Obesity (extreme)	31888951	2019-12-30	984	2012	0	2996	2643.268357810414	1
Obesity (extreme) (SNP x SNP interaction)	31118946	2019-05-01	493	537	0	1030	1028.1203883495145	38
Obesity in adult survivors of childhood cancer exposed to cranial radiation	25963547	2015-05-11	0	0	776	776	776	1
Obesity-related traits	17658951	2007-07-20	0	0	4741	4741	4741	1
Obesity-related traits	22013104	2011-10-19	0	0	598	598	598	2
Obesity-related traits	23251661	2012-12-04	0	0	1078	1078	1078	15
Objective response to lithium treatment	26503763	2015-10-27	323	6684	0	7007	1232.4429855858427	2
Obsessive-compulsive symptoms	26859814	2016-02-09	0	0	6931	6931	6931	1
Obstetric antiphospholipid syndrome	28424481	2017-04-20	115	419	0	534	360.936329588015	1
Obstructive sleep apnea trait (apnea hypopnea index)	26977737	2016-03-15	0	0	12558	12558	12558	1
Obstructive sleep apnea trait (apnea hypopnea index, change over time)	31786426	2019-08-14	0	0	706	706	706	2
Obstructive sleep apnea trait (average respiratory event duration)	26977737	2016-03-15	0	0	10238	10238	10238	1
Occipital cortical area (total cortical area interaction)	22343285	2012-02-16	0	0	421	421	421	1
Occipital lobe volume	31396565	2019-08-02	0	0	15269	15269	15269	4
Ocular sarcoidosis	32141793	2020-03-06	260	1551	0	1811	890.6902263942573	4
Odorant perception (&beta;-ionone)	23910658	2013-07-31	0	0	187	187	187	1
Odorant perception (isobutyraldehyde)	23910658	2013-07-31	0	0	187	187	187	1
Offspring birth weight	29309628	2018-01-03	0	0	68258	68258	68258	2
Offspring birth weight	31043758	2019-05-01	0	0	230069	230069	230069	107
Oleic acid (18:1n-9) levels	23362303	2013-01-29	0	0	8961	8961	8961	1
Oleic acid (18:1n-9) levels	28298293	2017-03-15	0	0	3521	3521	3521	4
Oligoclonal band status in multiple sclerosis	25616667	2015-01-22	0	0	3026	3026	3026	2
Open-angle glaucoma and optic cup area	29449654	2018-02-15	3071	6750	29828	39649	8442.826596069646	2
Open-angle glaucoma and vertical cup-disc ratio	29449654	2018-02-15	3071	6750	32272	42093	8442.826596069646	2
Opioid dependence	26239289	2015-08-04	1167	161	0	1328	565.9246987951807	1
Opioid dependence	29478698	2018-01-11	0	0	3058	3058	3058	2
Opioid dependence	31250797	2019-05-01	2120	1944	0	4064	4056.377952755905	2
Opioid dependence	32099098	2020-02-26	4238	17700	0	21938	13677.19938007111	1
Opioid dependence x sex interaction	31792237	2019-12-02	4715	3672	0	8387	8257.293430308811	9
Opioid exposure	32099098	2020-02-26	4173	32500	0	36673	14792.6267281106	1
Opioid overdose severity score	31362332	2019-07-30	0	0	3477	3477	3477	3
Opioid requirements during laparoscopic-assisted colectomy	29207912	2017-12-06	0	0	117	117	117	1
Opioid sensitivity	24143882	2013-10-19	2066	3631	0	5697	5267.085132525891	1
Opioid use disorder	32005204	2020-01-31	199	253	0	452	445.54867256637175	2
Optic cup area	25631615	2015-01-28	0	0	17218	17218	17218	36
Optic cup area	28073927	2017-01-10	0	0	22484	22484	22484	37
Optic cup area	31798171	2019-11-27	0	0	24493	24493	24493	21
Optic disc area	21307088	2011-02-09	0	0	4445	4445	4445	4
Optic disc area	25631615	2015-01-28	0	0	24089	24089	24089	20
Optic disc area	28073927	2017-01-10	0	0	22504	22504	22504	27
Optic disc area	31798171	2019-11-27	0	0	24509	24509	24509	15
Optic disc parameters	20548946	2010-06-10	0	0	7360	7360	7360	3
Optic disc radius	31597446	2019-10-10	0	0	3094	3094	3094	2
Optic disc size	31809533	2019-09-06	0	0	67040	67040	67040	115
Optic nerve head parameters (multi-trait analysis)	31798171	2019-11-27	0	0	25180	25180	25180	6
Optic nerve measurement (cup-to-disc ratio)	28061514	2017-01-01	0	0	3596	3596	3596	1
Optic nerve measurement (disc area)	20395239	2010-04-15	0	0	2034	2034	2034	2
Oral cavity and pharyngeal cancer	21437268	2011-03-17	2091	8334	0	10425	6686.38618705036	4
Oral cavity and pharyngeal cancer	27749845	2016-10-17	6034	6585	0	12619	12594.940962041368	4
Oral cavity cancer	27749845	2016-10-17	2990	6585	0	9575	8225.232375979112	5
Orofacial clefts	19270707	2009-03-08	224	383	0	607	565.3509060955519	1
Orofacial clefts	19656524	2009-08-03	111	5951	0	6062	435.8700098977235	1
Orofacial clefts	20023658	2009-12-20	399	1318	0	1717	1225.1182294700059	2
Orofacial clefts	22863734	2012-08-05	399	1318	666	2383	1225.1182294700059	17
Orofacial clefts	28054174	2017-01-04	901	1700	3427	6028	2355.5555555555557	16
Orofacial clefts (maternal alcohol consumption interaction)	21618603	2011-05-26	0	0	550	550	550	1
Oropharynx cancer	27749845	2016-10-17	2641	6585	0	9226	7539.989161066551	2
Orthostatic hypotension	24124408	2013-09-30	667	5761	0	6428	2391.1555693839455	1
Ossification of the posterior longitudinal ligament of the spine	25064007	2014-07-27	1112	6810	0	7922	3823.640494824539	6
Osteoarthritis	21871595	2011-08-25	3177	4894	0	8071	7705.730640564987	1
Osteoarthritis	22566624	2012-05-07	0	0	6523	6523	6523	1
Osteoarthritis	22763110	2012-07-03	7410	11009	0	18419	17715.769585753842	1
Osteoarthritis	30664745	2019-01-21	77052	378169	0	455221	256039.8381269757	34
Osteoarthritis (hand, severe)	24728293	2014-04-13	623	69153	0	69776	2469.75	1
Osteoarthritis (hip)	23989986	2013-08-29	4734	46903	0	51637	17199.976915777446	2
Osteoarthritis (hip)	30374069	2018-10-29	17151	596639	0	613790	66687.01340197788	29
Osteoarthritis (hip)	30664745	2019-01-21	15704	378169	0	393873	60311.48086819863	30
Osteoarthritis (hospital diagnosed)	29559693	2018-03-20	10083	40425	0	50508	32280.45260156807	1
Osteoarthritis (with total hip replacement)	28319091	2017-03-20	3110	99911	109150	212171	12064.461032216732	2
Osteoarthritis biomarkers	25057126	2014-07-23	0	0	4654	4654	4654	1
Osteoarthritis of the hand	28855172	2017-08-30	0	0	8743	8743	8743	1
Osteoarthritis of the hip (hospital diagnosed)	29559693	2018-03-20	2396	9593	0	11989	7668.638919009091	2
Osteoarthritis of the hip (with total joint replacement)	29436472	2018-02-07	2517	9939	0	12456	8033.546242774566	1
Osteoarthritis of the hip or knee	29436472	2018-02-07	5414	9939	0	15353	14019.343711326776	1
Osteoarthritis of the hip or knee	30664745	2019-01-21	39427	378169	0	417596	142818.1224245443	28
Osteoarthritis of the hip or knee (hospital diagnosed)	29559693	2018-03-20	6586	26384	0	32970	21081.592235365482	1
Osteoarthritis of the hip or knee (with total joint replacement)	29436472	2018-02-07	5414	9939	0	15353	14019.343711326776	1
Osteoporosis	20072603	2010-01-08	350	350	0	700	700.0	1
Osteoporosis	21573128	2011-05-15	190	1557	0	1747	677.3440183171151	1
Osteoporosis	23349225	2013-01-24	288	1139	0	1427	919.501051156272	1
Osteoporosis-related phenotypes	20548944	2010-06-10	0	0	3569	3569	3569	2
Osteoprotegerin levels	25080503	2014-07-30	0	0	10336	10336	10336	4
Osteosarcoma	23727862	2013-06-02	694	2703	0	3397	2208.869002060642	2
Other erythrocyte phenotypes	19862010	2009-10-11	0	0	24167	24167	24167	4
Otitis media (chronic)	27632927	2016-09-16	512	2073	0	2585	1642.3613152804642	1
Otitis media (chronic/recurrent)	23974705	2013-08-23	0	0	745	745	745	1
Otosclerosis	19230858	2009-02-18	302	302	0	604	604.0	1
Ovarian cancer	19648919	2009-08-02	1817	2353	0	4170	4101.104076738609	1
Ovarian cancer	20852632	2010-09-19	1768	2354	0	4122	4038.691897137311	2
Ovarian cancer	21964575	2011-10-02	640	41607	0	42247	2521.218548062584	1
Ovarian cancer	23535730	2013-04-01	3769	4396	0	8165	8116.851928965096	15
Ovarian cancer	31488892	2019-09-05	647	39556	0	40203	2546.350471357859	2
Ovarian cancer (multi-trait analysis)	31488892	2019-09-05	647	39556	0	40203	2546.350471357859	1
Ovarian cancer in BRCA1 mutation carriers	23544013	2013-03-27	683	2044	0	2727	2047.7477081041438	6
Ovarian cancer in BRCA1 mutation carriers	28346442	2017-03-27	2933	16103	0	19036	9924.37465854171	1
Ovarian cancer in BRCA2 mutation carriers	28346442	2017-03-27	954	11458	0	12412	3522.69803416049	1
Ovarian clear cell cancer	28346442	2017-03-27	1366	40941	0	42307	5287.5794549365355	1
Overall survival in osteosarcoma	29210060	2017-12-06	0	0	523	523	523	1
Oxygenated hemoglobin levels	30188897	2018-09-06	0	0	920	920	920	1
P wave duration	24850809	2014-05-21	0	0	16468	16468	16468	3
P wave duration	28794112	2017-08-01	0	0	44456	44456	44456	20
P wave terminal force	28794112	2017-08-01	0	0	40733	40733	40733	12
PCA3 expression level	23555189	2013-04-01	0	0	1371	1371	1371	2
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	30450575	2018-11-18	59	772	0	831	219.24428399518652	1
PR interval	20062060	2010-01-10	0	0	28517	28517	28517	9
PR interval	21347284	2011-02-10	0	0	6247	6247	6247	5
PR interval	23139255	2012-11-08	0	0	13415	13415	13415	8
PR interval	25035420	2014-07-17	0	0	6085	6085	6085	3
PR interval	29127183	2017-11-10	0	0	14756	14756	14756	9
PR interval	30046033	2018-07-25	0	0	92340	92340	92340	44
PR interval	30679814	2019-01-24	0	0	31695	31695	31695	15
PR interval	31217584	2019-06-19	0	0	17422	17422	17422	23
PR interval in Tripanosoma cruzi seropositivity	24324551	2013-11-20	0	0	580	580	580	6
PR segment	24850809	2014-05-21	0	0	16468	16468	16468	8
Paclitaxel-induced cytotoxicity	26015512	2015-05-26	0	0	116	116	116	1
Paediatric migraine	30266756	2018-09-28	979	9456	0	10435	3548.6052707235267	2
Paget's disease	20436471	2010-05-02	692	1001	0	1693	1636.6024808033076	4
Paget's disease	21623375	2011-05-29	741	2699	0	3440	2325.5337209302324	7
Pain	19207018	2009-02-01	0	0	112	112	112	1
Pain medicine use during menstruation	29855537	2018-05-31	1813	3921	0	5734	4959.032438088594	3
Pallidum volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	1
Pallidum volume	31636452	2019-10-21	0	0	34413	34413	34413	11
Palmitic acid (16:0) levels	23362303	2013-01-29	0	0	8961	8961	8961	1
Palmitoleic acid (16:1n-7) levels	23362303	2013-01-29	0	0	8961	8961	8961	5
Palmitoleic acid (16:1n-7) levels	28298293	2017-03-15	0	0	3521	3521	3521	4
Pancreatic cancer	19648918	2009-08-02	1771	1805	0	3576	3575.6767337807605	1
Pancreatic cancer	20101243	2010-01-24	0	0	7785	7785	7785	2
Pancreatic cancer	22158540	2011-12-11	981	1991	0	2972	2628.7631224764464	6
Pancreatic cancer	25086665	2014-08-03	1582	5203	0	6785	4852.554753131908	9
Pancreatic cancer	26098869	2015-06-22	7638	7364	0	15002	14996.995600586588	9
Pancreatic cancer	27579533	2016-08-01	5107	8845	0	13952	12950.520355504588	3
Pancreatic cancer	29422604	2018-02-08	9040	12496	0	21536	20981.396731054978	20
Pancreatic cancer	30206226	2018-09-11	943	3908	0	4851	3038.749948464234	3
Pancreatitis	23143602	2012-11-11	676	4507	0	5183	2351.327030677214	2
Panic disorder	19165232	2009-01-23	200	200	0	400	400.0	2
Papillary thyroid cancer	28703219	2017-07-13	410	8279	0	8689	1562.6148003222465	3
Paraoxonase activity	22982463	2012-09-13	0	0	2136	2136	2136	2
Parent of origin effect on language impairment (paternal)	24571439	2014-02-26	18	0	219	237	237	1
Parental extreme longevity (95 years and older)	27015805	2016-03-23	1339	40934	0	42273	5186.348354741797	2
Parental lifespan	29030599	2017-10-13	0	0	606059	606059	606059	5
Parental lifespan	30642433	2019-01-15	0	0	500193	500193	500193	12
Parental longevity (both parents in top 10%)	29227965	2017-12-01	7182	79767	0	86949	26355.0630369527	6
Parental longevity (combined parental age at death)	29227965	2017-12-01	0	0	208118	208118	208118	7
Parental longevity (combined parental attained age, Martingale residuals)	29227965	2017-12-01	0	0	389166	389166	389166	23
Parental longevity (father's age at death or father's attained age)	31484785	2019-09-04	0	0	699000	699000	699000	14
Parental longevity (father's age at death)	29227965	2017-12-01	0	0	317652	317652	317652	4
Parental longevity (father's age at death)	31484785	2019-09-04	0	0	309383	309383	309383	5
Parental longevity (father's attained age)	29227965	2017-12-01	0	0	415311	415311	415311	14
Parental longevity (mother's age at death or mother's attained age)	31484785	2019-09-04	0	0	699000	699000	699000	5
Parental longevity (mother's age at death)	27015805	2016-03-23	0	0	52776	52776	52776	2
Parental longevity (mother's age at death)	29227965	2017-12-01	0	0	246941	246941	246941	1
Parental longevity (mother's attained age)	29227965	2017-12-01	0	0	412937	412937	412937	6
Parietal lobe volume	31396565	2019-08-02	0	0	16016	16016	16016	1
Parkinson disease and lewy body pathology	25663231	2015-02-06	484	1145	0	1629	1360.7857581338244	1
Parkinson's disease	19915575	2009-11-15	1713	3978	0	5691	4789.537163943068	3
Parkinson's disease	19915576	2009-11-15	988	2521	0	3509	2839.268167569108	4
Parkinson's disease	20711177	2010-08-15	2000	1986	0	3986	3985.950827897642	3
Parkinson's disease	21044948	2010-11-02	1705	5175	0	6880	5129.8691860465115	2
Parkinson's disease	21084426	2010-11-17	1039	1984	0	3023	2727.589811445584	1
Parkinson's disease	21292315	2011-02-01	5333	12019	0	17352	14775.77846934071	11
Parkinson's disease	21738487	2011-06-23	3426	29624	0	33050	12283.42801815431	7
Parkinson's disease	22438815	2012-03-15	2197	2061	0	4258	4253.656176608736	6
Parkinson's disease	22451204	2012-03-01	4238	4239	0	8477	8476.999882033739	6
Parkinson's disease	24511991	2014-02-10	2000	1986	0	3986	3985.950827897642	6
Parkinson's disease	24842889	2014-05-19	1130	2611	0	3741	3154.6966051857794	3
Parkinson's disease	25064009	2014-07-27	13708	95282	0	108990	47935.61449674282	23
Parkinson's disease	27182965	2016-05-16	9619	324522	0	334141	37368.38182683358	23
Parkinson's disease	28011712	2016-12-22	779	13227	0	14006	2942.691132371841	3
Parkinson's disease	28892059	2017-09-11	20184	397324	0	417508	76832.90012167432	40
Parkinson's disease	31660654	2019-10-29	4639	2949	0	7588	7211.603057459145	5
Parkinson's disease	32310270	2020-04-20	6724	24851	0	31575	21168.40842438638	8
Parkinson's disease (age at diagnosis)	30338293	2018-10-05	1950	0	0	1950	1950	1
Parkinson's disease (age of onset)	30957308	2019-04-07	17996	0	0	17996	17996	2
Parkinson's disease (age of onset)	31660654	2019-10-29	0	0	3997	3997	3997	1
Parkinson's disease (familial, age at onset)	27402877	2016-07-11	431	0	0	431	431	3
Parkinson's disease in GBA mutation carriers	31755958	2019-11-22	1588	7584	0	9172	5252.242477104231	1
Parkinson's disease or first degree relation to individual with Parkinson's disease	31701892	2019-12-01	33674	449056	0	482730	125299.9543761523	107
Paternal history of Alzheimer's disease	29777097	2018-05-18	14338	245941	0	260279	54192.64801232524	1
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	29551627	2018-03-15	407	0	0	407	407	2
Peak expiratory flow	30804560	2019-02-25	0	0	321047	321047	321047	91
Peak insulin response	28490609	2017-05-10	0	0	4828	4828	4828	5
Peak insulin response (BMI and insulin secretion adjusted)	28490609	2017-05-10	0	0	4828	4828	4828	1
Peak velocity of the mitral A-wave	28394258	2017-04-10	0	0	21852	21852	21852	1
Peanut allergy	25710614	2015-02-24	316	1881	0	2197	1082.195721438325	3
Pediatric areal bone mineral density (concordant skeletal phenotype)	29240982	2017-12-14	0	0	1399	1399	1399	2
Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	29240982	2017-12-14	0	0	1399	1399	1399	4
Pediatric areal bone mineral density (radius)	26041818	2015-06-03	0	0	1371	1371	1371	2
Pediatric areal bone mineral density (radius)	28181694	2017-02-09	0	0	933	933	933	3
Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	29240982	2017-12-14	0	0	1399	1399	1399	2
Pediatric autoimmune diseases	26301688	2015-08-24	6036	10718	0	16754	15445.588635549719	28
Pediatric bone mineral content (femoral neck)	28181694	2017-02-09	0	0	933	933	933	1
Pediatric bone mineral content (hip)	28181694	2017-02-09	0	0	933	933	933	2
Pediatric bone mineral content (radius)	26041818	2015-06-03	0	0	1371	1371	1371	2
Pediatric bone mineral content (radius)	28181694	2017-02-09	0	0	933	933	933	1
Pediatric bone mineral density (femoral neck)	28181694	2017-02-09	0	0	933	933	933	1
Pediatric bone mineral density (spine)	28181694	2017-02-09	0	0	933	933	933	1
Pediatric non-alcoholic fatty liver disease activity score	23535911	2013-03-28	392	934	0	1326	1104.4585218702866	1
Pemphigus	30230522	2018-09-19	350	501	0	851	824.2068155111633	2
Pemphigus foliaceus	30169916	2018-08-31	65	844	0	909	241.4081408140814	2
Pemphigus vulgaris	29857070	2018-05-29	240	1031	0	1271	778.7254130605822	4
Pemphigus vulgaris	30230522	2018-09-19	255	501	0	756	675.952380952381	2
Pepsinogen I/II ratio	30753327	2019-02-08	0	0	3385	3385	3385	4
Perceived skin darkness	25963972	2015-05-12	0	0	9316	9316	9316	2
Perceived unattractiveness to mosquitoes	28199695	2017-04-01	0	0	16576	16576	16576	6
Percent glycated albumin	29844224	2018-05-29	0	0	9751	9751	9751	2
Percent mammographic density	21278746	2011-01-30	0	0	4877	4877	4877	1
Percent mammographic density	22532574	2012-04-24	0	0	1241	1241	1241	1
Percent mammographic density	25342443	2014-10-24	0	0	7916	7916	7916	4
Percentage gas trapping	26030696	2015-06-01	4144	5194	0	9338	9219.934032983509	2
Perceptual rivalry (voluntary modulation strength)	30242048	2018-09-21	0	0	1876	1876	1876	1
Pericardial adipose tissue adjusted for height and weight	27918534	2016-12-05	0	0	12240	12240	12240	5
Pericardial fat	22589742	2012-05-10	0	0	5487	5487	5487	1
Pericardial fat	27918534	2016-12-05	0	0	12240	12240	12240	2
Periodontal disease related phenotype (PCT3)	26962152	2016-03-08	0	0	975	975	975	2
Periodontal disease related phenotype (PCT4)	26962152	2016-03-08	0	0	975	975	975	1
Periodontal disease related phenotype (PCT5)	26962152	2016-03-08	0	0	975	975	975	3
Periodontal disease-related phenotype (Socransky)	26962152	2016-03-08	0	0	975	975	975	6
Periodontitis	19897590	2009-11-06	283	972	0	1255	876.7362549800797	1
Periodontitis	30218097	2018-09-14	4102	8489	0	12591	11062.466206020174	2
Peripheral arterial disease (traffic-related air pollution interaction)	27082954	2016-04-15	138	2039	0	2177	517.0087276067983	10
Peripheral artery disease	26488411	2015-10-21	785	3383	0	4168	2548.6132437619963	2
Peripheral artery disease	31285632	2019-07-08	31307	211753	0	243060	109098.18433308648	20
Permanent tooth development	21931568	2011-09-08	0	0	5088	5088	5088	4
Personality dimensions	23903073	2013-08-01	0	0	1089	1089	1089	1
Personality traits in bipolar disorder	21368711	2011-03-02	1951	0	0	1951	1951	3
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	25944848	2015-05-05	185	0	0	185	185	1
Phenytoin-induced maculopapular exanthema	29288229	2017-12-29	74	530	0	604	259.73509933774835	1
Philtrum width	30067744	2018-08-01	0	0	6136	6136	6136	2
Phosphatidylcholine levels	31551469	2019-09-24	0	0	2045	2045	2045	25
Phosphatidylcholine-ether levels	31551469	2019-09-24	0	0	2045	2045	2045	9
Phosphatidylethanolamine levels	31551469	2019-09-24	0	0	2045	2045	2045	12
Phosphatidylethanolamine-ether levels	31551469	2019-09-24	0	0	2045	2045	2045	4
Phosphatidylinositol levels	31551469	2019-09-24	0	0	2045	2045	2045	9
Phospholipid levels (plasma)	22359512	2012-02-16	0	0	4034	4034	4034	25
Phospholipid levels in chylomicrons and largest VLDL	29084231	2017-10-30	0	0	8372	8372	8372	3
Phospholipid levels in large HDL	29084231	2017-10-30	0	0	8372	8372	8372	19
Phospholipid levels in large VLDL	29084231	2017-10-30	0	0	8372	8372	8372	18
Phospholipid levels in medium HDL	29084231	2017-10-30	0	0	8372	8372	8372	17
Phospholipid levels in medium LDL	29084231	2017-10-30	0	0	8372	8372	8372	1
Phospholipid levels in medium VLDL	29084231	2017-10-30	0	0	8372	8372	8372	23
Phospholipid levels in small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	23
Phospholipid levels in very large VLDL	29084231	2017-10-30	0	0	8372	8372	8372	2
Phospholipid levels in very small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	3
Phosphorus levels	20558539	2010-06-17	0	0	16264	16264	16264	5
Phosphorus levels	29403010	2018-02-05	0	0	42793	42793	42793	9
Photic sneeze reflex	27182965	2016-05-16	32446	67249	0	99695	87545.45580019058	50
Photic sneeze reflex	29559738	2018-03-20	360	11049	0	11409	1394.5621877465157	1
Photic sneeze reflex	30899065	2019-03-21	874	2543	0	3417	2601.793386011121	3
Physical activity (moderate intensity activity duration)	30531941	2018-12-10	0	0	91105	91105	91105	1
Physical activity (overall physical activity time)	30531941	2018-12-10	0	0	91105	91105	91105	6
Physical activity (walking duration)	30531941	2018-12-10	0	0	91105	91105	91105	1
Phytosterol levels	20529992	2010-06-07	0	0	1495	1495	1495	3
Pit-and-Fissure caries	24556642	2014-02-18	0	0	979	979	979	1
Placebo response in major depressive disorder (% change in symptom score)	28696415	2017-07-11	0	0	205	205	205	1
Plantar fascial disorders	29534260	2018-03-13	21629	80879	0	102508	68261.28267062083	2
Plantar warts	28928442	2017-09-19	24994	37451	0	62445	59959.98360156938	24
Planum temporale asymmetry index	31887566	2019-11-29	0	0	18049	18049	18049	2
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	30648747	2019-01-16	0	0	687	687	687	5
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	29678681	2018-04-18	0	0	2629	2629	2629	1
Plasma clozapine levels in treatment-resistant schizophrenia	30922102	2019-03-29	0	0	2989	2989	2989	1
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	30922102	2019-03-29	0	0	2989	2989	2989	3
Plasma cystastin c levels in acute coronary syndrome	24952865	2014-04-04	9978	0	0	9978	9978	1
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	28429243	2017-04-20	774	0	0	774	774	2
Plasma factor V levels in venous thrombosis	31271701	2019-07-04	0	0	510	510	510	2
Plasma factor VII activating protease levels	30070759	2018-08-02	0	0	3126	3126	3126	6
Plasma free amino acid levels	30659259	2019-01-18	0	0	1338	1338	1338	32
Plasma free amino acid levels (adjusted for one other PFAA)	30659259	2019-01-18	0	0	1338	1338	1338	63
Plasma free amino acid levels (adjusted for twenty other PFAAs)	30659259	2019-01-18	0	0	1338	1338	1338	36
Plasma free asparagine levels	30659259	2019-01-18	0	0	1338	1338	1338	1
Plasma free proline levels	30659259	2019-01-18	0	0	1338	1338	1338	1
Plasma haptoglobin levels in type 2 diabetes	29572449	2018-03-23	0	0	236	236	236	1
Plasma homocysteine levels	26519441	2015-10-30	71	0	1787	1858	1858	1
Plasma homocysteine levels	30339177	2018-10-19	0	0	2232	2232	2232	5
Plasma homocysteine levels (post-methionine load test)	24651765	2014-03-20	0	0	4810	4810	4810	5
Plasma lactate levels	26433129	2015-10-03	0	0	6901	6901	6901	3
Plasma norclozapine levels in treatment-resistant schizophrenia	30922102	2019-03-29	0	0	2989	2989	2989	2
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	21829377	2011-07-28	0	0	8866	8866	8866	12
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	21829377	2011-07-28	0	0	8866	8866	8866	8
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	26584805	2015-11-19	717	644	0	1361	1357.084496693608	2
Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	21829377	2011-07-28	0	0	8866	8866	8866	3
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	21829377	2011-07-28	0	0	8866	8866	8866	13
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	24823311	2014-05-13	0	0	8631	8631	8631	1
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	24823311	2014-05-13	0	0	8631	8631	8631	4
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	26584805	2015-11-19	717	644	0	1361	1357.084496693608	4
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	24823311	2014-05-13	0	0	8631	8631	8631	3
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	26584805	2015-11-19	717	644	0	1361	1357.084496693608	2
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	24823311	2014-05-13	0	0	8631	8631	8631	2
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	26584805	2015-11-19	717	644	0	1361	1357.084496693608	5
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	24823311	2014-05-13	0	0	8631	8631	8631	5
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	26584805	2015-11-19	717	644	0	1361	1357.084496693608	3
Plasma parathyroid hormone levels	30134803	2018-04-11	0	0	2596	2596	2596	2
Plasma plasminogen activator levels	24578379	2014-02-27	0	0	26929	26929	26929	4
Plasma plasminogen levels	25208887	2014-09-10	0	0	3244	3244	3244	4
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	29748315	2018-05-01	0	0	3290	3290	3290	8
Plasma pyridoxal phosphate to pyridoxal ratio	30583557	2018-12-22	0	0	493	493	493	1
Plasma pyridoxal phosphate to pyridoxal ratio	31641590	2019-10-11	0	0	2232	2232	2232	2
Plasma renin activity levels	25477429	2014-12-04	0	0	5275	5275	5275	2
Plasma t-tau levels	28100725	2017-01-18	463	0	314	777	777	1
Plasma thyroid-stimulating hormone levels	24722205	2014-04-17	0	0	2789	2789	2789	2
Plasma thyroid-stimulating hormone levels	28333968	2017-03-23	0	0	1680	1680	1680	5
Plasma trimethylamine N-oxide levels	28439531	2017-03-08	0	0	626	626	626	2
Plasminogen activator inhibitor type 1 levels (PAI-1)	22990020	2012-09-18	0	0	19599	19599	19599	3
Platelet aggregation	20526338	2010-06-06	0	0	3991	3991	3991	5
Platelet aggregation	29185836	2017-11-29	0	0	4213	4213	4213	11
Platelet count	19853236	2009-10-22	0	0	6015	6015	6015	1
Platelet count	20139978	2010-02-07	0	0	14806	14806	14806	7
Platelet count	22139419	2011-11-30	0	0	48666	48666	48666	55
Platelet count	22423221	2012-03-08	0	0	16388	16388	16388	10
Platelet count	23263863	2012-12-20	0	0	14177	14177	14177	6
Platelet count	24026423	2013-09-12	0	0	13582	13582	13582	5
Platelet count	24777453	2014-04-28	0	0	24814	24814	24814	2
Platelet count	25705162	2014-12-31	0	0	8842	8842	8842	3
Platelet count	26805783	2016-01-21	0	0	12491	12491	12491	9
Platelet count	27863252	2016-11-17	0	0	166066	166066	166066	287
Platelet count	29066854	2017-11-01	0	0	5901	5901	5901	4
Platelet count	29403010	2018-02-05	0	0	108208	108208	108208	94
Platelet count	31194788	2019-06-13	0	0	4675	4675	4675	1
Platelet count	31217584	2019-06-19	0	0	29328	29328	29328	27
Platelet distribution width	27863252	2016-11-17	0	0	164433	164433	164433	206
Platelet reactivity measurement (collagen-ADP)	31262040	2019-06-30	0	0	935	935	935	1
Platelet reactivity measurement (collagen-epinephrine)	31262040	2019-06-30	0	0	935	935	935	1
Platelet thrombus formation	22550155	2012-05-01	0	0	241	241	241	1
Platelet-derived growth factor BB levels	27989323	2016-12-13	0	0	8293	8293	8293	6
Plateletcrit	27863252	2016-11-17	0	0	164339	164339	164339	272
Pneumococcal bacteremia	27236921	2016-06-02	429	2677	0	3106	1478.9864777849323	1
Pneumococcal meningitis x streptococcus pneumoniae antigen allele interaction	31092817	2019-05-15	0	0	347	347	347	2
Pneumococcal meningitis x streptococcus pneumoniae genotype cluster interaction	31092817	2019-05-15	0	0	145	145	145	1
Pneumoconiosis in silica exposure	24986923	2014-07-01	202	198	0	400	399.96	1
Pneumonia	28928442	2017-09-19	40600	90039	0	130639	111929.3136046663	18
Polychlorinated biphenyl levels	25839716	2015-04-02	0	0	922	922	922	6
Polycystic ovary syndrome	21151128	2010-12-12	744	895	0	1639	1625.0884685784013	5
Polycystic ovary syndrome	22885925	2012-08-12	2254	3001	0	5255	5148.813701236917	11
Polycystic ovary syndrome	25574032	2015-01-08	976	946	0	1922	1921.5317377731528	1
Polycystic ovary syndrome	26284813	2015-08-18	984	2964	0	3948	2954.9908814589667	3
Polycystic ovary syndrome	26416764	2015-09-29	5184	82759	0	87943	19513.669354013397	6
Polycystic ovary syndrome	30343302	2018-10-19	182	240	0	422	414.02843601895734	1
Polycystic ovary syndrome	30566500	2018-12-19	10074	103164	0	113238	36711.14417421714	14
Polymyositis	26362759	2015-09-11	931	15651	0	16582	3514.9152092630566	2
Poor prognosis in Crohn's disease	28067912	2017-01-09	1762	0	972	2734	2734	4
Poor prognosis in Crohn's disease	29905830	2018-08-01	243	364	0	607	582.8797364085666	1
Positive affect	30643256	2019-01-14	0	0	410603	410603	410603	191
Post bronchodilator FEV1	26634245	2015-12-03	0	0	13532	13532	13532	300
Post bronchodilator FEV1/FVC ratio	26634245	2015-12-03	0	0	13532	13532	13532	351
Post bronchodilator FEV1/FVC ratio in smoking	30068317	2018-08-01	1086	559	0	1645	1476.1677811550153	1
Post bronchodilator percent predicted FEV1 in smoking	30068317	2018-08-01	1086	559	0	1645	1476.1677811550153	1
Post-term birth	31477735	2019-09-02	7888	60148	0	68036	27893.90463872068	1
Post-traumatic stress disorder	23726511	2013-05-28	744	4474	0	5218	2551.671904944423	1
Post-traumatic stress disorder	25456346	2014-10-30	0	0	3494	3494	3494	1
Post-traumatic stress disorder	31594949	2019-10-08	29556	166145	0	195701	100369.065462108	5
Post-traumatic stress disorder (asjusted for relatedness)	23726511	2013-05-28	764	4474	0	5238	2610.2604047346313	2
Post-traumatic stress disorder symptoms in trauma-exposed soldiers	30999091	2019-04-09	462	2019	0	2481	1503.8742442563482	1
Posterior cortical atrophy and Alzheimer's disease	26993346	2016-03-15	293	10547	0	10840	1140.321402214022	4
Postoperative acute renal failure after cardiac surgery	30678657	2019-01-24	52	1020	0	1072	197.910447761194	1
Postoperative survival time in hepatocellular carcinoma	30945673	2019-03-01	0	0	367	367	367	5
Postoperative survival time in hepatocellular carcinoma	30945699	2019-04-04	367	0	0	367	367	5
Postprandial triglyceride response to high fat diet meal	26256467	2015-07-03	0	0	872	872	872	1
Potassium levels	29403010	2018-02-05	0	0	132938	132938	132938	15
Pre bronchodilator FEV1	26634245	2015-12-03	0	0	6659	6659	6659	8
Pre bronchodilator FEV1/FVC ratio	26634245	2015-12-03	0	0	6659	6659	6659	12
Pre bronchodilator FEV1/FVC ratio in never-smokers	27612410	2016-09-06	0	0	5070	5070	5070	1
Pre-treatment pain in head and neck squamous cell carcinoma	27670397	2016-09-27	148	810	0	958	500.54279749478076	1
Pre-treatment viral load in HIV-1 infection	31219150	2019-06-13	0	0	2440	2440	2440	93
Pre-treatment viral load in hepatitis C virus genotype 3	31260374	2019-07-01	0	0	1498	1498	1498	1
Precentral gyrus volume	31530798	2019-09-17	483	294	0	777	731.0270270270271	1
Predicted suicide risk	30610202	2019-01-04	0	0	24546	24546	24546	2
Predicted visceral adipose tissue	31501611	2019-09-09	0	0	163984	163984	163984	209
Presence of antiphospholipid antibodies	27098658	2016-04-21	0	0	4163	4163	4163	6
Presubiculum volume	30279459	2018-10-02	0	0	21297	21297	21297	1
Presubiculum volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	1
Preterm birth (maternal effect)	28877031	2017-09-07	0	0	43567	43567	43567	4
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	28598419	2017-06-09	0	0	1886	1886	1886	1
Prevalent atrial fibrillation	28416818	2017-04-17	8656	0	102776	111432	111432	9
Priapism in sickle cell disease	31668730	2019-10-24	0	0	602	602	602	2
Primary biliary cholangitis	19458352	2009-05-20	505	1507	0	2012	1512.9920477137175	4
Primary biliary cholangitis	20639880	2010-07-18	453	0	945	1398	1398	6
Primary biliary cholangitis	21399635	2011-03-13	1840	0	5163	7003	7003	20
Primary biliary cholangitis	23000144	2012-09-18	487	476	0	963	962.8743509865004	5
Primary biliary cholangitis	26394269	2015-09-22	2764	10475	0	13239	8747.760404864417	29
Primary biliary cholangitis	28062665	2017-01-05	1381	1505	0	2886	2880.6722106722104	6
Primary biliary cholangitis	28425483	2017-04-20	1122	4036	0	5158	3511.742535866615	19
Primary biliary cholangitis	30643196	2019-01-14	1855	1719	0	3574	3568.8248461108	5
Primary biliary cirrhosis	22936693	2012-08-29	2216	5594	0	7810	6348.939308578745	18
Primary biliary cirrhosis	22961000	2012-10-01	2861	8514	0	11375	8565.645362637362	44
Primary central nervous system lymphoma	31102405	2019-05-17	475	1134	0	1609	1339.0926041019268	2
Primary sclerosing cholangitis	21151127	2010-12-12	715	2962	0	3677	2303.8672831112317	2
Primary sclerosing cholangitis	23603763	2013-06-01	3789	25079	0	28868	13166.73562422059	17
Primary sclerosing cholangitis	27992413	2016-12-19	2871	12019	0	14890	9269.724378777702	18
Primary tooth development (number of teeth)	20195514	2010-02-26	0	0	5752	5752	5752	4
Primary tooth development (number of teeth)	23704328	2013-05-23	0	0	11513	11513	11513	11
Primary tooth development (time to first tooth eruption)	20195514	2010-02-26	0	0	5919	5919	5919	3
Primary tooth development (time to first tooth eruption)	23704328	2013-05-23	0	0	11118	11118	11118	10
Primary vesicoureteric reflux	29097723	2017-11-06	0	0	2860	2860	2860	1
Problematic alcohol use in trauma-exposed individuals	29082582	2017-10-30	0	0	1036	1036	1036	1
Progesterone levels	31169883	2019-06-06	0	0	2619	2619	2619	8
Progranulin levels	21087763	2010-12-10	0	518	0	518	518	1
Progranulin levels	29186428	2017-11-27	0	0	2811	2811	2811	3
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	26222057	2015-07-29	0	0	520	520	520	1
Progressive supranuclear palsy	21685912	2011-06-19	1114	3287	0	4401	3328.078164053624	7
Progressive supranuclear palsy	30089514	2018-08-08	1646	10662	0	12308	5703.494312642184	7
Progressive supranuclear palsy	31059154	2019-05-06	283	4472	0	4755	1064.6275499474236	1
Proinsulin levels	21873549	2011-08-26	0	0	10701	10701	10701	9
Proinsulin levels (early-phase conversion)	23263489	2012-12-23	0	0	8229	8229	8229	1
Proinsulin levels (late-phase conversion)	23263489	2012-12-23	0	0	8229	8229	8229	1
Proliferative diabetic retinopathy	31482010	2019-08-29	64	227	0	291	199.6975945017182	3
Proliferative diabetic retinopathy (vs NPDR and no DR)	30487263	2018-11-28	1495	4362	0	5857	4453.604234249616	1
Proliferative diabetic retinopathy (vs no DR)	30487263	2018-11-28	1495	2911	0	4406	3950.9260099863823	2
Prostate cancer	17401363	2007-04-01	1172	1157	0	2329	2328.90339201374	2
Prostate cancer	17401366	2007-04-01	1453	3064	0	4517	3942.432588000885	3
Prostate cancer	17603485	2007-07-01	1501	11290	0	12791	5299.441795012118	2
Prostate cancer	18264096	2008-02-10	1172	1157	0	2329	2328.90339201374	5
Prostate cancer	18264097	2008-02-10	1854	1894	0	3748	3747.5731056563504	10
Prostate cancer	18264098	2008-02-10	1854	21372	0	23226	6824.022733143891	2
Prostate cancer	19767753	2009-09-20	1854	1894	0	3748	3747.5731056563504	17
Prostate cancer	19767754	2009-09-20	1968	35382	0	37350	7457.218313253011	7
Prostate cancer	20676098	2010-08-01	1583	3386	0	4969	4314.782048701953	9
Prostate cancer	21602798	2011-05-22	3425	3290	0	6715	6712.285927029039	1
Prostate cancer	21743057	2011-07-08	2782	4458	0	7240	6852.019889502762	7
Prostate cancer	21743467	2011-07-10	6621	6939	0	13560	13552.542477876106	9
Prostate cancer	22130093	2011-12-01	316	229	0	545	531.1119266055047	2
Prostate cancer	22923026	2012-08-24	2076	2099	0	4175	4174.873293413174	3
Prostate cancer	23023329	2012-09-30	1417	1008	0	2425	2356.018144329897	3
Prostate cancer	23065704	2012-10-12	11085	11463	0	22548	22541.663118680146	2
Prostate cancer	23104005	2012-10-28	5141	54444	0	59585	18789.73594025342	1
Prostate cancer	23535732	2013-04-01	11085	11463	0	22548	22541.663118680146	23
Prostate cancer	24753544	2014-04-21	1146	1804	0	2950	2803.232542372881	6
Prostate cancer	25217961	2014-09-14	43303	43737	0	87040	87037.8359834559	32
Prostate cancer	25939597	2015-05-05	4600	2941	0	7541	7176.024399946956	15
Prostate cancer	26034056	2015-06-01	7295	8217	0	15512	15457.198298091802	44
Prostate cancer	26443449	2015-10-07	3000	4394	0	7394	7131.187449283202	8
Prostate cancer	27262462	2016-06-04	2511	1382	0	3893	3565.5812997688163	9
Prostate cancer	29117387	2017-08-01	10202	10810	0	21012	20994.407005520658	2
Prostate cancer	29356057	2018-01-21	560	480	0	1040	1033.8461538461538	1
Prostate cancer	29892016	2018-06-11	79148	61106	0	140254	137933.11243886093	135
Prostate cancer	30410027	2018-11-08	11708	284184	0	295892	44978.92841982886	1
Prostate cancer	31226226	2019-06-21	2714	5239	0	7953	7151.337105494781	2
Prostate cancer	31562322	2019-09-27	5088	10682	0	15770	13785.673050095118	29
Prostate cancer (advanced)	29892016	2018-06-11	15167	58308	0	73475	48144.67157536577	4
Prostate cancer (early onset)	24740154	2014-04-16	931	4120	0	5051	3037.592555929519	3
Prostate cancer (early onset)	29892016	2018-06-11	6988	44256	0	51244	24140.264460229493	3
Prostate cancer aggressiveness	25939597	2015-05-05	4545	0	0	4545	4545	3
Prostate-specific antigen levels	23269536	2012-12-27	0	0	1999	1999	1999	3
Prostate-specific antigen levels	23359319	2013-01-01	0	0	3192	3192	3192	2
Prostate-specific antigen levels	24919509	2014-06-11	0	0	1086	1086	1086	2
Prostate-specific antigen levels	25434496	2014-11-27	0	0	554	554	554	5
Prostate-specific antigen levels	28139693	2017-01-31	0	0	28503	28503	28503	39
Prostate-specific antigen levels	30410027	2018-11-08	0	0	33572	33572	33572	5
Prostate-specific antigen levels (conditioned on lead SNPs)	28139693	2017-01-31	0	0	28503	28503	28503	15
Protein C levels	20802025	2010-08-27	0	0	8048	8048	8048	4
Protein C levels	25376901	2014-11-05	0	0	2701	2701	2701	4
Protein C levels	28082259	2017-01-12	0	0	13484	13484	13484	11
Protein biomarker	23056639	2012-10-09	0	0	3776	3776	3776	2
Protein quantitative trait loci	18464913	2008-05-09	0	0	1200	1200	1200	8
Proteinuria	30476138	2019-04-01	54009	0	91538	145547	145547	2
Proteinuria (mild)	30476138	2019-04-01	28692	0	91538	120230	120230	1
Proteinuria (moderate to severe)	30476138	2019-04-01	25317	0	91538	116855	116855	1
Prothrombin time	22703881	2012-06-14	0	0	2583	2583	2583	2
Prothrombin time	29403010	2018-02-05	0	0	58110	58110	58110	12
Pseudoexfoliation syndrome	29278698	2017-12-23	103	106	0	209	208.95693779904306	1
Psoriasis	18364390	2008-03-25	318	288	0	606	604.5148514851485	2
Psoriasis	18369459	2008-04-04	218	519	0	737	614.067842605156	2
Psoriasis	19169254	2009-01-25	1359	1400	0	2759	2758.390721275825	7
Psoriasis	19169255	2009-01-25	1139	1132	0	2271	2270.9784236019377	3
Psoriasis	20953188	2010-10-17	472	1146	0	1618	1337.2360939431396	3
Psoriasis	20953189	2010-10-17	1831	2546	0	4377	4260.201964816084	3
Psoriasis	20953190	2010-10-17	2178	5175	0	7353	6131.456548347613	11
Psoriasis	23143594	2012-12-01	10588	22806	0	33394	28923.750134754748	39
Psoriasis	25574825	2015-01-08	4212	8032	0	12244	11052.199934661874	12
Psoriasis	25854761	2015-04-09	11245	11177	0	22422	22421.793773971993	22
Psoriasis	25903422	2015-04-23	5084	8732	0	13816	12852.775911986102	36
Psoriasis	25939698	2015-05-05	3994	7699	0	11693	10519.047635337382	5
Psoriasis	28537254	2017-05-24	11988	275335	0	287323	45951.29495376284	58
Psoriasis	30315195	2018-10-12	2280	2002	0	4282	4263.951424567958	134
Psoriasis	30921485	2019-03-28	215	416	0	631	566.973058637084	3
Psoriasis vulgaris	26626624	2015-11-28	4007	4934	0	8941	8844.888938597473	25
Psoriasis vulgaris	29031612	2017-10-12	282	426	0	708	678.7118644067797	2
Psoriatic arthritis	20953186	2010-10-17	572	888	0	1460	1391.6054794520549	3
Psoriatic arthritis	22170493	2011-12-15	535	3432	0	3967	1851.3940005041593	1
Psoriatic arthritis	26626624	2015-11-28	1946	4934	0	6880	5582.30465116279	5
Psoriatic arthritis	30552173	2018-12-14	744	1454	0	2198	1968.6551410373063	27
Psychiatric diseases (pleiotropy) (HIPO component 1)	30289880	2018-10-05	33332	27888	0	61220	60735.89127736035	1
Psychological distress	30705256	2019-01-31	3981	6349	0	10330	9787.17095837367	1
Psychological resilience (outcome-based) in high deployment stress exposure	31081985	2019-05-13	0	581	0	581	581	1
Psychological resilience (self-assessed)	31081985	2019-05-13	0	0	11473	11473	11473	1
Psychological wellbeing index 1 (lack of subjective wellbeing and health)	31003110	2019-04-08	0	0	12680	12680	12680	1
Psychological wellbeing index 12 (lack of enjoying daily life)	31003110	2019-04-08	0	0	12680	12680	12680	1
Psychosis and Alzheimer's disease	22005930	2011-10-18	0	5659	1563	7222	7222	1
Psychosis proneness (hypomanic personality scale)	28525603	2017-05-19	0	0	3967	3967	3967	1
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	28525603	2017-05-19	0	0	3812	3812	3812	1
Psychotic experience	31553412	2019-09-25	6123	121379	0	127502	23315.826167432668	2
Psychotic experience (distressing)	31553412	2019-09-25	2143	121379	0	123522	8423.283204611324	2
Pubertal anthropometrics	23449627	2013-02-27	0	0	10799	10799	10799	5
Puberty onset	24770850	2014-04-25	0	0	9916	9916	9916	1
Puberty onset (genital enlargement)	24770850	2014-04-25	0	0	3769	3769	3769	1
Pulmonary arterial hypertension	29088834	2017-08-24	23	2002	0	2025	90.95506172839507	1
Pulmonary arterial hypertension	30527956	2018-12-05	2085	9659	0	11744	6859.337534059946	3
Pulmonary arterial hypertension (without BMPR2 mutations)	23502781	2013-03-17	340	1068	0	1408	1031.590909090909	1
Pulmonary artery enlargement and chronic obstructive pulmonary disease	25101718	2015-03-01	1266	4461	0	5727	3944.5615505500264	1
Pulmonary artery enlargement in chronic obstructive pulmonary disease	25101718	2015-03-01	1266	3775	0	5041	3792.223765125967	2
Pulmonary emphysema	24383474	2014-01-02	0	0	7914	7914	7914	3
Pulmonary function	19300500	2009-03-20	0	0	7691	7691	7691	1
Pulmonary function	20010834	2009-12-13	0	0	20288	20288	20288	6
Pulmonary function	20010835	2009-12-13	0	0	20890	20890	20890	6
Pulmonary function	21946350	2011-09-25	0	0	48201	48201	48201	17
Pulmonary function	23932459	2013-08-06	0	0	1144	1144	1144	1
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	30199657	2018-09-10	0	0	11962	11962	11962	1
Pulmonary function (smoking interaction)	23284291	2012-12-20	0	0	50047	50047	50047	22
Pulmonary function decline	22424883	2012-03-15	1441	2677	0	4118	3747.0199125789222	1
Pulse pressure	26390057	2015-09-21	0	0	99994	99994	99994	7
Pulse pressure	27618447	2016-10-01	0	0	192763	192763	192763	8
Pulse pressure	27618448	2016-10-01	0	0	146562	146562	146562	8
Pulse pressure	27841878	2016-11-14	0	0	321262	321262	321262	292
Pulse pressure	28135244	2017-01-30	0	0	140886	140886	140886	57
Pulse pressure	28498854	2017-05-12	0	0	31155	31155	31155	2
Pulse pressure	28739976	2017-07-24	0	0	150134	150134	150134	30
Pulse pressure	29403010	2018-02-05	0	0	136249	136249	136249	17
Pulse pressure	30224653	2018-09-17	0	0	757601	757601	757601	151
Pulse pressure	30487518	2018-11-28	0	0	130777	130777	130777	65
Pulse pressure	30578418	2018-12-21	0	0	459777	459777	459777	374
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	29912962	2018-06-18	0	0	73031	73031	73031	17
Pulse pressure x alcohol consumption interaction (2df test)	29912962	2018-06-18	0	0	133350	133350	133350	58
Pure non-grapefruit juice consumption	31046077	2019-05-02	0	0	85852	85852	85852	1
Pursuit maintenance gain	29064472	2017-10-24	591	258	0	849	718.3886925795052	2
Pursuit maintenance gain in psychotic disorders	29064472	2017-10-24	591	0	0	591	591	3
Putamen volume	29147026	2017-11-16	0	0	12596	12596	12596	5
Putamen volume	31636452	2019-10-21	0	0	37571	37571	37571	14
Pyridoxal 5'-phosphate levels	25972531	2015-05-13	0	0	2158	2158	2158	1
Pyridoxal 5'-phosphate levels	31641590	2019-10-11	0	0	2232	2232	2232	1
Pyridoxal levels	31641590	2019-10-11	0	0	2232	2232	2232	1
QRS complex (12-leadsum)	27659466	2016-09-27	0	0	48632	48632	48632	16
QRS complex (Cornell)	27659466	2016-09-27	0	0	58862	58862	58862	10
QRS complex (Sokolow-Lyon)	27659466	2016-09-27	0	0	54993	54993	54993	5
QRS duration	21076409	2010-11-14	0	0	40407	40407	40407	12
QRS duration	25035420	2014-07-17	0	0	6085	6085	6085	3
QRS duration	27577874	2016-08-29	0	0	53438	53438	53438	42
QRS duration	27659466	2016-09-27	0	0	60255	60255	60255	44
QRS duration	30012220	2018-07-17	0	0	85593	85593	85593	56
QRS duration	30679814	2019-01-24	0	0	25509	25509	25509	12
QRS duration	31217584	2019-06-19	0	0	17046	17046	17046	20
QRS duration	31251759	2019-06-28	0	0	15124	15124	15124	10
QRS interval (sulfonylurea treatment interaction)	27958378	2016-12-13	0	0	71857	71857	71857	1
QT interval	16648850	2006-04-30	0	0	200	200	200	1
QT interval	19305408	2009-03-22	0	0	13685	13685	13685	13
QT interval	19305409	2009-03-22	0	0	15842	15842	15842	12
QT interval	19587794	2009-07-09	0	0	3558	3558	3558	2
QT interval	20031603	2009-08-01	0	0	2325	2325	2325	2
QT interval	22726844	2012-06-20	0	0	6805	6805	6805	2
QT interval	23166209	2012-11-19	0	0	13105	13105	13105	2
QT interval	24952745	2014-06-22	0	0	71061	71061	71061	68
QT interval	29213071	2017-12-06	0	0	15997	15997	15997	19
QT interval	30679814	2019-01-24	0	0	26794	26794	26794	13
QT interval	31217584	2019-06-19	0	0	17348	17348	17348	44
QT interval (ambient particulate matter interaction)	28749367	2017-06-08	0	0	22158	22158	22158	1
QT interval (sulfonylurea treatment interaction)	27958378	2016-12-13	0	0	71857	71857	71857	2
QT interval (tricyclic/tetracyclic antidepressant use interaction)	28039329	2016-12-30	0	0	121935	121935	121935	1
Quantitative traits	19197348	2009-02-06	0	0	2906	2906	2906	1
RANTES levels	27989323	2016-12-13	0	0	3421	3421	3421	1
RR interval (heart rate)	20031603	2009-08-01	0	0	2325	2325	2325	1
RR interval (heart rate)	30679814	2019-01-24	0	0	28698	28698	28698	8
RR interval (tricyclic/tetracyclic antidepressant use interaction)	28039329	2016-12-30	0	0	69749	69749	69749	2
Radiation-induced brain injury in nasopharyngeal carcinoma	30299488	2018-10-08	243	839	0	1082	753.7042513863216	1
Random C-peptide levels in type I diabetes	29404672	2018-02-05	0	0	1497	1497	1497	1
Rapid alternating stimulus test for letters/numbers	30995994	2019-04-17	0	0	1324	1324	1324	1
Rapid automised naming and rapid alternating stimulus test performance	30995994	2019-04-17	0	0	1324	1324	1324	1
Rapid automised naming of letters	30741946	2019-02-11	0	0	2563	2563	2563	2
Rapid functional decline in sporadic amyotrophic lateral sclerosis	26746183	2016-01-08	0	0	454	454	454	1
Rate of cognitive decline in mild cognitive impairment (time interaction)	22833209	2011-11-15	0	0	822	822	822	3
Rate of ventricular enlargement	31711042	2019-11-11	0	0	507	507	507	1
Ratio of apolipoprotein A1 to apolipoprotein B	29084231	2017-10-30	0	0	8372	8372	8372	4
Reaction time	27046643	2016-04-05	0	0	111483	111483	111483	2
Reaction time	29844566	2018-05-29	0	0	330069	330069	330069	111
Reading ability (multivariate)	30741946	2019-02-11	0	0	3468	3468	3468	1
Reading or mathematical ability	25003214	2014-07-08	0	0	2794	2794	2794	1
Reasoning	29907492	2018-06-12	127	136	0	263	262.6920152091255	2
Recalcitrant atopic dermatitis	25935106	2015-04-30	246	551	0	797	680.2810539523211	1
Recombination measurement	21775986	2011-07-20	0	0	30033	30033	30033	4
Recombination measurement (females)	20981099	2010-10-28	0	0	6041	6041	6041	1
Recombination measurement (males)	20981099	2010-10-28	0	0	4389	4389	4389	1
Recombination rate (females)	18239089	2008-02-02	0	0	1702	1702	1702	1
Recombination rate (males)	18239089	2008-02-02	0	0	1887	1887	1887	1
Recurrence of mild malaria attacks	31667592	2019-10-30	0	0	525	525	525	1
Red blood cell count	20139978	2010-02-07	0	0	14392	14392	14392	8
Red blood cell count	27863252	2016-11-17	0	0	172952	172952	172952	212
Red blood cell count	28017375	2016-12-22	0	0	71638	71638	71638	17
Red blood cell count	28453575	2017-04-28	0	0	12502	12502	12502	5
Red blood cell count	28548082	2017-05-26	0	0	3213	3213	3213	1
Red blood cell count	29403010	2018-02-05	0	0	108794	108794	108794	60
Red blood cell count	30595370	2018-12-27	0	0	445000	445000	445000	851
Red blood cell count	31080455	2019-04-26	0	0	1625	1625	1625	2
Red blood cell count	31675503	2019-10-01	0	0	7526	7526	7526	1
Red blood cell fatty acid levels	25500335	2014-12-02	0	0	2633	2633	2633	13
Red blood cell folate levels	30339177	2018-10-19	0	0	2232	2232	2232	2
Red blood cell traits	20927387	2010-09-28	0	0	3012	3012	3012	12
Red blood cell traits	23222517	2012-12-05	0	0	71861	71861	71861	45
Red blood cell traits	23446634	2013-02-26	0	0	16485	16485	16485	13
Red blood cell traits	23696099	2013-05-20	0	0	1904	1904	1904	7
Red cell distribution width	27863252	2016-11-17	0	0	171529	171529	171529	212
Red cell distribution width	28453575	2017-04-28	0	0	12502	12502	12502	1
Red cell distribution width	28957414	2017-09-28	0	0	116666	116666	116666	195
Red cell distribution width	30595370	2018-12-27	0	0	445000	445000	445000	658
Red cell distribution width	31080455	2019-04-26	0	0	1625	1625	1625	1
Red cell distribution width	31675503	2019-10-01	0	0	7526	7526	7526	2
Red vs non-red hair color	17952075	2007-10-21	0	0	2986	2986	2986	1
Red vs non-red hair color	26184321	2015-07-13	0	0	7091	7091	7091	2
Red vs. brown/black hair color	30531825	2018-12-10	0	0	299651	299651	299651	40
Red vs. non-red hair color	18488028	2008-05-18	0	0	5130	5130	5130	1
Refractive astigmatism	25367360	2014-11-04	0	0	48020	48020	48020	1
Refractive astigmatism	30306274	2018-10-10	70505	17500	0	88005	56080.33634452587	4
Refractive error	20835236	2010-09-12	0	0	4270	4270	4270	1
Refractive error	20835239	2010-09-12	0	0	5328	5328	5328	1
Refractive error	23396134	2013-02-10	0	0	45758	45758	45758	24
Refractive error	23474815	2013-03-07	0	0	7280	7280	7280	1
Refractive error	32231278	2020-03-30	0	0	542934	542934	542934	448
Refractory celiac disease type II	29787419	2018-05-21	38	846	0	884	145.4660633484163	2
Regular attendance at a gym or sports club	29970889	2018-07-03	135060	317242	0	452302	378921.20326684386	6
Regular attendance at a pub or social club	29970889	2018-07-03	124047	328255	0	452302	360104.95629026624	13
Regular attendance at a religious group	29970889	2018-07-03	66259	386043	0	452302	226210.1263049909	18
Relapse in multiple sclerosis	28739605	2017-07-24	268	0	0	268	268	1
Relative amplitude of rest-activity cycles	30120083	2018-08-14	0	0	77440	77440	77440	1
Relative hand skill in reading disability	24068947	2013-09-12	0	0	728	728	728	1
Relative wall thickness	29403010	2018-02-05	0	0	19311	19311	19311	1
Relative wall thickness x antihypertensive treatment interaction	31407531	2019-08-13	0	0	2068	2068	2068	1
Remission after SSRI treatment in MDD or neuroticism	29559929	2018-03-06	0	0	171776	171776	171776	7
Renal cell carcinoma	21131975	2010-12-05	3772	8505	0	12277	10452.345035432108	3
Renal cell carcinoma	22010048	2011-10-18	894	1516	0	2410	2249.4672199170127	1
Renal cell carcinoma	23184150	2012-11-25	2215	8566	0	10781	7039.677209906317	1
Renal cell carcinoma	24220699	2013-11-13	1505	67725	0	69230	5889.130434782609	1
Renal cell carcinoma	25826619	2015-03-31	2215	8566	0	10781	7039.677209906317	2
Renal cell carcinoma	28598434	2017-06-09	10784	20406	0	31190	28221.64847707598	17
Renal cell carcinoma	31231134	2019-06-23	1992	3095	0	5087	4847.839591114606	7
Renal function and chronic kidney disease	19430482	2009-05-10	2388	17489	0	19877	8404.433667052372	4
Renal function-related traits (BUN)	22797727	2012-07-15	0	0	39717	39717	39717	13
Renal function-related traits (eGRFcrea)	22797727	2012-07-15	0	0	42451	42451	42451	7
Renal function-related traits (sCR)	22797727	2012-07-15	0	0	42257	42257	42257	8
Renal function-related traits (urea)	22797727	2012-07-15	0	0	21417	21417	21417	4
Renal overload gout	27899376	2016-11-29	560	1213	0	1773	1532.498589960519	4
Renal transplant outcome	23432519	2013-02-21	0	0	263	263	263	1
Renal underexcretion gout	27899376	2016-11-29	619	1213	0	1832	1639.4039301310042	7
Resistance to antihypertensive treatment in hypertension	31545351	2019-09-23	931	14210	0	15141	3495.016181229774	1
Resistant hypertension	30237584	2018-09-20	369	825	0	1194	1019.8492462311558	1
Resistant hypertension	31545351	2019-09-23	1159	16690	0	17849	4334.967785310101	3
Resistin levels	22843503	2012-07-26	0	0	3248	3248	3248	2
Resistin levels	27664181	2016-09-23	0	0	448	448	448	2
Respiratory diseases	30595370	2018-12-27	0	0	459000	459000	459000	103
Response to Dalcetrapib treatment in acute coronary syndrome	25583994	2015-01-11	0	0	2845	2845	2845	1
Response to Pazopanib in cancer (hepatotoxicity)	26546620	2015-11-06	1188	0	0	1188	1188	1
Response to SSRI in MDD or conscientiouness	29559929	2018-03-06	0	0	261726	261726	261726	1
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	30166627	2018-08-31	0	0	1723	1723	1723	9
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	30166627	2018-08-31	0	0	1723	1723	1723	2
Response to Vitamin E supplementation	22437554	2012-03-21	0	0	2112	2112	2112	1
Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase)	31465739	2019-08-26	0	0	307	307	307	1
Response to alcohol consumption (flushing response)	24277619	2013-11-26	108	190	0	298	275.4362416107383	1
Response to alcohol consumption (flushing response)	29460428	2018-02-20	0	0	1045	1045	1045	1
Response to allopurinol in gout (change in serum uric acid levels)	30924126	2019-03-28	3179	0	0	3179	3179	1
Response to amphetamines	22952603	2012-08-28	0	0	381	381	381	1
Response to anti-TNF therapy in rheumatoid arthritis	26776603	2016-01-18	444	0	0	444	444	1
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	24554482	2014-02-20	58	164	0	222	171.3873873873874	1
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	24554482	2014-02-20	23	164	0	187	80.68449197860963	8
Response to antidepressants	20360315	2010-04-01	0	0	706	706	706	1
Response to antipsychotic therapy (extrapyramidal side effects)	19875103	2009-10-27	738	0	0	738	738	1
Response to antipsychotic treatment	20195266	2010-03-02	103	0	635	738	738	3
Response to antipsychotic treatment	23241943	2012-12-12	421	0	317	738	738	2
Response to antipsychotic treatment in schizophrenia	29503163	2018-03-01	2413	0	0	2413	2413	5
Response to aripiprazole in schizophrenia	29503163	2018-03-01	397	0	0	397	397	1
Response to bleomycin (chromatid breaks)	21106707	2010-11-24	0	0	673	673	673	1
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	26503814	2016-10-27	6577	0	0	6577	6577	6
Response to bupropion in depression	27622933	2016-09-13	4536	0	0	4536	4536	1
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	25117820	2014-08-12	255	387	0	642	614.8598130841121	1
Response to citalopram treatment	22760553	2012-07-03	1762	0	0	1762	1762	1
Response to clopidogrel therapy	19706858	2009-08-26	0	0	429	429	429	1
Response to clopidogrel therapy	28207573	2017-04-01	0	0	513	513	513	1
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	26980576	2016-03-15	109	0	0	109	109	1
Response to fenofibrate	22890011	2012-08-09	0	0	817	817	817	1
Response to fenofibrate (HDL cholesterol levels)	30263045	2018-09-17	0	0	817	817	817	1
Response to fenofibrate (LDL cholesterol levels)	27002377	2016-07-01	0	0	1594	1594	1594	2
Response to fenofibrate (adiponectin levels)	23149075	2012-11-10	0	0	793	793	793	1
Response to gemcitabine in pancreatic cancer	22142827	2011-12-05	294	0	0	294	294	1
Response to hepatitis B vaccine	29534301	2018-03-13	0	0	1193	1193	1193	10
Response to hepatitis B vaccine	31243853	2019-06-27	0	0	6867	6867	6867	1
Response to hepatitis C treatment	19684573	2009-08-16	1137	0	0	1137	1137	1
Response to hepatitis C treatment	19749757	2009-09-13	0	0	142	142	142	1
Response to hepatitis C treatment	19749758	2009-09-13	0	0	293	293	293	1
Response to hepatitis C treatment	21228123	2011-01-12	2101	282	0	2383	994.5144775493077	1
Response to hepatitis C treatment	21659334	2011-06-09	303	0	0	303	303	4
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	25601762	2015-01-20	0	0	120	120	120	2
Response to interferon beta therapy	21502966	2011-04-19	0	0	362	362	362	2
Response to ketogenic dietary therapies in epilepsy	30009487	2018-07-16	0	0	235	235	235	1
Response to lithium treatment in bipolar disorder	26806518	2016-01-22	0	0	2563	2563	2563	3
Response to lurasidone in schizophrenia	29730043	2018-05-02	422	0	0	422	422	1
Response to metformin in type 2 diabetes (HbA1c reduction)	27500523	2016-09-01	0	0	1372	1372	1372	1
Response to metformin in type 2 diabetes (glycemic)	21186350	2010-12-26	1024	0	0	1024	1024	1
Response to montelukast in asthma (change in FEV1)	26083242	2015-06-17	133	0	0	133	133	1
Response to olanzapine in schizophrenia	29503163	2018-03-01	412	0	0	412	412	1
Response to opioid analgesics in cancer (pain decrease)	30277654	2018-09-14	0	0	71	71	71	2
Response to paliperidone in schizophrenia (CGI-S score)	27846195	2016-11-11	1390	0	0	1390	1390	1
Response to paliperidone in schizophrenia (Multivariate)	27846195	2016-11-11	0	0	1390	1390	1390	1
Response to paliperidone in schizophrenia (PANSS score)	27846195	2016-11-11	0	0	1390	1390	1390	2
Response to paliperidone in schizophrenia (negative Marder score)	27846195	2016-11-11	1390	0	0	1390	1390	2
Response to paliperidone in schizophrenia (positive Marder score)	27846195	2016-11-11	1390	0	0	1390	1390	2
Response to platinum-based neoadjuvant chemotherapy in cervical cancer	28120872	2017-01-25	226	0	0	226	226	1
Response to radiotherapy in cancer (late toxicity)	24785509	2014-04-28	1773	0	0	1773	1773	1
Response to radiotherapy in prostate cancer (overall toxicity)	27515689	2016-07-20	0	0	1346	1346	1346	1
Response to radiotherapy in prostate cancer (toxicity)	24974847	2014-06-29	652	0	0	652	652	1
Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	27515689	2016-07-20	0	0	1409	1409	1409	1
Response to risperidone in schizophrenia	29503163	2018-03-01	425	0	0	425	425	1
Response to serotonin reuptake inhibitors in major depressive disorder	25897834	2015-04-21	2394	0	0	2394	2394	1
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	24528284	2014-08-01	0	0	430	430	430	7
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	26348319	2015-09-08	481	0	0	481	481	1
Response to statin therapy	18650507	2008-07-23	85	90	0	175	174.85714285714283	1
Response to statin therapy	20339536	2010-03-22	0	0	3928	3928	3928	2
Response to statin therapy	22368281	2012-02-24	0	0	2702	2702	2702	1
Response to statins (HDL cholesterol change)	27587472	2016-09-01	0	0	16769	16769	16769	1
Response to statins (LDL cholesterol change)	22331829	2012-02-13	0	0	6989	6989	6989	4
Response to statins (LDL cholesterol change)	25350695	2014-10-28	0	0	18596	18596	18596	2
Response to statins (LDL cholesterol percent change)	31969989	2020-01-16	0	0	34874	34874	34874	3
Response to tamoxifen in breast cancer	22180457	2011-12-16	240	0	0	240	240	1
Response to temozolomide	23047291	2012-11-01	0	0	516	516	516	1
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	25217962	2014-09-14	172	2035	0	2207	634.381513366561	1
Response to tocilizumab in rheumatoid arthritis	22491018	2012-04-10	1157	0	0	1157	1157	3
Resting heart rate	20639392	2010-07-16	0	0	38991	38991	38991	8
Resting heart rate	23183192	2012-11-23	0	0	13372	13372	13372	1
Resting heart rate	24680774	2014-03-25	0	0	855	855	855	2
Resting heart rate	27798624	2016-10-31	0	0	134251	134251	134251	78
Resting heart rate	28270201	2017-03-07	0	0	26783	26783	26783	6
Resting heart rate	29769521	2018-05-16	0	0	67062	67062	67062	17
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	24825563	2014-05-13	820	0	0	820	820	2
Resting-state electroencephalogram vigilance	29703947	2018-04-27	0	0	1877	1877	1877	1
Restless legs syndrome	17634447	2007-07-19	306	15664	0	15970	1200.5470256731371	1
Restless legs syndrome	17637780	2007-07-18	401	1644	0	2045	1289.474816625917	3
Restless legs syndrome	18660810	2008-07-27	628	1644	0	2272	1817.6619718309857	2
Restless legs syndrome	21779176	2011-07-14	922	1526	0	2448	2298.97385620915	6
Restless legs syndrome	29029846	2017-11-01	15126	95725	0	110851	52248.02121767056	19
Restricted and repetitive behaviours in autism spectrum disorder	28533516	2017-05-23	0	0	6809	6809	6809	1
Reticulocyte count	27863252	2016-11-17	0	0	170641	170641	170641	210
Reticulocyte fraction of red cells	27863252	2016-11-17	0	0	170690	170690	170690	218
Retinal arteriolar caliber	23776548	2013-06-12	0	0	18722	18722	18722	2
Retinal arteriolar tortuosity	31597446	2019-10-10	0	0	3094	3094	3094	1
Retinal detachment	31816047	2019-12-09	2893	360233	0	363126	11479.806667658058	2
Retinal detachment or retinal break	31816047	2019-12-09	3977	360233	0	364210	15734.29220504654	5
Retinal vascular caliber	21060863	2010-10-28	0	0	15358	15358	15358	4
Retinal venular tortuosity	31597446	2019-10-10	0	0	3094	3094	3094	1
Retinol levels	21878437	2011-08-30	0	0	5006	5006	5006	2
Rheumatic heart disease	28492228	2017-05-11	1006	1849	0	2855	2606.0861646234675	2
Rheumatoid arthritis	17554300	2007-06-07	1860	2938	0	4798	4555.79824927053	3
Rheumatoid arthritis	17804836	2007-09-05	1522	1850	0	3372	3340.0948991696323	3
Rheumatoid arthritis	17982456	2007-11-04	397	1211	0	1608	1195.9378109452737	1
Rheumatoid arthritis	18668548	2008-08-01	400	400	0	800	800.0	1
Rheumatoid arthritis	18794853	2008-09-14	3393	12460	0	15853	10667.199899072732	5
Rheumatoid arthritis	19503088	2009-06-07	2418	4504	0	6922	6293.367234903207	5
Rheumatoid arthritis	20453841	2010-05-09	2303	3380	0	5683	5478.894949850431	2
Rheumatoid arthritis	20453842	2010-05-09	5539	20169	0	25708	17382.307608526527	15
Rheumatoid arthritis	21156761	2010-12-14	1921	1079	0	3000	2763.6786666666667	4
Rheumatoid arthritis	21452313	2011-04-01	801	757	0	1558	1556.7573812580233	2
Rheumatoid arthritis	21505073	2011-04-19	1247	1486	0	2733	2712.0995243322354	3
Rheumatoid arthritis	21844665	2011-08-16	100	600	0	700	342.85714285714283	1
Rheumatoid arthritis	22446963	2012-03-25	4074	16891	0	20965	13129.29816360601	9
Rheumatoid arthritis	23028356	2012-09-13	2303	3380	0	5683	5478.894949850431	2
Rheumatoid arthritis	23143596	2012-12-01	13838	33742	0	47580	39253.61883144178	31
Rheumatoid arthritis	23918589	2013-12-01	706	761	0	1467	1464.93796864349	1
Rheumatoid arthritis	24390342	2013-12-25	19234	60565	0	79799	58392.070577325525	147
Rheumatoid arthritis	24449572	2014-01-01	3034	5271	0	8305	7702.45105358218	4
Rheumatoid arthritis	24782177	2014-05-01	952	943	0	1895	1894.9572559366754	15
Rheumatoid arthritis	25014791	2014-08-14	0	637	0	637	637	1
Rheumatoid arthritis	28118524	2017-01-24	511	352	0	863	833.7056778679026	3
Rheumatoid arthritis	30423114	2018-11-13	916	0	1392	2308	2308	107
Rheumatoid arthritis	30572963	2018-12-20	15523	22308	0	37831	36614.10842959478	18
Rheumatoid arthritis	30891314	2019-01-18	868	1194	0	2062	2010.459747817653	31
Rheumatoid arthritis (ACPA-negative)	23143596	2012-12-01	3297	15870	0	19167	10919.474096102676	2
Rheumatoid arthritis (ACPA-negative)	24532677	2014-02-14	1148	6008	0	7156	3855.3292342090554	2
Rheumatoid arthritis (ACPA-positive)	23143596	2012-12-01	9585	33742	0	43327	29858.247282295102	37
Rheumatoid arthritis (ACPA-positive)	24532676	2014-02-14	12522	42567	0	55089	38702.75183793498	43
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	28118524	2017-01-24	357	352	0	709	708.9647390691115	3
Rheumatoid factor seropositivity in rheumatoid arthritis	26815016	2016-01-27	1178	0	0	1178	1178	1
Ribavirin-induced anemia	20637204	2010-07-13	0	0	453	453	453	1
Right planum temporale grey matter volume	31887566	2019-11-29	0	0	18039	18039	18039	1
Risk-taking tendency (4-domain principal component model)	30643258	2019-01-14	0	0	315894	315894	315894	106
Risky sexual behaviors (alcohol dependence interaction)	27531626	2016-08-17	2977	947	0	3924	2873.8216106014274	1
Risky sexual behaviors (alcohol dependence interaction)	28990359	2017-10-09	2977	947	0	3924	2873.8216106014274	7
Risky sexual behaviors in alcohol dependence	28990359	2017-10-09	0	0	2977	2977	2977	3
Rosacea symptom severity	29771307	2018-05-16	0	0	73265	73265	73265	18
Rotator cuff tears	26350878	2015-09-05	311	2641	0	2952	1112.9417344173442	1
Rubella-specific interleukin-6 secretion	29253144	2017-12-14	0	0	1845	1845	1845	1
S-phenylmercapturic acid levels in smokers	26959369	2016-03-09	0	0	2239	2239	2239	3
Sagittal craniosynostosis	23160099	2012-11-18	0	0	130	130	130	2
Salivary metabolite levels	31960908	2020-01-21	0	0	1419	1419	1419	4
Sarcoidosis	22837380	2012-07-26	564	1575	0	2139	1661.1500701262273	1
Sarcoidosis	22936702	2012-08-30	637	1233	0	1870	1680.044919786096	1
Sarcoidosis	26051272	2015-09-15	1726	5482	0	7208	5250.794672586016	6
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	26651848	2016-05-01	1048	0	0	1048	1048	25
Sarcoidosis (Lofgren's syndrome)	26651848	2016-05-01	345	2025	0	2370	1179.113924050633	1
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	26651848	2016-05-01	451	2086	0	2537	1483.3046905794247	2
Sarcoidosis (non-Lofgren's syndrome)	26651848	2016-05-01	568	2025	0	2593	1774.3154647126878	1
Scalp hair shape	26926045	2016-03-01	0	0	6357	6357	6357	4
Scarlet fever	28928442	2017-09-19	6812	113837	0	120649	25709.54235841159	4
Schizophrenia	19571808	2009-07-01	2663	13498	0	16161	8896.769754346884	4
Schizophrenia	19571809	2009-07-01	3967	3626	0	7593	7577.68576320295	1
Schizophrenia	19571811	2009-07-01	3322	3587	0	6909	6898.835721522652	1
Schizophrenia	21926974	2011-09-18	9394	12462	0	21856	21425.3345534407	8
Schizophrenia	22037552	2011-10-30	746	1599	0	2345	2034.7189765458422	2
Schizophrenia	22037555	2011-10-30	3750	6468	0	10218	9495.008807985907	2
Schizophrenia	22688191	2012-06-12	2111	2535	0	4646	4607.305208781748	4
Schizophrenia	22883433	2012-08-07	1606	1794	0	3400	3389.604705882353	1
Schizophrenia	23142968	2012-11-07	188	376	0	564	501.33333333333337	1
Schizophrenia	23894747	2013-02-01	11185	10768	0	21953	21945.079032478476	1
Schizophrenia	23974872	2013-08-25	13833	18310	0	32143	31519.42631366083	24
Schizophrenia	24043878	2013-09-16	481	2025	0	2506	1554.708699122107	1
Schizophrenia	24253340	2013-11-19	904	1640	0	2544	2331.069182389937	1
Schizophrenia	25056061	2014-07-22	34241	45604	3705	83550	78227.89474607051	98
Schizophrenia	26198764	2015-07-21	37581	113580	0	151161	112951.09135292833	150
Schizophrenia	27922604	2016-12-06	0	10154	0	10154	10154	4
Schizophrenia	28991256	2017-10-09	43175	65166	0	108341	103877.27822338726	126
Schizophrenia	29483656	2018-02-26	40675	64643	0	105318	99863.42410604075	97
Schizophrenia	30285260	2018-10-03	1940	7408	0	9348	6149.559264013692	287
Schizophrenia	30470734	2018-11-23	924	1125	0	2049	2029.2825768667642	1
Schizophrenia	31268507	2019-07-03	37805	113975	1781	153561	113554.48346290682	74
Schizophrenia	31740837	2019-11-18	22778	35362	0	58140	55416.28042655659	229
Schizophrenia and type 2 diabetes	30470734	2018-11-23	505	1125	0	1630	1394.1717791411045	2
Schizophrenia or bipolar disorder	24280982	2013-11-26	19779	19423	0	39202	39198.7671037192	7
Schizophrenia or schizoaffective disorder	31591465	2019-10-07	41627	52612	1235	95474	92958.5298655546	3
Schizophrenia vs type 2 diabetes	30470734	2018-11-23	1746	0	0	1746	1746	1
Schizophrenia, bipolar disorder and depression (combined)	20713499	2010-08-16	3126	1060	0	4186	3166.3258480649783	1
Schizophrenia, schizoaffective disorder or bipolar disorder	24166486	2013-10-29	1032	0	47038	48070	48070	5
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	28223688	2017-02-22	3097	132966	151275	287338	12106.030353586208	1
Sclerosing cholangitis and ulcerative colitis (combined)	22821403	2012-07-23	1376	2968	0	4344	3760.5598526703498	2
Scoliosis	22019779	2011-10-23	1033	1473	0	2506	2428.7454110135673	1
Scoliosis	23666238	2013-05-12	1033	1473	0	2506	2428.7454110135673	2
Seborrheic dermatitis	29203360	2017-12-02	609	3441	0	4050	2069.697777777778	2
Sedentary behaviour duration	30531941	2018-12-10	0	0	91105	91105	91105	6
Select biomarker traits	17903293	2007-09-19	0	0	1012	1012	1012	3
Selective IgA deficiency	27723758	2016-10-10	1635	4852	0	6487	4891.641745028519	7
Self-rated health	27864402	2017-06-01	0	0	111749	111749	111749	13
Self-reported allergy	23817569	2013-06-30	0	0	53862	53862	53862	16
Self-reported childhood asthma in adult smokers	30373671	2018-10-29	710	7321	0	8031	2588.9229236707756	1
Self-reported math ability	30038396	2018-07-23	0	0	564698	564698	564698	544
Self-reported math ability (MTAG)	30038396	2018-07-23	0	0	670471	670471	670471	751
Self-reported risk-taking behaviour	29391395	2018-02-02	29703	86552	0	116255	88455.68985419981	1
Self-reported risk-taking behaviour	30181555	2018-09-04	83677	244662	0	328339	249407.86411605083	23
Self-reported risk-taking behaviour	30271922	2018-05-03	113882	322354	0	436236	336609.7087631466	26
Self-reported tiredness	28194004	2017-02-14	0	0	108976	108976	108976	1
Sensation seeking	30718321	2019-02-04	0	0	22745	22745	22745	1
Sensorimotor dexterity	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	1
Sensory disturbances after bilateral sagittal split ramus osteotomy	23834954	2013-07-08	0	0	105	105	105	1
Sero-negative rheumatoid arthritis	28706201	2017-07-13	3323	15785	0	19108	10980.438559765542	2
Serous borderline ovarian cancer	28346442	2017-03-27	0	42895	0	42895	42895	5
Serous invasive ovarian cancer	28346442	2017-03-27	0	54990	0	54990	54990	16
Serum 25-Hydroxyvitamin D levels	29325163	2018-01-09	0	0	28150	28150	28150	11
Serum 25-Hydroxyvitamin D levels	29545823	2018-03-01	0	0	1829	1829	1829	2
Serum 25-Hydroxyvitamin D levels	31841498	2019-12-16	0	0	761	761	761	2
Serum C3d:C3 ratio (systemic complement activation)	29398083	2018-02-01	0	0	1548	1548	1548	1
Serum IgA levels	24676358	2014-03-27	0	0	9617	9617	9617	1
Serum VEGFR2 concentration	25411163	2014-11-19	0	0	736	736	736	1
Serum albumin level	23022100	2012-09-26	0	0	62570	62570	62570	12
Serum albumin level	29403010	2018-02-05	0	0	102223	102223	102223	17
Serum albumin level	31675503	2019-10-01	0	0	14126	14126	14126	1
Serum alkaline phosphatase levels	24094242	2013-10-05	0	0	1452	1452	1452	4
Serum alkaline phosphatase levels	29403010	2018-02-05	0	0	105030	105030	105030	46
Serum alkaline phosphatase levels	31666285	2019-10-30	0	0	162774	162774	162774	48
Serum alkaline phosphatase levels	31675503	2019-10-01	0	0	14126	14126	14126	2
Serum alkaline phosphatase levels	32084209	2020-02-21	0	0	4457	4457	4457	1
Serum alpha-fetoprotein levels	31666285	2019-10-30	0	0	22686	22686	22686	3
Serum alpha1-antitrypsin levels	26174136	2015-07-15	0	0	3294	3294	3294	3
Serum bilirubin levels in metabolic syndrome	30621171	2019-01-04	0	0	430	430	430	9
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	30621171	2019-01-04	0	0	418	418	418	1
Serum cancer antigen 125 levels	31666285	2019-10-30	0	0	9824	9824	9824	9
Serum cancer antigen 15.3 levels	31666285	2019-10-30	0	0	7107	7107	7107	6
Serum cancer antigen 19.9 levels	31666285	2019-10-30	0	0	9945	9945	9945	4
Serum carcinoembryonic antigen levels	31666285	2019-10-30	0	0	22309	22309	22309	9
Serum ceruloplasmin levels	22075249	2011-11-10	0	0	2647	2647	2647	1
Serum creatinine levels	29779033	2018-05-18	0	0	11283	11283	11283	2
Serum dimethylarginine levels (asymmetric/symetric ratio)	24159190	2013-10-24	0	0	5110	5110	5110	2
Serum erythropoietin levels	30271932	2018-05-17	0	0	4187	4187	4187	1
Serum folate levels	29953918	2018-06-25	0	0	1999	1999	1999	1
Serum folate levels	30339177	2018-10-19	0	0	2232	2232	2232	2
Serum galactose-deficient IgA1 levels	28187132	2017-02-10	0	0	1195	1195	1195	1
Serum lipase activity	25028398	2014-07-15	0	0	3966	3966	3966	2
Serum lycopene concentrations	26861389	2016-02-06	0	0	749	749	749	1
Serum magnesium levels	29093028	2017-11-01	0	0	7976	7976	7976	1
Serum metabolite concentrations in chronic kidney disease	29545352	2018-03-15	1143	0	0	1143	1143	40
Serum metabolite levels	23093944	2012-10-18	0	0	1678	1678	1678	110
Serum metabolite levels	24625756	2014-03-13	0	0	1260	1260	1260	19
Serum metabolite levels	25569235	2015-01-08	0	0	2118	2118	2118	9
Serum metabolite levels	31636271	2019-10-21	0	0	6263	6263	6263	371
Serum metabolite levels (CMS)	31636271	2019-10-21	0	0	6263	6263	6263	586
Serum metabolite ratios in chronic kidney disease	29545352	2018-03-15	1143	0	0	1143	1143	259
Serum oxytocin levels	31361301	2019-07-30	0	0	951	951	951	1
Serum parathyroid hormone levels	27927781	2016-12-07	0	0	22653	22653	22653	6
Serum platinum levels after completion of cisplatin chemotherapy	31296530	2019-07-11	0	0	1010	1010	1010	1
Serum prostate-specific antigen levels	21160077	2010-12-15	0	0	7538	7538	7538	7
Serum protein levels (sST2)	23999434	2013-09-03	0	0	2797	2797	2797	11
Serum sclerostin levels	31170332	2019-08-02	0	0	10584	10584	10584	2
Serum sulfate level	27412988	2016-07-13	0	0	917	917	917	1
Serum thyroid-stimulating hormone levels	24852370	2014-05-22	0	0	1346	1346	1346	2
Serum thyroid-stimulating hormone levels	25436638	2014-12-01	0	0	4852	4852	4852	1
Serum total cholesterol levels	29084231	2017-10-30	0	0	8372	8372	8372	34
Serum total protein level	23022100	2012-09-26	0	0	35707	35707	35707	6
Serum total protein level	29403010	2018-02-05	0	0	113509	113509	113509	39
Serum urate levels in chronic kidney disease	30181573	2018-09-04	4941	0	0	4941	4941	4
Serum urea levels	30808845	2019-02-26	0	0	13312	13312	13312	4
Serum uric acid levels	21983786	2011-10-09	0	0	15506	15506	15506	4
Serum uric acid levels	24379826	2013-12-16	0	0	632	632	632	1
Serum uric acid levels	24513273	2014-02-11	0	0	3451	3451	3451	4
Serum uric acid levels	26902266	2016-02-23	0	0	1109	1109	1109	3
Serum uric acid levels	29124443	2017-11-09	0	0	5847	5847	5847	27
Serum uric acid levels	29403010	2018-02-05	0	0	109029	109029	109029	48
Serum uric acid levels	29408531	2018-02-02	0	0	1634	1634	1634	2
Serum uric acid levels	30305239	2018-10-01	0	0	2153	2153	2153	3
Serum uric acid levels	30993211	2019-04-08	0	0	121745	121745	121745	84
Serum uric acid levels	31207883	2019-06-14	0	0	396	396	396	3
Serum uric acid levels	31841133	2019-12-16	0	0	9133	9133	9133	4
Serum uric acid levels in response to allopurinol in gout	25676789	2015-05-01	0	0	2027	2027	2027	2
Serum vitamin D-binding protein levels	24740207	2014-04-16	0	0	1380	1380	1380	2
Setpoint viral load in HIV-1 infection	26553974	2015-11-09	6315	0	0	6315	6315	15
Severe aplastic anemia	32004448	2020-01-30	359	1396	0	1755	1142.254131054131	2
Severe bacterial meningitis	31092817	2019-05-15	277	4836	0	5113	1047.9734011343633	1
Severe depressive disorders in coronary artery disease	30563176	2018-12-05	78	264	0	342	240.8421052631579	1
Severe diabetic retinopathy in type 2 diabetes	30178632	2018-09-04	560	4106	0	4666	1971.161594513502	2
Severe gastric atrophy	30753327	2019-02-08	120	760	0	880	414.5454545454545	1
Severe gingival inflammation	28459102	2016-04-20	0	0	4077	4077	4077	1
Severe influenza A (H1N1) infection	26379185	2015-09-17	49	549	0	598	179.93979933110367	34
Severe malaria	26416757	2015-09-30	5130	5291	0	10421	10418.5126187506	2
Severe malaria	29381699	2018-01-30	449	465	0	914	913.7199124726478	1
Severity of nausea and vomiting of pregnancy	29563502	2018-03-21	0	0	53731	53731	53731	7
Sex hormone levels	26014426	2015-05-27	0	0	2913	2913	2913	10
Sex hormone-binding globulin levels	22675492	2012-06-04	0	0	1598	1598	1598	1
Sex hormone-binding globulin levels	22829776	2012-07-19	0	0	21791	21791	21791	22
Sex ratio	26763874	2016-01-14	0	0	8842	8842	8842	1
Sexual dimorphism in anthropometric traits	23754948	2013-06-06	0	0	133723	133723	133723	3
Shingles	28928442	2017-09-19	16711	118152	0	134863	58561.29767245278	36
Shingles	30298529	2018-10-08	3599	40882	756	45237	13231.205953103574	11
Sickle cell anemia (haemolysis)	23406172	2013-02-14	0	0	1117	1117	1117	3
Sitting height ratio	25865494	2015-04-09	0	0	25135	25135	25135	10
Sjögren's syndrome	24097066	2013-10-06	542	1050	0	1592	1429.8994974874374	5
Sjögren's syndrome	24097067	2013-11-01	395	1975	0	2370	1316.6666666666667	10
Sjögren's syndrome	27503288	2016-08-08	242	1444	0	1686	829.0581257413996	1
Sjögren's syndrome	28076899	2017-01-11	1429	4584	148	6161	4357.582571095959	6
Skin aging (microtopography measurement)	28502801	2017-05-11	0	0	5087	5087	5087	4
Skin aging measurement	31522824	2019-09-06	0	0	1534	1534	1534	7
Skin and soft tissue Staphylococcus aureus infection	26450422	2015-10-08	2130	45434	0	47564	8138.459338995879	1
Skin colour saturation	25963972	2015-05-12	0	0	5857	5857	5857	7
Skin fluorescence in type 1 diabetes	27207532	2016-04-12	1359	0	0	1359	1359	1
Skin pigmentation	17999355	2007-10-15	0	0	737	737	737	3
Skin pigmentation	28300201	2017-03-16	0	0	285	285	285	3
Skin pigmentation	29195075	2017-11-30	0	0	216	216	216	2
Skin pigmentation	30664655	2019-01-21	0	0	6236	6236	6236	12
Skin pigmentation	31315583	2019-07-17	0	0	762	762	762	6
Skin pigmentation (conditioned on rs1426654 and rs35397)	31315583	2019-07-17	0	0	2104	2104	2104	11
Skin pigmentation traits	30166351	2018-08-30	0	0	4988	4988	4988	43
Skin reflectance (Melanin index)	30895295	2019-03-21	0	0	720	720	720	3
Skin sensitivity to sun	17952075	2007-10-21	0	0	2986	2986	2986	1
Skin sensitivity to sun	18488028	2008-05-18	0	0	5130	5130	5130	1
Skin sensitivity to sun	25963972	2015-05-12	0	0	2668	2668	2668	1
Skin, hair and eye pigmentation (multivariate analysis)	30664655	2019-01-21	0	0	6236	6236	6236	11
Sleep (number of episodes)	30952852	2019-04-05	0	0	84810	84810	84810	1
Sleep duration	25469926	2014-12-02	0	0	47180	47180	47180	2
Sleep duration	27494321	2016-08-05	0	0	127573	127573	127573	3
Sleep duration	27992416	2016-12-19	0	0	111975	111975	111975	1
Sleep duration	28604731	2017-06-12	0	0	112411	112411	112411	3
Sleep duration	30531941	2018-12-10	0	0	91105	91105	91105	22
Sleep duration	30804565	2019-02-25	0	0	384317	384317	384317	53
Sleep duration	30846698	2019-03-07	0	0	446118	446118	446118	52
Sleep duration (long sleep)	30846698	2019-03-07	34184	305742	0	339926	122985.40891841165	8
Sleep duration (short sleep)	30846698	2019-03-07	106192	305742	0	411934	315267.53765409027	27
Sleep traits (multi-trait analysis)	27992416	2016-12-19	0	0	112586	112586	112586	6
Sleep-related phenotypes	17903308	2007-09-19	0	0	941	941	941	1
Small HDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	2
Small LDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	26
Small VLDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	25
Small cell lung carcinoma	28604730	2017-06-12	2664	21444	0	24108	9478.482827277252	4
Small intestine neuroendocrine tumor	27492634	2016-08-01	293	4783	0	5076	1104.3490937746258	1
Small vessel stroke	26732560	2016-01-05	601	21969	0	22570	2339.9856446610543	1
Small vessel stroke	27997041	2016-12-20	2275	12285	0	14560	7678.125000000001	1
Smoking behavior	20418888	2010-04-25	0	0	31266	31266	31266	3
Smoking behavior	20418889	2010-04-25	0	0	41150	41150	41150	1
Smoking behavior	20418890	2010-04-25	0	0	74035	74035	74035	5
Smoking behavior	22832964	2012-05-22	0	0	32389	32389	32389	1
Smoking behavior	23049750	2012-09-25	0	0	11696	11696	11696	1
Smoking behaviour (age at first cigarette)	30679032	2018-12-06	0	0	146117	146117	146117	3
Smoking behaviour (cigarette pack-years)	30679032	2018-12-06	0	0	150993	150993	150993	17
Smoking behaviour (cigarette pack-years)	32157176	2020-03-10	0	0	4676	4676	4676	2
Smoking behaviour (cigarettes smoked per day)	30617275	2019-01-07	0	0	128746	128746	128746	7
Smoking behaviour (cigarettes smoked per day)	30643251	2019-01-14	0	0	377334	377334	377334	55
Smoking behaviour (cigarettes smoked per day)	30679032	2018-12-06	0	0	2685	2685	2685	13
Smoking behaviour (cigarettes smoked per day)	31089300	2019-03-25	0	0	72655	72655	72655	11
Smoking behaviour (cigarettes smoked per day)	31217584	2019-06-19	0	0	15862	15862	15862	4
Smoking behaviour (cigarettes smoked per day)	32157176	2020-03-10	0	0	4772	4772	4772	2
Smoking behaviour (maximum cigarettes in a 24 hour period)	29532581	2018-03-13	0	0	2450	2450	2450	2
Smoking cessation	30617275	2019-01-07	0	0	121543	121543	121543	2
Smoking cessation	30643251	2019-01-14	0	0	547219	547219	547219	24
Smoking cessation (MTAG)	30643251	2019-01-14	0	0	820192	820192	820192	80
Smoking initiation	30617275	2019-01-07	0	0	346813	346813	346813	40
Smoking initiation (ever regular vs never regular)	30643251	2019-01-14	0	0	1232091	1232091	1232091	378
Smoking initiation (ever regular vs never regular)	30679032	2018-12-06	0	0	433216	433216	433216	97
Smoking initiation (ever regular vs never regular)	31089300	2019-03-25	0	0	89678	89678	89678	2
Smoking initiation (ever regular vs never regular) (MTAG)	30643251	2019-01-14	0	0	1359002	1359002	1359002	643
Smoking intensity (cotinine levels/cigarettes per day)	32157176	2020-03-10	0	0	4772	4772	4772	2
Smoking status	30595370	2018-12-27	0	0	458000	458000	458000	158
Smoking status (ever vs never smokers)	30271922	2018-05-03	207229	243177	0	450406	447536.9025545841	2
Smoking status (ever vs never smokers)	30643258	2019-01-14	0	0	518633	518633	518633	223
Smoking status (ever vs never smokers)	32231276	2020-03-30	0	0	336066	336066	336066	35
Smoking status (heavy vs light)	28520984	2017-05-17	1929	3156	0	5085	4788.927433628319	2
Smoking status (heavy vs never)	26423011	2015-09-27	0	0	48931	48931	48931	6
Snoring	28604731	2017-06-12	0	105377	0	105377	105377	1
Snoring	30804565	2019-02-25	0	0	359916	359916	359916	42
Snoring	32060260	2020-02-14	61792	156554	0	218346	177219.36317587682	79
Social communication problems	24564958	2014-02-24	0	0	5628	5628	5628	1
Social science traits (pleiotropy) (HIPO component 1)	30289880	2018-10-05	0	0	630791	630791	630791	12
Sodium levels	29403010	2018-02-05	0	0	127304	127304	127304	14
Soluble E-selectin levels	19729612	2009-09-03	0	0	686	686	686	1
Soluble E-selectin levels	31217265	2019-06-19	0	0	5284	5284	5284	2
Soluble ICAM-1	18604267	2008-07-04	0	0	4570	4570	4570	4
Soluble ICAM-1	21533024	2011-04-21	0	0	22435	22435	22435	3
Soluble ICAM-1	31217265	2019-06-19	0	0	5284	5284	5284	3
Soluble VCAM-1 levels	31217265	2019-06-19	0	0	5284	5284	5284	3
Soluble interleukin-2 receptor subunit alpha	26293465	2015-08-20	0	0	3647	3647	3647	5
Soluble leptin receptor levels	20167575	2010-02-22	686	820	0	1506	1494.0770252324037	1
Soluble levels of adhesion molecules	20167578	2010-02-18	0	0	9813	9813	9813	5
Spatial processing	31596458	2019-10-09	623	910	0	1533	1479.2694063926942	2
Speech perception in dyslexia	19786962	2009-09-29	200	0	0	200	200	1
Sperm motility	29453196	2018-02-16	0	0	811	811	811	1
Spherical equivalent	29808027	2018-05-28	0	0	66127	66127	66127	49
Spherical equivalent (joint analysis main effects and education interaction)	27020472	2016-03-29	0	0	50351	50351	50351	42
Spherical equivalent or myopia (age of diagnosis)	29808027	2018-05-28	0	0	170420	170420	170420	140
Sphingolipid d18:1/d18:2 ratio	31862735	2019-12-20	0	0	658	658	658	1
Sphingolipid levels	19798445	2009-10-02	0	0	4110	4110	4110	5
Sphingolipid levels	22359512	2012-02-16	0	0	4034	4034	4034	10
Sphingolipid levels	26068415	2015-06-12	0	0	7478	7478	7478	7
Sphingomyelin levels	31551469	2019-09-24	0	0	2045	2045	2045	21
Spine bone mineral density and alcohol drinking	28012008	2016-12-23	0	0	2059	2059	2059	1
Spine bone size	31053729	2019-05-03	0	0	29059	29059	29059	7
Spontaneous dizygotic twinning	27132594	2016-05-05	0	12953	1980	14933	14933	2
Spontaneous preterm birth (maternal effect)	28598419	2017-06-09	0	0	1496	1496	1496	2
Spontaneous preterm birth (preterm birth)	25599974	2015-01-19	0	0	1851	1851	1851	1
Sporadic neuroblastoma	28545128	2017-05-18	2101	4202	0	6303	5602.666666666667	8
Sporadic pituitary adenoma	26029870	2015-06-01	771	2788	0	3559	2415.901095813431	3
Squamous cell carcinoma	23341777	2013-01-17	833	3094	0	3927	2625.2121212121215	1
Squamous cell carcinoma	26829030	2016-01-29	6891	54566	0	61457	24473.326455895993	12
Squamous cell carcinoma	26908436	2016-02-12	745	12805	0	13550	2816.1549815498156	1
Squamous cell carcinoma	31174203	2019-06-07	9674	625657	0	635331	38106.7872841086	13
Squamous cell lung carcinoma	28604730	2017-06-12	7426	55627	0	63053	26205.642998747084	43
Squamous cell lung carcinoma	31326317	2019-07-17	8350	27355	0	35705	25589.049152779724	3
Staphylococcus aureus infection	26450422	2015-10-08	4701	45344	0	50045	17037.637646118495	1
Staphylococcus aureus nasal carriage (intermittent)	26569114	2015-11-16	0	0	717	717	717	1
Statin-induced myopathy (severe)	31220337	2019-06-20	32	2501	0	2533	126.38294512435849	1
Stearic acid (18:0) levels	23362303	2013-01-29	0	0	8961	8961	8961	5
Stem cell factor levels	27989323	2016-12-13	0	0	8290	8290	8290	2
Stem cell growth factor beta levels	27989323	2016-12-13	0	0	3682	3682	3682	10
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	21912425	2011-09-13	14	991	0	1005	55.21990049751244	1
Strabismus	31073882	2019-05-09	1345	65349	0	66694	5271.5029837766515	1
Straight vs curly hair	27487801	2016-11-01	2675	224	0	2899	826.7678509830977	2
Straight vs curly hair	29895819	2018-06-12	0	0	4878	4878	4878	1
Strenuous sports or other exercises	29899525	2018-06-13	124842	225650	0	350492	321497.74944934546	8
Strep throat	28928442	2017-09-19	52487	22017	0	74504	62042.64356276174	4
Stress urinary incontinence	31729902	2019-11-15	1809	4811	0	6620	5258.670090634441	1
Stress-related disorders	31116379	2019-05-22	9831	19225	0	29056	26018.85669052863	1
Stress-related phenotypes (multivariate analysis)	31606302	2019-10-09	0	0	583	583	583	2
Stroke	19369658	2009-04-15	1544	18058	0	19602	5689.532088562391	4
Stroke	22306652	2012-02-05	3548	5972	0	9520	8902.796638655462	1
Stroke	26089329	2015-06-18	1592	13154	0	14746	5680.501288485013	3
Stroke	27068588	2016-04-07	4348	80613	0	84961	16501.939666435188	1
Stroke	29531354	2018-03-12	67162	457192	0	524354	234238.16050988453	23
Stroke	30383316	2018-11-01	72147	823869	0	896016	265350.9613355119	3
Stroke (ischemic)	18991354	2008-10-01	1661	10815	0	12476	5759.446938121193	1
Stroke (ischemic)	22941190	2012-09-02	1162	1244	0	2406	2403.2053200332502	1
Stroke (ischemic)	23041239	2012-10-05	12389	62004	0	74393	41303.21702310701	4
Sub-foveal choroidal thickness	29844195	2018-05-29	0	0	3418	3418	3418	1
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	28521775	2017-05-18	0	0	7671	7671	7671	9
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	28521775	2017-05-18	0	0	7671	7671	7671	4
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	28521775	2017-05-18	0	0	7671	7671	7671	1
Subcortical brain region volumes	25607358	2015-01-21	0	0	13171	13171	13171	10
Subcutaneous adipose tissue	26480920	2015-10-20	0	0	2513	2513	2513	4
Subcutaneous adipose tissue	27918534	2016-12-05	0	0	18247	18247	18247	2
Subcutaneous adipose tissue	30363675	2018-09-27	0	0	2545	2545	2545	1
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	27918534	2016-12-05	0	0	6148	6148	6148	1
Subiculum volume	30279459	2018-10-02	0	0	21297	21297	21297	4
Subiculum volume (corrected for total hippocampal volume)	30279459	2018-10-02	0	0	21297	21297	21297	1
Subjective well-being	27089181	2016-04-18	0	0	298420	298420	298420	5
Subjective well-being	29292387	2018-01-01	0	0	388538	388538	388538	13
Subjective well-being (MTAG)	29292387	2018-01-01	0	0	388538	388538	388538	49
Subpleural-predominant interstitial lung abnormalities	31339356	2019-07-24	1287	9422	0	10709	4529.317023064712	4
Sudden cardiac arrest	21658281	2011-06-10	88	517	0	605	300.8	12
Sudden cardiac arrest	21738491	2011-06-30	1283	0	0	1283	1283	1
Suffering from nerves	29500382	2018-03-02	0	0	369499	369499	369499	12
Sugar-sweetened beverage consumption	31046077	2019-05-02	0	0	85852	85852	85852	1
Suicidality	30745170	2019-02-07	0	0	122808	122808	122808	3
Suicidality (suicidal ideation/attempts)	30745170	2019-02-07	0	0	108090	108090	108090	1
Suicide attempt severity	30655502	2019-01-17	0	0	6320	6320	6320	1
Suicide attempts	30116032	2018-08-16	6024	44240	0	50264	21208.161706191313	2
Suicide attempts in bipolar disorder	21423239	2011-03-25	0	0	2698	2698	2698	1
Suicide attempts in major depressive disorder	31164008	2019-06-05	0	0	10408	10408	10408	1
Sulfasalazine-induced agranulocytosis	28762467	2017-08-01	36	5170	0	5206	143.00422589320016	7
Sum basophil neutrophil counts	27863252	2016-11-17	0	0	170143	170143	170143	153
Sum eosinophil basophil counts	27863252	2016-11-17	0	0	171771	171771	171771	206
Sum neutrophil eosinophil counts	27863252	2016-11-17	0	0	170384	170384	170384	154
Sunburns	23548203	2013-04-01	0	0	9283	9283	9283	2
Sunburns	30595370	2018-12-27	0	0	344000	344000	344000	81
Superior frontal gyrus grey matter volume	25335168	2014-10-21	158	378	0	536	445.70149253731347	1
Supraventricular ectopy	29618737	2018-04-04	2624	40352	0	42976	9855.14221891288	1
Sural nerve amplitude potential	30992453	2019-04-16	0	0	6879	6879	6879	1
Surgical necrotising enterocolitis in extremely premature birth	29538362	2018-03-14	30	413	133	576	111.87358916478556	1
Survival in breast cancer (estrogen-receptor positive)	29423119	2017-11-28	0	0	3136	3136	3136	1
Survival in colorectal cancer (distant metastatic)	26586795	2015-11-19	462	0	0	462	462	2
Survival in endocrine treated breast cancer (estrogen-receptor positive)	29423119	2017-11-28	0	0	2751	2751	2751	1
Survival in pancreatic cancer	28470677	2017-05-03	868	0	0	868	868	1
Survival in sporadic amyotrophic lateral sclerosis	27244217	2016-05-31	4256	0	0	4256	4256	2
Susceptibility to persistent hepatitis B virus infection	27244555	2016-05-31	1251	1057	0	2308	2291.693240901213	1
Symmetrical dimethylarginine levels	24159190	2013-10-24	0	0	5110	5110	5110	3
Symmetrical dimethylarginine levels	25245031	2014-09-21	0	0	6737	6737	6737	1
Systemic juvenile idiopathic arthritis	27927641	2016-12-07	770	6947	0	7717	2772.678502008552	2
Systemic lupus erythematosus	18204098	2008-01-20	1311	3340	0	4651	3765.848204687164	5
Systemic lupus erythematosus	18204446	2008-01-20	720	2337	0	3057	2201.6879293424927	5
Systemic lupus erythematosus	18204447	2008-01-20	279	515	0	794	723.8539042821159	1
Systemic lupus erythematosus	19165918	2008-08-01	431	2155	0	2586	1436.6666666666667	3
Systemic lupus erythematosus	19838193	2009-10-18	1047	1205	0	2252	2240.9147424511543	17
Systemic lupus erythematosus	19838195	2009-11-01	1310	7859	0	9169	4491.346929872397	14
Systemic lupus erythematosus	20169177	2010-02-12	314	1484	0	1798	1036.6540600667408	2
Systemic lupus erythematosus	21044949	2010-11-02	612	1160	0	1772	1602.5282167042888	1
Systemic lupus erythematosus	21408207	2011-03-03	1717	4813	0	6530	5062.126186830015	7
Systemic lupus erythematosus	22291604	2012-01-26	891	3384	0	4275	2821.1873684210523	1
Systemic lupus erythematosus	23053960	2012-10-07	1527	0	3421	4948	4948	5
Systemic lupus erythematosus	23273568	2012-12-27	1656	3394	0	5050	4451.852673267327	17
Systemic lupus erythematosus	24871463	2014-05-29	725	2438	0	3163	2235.282959215934	12
Systemic lupus erythematosus	25862617	2015-04-10	1656	3394	0	5050	4451.852673267327	1
Systemic lupus erythematosus	26316170	2015-08-28	661	487	0	1148	1121.6271777003483	3
Systemic lupus erythematosus	26502338	2015-10-26	5201	9066	0	14267	13219.952617929488	81
Systemic lupus erythematosus	26606652	2015-11-25	1393	2317	0	3710	3479.871698113207	18
Systemic lupus erythematosus	26663301	2016-05-01	1174	4246	0	5420	3678.822140221402	12
Systemic lupus erythematosus	27399966	2016-07-11	5695	10357	0	16052	14698.010216795414	49
Systemic lupus erythematosus	28714469	2017-07-17	11590	15984	0	27574	26873.80285776456	126
Systemic lupus erythematosus	29494758	2018-03-01	1047	1205	0	2252	2240.9147424511543	3
Systemic lupus erythematosus	29848360	2018-05-30	4943	8483	0	13426	12492.61701176821	5
Systemic lupus erythematosus and Systemic sclerosis	23740937	2013-06-10	3530	7381	0	10911	9551.80276784896	11
Systemic lupus erythematosus or rheumatoid arthritis	27193031	2016-05-18	6148	10398	0	16546	15454.346428139732	7
Systemic sclerosis	20383147	2010-04-11	2296	5171	0	7467	6360.046069371902	4
Systemic sclerosis	21750679	2011-07-07	564	1776	0	2340	1712.246153846154	4
Systemic sclerosis	21779181	2011-07-14	2296	5172	0	7468	6360.424209962507	9
Systemic sclerosis	24387989	2014-01-02	1833	3466	0	5299	4795.756180411399	8
Systemic sclerosis	28314753	2017-03-17	1264	3573	0	4837	3734.771139135828	3
Systemic sclerosis	29293537	2018-01-02	2124	3726	0	5850	5411.298461538461	7
Systemic sclerosis	30247649	2018-09-21	764	1343	0	2107	1947.8917892738489	1
Systemic sclerosis	30572963	2018-12-20	3477	22308	0	25785	12032.56404886562	6
Systemic sclerosis	31672989	2019-10-31	9095	17584	0	26679	23977.88222946887	23
Systemic sclerosis (anti-centromere-positive)	29293537	2018-01-02	692	3726	0	4418	2334.4427342689	2
Systemic sclerosis (anti-topoisomerase-positive)	29293537	2018-01-02	416	3726	0	4142	1496.8768710767745	1
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	30573655	2018-12-20	11704	19704	0	31408	29370.302598064187	26
Systemising	31508503	2019-09-03	0	0	51564	51564	51564	3
Systolic blood pressure	19430479	2009-05-10	0	0	29136	29136	29136	4
Systolic blood pressure	19430483	2009-05-10	0	0	34433	34433	34433	3
Systolic blood pressure	21909115	2011-09-11	0	0	69395	69395	69395	18
Systolic blood pressure	25249183	2014-09-23	0	0	11816	11816	11816	12
Systolic blood pressure	26390057	2015-09-21	0	0	99994	99994	99994	9
Systolic blood pressure	26969751	2016-03-11	0	0	23689	23689	23689	2
Systolic blood pressure	27618447	2016-10-01	0	0	192763	192763	192763	22
Systolic blood pressure	27618448	2016-10-01	0	0	146562	146562	146562	12
Systolic blood pressure	27618452	2016-09-12	0	0	201529	201529	201529	54
Systolic blood pressure	27736895	2016-10-13	0	0	38450	38450	38450	1
Systolic blood pressure	27841878	2016-11-14	0	0	321262	321262	321262	243
Systolic blood pressure	28135244	2017-01-30	0	0	140882	140882	140882	36
Systolic blood pressure	28234671	2017-07-01	0	0	15914	15914	15914	3
Systolic blood pressure	28498854	2017-05-12	0	0	31155	31155	31155	4
Systolic blood pressure	28739976	2017-07-24	0	0	150134	150134	150134	57
Systolic blood pressure	29208002	2017-12-06	0	0	2146	2146	2146	1
Systolic blood pressure	29403010	2018-02-05	0	0	136597	136597	136597	23
Systolic blood pressure	30224653	2018-09-17	0	0	757601	757601	757601	190
Systolic blood pressure	30487518	2018-11-28	0	0	130777	130777	130777	117
Systolic blood pressure	30578418	2018-12-21	0	0	459777	459777	459777	351
Systolic blood pressure	30595370	2018-12-27	0	0	422000	422000	422000	673
Systolic blood pressure	31217584	2019-06-19	0	0	35433	35433	35433	6
Systolic blood pressure (alcohol consumption interaction)	24376456	2013-12-12	0	0	6882	6882	6882	2
Systolic blood pressure (cigarette smoking interaction)	26752167	2016-01-11	0	0	1083	1083	1083	1
Systolic blood pressure (cigarette smoking interaction)	29455858	2018-02-15	0	0	129913	129913	129913	46
Systolic blood pressure (dietary potassium intake interaction)	29212900	2017-12-06	0	0	1876	1876	1876	1
Systolic blood pressure (long-term average)	28348047	2017-04-01	0	0	18422	18422	18422	4
Systolic blood pressure change trajectories	27980656	2016-10-18	0	0	703	703	703	1
Systolic blood pressure night-to-day ratio in hypertension	29973135	2018-07-04	0	0	204	204	204	1
Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension	31754133	2019-11-21	0	0	687	687	687	2
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	29912962	2018-06-18	0	0	72871	72871	72871	43
Systolic blood pressure x alcohol consumption interaction (2df test)	29912962	2018-06-18	0	0	133355	133355	133355	114
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	31167214	2019-06-05	0	0	6705	6705	6705	1
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	29455858	2018-02-15	0	0	129901	129901	129901	4
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	29455858	2018-02-15	0	0	129901	129901	129901	80
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	29455858	2018-02-15	0	0	128608	128608	128608	79
Systolic blood pressure x sodium interaction (1df test)	30242241	2018-09-21	0	0	4527	4527	4527	1
Systolic blood pressure x sodium interaction (2df test)	27271309	2016-08-01	0	0	1876	1876	1876	2
T wave morphology restitution during exercise	31607149	2019-10-14	0	0	51574	51574	51574	5
T wave morphology restitution during exercise (MTAG)	31607149	2019-10-14	0	0	51574	51574	51574	8
T wave morphology restitution during recovery from exercise	31607149	2019-10-14	0	0	51574	51574	51574	7
T wave morphology restitution during recovery from exercise (MTAG)	31607149	2019-10-14	0	0	51574	51574	51574	7
TB-LM or TBLH-BMD (pleiotropy)	28743860	2017-07-25	0	0	10414	10414	10414	12
TRAIL levels	27989323	2016-12-13	0	0	8186	8186	8186	23
Tacrolimus trough concentration in kidney transplant patients	29160300	2017-11-21	0	0	1345	1345	1345	1
Tacrolimus trough concentration in kidney transplant patients	30801552	2019-02-19	0	0	1662	1662	1662	4
Takayasu arteritis	23830517	2013-07-03	411	1036	0	1447	1177.0449205252246	3
Takayasu arteritis	25604533	2015-01-20	635	1455	0	2090	1768.2775119617224	11
Takayasu arteritis	30498034	2018-11-29	411	2158	0	2569	1380.9855975087582	7
Tanning	19340012	2009-04-02	0	0	2287	2287	2287	5
Tanning	23548203	2013-04-01	0	0	9678	9678	9678	5
Tanning	29195075	2017-11-30	0	0	216	216	216	1
Tea consumption	31046077	2019-05-02	0	0	336898	336898	336898	16
Telomere length	20139977	2010-02-07	0	0	2917	2917	2917	1
Telomere length	20421499	2010-04-26	0	0	3417	3417	3417	1
Telomere length	21573004	2011-05-10	0	0	3554	3554	3554	1
Telomere length	23001564	2012-09-25	0	0	9190	9190	9190	4
Telomere length	23535734	2013-04-01	0	0	37684	37684	37684	3
Telomere length	23900074	2013-07-29	0	0	2240	2240	2240	1
Telomere length	24478790	2014-01-17	0	0	5415	5415	5415	1
Telomere length	24795349	2014-05-03	844	774	0	1618	1614.9715698393074	1
Telomere length	29151059	2017-11-18	0	0	5075	5075	5075	1
Temperament (bipolar disorder)	22365631	2012-02-22	1263	1434	0	2697	2686.157953281424	3
Temporal lobe volume	31396565	2019-08-02	0	0	16016	16016	16016	1
Temporomandibular joint disorder	28081371	2017-01-12	769	9384	0	10153	2843.020191076529	3
Tenofovir clearance in HIV infection	26148204	2015-09-01	501	0	0	501	501	1
Testicular cancer	19483682	2009-05-31	277	919	0	1196	851.38127090301	1
Testicular cancer	21551455	2011-05-06	349	919	0	1268	1011.769716088328	2
Testicular germ cell cancer	20543847	2010-06-13	979	4947	0	5926	3269.0604117448534	6
Testicular germ cell tumor	19483681	2009-05-31	730	1435	0	2165	1935.4272517321017	4
Testicular germ cell tumor	23666239	2013-05-12	582	1056	0	1638	1500.8351648351647	6
Testicular germ cell tumor	23666240	2013-05-12	986	4946	0	5932	3288.4396493594068	15
Testicular germ cell tumor	25877299	2015-04-15	1326	6687	0	8013	4426.288281542494	4
Testicular germ cell tumor	26503584	2015-10-27	986	4946	0	5932	3288.4396493594068	4
Testicular germ cell tumor	28604728	2017-06-12	5518	19055	0	24573	17115.613071257074	39
Testicular germ cell tumor	28604732	2017-06-12	3558	13970	0	17528	11343.053400273848	31
Testosterone levels	21998597	2011-10-06	0	0	8938	8938	8938	2
Testosterone levels	31169883	2019-06-06	0	0	7643	7643	7643	12
Tetanus toxoid IgG concentrations post childhood immunization	31189108	2019-06-01	0	0	549	549	549	1
Tetralogy of Fallot	23297363	2013-01-07	835	5159	0	5994	2874.718051384718	2
Thalamus volume	31636452	2019-10-21	0	0	34464	34464	34464	2
Thiazide-induced adverse metabolic effects in hypertensive patients	23400010	2013-02-12	767	0	0	767	767	1
Thick vs thin eyebrows	29895819	2018-06-12	0	0	3941	3941	3941	1
Thionamide-induced agranulocytosis in Graves' disease	26151496	2015-07-07	0	0	683	683	683	6
Thiopurine S-methyltransferase activity	27770449	2016-10-22	0	0	1212	1212	1212	4
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	27564568	2016-08-26	963	0	0	963	963	1
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	29923122	2018-06-19	43	1172	0	1215	165.9127572016461	1
Thiopurine-induced alopecia in inflammatory bowel disease	29923122	2018-06-19	81	1139	0	1220	302.48852459016393	1
Thiopurine-induced early leukopenia in Crohn's disease	25108385	2014-08-10	33	307	0	340	119.18823529411763	1
Thiopurine-induced leukopenia in inflammatory bowel disease	27558924	2016-08-24	113	154	0	267	260.7041198501873	2
Thiopurine-induced leukopenia in inflammatory bowel disease	29923122	2018-06-19	196	1024	0	1220	658.0459016393443	1
Thiopurine-induced myelosuppression in inflammatory bowel disease	30806694	2019-02-01	311	608	0	919	823.0163220892274	1
Thiopurine-induced severe alopecia in inflammatory bowel disease	29923122	2018-06-19	41	1179	0	1220	158.48852459016393	1
Thiopurine-induced severe leukopenia in inflammatory bowel disease	29923122	2018-06-19	72	1148	0	1220	271.00327868852463	1
Thoracic aortic aneurysms and dissections	21909107	2011-09-11	765	874	0	1639	1631.7510677242221	1
Thoracic-to-hip circumference ratio	26675016	2015-12-16	0	0	4988	4988	4988	1
Thrombin generation potential phenotypes	24357727	2013-12-19	714	0	1253	1967	1967	3
Thrombin-activatable fibrinolysis inhibitor activation peptide	29378355	2018-02-01	0	0	3124	3124	3124	2
Thrombin-activatable fibrinolysis inhibitor levels	29378355	2018-02-01	0	0	3116	3116	3116	2
Thrombosis	26908601	2016-02-09	6135	252827	0	258962	23958.629374193893	8
Thyroglobulin plasma levels	30929638	2019-03-30	0	0	1094	1094	1094	1
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase  (TPOAb) levels)	31794020	2019-12-03	619	1994	0	2613	1889.454267125909	2
Thyroid cancer	19198613	2009-02-06	192	37196	0	37388	764.056060768161	2
Thyroid cancer	22267200	2012-01-22	0	0	27758	27758	27758	3
Thyroid cancer	23894154	2013-07-26	690	497	0	1187	1155.6192080876158	2
Thyroid cancer	25855579	2015-04-22	398	502	0	900	887.9822222222222	3
Thyroid cancer	28195142	2017-02-14	2637	134811	153103	290551	10345.632006286014	11
Thyroid cancer	30104761	2018-08-13	358	407399	0	407757	1430.7427413876403	1
Thyroid cancer (Papillary, radiation-related)	20350937	2010-03-29	401	620	0	1021	974.0254652301666	1
Thyroid function	22494929	2012-04-16	0	0	3736	3736	3736	4
Thyroid hormone levels	23408906	2013-02-07	0	0	26420	26420	26420	43
Thyroid nodules	30099483	2018-08-06	811	691	0	1502	1492.4127829560584	1
Thyroid peroxidase antibody levels	24586183	2014-02-27	0	0	12353	12353	12353	3
Thyroid peroxidase antibody positivity	24586183	2014-02-27	1769	16528	0	18297	6391.874514947805	3
Thyroid peroxidase antibody positivity	24722205	2014-04-17	377	3019	0	3396	1340.5924617196704	1
Thyroid stimulating hormone levels	18514160	2008-06-01	0	0	4300	4300	4300	1
Thyroid stimulating hormone levels	25743335	2015-03-06	0	0	16335	16335	16335	13
Thyroid stimulating hormone levels	30367059	2018-10-26	0	0	54288	54288	54288	19
Thyroid stimulating hormone levels	30843173	2019-03-07	0	0	1731	1731	1731	1
Thyroid volume	21565293	2011-05-13	0	0	3620	3620	3620	8
Thyroid volume in Hashimoto’s thyroiditis	32019955	2020-02-04	0	0	345	345	345	2
Thyrotoxic hypokalemic periodic paralysis	22399142	2012-03-08	78	74	0	152	151.89473684210526	1
Thyrotoxic hypokalemic periodic paralysis	22863731	2012-08-05	69	1170	0	1239	260.62953995157386	1
Thyrotoxic hypokalemic periodic paralysis and Graves disease	31050781	2019-05-03	171	2160	0	2331	633.8223938223939	12
Thyrotoxic hypokalemic periodic paralysis in Graves disease	31050781	2019-05-03	0	0	1575	1575	1575	2
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	25935875	2015-05-02	1812	0	0	1812	1812	6
Time to smoke first cigarette in the morning	31294817	2019-07-11	0	0	18567	18567	18567	2
Toenail selenium levels	25343990	2014-10-24	0	0	4162	4162	4162	3
Tofu consumption	31959922	2020-01-20	0	0	152943	152943	152943	1
Tonsillectomy	27182965	2016-05-16	60098	113323	0	173421	157085.60448849908	36
Tonsillectomy	27941131	2016-12-09	0	0	13483	13483	13483	1
Tonsillectomy	28928442	2017-09-19	60098	113323	0	173421	157085.60448849908	75
Tooth agenesis	29364747	2018-01-01	1944	0	338554	340498	340498	4
Tooth agenesis (mandibular second premolars)	29364747	2018-01-01	1196	0	338554	339750	339750	1
Tooth agenesis (maxillary lateral incisors)	29364747	2018-01-01	600	0	338554	339154	339154	2
Tooth agenesis (maxillary second premolars)	29364747	2018-01-01	600	0	338554	339154	339154	1
Total bilirubin levels	29403010	2018-02-05	0	0	110207	110207	110207	20
Total bilirubin levels in HIV-1 infection	25884002	2015-01-09	0	0	2547	2547	2547	10
Total body bone mineral density	29304378	2018-01-04	0	0	66945	66945	66945	242
Total body bone mineral density (MTAG)	30690781	2019-02-28	0	0	66628	66628	66628	14
Total body bone mineral density (age 0-15)	29304378	2018-01-04	0	0	11807	11807	11807	8
Total body bone mineral density (age 15-30)	29304378	2018-01-04	0	0	4180	4180	4180	1
Total body bone mineral density (age 30-45)	29304378	2018-01-04	0	0	10062	10062	10062	8
Total body bone mineral density (age 45-60)	29304378	2018-01-04	0	0	18805	18805	18805	18
Total body bone mineral density (age over 60)	29304378	2018-01-04	0	0	22504	22504	22504	20
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	28736931	2017-07-24	0	0	1264	1264	1264	3
Total cholesterol levels	26690388	2015-12-22	0	0	12685	12685	12685	4
Total cholesterol levels	28334899	2017-02-21	0	0	219941	219941	219941	84
Total cholesterol levels	28548082	2017-05-26	0	0	3213	3213	3213	2
Total cholesterol levels	29083408	2017-10-30	0	0	297824	297824	297824	20
Total cholesterol levels	29403010	2018-02-05	0	0	128305	128305	128305	45
Total cholesterol levels	29507422	2018-03-05	0	0	283251	283251	283251	653
Total cholesterol levels	29615537	2018-03-01	0	0	33431	33431	33431	4
Total cholesterol levels	30275531	2018-10-01	0	0	297626	297626	297626	140
Total cholesterol levels	30718733	2019-02-04	0	0	6949	6949	6949	8
Total cholesterol levels	30911093	2019-03-25	0	0	1036	1036	1036	1
Total cholesterol levels	31217584	2019-06-19	0	0	33185	33185	33185	115
Total cholesterol levels	31393916	2019-08-08	0	0	11103	11103	11103	8
Total cholesterol levels	31675503	2019-10-01	0	0	14126	14126	14126	5
Total cholesterol levels in HDL	29084231	2017-10-30	0	0	8372	8372	8372	16
Total cholesterol levels in LDL	29084231	2017-10-30	0	0	8372	8372	8372	38
Total cholesterol levels in large HDL	29084231	2017-10-30	0	0	8372	8372	8372	3
Total cholesterol levels in large LDL	29084231	2017-10-30	0	0	8372	8372	8372	8
Total cholesterol levels in medium HDL	29084231	2017-10-30	0	0	8372	8372	8372	5
Total cholesterol levels in medium LDL	29084231	2017-10-30	0	0	8372	8372	8372	8
Total cholesterol levels in medium VLDL	29084231	2017-10-30	0	0	8372	8372	8372	19
Total cholesterol levels in small LDL	29084231	2017-10-30	0	0	8372	8372	8372	22
Total cholesterol levels in small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	1
Total glycated albumin levels	29844224	2018-05-29	0	0	9751	9751	9751	1
Total hippocampal volume	30279459	2018-10-02	0	0	21297	21297	21297	8
Total mean fractional anisotropy measurement in first episode schizophrenia	28924203	2017-09-18	93	134	0	227	219.59471365638765	1
Total triglycerides levels	26690388	2015-12-22	0	0	12685	12685	12685	5
Total triglycerides levels	29084231	2017-10-30	0	0	8372	8372	8372	38
Tourette syndrome	22889924	2012-08-14	1285	4964	0	6249	4083.0468875020006	1
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	27515689	2016-07-20	0	0	1245	1245	1245	1
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	31095341	2019-05-16	0	0	3470	3470	3470	4
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	31095341	2019-05-16	0	0	3619	3619	3619	2
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	31095341	2019-05-16	0	0	3782	3782	3782	1
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	31095341	2019-05-16	0	0	3379	3379	3379	3
Trans fatty acid levels	25646338	2014-12-10	0	0	8013	8013	8013	32
Trans-epidermal water loss	28011148	2016-12-21	0	0	611	611	611	1
Trauma exposure	31969693	2020-01-23	35269	63451	0	98720	90674.76981361426	6
Triacylglyceride levels	31551469	2019-09-24	0	0	2045	2045	2045	20
Triacylglycerol 56:2 levels	31560688	2019-09-27	0	0	1937	1937	1937	1
Triacylglycerol 56:6 levels	31560688	2019-09-27	0	0	1937	1937	1937	2
Trichloroethylene-induced hypersensitivity syndrome	26190474	2015-07-20	98	98	0	196	196.00000000000003	3
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	28736931	2017-07-24	0	0	1264	1264	1264	4
Triglyceride levels	26763881	2016-01-14	0	0	2994	2994	2994	3
Triglyceride levels	28334899	2017-02-21	0	0	206044	206044	206044	56
Triglyceride levels	28371326	2017-03-30	862	880	0	1742	1741.814006888634	3
Triglyceride levels	28548082	2017-05-26	0	0	3213	3213	3213	4
Triglyceride levels	29083408	2017-10-30	0	0	237050	237050	237050	27
Triglyceride levels	29212154	2017-09-16	0	0	10300	10300	10300	1
Triglyceride levels	29403010	2018-02-05	0	0	105597	105597	105597	35
Triglyceride levels	29404214	2018-01-29	0	0	2782	2782	2782	1
Triglyceride levels	29615537	2018-03-01	0	0	33431	33431	33431	10
Triglyceride levels	30108155	2018-08-14	0	0	1353	1353	1353	13
Triglyceride levels	30255771	2018-09-17	0	0	173	173	173	1
Triglyceride levels	30698716	2019-01-29	0	0	127326	127326	127326	55
Triglyceride levels	30718733	2019-02-04	0	0	6949	6949	6949	9
Triglyceride levels	30911093	2019-03-25	0	0	1036	1036	1036	5
Triglyceride levels	30926973	2019-03-29	0	0	111909	111909	111909	34
Triglyceride levels	31217584	2019-06-19	0	0	33096	33096	33096	113
Triglyceride levels	31551469	2019-09-24	0	0	2045	2045	2045	1
Triglyceride levels	31675503	2019-10-01	0	0	14126	14126	14126	4
Triglyceride levels in IDL	29084231	2017-10-30	0	0	8372	8372	8372	10
Triglyceride levels in chylomicrons and largest VLDL	29084231	2017-10-30	0	0	8372	8372	8372	1
Triglyceride levels in current drinkers	30698716	2019-01-29	0	0	71394	71394	71394	86
Triglyceride levels in large VLDL	29084231	2017-10-30	0	0	8372	8372	8372	20
Triglyceride levels in medium VLDL	29084231	2017-10-30	0	0	8372	8372	8372	26
Triglyceride levels in small HDL	29084231	2017-10-30	0	0	8372	8372	8372	3
Triglyceride levels in small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	30
Triglyceride levels in very large HDL	29084231	2017-10-30	0	0	8372	8372	8372	19
Triglyceride levels in very large VLDL	29084231	2017-10-30	0	0	8372	8372	8372	4
Triglyceride levels in very small VLDL	29084231	2017-10-30	0	0	8372	8372	8372	11
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	30698716	2019-01-29	0	0	127326	127326	127326	125
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	30698716	2019-01-29	0	0	71394	71394	71394	125
Triglyceride levels x long total sleep time interaction (1df test)	31719535	2019-11-12	0	49886	12104	61990	61990	2
Triglyceride levels x long total sleep time interaction (2df test)	31719535	2019-11-12	0	49886	12104	61990	61990	55
Triglyceride levels x loop diuretics use interaction	31806883	2019-12-06	0	0	38834	38834	38834	4
Triglyceride levels x short total sleep time interaction (1df test)	31719535	2019-11-12	0	49135	12855	61990	61990	1
Triglyceride levels x short total sleep time interaction (2df test)	31719535	2019-11-12	0	49135	12855	61990	61990	60
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	30926973	2019-03-29	0	0	111908	111908	111908	1
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	30926973	2019-03-29	0	0	111908	111908	111908	3
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	30926973	2019-03-29	0	0	111913	111913	111913	1
Triglyceride to HDL cholesterol ratio	28046027	2017-01-03	0	0	5292	5292	5292	2
Triglycerides	18193043	2008-01-13	0	0	8684	8684	8684	8
Triglycerides	18193044	2008-01-13	0	0	2758	2758	2758	8
Triglycerides	18193046	2008-01-13	0	0	2011	2011	2011	4
Triglycerides	19060906	2008-12-07	0	0	19840	19840	19840	10
Triglycerides	19060911	2008-12-07	0	0	17815	17815	17815	7
Triglycerides	19074352	2008-12-17	0	0	809	809	809	1
Triglycerides	20139978	2010-02-07	0	0	8993	8993	8993	4
Triglycerides	20686565	2010-08-05	0	0	96598	96598	96598	32
Triglycerides	20864672	2010-09-23	0	0	17723	17723	17723	8
Triglycerides	21909109	2011-09-11	0	0	12545	12545	12545	5
Triglycerides	22171074	2011-12-30	0	0	1999	1999	1999	2
Triglycerides	23726366	2013-05-29	0	0	10936	10936	10936	7
Triglycerides	24097068	2013-10-06	0	0	94595	94595	94595	39
Triglycerides	24507774	2014-02-01	0	0	56538	56538	56538	8
Triglycerides	24886709	2014-06-02	1678	1645	0	3323	3322.67228408065	8
Triglycerides	25961943	2015-05-11	0	0	62166	62166	62166	34
Triglycerides	26160806	2015-08-01	0	0	3681	3681	3681	4
Triglycerides	26582766	2015-11-18	0	0	8344	8344	8344	9
Triglycerides	26780889	2016-01-19	0	0	4383	4383	4383	4
Triglycerides	27036123	2016-04-01	0	0	49549	49549	49549	19
Triglycerides	29404214	2018-01-29	0	0	2782	2782	2782	2
Triglycerides	29507422	2018-03-05	0	0	283251	283251	283251	537
Triglycerides	30275531	2018-10-01	0	0	297626	297626	297626	151
Triglycerides x physical activity interaction (2df test)	30670697	2019-01-22	0	0	102281	102281	102281	24
Triglycerides-Blood Pressure (TG-BP)	21386085	2011-03-08	0	0	22161	22161	22161	6
Triiodothyronine levels	30843173	2019-03-07	0	0	1729	1729	1729	1
Triiodothyronine levels and thyroxine levels	30843173	2019-03-07	0	0	1729	1729	1729	1
Triiodothyronine/thyroxine ratio	30824882	2019-03-01	0	0	623	623	623	1
Trochanter size	31053729	2019-05-03	0	0	28944	28944	28944	3
Trunk fat mass	28552196	2017-06-01	0	0	16237	16237	16237	2
Trunk fat mass adjusted for trunk lean mass	30944420	2019-04-03	0	0	11569	11569	11569	3
Tuberculosis	20694014	2010-08-08	2237	3122	0	5359	5212.848665795857	1
Tuberculosis	22306650	2012-02-05	1329	1847	0	3176	3091.5151133501263	1
Tuberculosis	24057671	2013-09-18	642	91	0	733	318.81036834924964	3
Tuberculosis	25774636	2015-03-16	5530	5607	0	11137	11136.467630421119	2
Tuberculosis	28928442	2017-09-19	4426	84290	0	88716	16820.755669777718	27
Tuberculosis	29036319	2017-09-26	972	1537	0	2509	2381.768035073734	3
Tuberculosis	30287856	2018-10-04	833	1220	0	2053	1980.04870920604	2
Tuberculosis (SNP x SNP interaction)	30713548	2019-01-18	410	405	0	815	814.9693251533743	18
Tumor biomarkers	23300138	2013-01-07	0	0	3451	3451	3451	11
Tumor necrosis factor alpha levels	31217265	2019-06-19	0	0	13577	13577	13577	1
Tumor necrosis factor beta levels	27989323	2016-12-13	0	0	1559	1559	1559	3
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	28820441	2017-08-19	0	0	2703	2703	2703	1
Two-hour glucose	25043022	2014-06-18	0	0	2540	2540	2540	1
Two-hour glucose challenge	20081857	2010-01-17	0	0	15234	15234	15234	3
Two-hour glucose in pregnancy (gestational week 30-32)	30324795	2018-09-18	0	0	512	512	512	2
Type 1 diabetes	17554260	2007-06-06	2000	3000	0	5000	4800.0	8
Type 1 diabetes	17554300	2007-06-07	1963	2938	0	4901	4707.0344827586205	5
Type 1 diabetes	17632545	2007-07-15	561	1143	467	2171	1505.218309859155	3
Type 1 diabetes	18198356	2008-01-15	561	1143	467	2171	1505.218309859155	1
Type 1 diabetes	18840781	2008-10-07	563	1146	483	2192	1510.1181977764775	1
Type 1 diabetes	18978792	2008-11-02	3561	4646	0	8207	8063.55842573413	10
Type 1 diabetes	19430480	2009-05-10	7514	9045	0	16559	16417.447913521348	31
Type 1 diabetes	19966805	2009-12-06	7514	9045	0	16559	16417.447913521348	2
Type 1 diabetes	21829393	2011-08-04	8506	10596	0	19102	18873.32760967438	16
Type 1 diabetes	21980299	2011-09-29	9934	16956	0	26890	25056.289178133135	3
Type 1 diabetes	22293688	2012-02-01	0	0	16179	16179	16179	2
Type 1 diabetes	25751624	2015-04-01	6683	12173	2670	21526	17257.564488756892	41
Type 1 diabetes	30572963	2018-12-20	6670	22308	0	28978	20538.94126578784	26
Type 1 diabetes	30659077	2019-01-18	1021	2928	0	3949	3028.0962268928843	3
Type 1 diabetes	31152121	2019-05-31	1005	1257	0	2262	2233.925729442971	4
Type 1 diabetes and autoimmune thyroid diseases	25936594	2015-04-27	346	727	0	1073	937.7148182665425	10
Type 1 diabetes nephropathy	23028342	2012-09-20	0	0	6233	6233	6233	2
Type 2 diabetes	17293876	2007-02-11	661	614	0	1275	1273.2674509803921	1
Type 2 diabetes	17460697	2007-04-26	1399	5275	0	6674	4422.9697332933765	2
Type 2 diabetes	17463246	2007-04-26	1464	1467	0	2931	2930.99692937564	7
Type 2 diabetes	17463248	2007-04-26	1161	1174	0	2335	2334.927623126338	8
Type 2 diabetes	17463249	2007-04-26	1924	2938	0	4862	4650.5240641711225	6
Type 2 diabetes	17554300	2007-06-07	1924	2938	0	4862	4650.5240641711225	1
Type 2 diabetes	17668382	2007-06-26	500	497	0	997	996.9909729187563	1
Type 2 diabetes	18372903	2008-03-30	4549	5579	0	10128	10023.250789889415	8
Type 2 diabetes	18711366	2008-08-17	194	1558	0	1752	690.0730593607307	3
Type 2 diabetes	18711367	2008-08-17	187	1504	0	1691	665.2820816085157	1
Type 2 diabetes	19056611	2008-12-03	1913	2938	0	4851	4634.4209441352305	4
Type 2 diabetes	19401414	2009-04-29	519	503	0	1022	1021.7495107632095	6
Type 2 diabetes	19734900	2009-09-06	679	697	0	1376	1375.764534883721	4
Type 2 diabetes	20174558	2010-02-19	995	894	0	1889	1883.59978824775	3
Type 2 diabetes	20418489	2010-04-23	2591	3052	0	5643	5605.339004075846	1
Type 2 diabetes	20581827	2010-06-27	8130	38987	0	47117	26908.700469045143	23
Type 2 diabetes	20818381	2010-09-05	4470	3071	0	7541	7281.458692481103	1
Type 2 diabetes	20862305	2010-09-16	1019	1710	0	2729	2554.034444851594	2
Type 2 diabetes	21490949	2011-04-07	3781	4354	0	8135	8094.639950829747	1
Type 2 diabetes	21573907	2011-05-15	1804	780	0	2584	2178.204334365325	2
Type 2 diabetes	21799836	2011-07-22	793	806	0	1599	1598.8943089430895	1
Type 2 diabetes	21874001	2011-08-28	5561	14458	0	20019	16064.925920375643	6
Type 2 diabetes	22101970	2011-11-19	3223	3265	0	6488	6487.728113440197	1
Type 2 diabetes	22158537	2011-12-11	6952	11865	0	18817	17534.246691821227	8
Type 2 diabetes	22238593	2012-01-04	965	1029	0	1994	1991.9458375125378	1
Type 2 diabetes	22293688	2012-02-01	0	0	16179	16179	16179	1
Type 2 diabetes	22456796	2012-03-28	4470	3071	0	7541	7281.458692481103	2
Type 2 diabetes	22693455	2012-05-31	6239	54412	0	60651	22388.84555901799	10
Type 2 diabetes	22885922	2012-09-01	12171	56862	0	69033	40100.6708096128	73
Type 2 diabetes	22961080	2012-09-06	1839	1873	0	3712	3711.688577586207	9
Type 2 diabetes	23209189	2012-12-03	1101	1027	0	2128	2125.4266917293235	1
Type 2 diabetes	23300278	2013-01-08	842	774	0	1616	1613.1386138613861	9
Type 2 diabetes	23532257	2013-03-27	684	955	0	1639	1594.1915802318488	1
Type 2 diabetes	23945395	2013-08-14	5976	20829	0	26805	18574.759037493004	10
Type 2 diabetes	24101674	2013-10-07	407	0	938	1345	1345	1
Type 2 diabetes	24390345	2013-12-25	3848	4366	0	8214	8181.333333333333	3
Type 2 diabetes	24509480	2014-02-09	26488	83964	0	110452	80543.1656104009	30
Type 2 diabetes	25102180	2014-08-07	8284	15543	0	23827	21615.513828849624	9
Type 2 diabetes	25483131	2014-12-08	1384	1902	0	3286	3204.34327449787	1
Type 2 diabetes	26818947	2016-01-28	15463	26183	0	41646	38886.589732507324	32
Type 2 diabetes	26961502	2016-03-10	4040	113735	0	117775	15605.66843557631	6
Type 2 diabetes	27189021	2016-05-18	9747	61857	0	71604	33680.80995475113	10
Type 2 diabetes	27362418	2016-06-30	19809	111181	0	130990	67253.51336743262	1
Type 2 diabetes	28254843	2017-03-02	2499	5247	0	7746	6771.109217660728	4
Type 2 diabetes	28566273	2017-05-31	26676	132532	0	159208	88825.27591578313	13
Type 2 diabetes	28828242	2017-08-17	67	214	0	281	204.0996441281139	1
Type 2 diabetes	28838971	2017-08-24	0	8658	0	8658	8658	1
Type 2 diabetes	28869590	2017-09-04	45064	138587	0	183651	136025.05987988086	118
Type 2 diabetes	29358691	2018-01-22	34010	134410	0	168420	108568.67592922457	22
Type 2 diabetes	29632382	2018-04-09	48286	250671	153287	452244	161948.37258870006	44
Type 2 diabetes	29926116	2018-06-20	317	2631	0	2948	1131.651289009498	2
Type 2 diabetes	30054458	2018-07-27	62892	596424	0	659316	227570.9869501119	150
Type 2 diabetes	30130595	2018-08-18	45	47	0	92	91.95652173913044	1
Type 2 diabetes	30297969	2018-10-08	74124	824006	0	898130	272025.74568937684	287
Type 2 diabetes	30470734	2018-11-23	822	1125	0	1947	1899.8459167950693	2
Type 2 diabetes	30595370	2018-12-27	0	0	459000	459000	459000	76
Type 2 diabetes	30718926	2019-02-04	36614	155150	0	191764	118492.7744519305	104
Type 2 diabetes	31049640	2019-05-02	2633	1714	0	4347	4152.714055670578	2
Type 2 diabetes	31118516	2019-05-22	18233	17679	0	35912	35903.453664513254	20
Type 2 diabetes	31217584	2019-06-19	14042	31683	0	45725	38918.988387096775	1
Type 2 diabetes	31324766	2019-07-19	2342	2889	8599	13830	5173.800802905754	5
Type 2 diabetes (SNP x SNP interaction, 1df)	29691896	2018-04-24	2452	3772	0	6224	5944.051413881748	1
Type 2 diabetes (SNP x SNP interaction, 2df)	29691896	2018-04-24	2452	3772	0	6224	5944.051413881748	2
Type 2 diabetes (adjusted for BMI)	29632382	2018-04-09	48286	250671	153287	452244	161948.37258870006	44
Type 2 diabetes (adjusted for BMI)	30297969	2018-10-08	50409	523897	0	574306	183937.6490790624	12
Type 2 diabetes and end-stage kidney disease	31092297	2019-05-15	3432	6977	0	10409	9201.677010279565	21
Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	31092297	2019-05-15	2768	6059	0	8827	7600.0054378611085	13
Type 2 diabetes nephropathy	30566433	2018-12-19	2809	5592	0	8401	7479.075348172836	1
Type 2 diabetes nephropathy including microalbuminuria	30566433	2018-12-19	2809	5592	0	8401	7479.075348172836	1
Ulcerative colitis	18836448	2008-10-05	1167	777	0	1944	1865.7592592592591	2
Ulcerative colitis	19122664	2009-01-04	1022	2503	0	3525	2902.7699290780142	6
Ulcerative colitis	19915572	2009-11-15	2361	5417	0	7778	6577.2882489071735	7
Ulcerative colitis	19915573	2009-11-15	376	934	0	1310	1072.3175572519085	3
Ulcerative colitis	20228798	2010-03-14	1043	1703	0	2746	2587.3692643845593	5
Ulcerative colitis	20228799	2010-03-14	2693	6791	0	9484	7713.269928300296	15
Ulcerative colitis	20848476	2010-11-01	861	2601	0	3462	2587.476603119584	1
Ulcerative colitis	21297633	2011-02-06	6687	19718	0	26405	19974.136110585117	45
Ulcerative colitis	23128233	2012-11-01	12924	21442	0	34366	32254.717802479197	23
Ulcerative colitis	23511034	2013-04-01	388	739	0	1127	1017.6823425022183	4
Ulcerative colitis	24837172	2014-05-16	603	622	0	1225	1224.705306122449	3
Ulcerative colitis	25082827	2014-07-31	7483	21211	0	28694	22126.14665086778	1
Ulcerative colitis	26192919	2015-07-20	6968	20464	0	27432	20792.235637212012	91
Ulcerative colitis	26398853	2016-01-01	705	1178	0	1883	1764.1848114710567	3
Ulcerative colitis	28008999	2016-12-23	528	582	0	1110	1107.372972972973	2
Ulcerative colitis	28067908	2017-01-09	12366	33609	0	45975	36159.555758564435	50
Ulcerative colitis	28067910	2017-01-09	7760	16065	0	23825	20930.014690451208	1
Ulcerative colitis	32072174	2020-02-19	601	1962	0	2563	1840.2840421381193	2
Ulcerative colitis or Crohn's disease	21699788	2011-06-20	744	0	0	744	744	2
Ulna and radius bone mineral density	30172743	2018-08-30	0	0	2286	2286	2286	2
Upper eyelid morphology	29921221	2018-06-19	0	0	5643	5643	5643	2
Upper eyelid sagging severity	24869959	2014-08-01	0	0	6631	6631	6631	1
Upper eyelid sagging severity	29654602	2018-04-13	0	0	502	502	502	1
Urate levels	17997608	2007-11-09	0	0	4305	4305	4305	1
Urate levels	18179892	2008-01-10	0	0	1955	1955	1955	1
Urate levels	18327256	2008-03-09	0	0	1644	1644	1644	1
Urate levels	18327257	2008-03-09	0	0	794	794	794	1
Urate levels	18834626	2008-10-01	0	0	11847	11847	11847	3
Urate levels	20139978	2010-02-07	0	0	8868	8868	8868	4
Urate levels	20884846	2010-09-30	0	0	28283	28283	28283	10
Urate levels	21768215	2011-07-18	0	0	8651	8651	8651	4
Urate levels	23263486	2012-12-23	0	0	110347	110347	110347	31
Urate levels	28270201	2017-03-07	0	0	8940	8940	8940	4
Urate levels	31578528	2019-10-02	0	0	457690	457690	457690	466
Urate levels (BMI interaction)	25811787	2015-03-26	0	0	28610	28610	28610	1
Urate levels in lean individuals	25811787	2015-03-26	0	0	15282	15282	15282	8
Urate levels in obese individuals	25811787	2015-03-26	0	0	9445	9445	9445	4
Urate levels in overweight individuals	25811787	2015-03-26	0	0	17247	17247	17247	13
Urea levels	28270201	2017-03-07	0	0	26156	26156	26156	5
Urea levels	31015462	2019-04-23	0	0	20700	20700	20700	4
Uric acid levels	18759275	2008-09-01	0	0	868	868	868	1
Uric acid levels	19503597	2009-06-05	0	0	28141	28141	28141	11
Uric acid levels	21294900	2011-02-04	0	0	1017	1017	1017	1
Uric acid levels	22229870	2012-01-09	0	0	1300	1300	1300	1
Uric acid levels	23703922	2013-01-02	0	0	959	959	959	3
Uric acid levels	29558500	2018-03-20	0	0	7064	7064	7064	6
Urinary 1,3-butadiene metabolite levels in smokers	28292921	2017-03-14	0	0	1072	1072	1072	4
Urinary albumin excretion	21355061	2011-02-25	0	0	31580	31580	31580	1
Urinary albumin excretion	30220432	2018-09-06	0	0	382500	382500	382500	46
Urinary albumin excretion (no hypertensive medication)	30220432	2018-09-06	0	0	302687	302687	302687	23
Urinary albumin-to-creatinine ratio	26631737	2015-12-02	0	0	54450	54450	54450	1
Urinary albumin-to-creatinine ratio	27650483	2016-09-20	0	0	12226	12226	12226	3
Urinary albumin-to-creatinine ratio	30910378	2019-03-12	0	0	218759	218759	218759	12
Urinary albumin-to-creatinine ratio	31511532	2019-09-11	0	0	547361	547361	547361	122
Urinary albumin-to-creatinine ratio	31630189	2019-10-20	0	0	437027	437027	437027	59
Urinary albumin-to-creatinine ratio in diabetes	31511532	2019-09-11	0	0	51541	51541	51541	8
Urinary bladder cancer	18794855	2008-09-14	1803	34336	0	36139	6852.188273056808	1
Urinary bladder cancer	20348956	2010-03-28	1889	39310	0	41199	7209.552659045122	2
Urinary bladder cancer	24861552	2014-05-26	1670	90180	0	91850	6558.545454545454	1
Urinary calcium excretion	31993563	2019-11-22	0	0	6462	6462	6462	1
Urinary electrolytes (magnesium/calcium ratio)	27915449	2016-12-03	0	0	9320	9320	9320	3
Urinary haptoglobin levels in type 2 diabetes	29572449	2018-03-23	0	0	236	236	236	1
Urinary magnesium excretion	31993563	2019-11-22	0	0	6462	6462	6462	1
Urinary magnesium-to-creatinine ratio	29093028	2017-11-01	0	0	9205	9205	9205	2
Urinary metabolite levels in chronic kidney disease	29545352	2018-03-15	1143	0	0	1143	1143	9
Urinary metabolite levels in chronic kidney disease	31959995	2020-01-20	1221	0	0	1221	1221	240
Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	31959995	2020-01-20	1221	0	0	1221	1221	46
Urinary metabolite ratios in chronic kidney disease	29545352	2018-03-15	1143	0	0	1143	1143	14
Urinary metabolites	21572414	2011-05-15	0	0	862	862	862	5
Urinary metabolites	26352407	2015-09-09	0	0	3861	3861	3861	20
Urinary metabolites (H-NMR features)	24586186	2014-02-20	0	0	835	835	835	39
Urinary potassium excretion	31409800	2019-08-13	0	0	446230	446230	446230	13
Urinary potassium to creatinine ratio	30910378	2019-03-12	0	0	218435	218435	218435	4
Urinary sodium excretion	31409800	2019-08-13	0	0	446237	446237	446237	50
Urinary sodium to creatinine ratio	30910378	2019-03-12	0	0	218450	218450	218450	2
Urinary sodium to potassium ratio	30910378	2019-03-12	0	0	217996	217996	217996	1
Urinary tract infection frequency	28928442	2017-09-19	35000	33478	0	68478	68444.17185081339	3
Urinary uromodulin levels	24578125	2014-02-27	0	0	10884	10884	10884	3
Urine pH measurement	30476138	2019-04-01	0	0	149899	149899	149899	4
Urolithiasis	30975718	2019-04-11	11130	187639	0	198769	42027.118313217856	16
Uterine fibroid size (maximum dimension)	30196971	2018-09-01	0	0	1301	1301	1301	1
Uterine fibroids	21460842	2011-04-03	1607	1428	0	3035	3024.4428336079077	3
Uterine fibroids	28836065	2017-08-23	3999	4764	0	8763	8696.216364258815	1
Uterine fibroids	30194396	2018-09-07	16595	523330	0	539925	64339.76089271658	51
Uterine fibroids	31249589	2019-06-12	9446	67048	0	76494	33118.174392762834	11
Uterine fibroids	31488892	2019-09-05	5236	39556	0	44792	18495.732809430257	8
Uterine fibroids	31649266	2019-10-24	20406	223918	0	244324	74806.7436355004	50
Uterine fibroids (multi-trait analysis)	31488892	2019-09-05	5236	39556	0	44792	18495.732809430257	5
Uterine fibroids and heavy menstrual bleeding	31649266	2019-10-24	3409	199171	0	202580	13406.534485141672	2
Uveal melanoma	28781888	2017-03-10	259	401	0	660	629.4484848484849	1
Uveal melanoma with any chromosomal aberration	31626034	2019-10-11	417	5199	0	5616	1544.147435897436	1
Uveal melanoma with epithelioid cells	31626034	2019-10-11	285	5199	0	5484	1080.7549234135668	1
Uveitis (juvenile idiopathic arthritis-associated)	29513936	2018-03-07	192	398	0	590	518.0745762711865	1
Vaccenic acid (18:1n-7) levels	28298293	2017-03-15	0	0	15541	15541	15541	4
Varicose veins	30566020	2018-12-01	9577	327959	0	337536	37221.07677995828	30
Varicose veins	30998689	2019-04-18	10861	397594	0	408455	42288.80473001922	13
Vascular dementia	23480133	2011-02-28	84	200	0	284	236.61971830985914	1
Vascular endothelial growth factor levels	21757650	2011-07-14	0	0	3527	3527	3527	4
Vascular endothelial growth factor levels	26910538	2016-02-24	0	0	13312	13312	13312	10
Vascular endothelial growth factor levels	27989323	2016-12-13	0	0	7118	7118	7118	7
Vascular endothelial growth factor levels	31217265	2019-06-19	0	0	13577	13577	13577	3
Vascular endothelial growth factor levels	32173896	2020-03-16	0	0	145	145	145	1
Vascular endothelial growth factor levels in major depressive disorder	32173896	2020-03-16	0	0	121	121	121	1
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	28029757	2016-12-28	0	0	3582	3582	3582	1
Vaspin levels	22907691	2012-08-21	0	0	826	826	826	1
Velopharyngeal dysfunction	29855589	2018-05-31	54	922	0	976	204.04918032786884	5
Venous thromboembolism	19278955	2009-03-10	419	1228	0	1647	1249.6223436551306	1
Venous thromboembolism	21980494	2011-09-27	1542	1110	0	2652	2581.628959276018	4
Venous thromboembolism	22672568	2012-06-05	1503	1459	0	2962	2961.346387575962	5
Venous thromboembolism	23650146	2013-05-05	1618	42881	0	44499	6236.675700577542	4
Venous thromboembolism	25772935	2015-03-12	7507	52632	0	60139	26279.6803405444	9
Venous thromboembolism	26888256	2016-02-17	146	432	0	578	436.484429065744	3
Venous thromboembolism	28373160	2017-04-01	3290	116868	0	120158	12799.671099718704	8
Venous thromboembolism	31420334	2019-08-16	30234	172122	0	202356	102866.95819249244	94
Venous thromboembolism	31676865	2019-11-01	26066	624053	0	650119	100083.61852522384	18
Venous thromboembolism (SNP x SNP interaction)	23509962	2013-03-20	411	1228	0	1639	1231.7461866992069	37
Venous thromboembolism adjusted for sickle cell variant rs77121243-T	28203683	2017-02-16	393	0	4941	5334	5334	3
Ventricular ectopy or supraventricular ectopy (pleiotropy)	29618737	2018-04-04	5741	27727	10663	44131	19024.82454882276	2
Verbal declarative memory	25648963	2014-11-25	0	0	29076	29076	29076	9
Verbal memory	29907492	2018-06-12	127	136	0	263	262.6920152091255	1
Verbal memory performance (immediate recall change)	28800603	2017-08-11	0	0	7536	7536	7536	1
Verbal memory performance (residualized delayed recall level)	28800603	2017-08-11	0	0	7536	7536	7536	1
Verbal-numerical reasoning	27046643	2016-04-05	0	0	36035	36035	36035	3
Vertical cup-disc ratio	20548946	2010-06-10	0	0	7360	7360	7360	7
Vertical cup-disc ratio	25241763	2014-09-22	0	0	21094	21094	21094	17
Vertical cup-disc ratio	28073927	2017-01-10	0	0	23899	23899	23899	40
Vertical cup-disc ratio	31798171	2019-11-27	0	0	25180	25180	25180	20
Vertical cup-disc ratio (adjusted for vertical disc diameter)	31959993	2020-01-20	0	0	67040	67040	67040	76
Vertical cup-disc ratio (multi-trait analysis)	31959993	2020-01-20	0	0	90939	90939	90939	107
Very large HDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	2
Very large VLDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	25
Very long-chain saturated fatty acid levels (fatty acid 20:0)	25378659	2014-11-06	0	0	10129	10129	10129	3
Very long-chain saturated fatty acid levels (fatty acid 22:0)	25378659	2014-11-06	0	0	10129	10129	10129	2
Very long-chain saturated fatty acid levels (fatty acid 24:0)	25378659	2014-11-06	0	0	7915	7915	7915	2
Very low density lipoprotein cholesterol levels	28548082	2017-05-26	0	0	3213	3213	3213	3
Very small VLDL particle concentration	29084231	2017-10-30	0	0	8372	8372	8372	4
Vestibular neuritis	30079052	2018-07-20	131	2609	0	2740	498.9474452554745	4
Vigorous physical activity	29899525	2018-06-13	98060	162995	0	261055	244903.02350079484	8
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	25710658	2015-02-24	0	0	321	321	321	5
Viral capsid antigen IgG seropositivity	29868224	2017-11-27	1344	218	0	1562	750.2996158770807	4
Visceral adipose tissue adjusted for BMI	27918534	2016-12-05	0	0	18332	18332	18332	3
Visceral adipose tissue/subcutaneous adipose tissue ratio	22589738	2012-05-10	0	0	10557	10557	10557	1
Visceral adipose tissue/subcutaneous adipose tissue ratio	27918534	2016-12-05	0	0	18197	18197	18197	3
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	27918534	2016-12-05	0	0	18197	18197	18197	3
Visceral fat	22589738	2012-05-10	0	0	10557	10557	10557	1
Visceral fat	30942860	2019-04-03	0	0	1589	1589	1589	4
Visceral fat, circulating phospholipid PC(16:0/2:0) and white matter microstructure (shared variance)	31900429	2020-01-03	0	0	1358	1358	1358	1
Vitamin B levels in ischemic stroke	25147783	2014-08-06	2100	0	0	2100	2100	3
Vitamin B12 levels	18776911	2008-09-07	0	0	1658	1658	1658	1
Vitamin B12 levels	22367966	2012-02-24	0	0	1999	1999	1999	5
Vitamin B12 levels	28334792	2017-02-27	0	0	1001	1001	1001	4
Vitamin D insufficiency	20541252	2010-06-09	0	0	16125	16125	16125	3
Vitamin D levels	20418485	2010-04-23	0	0	4501	4501	4501	3
Vitamin D levels	22673963	2012-06-07	150	0	422	572	572	1
Vitamin D levels	25208829	2014-09-11	0	0	1853	1853	1853	5
Vitamin D levels	26704534	2015-12-15	0	0	1387	1387	1387	1
Vitamin D levels	28757204	2017-07-21	0	0	42274	42274	42274	16
Vitamin D levels	29343764	2018-01-17	0	0	79366	79366	79366	6
Vitamin D levels (dietary vitamin D intake interaction)	29343764	2018-01-17	0	0	39868	39868	39868	4
Vitamin E levels	21729881	2011-07-05	2402	1612	0	4014	3858.51918285999	3
Vitamin levels	23696881	2013-05-16	0	0	1200	1200	1200	3
Vitiligo	20410501	2010-04-21	1392	2629	0	4021	3640.4556080576967	9
Vitiligo	20526339	2010-06-06	1117	1429	0	2546	2507.7659073055775	3
Vitiligo	21326295	2011-02-17	1339	0	0	1339	1339	1
Vitiligo	22561518	2012-05-06	418	2810	0	3228	1455.4894671623297	13
Vitiligo	22951725	2012-09-06	1117	1701	0	2818	2696.97232079489	3
Vitiligo	27723757	2016-11-01	0	40258	0	40258	40258	51
Vitiligo (early onset)	30674883	2019-01-23	704	9031	0	9735	2612.3570621468925	2
Vitiligo (late onset)	30674883	2019-01-23	1467	19156	0	20623	5450.584686999951	1
Vitiligo (non-segmental)	23678272	2013-05-02	20	192	0	212	72.45283018867924	1
Vogt-Koyanagi-Harada syndrome	25108386	2014-08-10	774	2009	0	2783	2234.94933524973	4
Volumetric brain MRI	17903297	2007-09-19	0	0	705	705	705	1
Voxel-wise structural brain imaging measurements	30649180	2019-01-16	0	0	1721	1721	1721	4
Waist Circumference - Triglycerides (WC-TG)	21386085	2011-03-08	0	0	22161	22161	22161	7
Waist circumference	19557197	2009-06-26	0	0	31373	31373	31373	2
Waist circumference	23966867	2013-08-15	0	0	23564	23564	23564	1
Waist circumference	25673412	2015-02-12	0	0	143480	143480	143480	78
Waist circumference	26785701	2016-01-20	0	0	44609	44609	44609	4
Waist circumference	28552196	2017-06-01	0	0	50665	50665	50665	24
Waist circumference	30108283	2018-08-14	0	0	901	901	901	1
Waist circumference	31453325	2019-08-14	0	0	347158	347158	347158	13
Waist circumference adjusted for BMI (adjusted for smoking behaviour)	28443625	2017-04-26	0	0	195506	195506	195506	86
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	28448500	2017-04-27	0	0	160475	160475	160475	167
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	28443625	2017-04-26	0	0	195506	195506	195506	82
Waist circumference adjusted for BMI in active individuals	28448500	2017-04-27	0	0	122328	122328	122328	130
Waist circumference adjusted for BMI in inactive individuals	28448500	2017-04-27	0	0	38471	38471	38471	2
Waist circumference adjusted for BMI in non-smokers	28443625	2017-04-26	0	0	152914	152914	152914	58
Waist circumference adjusted for BMI in smokers	28443625	2017-04-26	0	0	41416	41416	41416	1
Waist circumference adjusted for body mass index	25673412	2015-02-12	0	0	143480	143480	143480	127
Waist circumference adjusted for body mass index	26785701	2016-01-20	0	0	44609	44609	44609	7
Waist circumference adjusted for body mass index	28448500	2017-04-27	0	0	160475	160475	160475	197
Waist circumference adjusted for body mass index	28552196	2017-06-01	0	0	50145	50145	50145	7
Waist circumference adjusted for body mass index	31669095	2019-10-24	0	0	457690	457690	457690	1260
Waist circumference and related phenotypes	18454146	2008-05-04	0	0	2684	2684	2684	3
Waist circumference variance	31453325	2019-08-14	0	0	347158	347158	347158	16
Waist-hip ratio	20935629	2010-10-10	0	0	77167	77167	77167	14
Waist-hip ratio	23563607	2013-04-07	0	0	10255	10255	10255	4
Waist-hip ratio	23966867	2013-08-15	0	0	19744	19744	19744	1
Waist-hip ratio	25673412	2015-02-12	0	0	143480	143480	143480	55
Waist-hip ratio	28548082	2017-05-26	0	0	3213	3213	3213	1
Waist-hip ratio	28552196	2017-06-01	0	0	37159	37159	37159	1
Waist-hip ratio	30239722	2018-09-14	0	0	697734	697734	697734	550
Waist-hip ratio	30575882	2018-12-01	0	0	663598	663598	663598	202
Waist-hip ratio	30595370	2018-12-27	0	0	458000	458000	458000	467
Waist-hip ratio	31217584	2019-06-19	0	0	24838	24838	24838	6
Waist-hip ratio	31453325	2019-08-14	0	0	347134	347134	347134	1
Waist-hip ratio variance	31453325	2019-08-14	0	0	347134	347134	347134	1
Waist-to-hip ratio adjusted for BMI	26426971	2015-10-01	0	0	252375	252375	252375	60
Waist-to-hip ratio adjusted for BMI	28552196	2017-06-01	0	0	36860	36860	36860	1
Waist-to-hip ratio adjusted for BMI	30239722	2018-09-14	0	0	379501	379501	379501	300
Waist-to-hip ratio adjusted for BMI	30575882	2018-12-01	0	0	660648	660648	660648	202
Waist-to-hip ratio adjusted for BMI	31669095	2019-10-24	0	0	457690	457690	457690	1074
Waist-to-hip ratio adjusted for BMI (additive genetic model)	30778226	2019-02-18	0	0	295214	295214	295214	165
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	28443625	2017-04-26	0	0	191661	191661	191661	76
Waist-to-hip ratio adjusted for BMI (age <50)	26426971	2015-10-01	0	0	94302	94302	94302	5
Waist-to-hip ratio adjusted for BMI (age >50)	26426971	2015-10-01	0	0	158073	158073	158073	10
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	28448500	2017-04-27	0	0	156653	156653	156653	96
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	28443625	2017-04-26	0	0	191661	191661	191661	21
Waist-to-hip ratio adjusted for BMI (recessive genetic model)	30778226	2019-02-18	0	0	288492	288492	288492	2
Waist-to-hip ratio adjusted for BMI in active individuals	28448500	2017-04-27	0	0	118949	118949	118949	72
Waist-to-hip ratio adjusted for BMI in non-smokers	28443625	2017-04-26	0	0	149672	149672	149672	24
Waist-to-hip ratio adjusted for BMI x sex interaction	26426971	2015-10-01	0	0	252375	252375	252375	11
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	26426971	2015-10-01	0	0	252375	252375	252375	53
Waist-to-hip ratio adjusted for body mass index	25673412	2015-02-12	0	0	143480	143480	143480	212
Waist-to-hip ratio adjusted for body mass index	26785701	2016-01-20	0	0	39869	39869	39869	4
Waist-to-hip ratio adjusted for body mass index	28270201	2017-03-07	0	0	26558	26558	26558	4
Waist-to-hip ratio adjusted for body mass index	28430825	2017-04-21	0	0	20384	20384	20384	9
Waist-to-hip ratio adjusted for body mass index	28448500	2017-04-27	0	0	156653	156653	156653	116
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma	30305637	2018-10-10	217	3798	0	4015	821.0869240348693	2
Warfarin maintenance dose	18535201	2008-06-05	0	0	181	181	181	2
Warfarin maintenance dose	19300499	2009-03-20	0	0	1053	1053	1053	4
Warfarin maintenance dose	20833655	2010-09-10	0	0	1508	1508	1508	2
Warfarin maintenance dose	23755828	2013-06-05	0	0	533	533	533	1
Warfarin maintenance dose	26265036	2015-08-12	0	0	367	367	367	2
Warfarin maintenance dose (adjusted for clinical factors)	28686080	2017-07-07	0	0	1240	1240	1240	3
Warfarin-associated bleeding	30357299	2018-10-01	31	184	0	215	106.12093023255815	1
Wegener's granulomatosis	23740775	2013-09-01	459	1503	0	1962	1406.4770642201836	2
Weight	19079260	2008-12-14	0	0	73758	73758	73758	11
Weight	28548082	2017-05-26	0	0	3213	3213	3213	1
Weight	28552196	2017-06-01	0	0	57043	57043	57043	23
Weight	30108283	2018-08-14	0	0	901	901	901	2
Weight gain in amisulpride-treated first-episode psychosis	32126890	2020-03-04	0	0	206	206	206	1
Weight loss (gastric bypass surgery)	23633212	2013-04-30	0	0	175	175	175	1
Well-being spectrum (multivariate analysis)	30643256	2019-01-14	0	0	2083151	2083151	2083151	231
Western dietary pattern	28644415	2017-06-23	0	0	141	141	141	1
White blood cell count	20139978	2010-02-07	0	0	14677	14677	14677	5
White blood cell count	21738479	2011-06-30	0	0	16388	16388	16388	1
White blood cell count	21738480	2011-07-01	0	0	19509	19509	19509	10
White blood cell count	22037903	2011-10-30	0	0	13533	13533	13533	4
White blood cell count	25096241	2014-08-05	0	0	52740	52740	52740	15
White blood cell count	27863252	2016-11-17	0	0	172435	172435	172435	180
White blood cell count	28158719	2017-02-01	0	0	11809	11809	11809	4
White blood cell count	28548082	2017-05-26	0	0	3213	3213	3213	2
White blood cell count	29403010	2018-02-05	0	0	107964	107964	107964	42
White blood cell count	30595370	2018-12-27	0	0	444000	444000	444000	715
White blood cell count	31217584	2019-06-19	0	0	28608	28608	28608	36
White blood cell count	31675503	2019-10-01	0	0	7526	7526	7526	2
White blood cell count	31869403	2019-12-23	0	0	42539	42539	42539	5
White blood cell count (basophil)	27863252	2016-11-17	0	0	171846	171846	171846	80
White blood cell count (basophil)	28158719	2017-02-01	0	0	11809	11809	11809	3
White blood cell count (basophil)	29403010	2018-02-05	0	0	62076	62076	62076	28
White blood cell count (eosinophil)	28158719	2017-02-01	0	0	11809	11809	11809	3
White blood cell count (lymphocyte)	28158719	2017-02-01	0	0	11809	11809	11809	2
White blood cell count (monocyte)	28158719	2017-02-01	0	0	11809	11809	11809	8
White blood cell count (neutrophil)	28158719	2017-02-01	0	0	11809	11809	11809	3
White blood cell types	21738478	2011-06-30	0	0	8794	8794	8794	13
White matter growth	29682794	2018-04-22	0	0	715	715	715	1
White matter hyperintensity burden	21681796	2011-06-16	0	0	9361	9361	9361	2
White matter hyperintensity burden	25663218	2015-07-02	0	0	21079	21079	21079	14
White matter hyperintensity volume	29752348	2018-05-11	0	0	8429	8429	8429	2
White matter hyperintensity volume	30659137	2019-01-18	0	0	11226	11226	11226	3
White matter integrity (fractional anisotropy)	29752348	2018-05-11	0	0	8239	8239	8239	2
White matter integrity (mean diffusivity)	29752348	2018-05-11	0	0	8239	8239	8239	2
White matter microstructure (axial diusivities)	31666681	2019-10-30	0	0	17706	17706	17706	234
White matter microstructure (fractional anisotropy)	31666681	2019-10-30	0	0	17706	17706	17706	336
White matter microstructure (global fractional anisotropy)	24736177	2014-04-13	0	0	841	841	841	5
White matter microstructure (mean diusivities)	31666681	2019-10-30	0	0	17706	17706	17706	490
White matter microstructure (mode of anisotropy)	31666681	2019-10-30	0	0	17706	17706	17706	115
White matter microstructure (radial diusivities)	31666681	2019-10-30	0	0	17706	17706	17706	517
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	28924203	2017-09-18	93	134	0	227	219.59471365638765	1
White wine liking	25758996	2015-03-11	0	0	2240	2240	2240	1
Wilms tumor	22544364	2012-04-29	757	1879	0	2636	2158.4264036418817	6
Worry	29942085	2018-06-25	0	0	348219	348219	348219	147
Worry too long after an embarrassing experience	29500382	2018-03-02	0	0	367725	367725	367725	34
Worry/vulnerability (special factor of neuroticism)	30867560	2019-03-13	0	0	270059	270059	270059	14
YKL-40 levels	18403759	2008-04-09	0	0	632	632	632	1
Yeast infection	28928442	2017-09-19	52218	10235	0	62453	34230.620146350055	4
anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)	31835028	2019-12-01	232874	494162	0	727036	633132.2332759313	146
beta-nerve growth factor levels	27989323	2016-12-13	0	0	3531	3531	3531	1
circulating leptin levels	26833098	2016-02-01	0	0	35292	35292	35292	3
circulating leptin levels adjusted for BMI	26833098	2016-02-01	0	0	33987	33987	33987	3
diarrhoeal disease at age 1	27559109	2016-08-23	2693	3065	0	5758	5733.966655088572	1
diarrhoeal disease at age 1 with doctor diagnosis	27559109	2016-08-23	1339	5064	0	6403	4235.94939871935	1
epithelial cell adhesion molecule levels	25147954	2014-08-22	0	0	653	653	653	2
facial morphology traits (multivariate analysis)	27193062	2016-05-19	0	0	5958	5958	5958	2
group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	31070471	2019-04-11	0	0	6692	6692	6692	14
interleukin 12 receptor subunit beta-1 levels	25147954	2014-08-22	0	0	653	653	653	1
interleukin 17 receptor B levels	25147954	2014-08-22	0	0	653	653	653	1
kallikrein-11 levels	25147954	2014-08-22	0	0	653	653	653	1
lower facial morphology traits (quantitative measurement)	27193062	2016-05-19	0	0	2955	2955	2955	1
melanoma-derived growth regulatory protein levels	25147954	2014-08-22	0	0	653	653	653	2
middle facial morphology traits (quantitative measurement)	27193062	2016-05-19	0	0	2955	2955	2955	6
same-sex sexual behaviour	31467194	2019-08-01	0	0	188825	188825	188825	2
vWF and FVIII levels	30586737	2018-11-20	0	0	49092	49092	49092	2
vWF levels	20231535	2010-03-15	0	0	17596	17596	17596	4
vWF levels	30586737	2018-11-20	0	0	46354	46354	46354	84
vWF levels in ischaemic stroke and hyperhomocysteinaemia	28495826	2017-06-01	0	0	1931	1931	1931	1
vascular endothelial growth factor D levels	25147954	2014-08-22	0	0	653	653	653	2
